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Abstract 
Introduction 
Delirium is an acute generalised impairment of brain function and a common complication 
of illness in older people. However it is commonly overlooked or misdiagnosed in clinical 
practice. Previous studies have found that delirium is linked to longer hospital stays, an 
increased need for institutionalisation and future complications e.g. increased risk of 
dementia and mortality. Delirium onset may be associated with an acute stroke, although 
few studies have investigated this association. The aims of this study were to identify 
delirium incidence in stroke, compare long term patient outcomes and identify confounding 
variables that may affect delirium onset.  
Methods 
Based on the findings from the systematic review, a UK based prospective cohort study 
with a one year follow up period was designed to recruit stroke patients with and without 
delirium. Additional assessments were administered within 72 hours of admission to assess 
physical function, mood, risk of dementia and cognitive impairment. These assessments 
were repeated six months post-stroke as well as monitoring outcomes such as mortality, 
length of stay and discharge destination.  
Results 
A total of 298 patients were recruited from the stroke unit at the Leeds Teaching Hospitals 
Trust, with a delirium incidence of 32.9%. Patients with delirium were associated with longer 
hospital stays, higher mortality rates at one and six months and an increased need for 
institutionalisation, as well as positive associations with a number of predisposing factors. 
Delirium patients also had lower assessment scores for physical function and dementia risk 
at six months.   
Conclusion 
The results of this study show that delirium has a significant effect on outcomes for stroke 
patients. Increased emphasis and awareness of delirium on the stroke units could help 
increase detection rates of delirium. Suggestions for the implementation of better education 
programmes and screening protocols may aid delirium management and these require 
further research.  
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Introduction  
This purpose of this thesis was to investigate the clinical condition of delirium in the acute 
stroke population. The last decade has seen a rise in the number of elderly living longer. 
The latest projections estimate that in 20 years time, the elderly population in the UK will 
almost double to around 19 million by the year 2050[1]. This ever increasing population is a 
testament to our dedicated healthcare services, better research and improvements in daily 
living and care of the general public.  
Historically stroke was regarded as a disease of old age and the majority of strokes tend to 
occur in the elderly population (over 65 years). Currently there are 10 million people in the 
UK aged over 65 years old[1] and each year there are approximately 152,000 strokes in the 
UK. In developing countries, the implementation of primary prevention initiatives focusing 
on smoking cessation and lowering blood pressure have helped to decrease stroke 
incidence and stroke mortality rates have also halved over the last 20 years[2]. However due 
to an ageing population, the overall rate of stroke remains high worldwide. In comparison to 
other chronic diseases, stroke has a large range of disabilities with many stroke survivors 
requiring long term care[2]. Quality of life is also affected as this population will unavoidably 
have an increased incidence and prevalence of illness, placing an increased strain on 
healthcare systems and providers such as the NHS, who are already under immense 
pressure.  
Currently half of the general hospital beds are thought to be occupied by older people for 
whom the management of illnesses such as stroke may be more complex. This may be due 
to increased sensitivity to the adverse events of treatment and the presence of more than 
one disorder/ multiple co-morbidities. Delirium is a clinical condition that when combined 
with multiple co-morbidities in the elderly can lead to higher rates of hospitalisation, 
increased use of community resources and poorer patient outcomes. This complex clinical 
syndrome has been a topic of interest to researchers and clinicians for centuries[3], as 
evidenced by collections of scientific medical descriptions of delirium during this period by 
writers such as Hippocrates. In fact it was thought to be a common occurrence in people of 
that time and the existence of delirium can be traced as far back as 1400 in the literature. 
More easily recognised descriptions can found in plays such as Shakespeare’s King Lear, 
where the king emerges from his delirium to recognise his daughter Cordelia.  
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In the present day, delirium has been described as a ‘cognitive superbug’ penetrating 
healthcare environments and complicating the course of hospitalisation and treatment, 
especially in the elderly[4]. Over time, a body of work on delirium has slowly started to build 
describing the various risk factors, highly susceptible patient populations, possible effects 
on prognosis and possible theories on the pathophysiology that may be responsible for 
delirium occurrence. However delirium has been historically understudied. As the average 
age of the population rises globally, a future parallel rise in stroke, delirium occurrence and 
an increased care burden is also likely be witnessed. Delirium will be a major concern to 
consider whilst tending to an increasingly aged population. It is clear that with time, the 
study of older adults and illnesses such as stroke are becoming gradually more significant 
as we look to ways to promote awareness and reduce the burden on our healthcare 
systems.  
As mentioned previously, the purpose of this thesis was to investigate delirium within the 
acute stroke population. The first chapter aims to give an overview, discussing the degree 
of co-morbidity in terms of the occurrence of delirium in susceptible populations and the 
effect on patient outcomes. The following chapter will briefly discuss stroke incidence, 
pathology and patient prognosis post-stroke. Chapter three will examine the current 
literature available on delirium and stroke and discuss the impact these conditions have on 
patient outcomes. Any potential gaps in the published literature will be identified by 
conducting a systematic review and a meta-analysis will also be performed on the studies 
included in the systematic review. The conclusions from Chapter three will be used to help 
form the research questions described in Chapter four and define the aims and objectives 
of the study.   
The study design and patient protocol will be designed to fulfil the research questions that 
have been selected. Any methodological, ethical and statistical considerations in addition to 
any amendments made to the study prior to patient recruitment, will be discussed in 
Chapter five. Chapter six will discuss the finalised study methodology by clarifying the 
details of the assessments methods and time periods. The results of the data collected will 
be analysed and presented in Chapter seven with any study limitations and areas for 
improvement to be discussed in Chapter eight. The final chapter will provide the study 
conclusions and summarise the key points of this thesis.  
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1 Delirium 
In the Oxford English dictionary, delirium is described as “an acutely disturbed state of mind 
characterised by restlessness, illusions, and incoherence, occurring in intoxication, fever, 
and other disorders”[5]. The origin of the word delirium is from the Latin word ‘delirare’ which 
literally means to deviate from or go out of the furrow (de- ‘away’ and lira ‘ridge between 
furrows’) and was first used by the Roman physician, Celsius. Although delirium is now the 
accepted term, there have been numerous alternatives for the syndrome such as; ‘acute 
confusional state’, ‘acute brain syndrome/ failure’, ‘metabolic encephalopathy’, ‘organic 
brain syndrome’ and ‘ICU psychosis’[6]. This collection of terms was the result of different 
aetiologies and populations in which delirium was observed, and to some extent it illustrates 
the complex nature of the syndrome. Consequently this has been reflected in issues such 
as lack of recognition, low detection rates and misdiagnosis. There is a need for further 
investigation within this area.  
 
1.1 The clinical profile  
Delirium is a complex neuropsychiatric disorder caused by an underlying physical illness, 
resulting in functional disturbances in the central nervous system. This multifactorial clinical 
syndrome has several well defined predisposing and precipitating factors and has a broad 
range of physiological and psychological manifestations. The definition of delirium has 
changed over time and was classically described as a ‘clouding of consciousness’ to 
describe this state of confusion and attempts were made to distinguish it from dementia. 
Eventually it was defined as a transient disorder of cognitive function. 
Delirium is characterised by a disturbance of consciousness and generalised impairment of 
cognitive function, resulting in instability of the autonomic nervous system and detrimental 
psychological symptoms[7, 8]. It is a characteristic syndrome, which has a distinct but 
variable presentation in relation to its cause. Its acute onset and fluctuating nature are good 
diagnostic indicators and other associated key features include; inattention/ distractibility, 
restlessness, anxiety, irritability, disorientation, perceptual disturbances, changes in thought 
processes and psychomotor activity and disturbances in the sleep wake cycle[9].  
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1.1.1 Features 
The clinical features of delirium are as follows;  
1. Altered levels of consciousness – Levels of consciousness may fluctuate between 
extremes such as unconsciousness or milder presentations such as inattention, 
drowsiness and inability to focus, the latter of which may be easily missed. Impaired 
cognition may mask changes in consciousness whilst a dementia patient may be 
drowsy due to sedation, reversal of sleep patterns or boredom. Because of this 
impairment of consciousness is not a reliable diagnostic indicator for delirium as it is 
intermittent and not easy to determine.  
2. Attention deficits – Patients have problems in concentrating, sustaining or shifting 
attention and thinking clearly. They are unable to process information (e.g. 
remembering instructions) and focus (e.g. they may have to ask for directions and ask 
questions as they are easily distracted). Inattention often increases during the latter 
part of the day due to fatigue and this is known as ‘sun downing’. Inattention is useful in 
screening and can be tested by asking patient to spell a word backwards or perform 
simple subtractions.  
3. Memory impairment – The ability to retain information is impacted by the altered 
levels of consciousness, inattention and lack of focus. Short term memory such as 
remembering recent events (e.g. reason for hospitalisation) are more heavily affected 
and contribute towards disorientation. These memory deficits, although short lived, are 
a constant sign in delirium diagnosis and can be tested using brief cognitive tests such 
as the Mini Mental State Exam (MMSE)[10] or the Abbreviated Mental Test Score 
(AMTS)[11]. 
4. Disorientation – Inability to register recent information partly due to inattentiveness. 
The patient’s ability to remember date, time, place and situation are decreased, leading 
to a reduced awareness of their environment. It can remain undetected if the patient is 
not asked directly for such information.  
5. Disorganised thinking – The patients present as being confused and are unable to 
relay clear and coherent thoughts. Patients lack reason, logic and judgement and so 
content of thought is of very little relevance and is dysphasic and rambling in nature. 
They may also have an altered rate of speech that is rapid and at times repetitive, 
stammering, hesitant and dysarthic.  
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6. Disturbance of perception – Perceptual disturbances fluctuate with the symptoms 
and are usually related to memory impairment and disorientation. They arise due to 
sensory discrimination and patients have difficulty making sense of what is real and 
what is unrelated to them. They manifest as misperceptions, illusions, hallucinations 
and delusions. Visual hallucinations (e.g. peculiar images, seeing animals or strange 
people) and illusions (patterns are misinterpreted as insects moving) are most 
common. Auditory hallucinations or sensory disturbances (taste and smell) can also 
occur. Patients may also suffer from paranoid delusions which involve suspicious or 
persecutory beliefs (e.g. staff intend to cause them harm), but often may not report 
them as they are afraid they will be perceived as ‘insane’.  
7. Emotional disturbances – Patients may exhibit a diverse range of rapidly changing 
emotions and more than one emotion can be prominent or intermittent during an 
episode. Responses may be dependent on the nature of any hallucinations and 
emotional lability is a key feature where euphoria may lead to sadness, fear, anger and 
then to euphoria. Symptoms of anxiety, fear, irritability, anger, depression, sadness 
apathy or euphoria may be noted. Patients may display apathy and withdrawal and 
may appear depressed due to disrupted sleep and decreased motivation and appetite. 
Suicidal thoughts may be expressed. Agitation may occur as a result of confusion and 
disorientation and can lead to a patient being non-compliant. The emotional 
disturbances can be problematic but they do not remain for long periods of time.  
8. Disturb sleep wake cycle – Sleep disorders include insomnia, fragmented/ reduced 
sleep, excessive drowsiness during the day, increased nocturnal agitation and reversal 
of the day and night sleep cycle. Reversal of the circadian sleep cycle combined with 
decreased environmental cues at night and the aforementioned symptoms previously 
discussed can make patient management difficult.  
9. Neurological signs – Higher integrative functions such as problem solving, planning, 
reading and writing, visuospatial functions (copying designs and finding words) and 
praxis of actions may be affected. Neurological signs and symptoms such as tremors 
(asterixis), involuntary twitching (myoclonus), urinary incontinence, language disorders 
(receptive/ expressive dysphasia) and data impairment are more frequent in older 
people suffering from delirium.  
10. Disturbances of psychomotor activity – Psychomotor activity is altered in patients 
with delirium and it is this motor behaviour upon which the different clinical 
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presentations can be based. These clinical presentations will now be discussed in 
further detail. 
 
1.1.2 Clinical presentations  
Lipowski (1990)[9] argued that there were different ‘types’ of delirium based on motor 
presentation; hyperactive, hypoactive and mixed and these subtypes were further studied 
by Liptzin and Levkoff[12]. Hyperactive patients exhibit an increased alertness and 
overactivity of the sympathetic nervous system. This may include autonomic features such 
as dry mouth, dilated pupils, sweating, raised blood pressure, rapid pulse and breathing, 
and tremors. It has been linked to adverse effects of drug intoxication and withdrawal. 
Hyperactive delirium is the most easily recognised presentation[13], but can be 
misdiagnosed as anxiety, schizophrenia, agitated dementia or a psychotic disorder. On the 
other hand, hypoactive patients exhibit subdued concentration, inattention, psychotic 
features such as delusions or disturbances of perception and may be frequently 
incontinent[14]. This presentation is not as easily detected, often remains unrecognised and 
is more common in elderly patients[15]. These cases are often dismissed as transient, or 
insignificant due to the lack of disruptive and odd behaviour. They can also be 
misdiagnosed as depression or dementia.  
There are a small proportion of delirium patients that have an unclassified presentation as 
they do not exhibit any changes in psychomotor behaviour at all[16]. However, most patients 
tend to experience mixed delirium, due to rapid unpredictable shifts between the hypo and 
hyper states. This may be due to the multiple aetiological factors, individual co-morbidities, 
fluctuating nature of the syndrome and it is suggested that mixed delirium may put patients 
most at risk of substantial morbidity and mortality[17-19, 14]. There is also another clinical 
presentation of delirium known as ‘sub-syndromal delirium’ (SSD)[20, 21], the presence of 
which may precede or follow an actual episode of delirium. The clinical profile and 
experiences of outcome are similar to the other presentations and in some cases it may not 
even progress to a full episode. It occurs when a patient displays two or more features of 
delirium, but they do not match all the features stated in the Diagnostic and Statistical 
Manual of Mental Disorders (DSM)[22, 23] criteria. Some studies have suggested that a 
broader definition of delirium is needed as the current criteria may be too narrow[24, 25] and 
the DSM criteria have recently been revised to reflect some of these changes[26]. Overall 
these different clinical presentations of delirium may have differences in aetiology and 
pathophysiology, which may make them more associative with a particular disease state[27]. 
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Their differences in clinical features means that there is no single pattern of delirium and 
this can lead to variations in detection, treatment responses and possibly even outcomes[28, 
29]. However that does not make them exclusive to a specific condition or predictive of a 
certain aetiological cause. They are simply a clinical descriptor of the different presentations 
of delirium.  
 
 
 
1.1.3 Onset, severity and duration  
The onset of delirium is acute meaning it can develop abruptly and be present one day and 
absent the next[30]. The symptoms are of a fluctuating nature as they wax and wane over of 
a period of time and often worsen at night[31, 32]. The majority of delirium within a general 
 
Image adapted from icudelirium.co.uk  
 
Figure 1.1: Clinical presentations of delirium.  
From the literature, the figure above summarises the different clinical presentations of 
delirium based on psychomotor activity and/or differences in arousal i.e. changes in 
attention and alertness.  
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medical or surgical setting tends to occur within 48 to 72 hours of admission, whereas in 
ICU, this onset may begin at an average of 2 to 3 days[33]. Severity of a delirium can be 
assessed with rating scales and studies show that patients with severe delirium have been 
associated with increased mortality, functional decline and a need for institutionalisation 
post-discharge[33, 34]. Around 22 to 51% of patients suffer from an episode of delirium that is 
classed as severe[35] and dementia has been suggested as a risk factor for severe 
delirium[36]. With regards to duration of delirium[37, 38], the reported literature for medical 
settings ranges from resolution of delirium in 24 to 48 hours, whilst others report delirium 
lasting up to 7 to 14 days[27, 39, 30].  
Delirium was traditionally considered to be a transient condition in which most cases 
resolve within days or weeks as the physical illness subsides. However reviews and recent 
studies have suggested that in some people, delirium can be persistent[40-42], ranging from 5 
to 39% of patients for a number of months subsequently[41]. The overlap between delirium, 
persisting delirium and onset of dementia has emerged as an important topic in the 
reviewed literature.  
 
1.2 Aetiology and pathophysiology of delirium  
In order to detect and manage delirium, a sound understanding of the syndrome and its 
causation is essential. In hospital settings underlying predisposing factors can combine with 
acute predicating insults leading to multiple aetiologies. These risk factors have a 
sequential multiplicative rather than an additive affect[43] and so single aetiology delirium is 
rare. Attempting to identify and treat a single cause is overly simplistic because in nearly 
half of elderly patients, there are usually two or more underlying conditions that contribute 
to an episode[44, 45]. Delirium risk factors will now be discussed in further detail. 
 
1.2.1 Risk factors for the development of delirium  
There are a number of risk factors associated with delirium, which can be present upon 
admission or develop during hospitalisation. Age (65 years and over)[46], pre-existing 
cognitive impairment[47], severe co-morbidity (deteriorating or risk of deterioration)[48], 
current hip fracture[49] and exposure to certain medications[50] are strong predictors of 
delirium onset. Risk factors can be related to the patient’s condition (e.g. infection), a 
clinical intervention (e.g. urinary catheter) or their surroundings (e.g. numerous ward 
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transfers). Some of these risk factors (e.g. medications or change in environment) can be 
modified to prevent delirium onset[51], whilst other factors (e.g. age or gender) are non-
modifiable[52].  
It has been suggested that certain patients may be more susceptible to delirium than 
others[53]. When vulnerability at baseline is low, the patient remains resistant to delirium 
despite exposure to significant risk factors. However when vulnerability is high, exposure to 
even mild risk factors can trigger the onset of delirium. Based on this theory by Inouye et al, 
it would be logical to closely monitor patients with a high susceptibility to delirium onset. As 
a result, models of causation that quantify the role of numerous risk factors have been 
developed[54]. The risk of delirium can be predicted by observing the cumulative interactions 
of risk factors with baseline susceptibility.  
Inouye et al, formed the concept that delirium risk factors can be divided into either the 
predisposing group or the precipitating group[55, 53]. Predisposing factors can be present 
upon hospital admission and these reflect the baseline vulnerability of the patient. Aside 
from age, pre-existing cognitive decline[56] is perhaps the most predictive risk factor for 
delirium as an increased risk has been reported in those with a prior history of delirium and 
poor cognition. Primary cerebral diseases such as Parkinson’s disease and psychiatric 
illness, have also been shown to be significant[57]. Precipitating risk factors on the other 
hand, are hospital related factors that contribute to the development of delirium. These can 
be a result of stress such as lack of familiarity with surroundings or more harmful input such 
as invasive urinary catheters. In the elderly, incontinence, urinary retention and faecal 
impaction have also been shown to be significant risk factors[58, 59]. 
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Medications 
[60]
 anticholinergic 
[61, 62]
 
Figure 1.2 presents variables which have been clearly defined as predisposing or 
precipitating factors, producing a collection of modifiable and non-modifiable variables[46]. 
However, defining whether certain conditions are confounders or risk factors for delirium is 
not as straightforward. This lack of clarity suggests the need for more comprehensive risk 
factor studies, similar to those by Inouye et al[54] and Carrasco et al[63], upon which risk 
score models could be based in order to identify high risk patients. A risk factor study was 
Predisposing factors 
 
Precipitating factors 
 
Demographic  
Age 
Gender 
 
Decreased oral intake  
Dehydration 
Malnutrition 
 
Primary neurologic 
diseases  
Stroke 
Intracranial bleeding 
CNS infection (e.g.  
meningitis or 
encephalitis)  
Epilepsy 
 
Drugs  
Sedative hypnotics  
Narcotics 
Anticholinergics 
Treatment with multiple 
drugs 
Alcohol or drug 
withdrawal 
 
Functional status  
Functional 
dependence 
Immobility 
Low level of activity 
History of falls 
 
Sensory impairment  
Visual impairment 
Hearing impairment 
 
Intercurrent 
illnesses  
Infections 
Iatrogenic 
complications 
Severe acute illness 
Hypoxia 
Shock 
Fever or 
hypothermia 
Anaemia 
Dehydration 
Malnutrition 
Low serum albumin  
Metabolic imbalance 
(e.g. fluid, 
electrolyte, glucose, 
acid-base) 
Surgery  
Orthopaedic  
Cardiac 
Prolonged 
cardiopulmonary 
bypass 
Non-cardiac surgery 
 
Co-existing medical 
conditions  
Severe illness 
Multiple co-morbidities 
Chronic renal or hepatic 
disease 
Dialysis 
History of stroke 
Neurologic disease 
Metabolic 
derangements 
Fracture or trauma 
Terminal illness 
Infection with HIV 
 
 
Cognitive status  
Dementia 
Cognitive 
impairment 
History of delirium 
Depression 
 Environmental  
Hospitalisation 
Admission to ICU 
Multiple ward transfers 
Physical restraints 
Bladder catheter 
Multiple procedures 
Pain 
 
Drugs  
Multiple 
psychoactive drugs 
Treatment with 
many drugs  
Alcohol abuse 
 
Image adapted from icudelirium.co.uk  
 
Figure 1.2: Associated risk factors for delirium.  
There are a vast range of delirium risk factors and one high risk groups is medications.  
Medications are implicated in 20 to 40% of cases[60] and almost every class of drug has 
the potential to cause delirium. Exposure to benzodiazepines, antipsychotics, tricyclic 
antidepressants, opiates, narcotics, anxiolytics, antihypertensives and anti 
inflammatories have all been implicated as predictors of delirium across different study 
populations. Anticholinergic medications have been not only been shown to increase 
risk but also increase the severity of symptoms after onset[61, 62] . Therefore it would be 
wise to minimise exposure to certain medications, especially during high risk periods 
such as post-operatively.  
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considered for this thesis and this is something that will be discussed in further detail in 
Chapters eight and nine.  
 
1.2.2 Studies addressing causation  
Causation is commonly the focus of epidemiological studies. Various studies have been 
conducted to try and find possible causes of delirium and some of these include 
deficiencies in the vitamin B12[64], lack of oxygen[65] and the use of medications such as 
anticholinergics[61]. As previously mentioned, most of the risk factor literature is based on a 
variety of different hospital settings. These range from the general medical population[66], 
the impact of a setting such as ICU[67, 68], the presence of risk factors for certain illnesses 
such as vascular disease[69] or cancer[70]or a specific patient population such as post-
operative patients[71, 72].  
There are a number of issues regarding the methodology of such studies and their reported 
findings may not be generalisable to other study populations. Examples of methodological 
considerations include: inadequate statistical analysis of risk factors (univariate analysis 
compared to multivariate analysis), small sample sizes (risk factor studies tend to have 
large numbers so that the results are statistically significant) and lack of consideration for 
confounding variables (as these could affect the outcome of results).  
 
1.2.3 Prevention measures for delirium  
Many risk factors may simply be markers of general morbidity; some are protective whilst 
others are causative factors, depending on the amount of exposure and the 
circumstances[58, 73]. Delirium risk factors can be modified by preventative interventions and 
reviews have highlighted that studies investigating the preventative impact of modifying 
these risk factors are of importance[74]. Preliminary evidence indicates that multicomponent 
interventions for modifiable clinical factors, tailored to the patient’s needs and care settings, 
can reduce the frequency and severity of delirium.[75] This has been illustrated by a review 
of trials in medical and post-operative patients, which reported an absolute risk reduction 
ranging from 13 to 19%[76, 77]. In another study, active preventative interventions and early 
detection resulted in an economic benefit by decreasing long term nursing home costs by 
15.7%[78].  
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Delirium prevention strategies can be simple and these are most effective when delivered 
by a competent multidisciplinary team who are adequately trained and experienced in 
delirium prevention. Education of health care professionals is essential so that they are 
familiar with identifying high risk patients and psychiatrists can help with training and 
identifying predisposing and precipitating factors for delirium. As well as the staff, it is 
important that family members are informed of the fluctuating and acute onset of delirium 
features so that they too can be involved in improving detection within community settings. 
Family members may also be able to provide insight into subtle changes in cognitive 
function, physical function, perception and social behaviour; all of which could be indicative 
of delirium onset.  
Those at high risk should be regularly monitored and disruptions to surroundings should be 
minimised (i.e. no excessive staff changes and ward transfers). Other common elements 
that can be modified with substantial clinical benefit include regular review of medications 
and elimination of unnecessary drugs, adequate hydration and nutrition, careful and 
effective prescribing of pain relief, monitoring for signs of infection or hypoxia, avoiding the 
use of catheterisation and physical restraints, correction of sensory deficits, reorientation, 
clear communication with the patient, non-pharmacological approaches to anxiety, sleep 
enhancement, early mobilisation and cognitive stimulation. 
It is worth noting that once delirium had developed, these interventions were found to be 
less effective and efficient[79, 80]. There is a clear need for more trials in the prevention of 
delirium[81-85]. Specific areas of interest include the use of psychotropic medications, the 
impact on psychological morbidity, activities of daily living, quality of life, cost of intervention 
and mortality.  
 
1.2.4 The pathophysiology of delirium 
The pathophysiology of delirium is poorly understood. O’Keeffe[86] summaries it best as a 
manifestation of diffuse, non-specific and non-psychiatric generalised disorder of cerebral 
oxidative metabolism and neurotransmission. It can also include the dysregulation of 
inflammatory agents in the cerebrum and any other neuro-biologic factors that are involved 
in neurotransmitter function. It is clear that further research is needed[87-90] and these 
changes in pathology could be used as potential biomarkers for the detection of delirium[91-
95, 88]. There are a number of theories which will now be briefly described. 
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1. Cerebral oxidative metabolism – This is the most well known theory and is still under 
research[96, 97]. Using electroencephalographs of delirious patients, it was theorised that 
delirium was due to oxidative metabolism in the brain leading to dysfunction of the 
cerebral cortex[98]. However since its initial conception, it has been proposed that 
neurotransmitters may also be a contributory factor.  
2. Disruption of neurotransmitters – Acetylcholine, dopamine, serotonin, γ 
aminobutyric acid, glutamate, melatonin and histamine have all been implicated in 
delirium pathology.  
a) Acetylcholine: is involved in the complex regulation of attention, arousal, cognition 
and consciousness and cholinergic neurones often undergo degenerative changes 
during ageing.  Therefore decreased levels of acetylcholine could be responsible for 
delirium features such as inattention and impaired cognition. Studies have also shown 
that multiple anticholinergic medications can cause an ‘anticholinergic burden’ 
increasing the risk of delirium[99] and the reversal of this could form the basis of a 
potential treatment for delirium.  
b) Dopamine: works in combination with acetylcholine as high levels of dopamine lead 
to lower levels of acetylcholine and so dopamine excess can cause delirium[100]. For 
example, opiates and also drugs used to treat Parkinson’s disease (Levodopa) can 
increase risk levels of dopamine, whilst dopamine antagonists such as antipsychotics 
can be used to treat delirium[101].  
c) Others substrates: such as serotonin, GABA, noradrenalin and glutamate may have 
a role as they interact with cholinergic and dopaminergic pathways[102]. GABA 
medications have also been linked to both the improvement and deterioration of 
delirium[103].   
3. Inflammatory agents – Both cortical and subcortical structures have been implicated 
and it has been suggested that cytokines such as interleukins, interferons and tumour 
necrosis factors may also be involved[104-106]. Studies have reported elevated levels of 
cytokines in delirious patients[107] whilst in other studies, specific interleukin levels were 
found to be lower in non-delirious patients[108], suggesting that they may be 
neuroprotective.  
4. Stress response or drug induced – Stress is an important modulator in brain function 
as it induces a rapid response in the sympathetic nervous system, increasing delivery 
of oxygen and glucose thus enhancing cognitive function. The Hypothalamic Pituitary 
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Adrenal (HPA) axis affects neuronal integrity and produces a slower sustained 
response that can last for days or even weeks. However excessive stimulation of the 
HPA axis leads to increased levels of glucocorticoids and this can have an adverse 
effect on the amygdala, prefrontal cortex and the hippocampus[109]. Studies have 
reported elevated cortical levels, resulting in hypercortisolism in stroke patients[110, 111]. 
 
1.3 Prevalence of delirium 
Delirium is a serious health issue, particularly in the older population as it has a high 
incidence and prevalence in community and hospital settings. It is frequently not 
recognised, poorly detected and badly managed[112]. Poor recognition is a well known issue 
as studies have reported that between a third and two thirds of cases remain undetected in 
clinical practice[113]. In a survey of US physicians, 89% considered delirium to be an 
important outcome, 40% routinely screened for delirium but only 16% used a specific tool 
for detection[114]. These identification problems exist across all clinical settings[115]. The rates 
of non-detection (43% to 66%) reflect the poor understanding and under appreciation of 
delirium as a serious independent condition.  
 
1.3.1 The occurrence of delirium  
Care home delirium is poorly recognised and there are only a few population based studies 
for delirium occurrence in the community. The majority of the delirium occurrence estimates 
are derived from hospital settings. In a paper by Meagher[32] incidence rates were reported 
as general population (0.4%), general population over 55 years of age (1.1%), general 
hospital admissions (9 to 30%) and elderly hospital admissions (5 to 55%). In the elderly, 
rates can range from 15% to 62% in post-operative patients[116, 117] and up to 70 to 87% in 
elderly patients in intensive care[118]. Delirium has been reported to be present in 10 to 24% 
of older adults upon admission to hospital (prevalent cases)[119]. This can then develop in a 
further 5 to 35% of elderly patients during hospitalisation (incident cases) and often this 
number can be as high as up to 50%[67, 120, 121]. The prevalence in intensive care units has 
been reported as up to 60 to 85%[122], up to 62% in hip fracture[123] and over 50% in post-
operative patients[124, 125] and the terminally ill[126, 127]. The occurrence of delirium within 
nursing home residents (over 75 years) has also been shown to have a wide variation 
ranging from 15% to 60%[30].  
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Meagher
[32]
   Hip fracture 
[71]
   Cardio 
[124, 128, 129]
 
Study population Delirium rates 
Community dwelling older adults (prevalence)  
- aged 55 years and over  
- aged 85 years and older  
N.B. Small number of cases in both studies 
- incidence of delirium in non-demented (over 3 year period) 
 
< 0.5 to 1.1% 
< 0.5 to 13.6% 
 
10%  
Skilled nursing facilities and long term care settings (prevalence)  
Frail older adults receiving Health Care Services: 
- Nursing homes 
- Assisted living facilities 
- Elders living at home with Home Care Services  
0.5 to 39%  
 
58% 
35% 
35% 
Hospitalised older adults: 
- Admission to medical wards (prevalence)  
- Subsequent incidence during hospitalization  
 
5 to 31%  
3 to 55%  
Elderly admissions to Accident and Emergency (prevalence)   
Elderly accident and emergency attendees 
5% to 10%  
16% 
Patients with AIDS 
Hospitalised patients with HIV 
17 to 40% 
30 to 40 % 
Cancer patient 
Cancer patient in the terminal stages 
25 to 40% 
28 to 85% 
Intensive care unit patients (overall) 
ICU setting 
Sub ICU setting 
N.B. In sub ICU setting, this was split into; 
- present at admission (prevalence) 
- developed during stay 
12 to 50% 
11 to 31%  
29.2% 
 
15.5%  
13.7%  
Post-operative patients (overall)  
- Elective non-cardiac surgeries 
- Elective vascular surgery 
- Major abdominal surgery 
- Cardiac surgery 
5 to 75% 
5 to 26% 
29 to 52.2% 
60% 
8 to 50% 
Elderly surgical patients with hip fracture (prevalence)  
Elderly surgical patients with hip fracture post-operative (incidence)  
Other studies: 
- patients with hip fracture 
- people with hip fractures 
- hip fracture in the elderly 
4.4 to 61% 
4 to 53.3% 
 
50% 
40 to 60% 
16 to 62 % 
Image adapted from the paper by Meagher et al
[31]
 
 
Figure 1.3: Rates of delirium in different clinical settings. 
The figure above summaries the delirium rates observed in various study populations. 
The highest rates of delirium are seen in the ICU and surgical hip fracture patients. The 
delirium rates for the elderly hip fracture population are relatively high, the reason for 
which is unknown. Some literature suggests that the occurrence of delirium in the hip 
fracture may be a separate entity[71], compared to the delirium observed in the general 
medical population. With regards to cardiac surgery, it is dependent on population and 
type of procedure being performed. It has been suggested that improvements in surgical, 
cardiopulmonary bypass and anaesthesia technique may have lowered this incidence 
rate[124, 128, 129], however this has not yet been confirmed.  
36  
 
Figure 1.3 summaries the delirium rates (unless otherwise stated) across some of the 
different clinical settings. We can see that the rates can vary and this can be due to the 
population under assessment, the nature of the study setting, the patient procedures being 
administered and the detection methods employed. Furthermore the definition of 
occurrence may change as different studies may choose different time periods for delirium 
detection ranging from acute admissions to the entire length of hospital stay. In some 
studies the presence of delirium may be assumed to be zero upon hospital admission, thus 
combining prevalence and new incidences of delirium to calculate a cumulative delirium 
incidence, which would produce inaccurate estimates.  
To summarise although the table may illustrate well defined rates, it may not be as accurate 
due to variations in methodology and definition. A standardised protocol for research 
studies in delirium may help to eliminate some of these issues and would allow for accurate 
and reliable comparisons to be made. For the purposes of this overview, overall delirium is 
more frequent in older populations, those with certain medical or surgical problems and 
those with pre-existing dementia.  
 
1.3.2 Detection of delirium (case ascertainment) 
A clear understanding of baseline cognition is essential to delirium detection and families 
can help identify subtle changes in mental state. A cognitive screening tool such as the 
MMSE or AMTS should be used to confirm this. The literature shows that routine cognitive 
assessment when used in combination with Confusion Assessment Method (CAM)[130] can 
help to increase delirium detection[32, 131]. Considering that delirium is an indicator for 
serious illness, any sudden deterioration in mental state should be treated as delirium 
specifically for elderly patients, who should be screened and regularly reviewed for risk 
factors. Once delirium has been detected, the search for the underlying causes and 
precipitants should begin[132, 133]. 
The clinical diagnosis and initial evaluation should involve history of alcohol and drug use, a 
review of medication and background history from the patient, family, carers and GP’s. 
Delirium cases are often prevalent upon hospital admission[76] and a thorough history can 
help identify when the condition developed and what triggered it, the duration of symptoms 
and identification of the risk factors[132, 133].  
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1.3.3 Diagnosis of delirium (case definition) 
Physical and neurological examinations are performed to help identify the underlying cause 
but this may not be straightforward as patients can be resistant and uncooperative. 
Investigations should be conducted to determine the aetiology of delirium which can 
include; blood tests, oxygen saturation, ECG, chest X-ray, urine analysis, liver enzyme and 
function tests, lumbar puncture and cerebral imaging scans[134-137]. Careful consideration of 
the results can help to distinguish delirium from other disorders. 
Once delirium has been identified, a clinical assessment should be carried out using the 
Diagnostic and Statistical Manual of Mental Disorders V (DSM-V)[23] or the International 
Classification of Diseases 10 (ICD-10)[138] which are considered the international standards 
for delirium diagnosis. Substantial developments in neuropsychology have been made in 
the past 20 years and this is of particular benefit to the elderly population[139-141]. These 
include; clearer definitions for delirium, a range of tools to identify, diagnose and assess 
delirium symptoms and the gradual recognition that delirium is associated with a significant 
independent morbidity. Figure 4.1 illustrates the range of diagnostic tools that can be used 
for delirium detection. It should be noted that some of the tools listed in Figure 1.4 are not 
specifically designed to detect and diagnose delirium. Therefore it is possible that certain 
tools may only focus on specific areas such as cognitive impairment, which is only one 
feature of a delirium episode. The use of delirium tools will be discussed in further detail 
later in Chapter five (Section 5.4.2). Consideration for choosing a suitable tool should be: 
(1) why is the instrument being used? (2) Who will be conducting the assessments, within 
what time frame and how often? (3) Is the tool suited to the setting and the population being 
studied?  
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[89]
 Aadmis 
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 Detect delirium
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 Scale Presence of 
delirium 
Characteristics 
M
IN
IM
A
L
 T
R
A
IN
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G
 
Mini-Mental State 
Exam 
< 20 5 domains/ 30 points; 10-20 minutes; widely 
used by most clinicians; requires verbal 
communication from patient; not suitable in ICU 
setting; not delirium specific.  
Cognitive Capacity 
Screening Exam 
< 19 7 domains/ 31 points; 10-20 minutes; cognitive 
screen, differentiation between ’functional 
psychoses’ and diffuse organic brain syndrome 
Short Portable 
Mental Status 
Questionnaire 
> 3 10 items/ 10 points; 3-5 minutes; cognitive 
screen; verbal; determines organic brain deficit; 
affected by education levels  
Clock Drawing Test Depends on 
completion  
Quick and easy; cognitive screen; psychomotor 
skills tested; useful in Alzheimer’s disease 
H
IG
H
 T
R
A
IN
IN
G
 
Memorial Delirium 
Assessment Scale 
> 7 10 items/ 30 points; especially useful for 
repeated assessments, severity; does not 
include items for diagnosis 
Confusion 
Assessment 
Method  
Positive  9 items; 20 minutes; best diagnostic tool; no 
rating of severity; not suitable in ICU setting 
Confusion 
Assessment 
Method ICU 
Positive  4 features only; 2-3 minutes; very quick; useful 
in ICU setting  
Delirium Rating 
Scale 
> 12 10 items/32 points; useful in screening, 
diagnosis and symptom severity; widely 
validated and available in different languages 
Delirium Rating 
Scale Revised 98 
> 15 16 items/ 46 points; 13 severity items and 3 
diagnostic items; ideal for longitudinal studies 
NEECHAM 
Confusion Scale  
< 24 3 subscales/ 9 items/ 54 points; 10 minutes; 
useful at delirium onset and in patients with 
‘quiet’ manifestations; suitable in ICU setting  
Cognitive Test for 
Delirium 
< 22 5 domains/ 30 points; 10-15 minutes; 
developed for ICU setting; 100% sensitivity  
Abbreviated 
Cognitive Test for 
Delirium  
< 10 28 points; visual attention span and recognition 
memory for pictures only; more practical for 
use by ICU Clinicians 
Intensive Care 
Delirium Screening 
Checklist 
> 4 8 items/ 8 points; suitable for ICU setting; 
especially for patients with language 
disturbance 
Delirium 
Observation 
Screening Scale  
> 3 25 items/ 5 point Likert scale per item; easy to 
use; observational scale; assesses severity; 
developed for use by nurses 
Image adapted from the paper by Pae et al
[55] 
and Adamis et al
[142]
 
 
Figure 1.4: Summary of the tools used to detect delirium. 
The figure above provides an overview of the current tools that are used to screen for 
delirium and the areas that they focus on. It should be noted that not all the tools listed 
above such as the MMSE, have been designed to specifically detect delirium [143].  
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1.3.4 Differential diagnosis of delirium 
The medical differential diagnoses for delirium is extensive and in order to treat delirium, a 
large number of aetiologies must be differentiated and investigated[144, 44, 145]. Differential 
diagnoses to consider in delirium are dementia and depression (common), dementia with 
Lewy Body, functional psychosis and mania (less common) and post-ictal confusion and 
dysphasia (rare), the latter of which are common post-stroke[146, 147]. Figure 1.5 illustrates 
the key differences between delirium and some of the aforementioned disorders.  
Dementia: The traditional distinction between delirium and dementia is the acute onset, 
fluctuating nature and reversibility of delirium[148-150]. However this aspect of reversibility can 
be complicated in some patients. This can include Lewy Body dementia (which has a slow 
fluctuating nature with psychosis)[151, 152], exposure to a prolonged delirious state (which 
leads to subsequent cognitive decline)[153] or often the persistence of delirium symptoms 
months after discharge[41]. It has been suggested that delirium may be an indicator of 
undiagnosed or evolving dementia[154, 150]. Recognition rates for dementia are considerably 
low in the community (estimated to be at around 40%) resulting in a rising prevalence of 
dementia in acute hospital settings[155].  
Diagnoses can become complicated as patients with pre-existing dementia can develop 
superimposed delirium[156, 157] (as evidenced by up to two thirds of superimposed delirium 
cases), which can result in worse outcomes for the patient[156, 158]. In cases where both 
dementia and delirium occur, the presentation of delirium remains the same as delirium 
symptoms are clinically dominant.  Therefore when diagnosing between delirium, dementia 
and delirium combined with dementia, careful history taking with emphasis on the onset, 
attention and fluctuation of key features is essential[159].  
Depression: The symptoms of depression (low mood, suicidal ideation, apathy, 
demotivation, withdrawn) occur frequently in delirium[160, 161]. The emotional and behavioural 
changes in delirium are often mistaken for adjustment reactions for cancer or trauma 
patients[162], however true onset of depression is often less acute and sustained. Cognitive 
impairment is occasionally seen in depression, known as depressive pseudo-dementia[163], 
can be mistaken as a confusional state. Therefore careful history is needed for an accurate 
diagnosis. A study showed that up to 40% of psychiatry referrals for suspected depression 
were actually found to be delirious[164]. It is important to distinguish between delirium and 
depression[165] as many antidepressants have anticholinergic properties[62] which in turn 
could worsen a delirium episode if incorrectly treated.  
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 Delirium Dementia Depression Psychosis 
Onset Acute Insidious Variable Variable 
Duration Short Lengthy Variable, 
recurrent 
Variable, 
recurrent  
Course  
 
Fluctuating  Steadily 
progressive 
Diurnal 
variation 
Variable 
Consciousness Clouded Clear until late 
stages 
Generally 
unimpaired 
Unimpaired 
Orientation  Poor  Poor Usually good Good  
Attention Poor  Preserved in 
early stages 
Poor Poor 
Cognition  Impaired Impaired Variable Normal 
Short term 
memory 
Reduced  Reduced  Normal Normal 
Hallucinations Common 
(visual)  
Infrequent Rare Common 
(auditory)  
Delusions Common 
  
psychotic ideas 
are 
unstructured, 
fleeting and 
simple in content 
Uncommon Occasional 
 
psychotic 
symptoms are 
complex and 
in keeping 
with prevailing 
mood 
Frequent 
  
psychotic 
symptoms are 
complex and 
paranoid 
Speech Incoherent Dysphasia Normal Normal 
Involuntary 
movements 
Present Absent  Absent Absent 
Physical illness Present Absent Variable Absent 
Electroencephal
ogram (EEG)  
 
Abnormal in 80 
– 90%; 
generalised 
diffused slowing 
in 80% 
Abnormal in 80 
– 90%; 
generalised 
diffused slowing 
in 80% 
Generally 
normal 
Generally 
normal 
Image adapted from the paper by Meagher et al
[165] 
 
Figure 1.5: Differential diagnosis of delirium. 
The figure above summarises the difference between different psychiatric symptoms. 
Delirium can frequently coexist with other disorders, which means that making a diagnosis 
can be more complicated. Principal disorders from which delirium must be distinguished 
are dementia and depression especially in hypoactive patients. The presentation of 
delirium can also mimic functional psychiatric disorders such as agitated depression or 
mania and hyperactive delirium can be mistaken for schizophrenia due to the auditory and 
visual hallucinations. 
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Meagher et al: optimising management 
[166] 
1.3.5 Considerations for prevalence studies 
Prevalence studies may be conducted in different settings and with different patient groups, 
for example: community settings, hospices, nursing homes and hospitals. The rates of 
occurrence listed in Figure 1.5 may not actually be a true representation of the populations 
studied due to lack of recognition or detection. There are a number of reasons for under-
diagnosis which will now be discussed[112]. 
Non-detection is a major obstacle in delirium research. The stereotypical image of delirium 
is that of delirium tremens (agitated and disturbed) which is a separate entity in itself and 
only accounts for a small minority of care. Due to this stereotype, somnolent or hypoactive 
presentations of the conditions are often ignored[133]. Paradoxically hypoactive is the most 
prevalent subtype in the elderly[167] and these are the cases that are often left unidentified 
upon examination of patients. 
Delirium prevalence in the community is low[168] and is not the focus of many 
epidemiological studies. Even in general hospital settings, upon admission the prevalence 
of dementia is usually higher than that of delirium. It is only upon hospitalisation that the 
incidence of delirium begins to increase due to the presence of multiple risk factors. This 
raises a few questions about future research. Firstly are prevalence rates in the community 
underestimated and do we need to conduct more studies to counteract this? And secondly 
are the current incidence studies sufficiently informative for delirium research? This leads 
onto my final point regarding the under diagnosis of delirium in clinical settings[169]. 
The clinical manifestations of delirium itself can lead to under diagnosis but the fluctuating 
nature of the delirium means that cases may present themselves between assessment 
periods. As a result patients with delirium may be classed as not having delirium and cases 
are therefore missed. Also with regards to certain subtypes (e.g. hypoactive), cases are not 
a cause for concern as previously mentioned so these cases may also be missed. Those 
that are hypoactive may be more compliant than hyperactive patients and this compliance 
may incorrectly be perceived as intact cognitive function. Misdiagnosis may occur as 
changes in cognition may be masked by conditions such as pre-existing dementia or 
psychomotor retarded depression[145]. The use of different diagnostic terms, as listed in the 
beginning of Chapter one, may also lead to uncertainty over what is being diagnosed.  
Methodologically, in certain settings screening for delirium or even cognitive impairment is 
not a routine procedure despite some studies suggesting that early recognition is helpful[170, 
171, 169, 172-175]. The minority of clinical settings that do screen for delirium often use tools that 
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assess cognitive function rather than those specifically designed for delirium detection. 
Furthermore, the delirium tools developed to screen and assess delirium vary in sensitivity 
and specificity (this will be discussed in Chapter four) which can have an impact on the 
reported findings. The timing and frequency of repeat assessments for delirium is also likely 
to have an effect on the occurrence rates reported[39].  
Screening for delirium alone is not sufficient and interviews with carers are required to 
detect subtle changes in behaviour. There is often a lack of informant history regarding the 
patient’s prior baseline cognitive and physical function. Unfortunately a formal cognitive 
assessment routine is often lacking in the technological world of medicine. Frequent and 
continuous monitoring of patient cognitive function is required to highlight any deterioration 
in mental state, an indicator of delirium. Symptoms of delirium can often to be attributed to 
sensory deprivation of the hospital environment rather than delirium itself. There is also the 
issue of the lack of appreciation of delirium as a distinct entity and an indicator for serious 
morbidity and mortality[176]. This may in part be due to technological focus and rapid pace of 
modern hospital care and partly due to the inattentive or ageist attitudes towards helpless 
patients, older adults or those that present with confusion. These attitudes can lead to 
people normalising such behaviour when in fact these features of delirium are of medical 
significance.  
The shift pattern of staff and system and communication problems between numerous ward 
transfers can also lead to information not being relayed correctly and diagnoses being 
missed[177, 178]. Nurses spend a significant amount of time with patients and their families so 
they are well placed to detect delirium[179, 180]. However if nurses are not adequately trained, 
then they may be overly reliant on monitoring cognition or use of orientation cues[181]. 
Therefore decreased levels of skilled nursing staff could contribute to low levels of 
detection. Similarly other medical staff that may not have any experience of delirium 
diagnosis could lead to inaccuracies in the assessments. Compared to psychiatrists, 
doctors are more likely to use their own clinical diagnosis as they are less familiar with 
methods to assess cognition and inattention[114]. Possible solutions would be the 
introduction of educational programmes, routine cognitive testing, using delirium screening 
tools and more frequent involvement of psychiatrists for delirium management[32, 25, 166, 180].  
Considering these reasons, the occurrence of delirium reported in the elderly could possibly 
be an underestimation. This wide variation illustrates the differences in patient groups, 
potential confounders, methodology and lack of consensus regarding delirium definition. 
Errors in delirium diagnosis impact upon management of delirium and the long term 
outcomes which will now be discussed.  
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1.4 Management of delirium 
The management of delirium requires a multifaceted bio-psychosocial approach using a 
competent and well trained multidisciplinary team[132, 133]. Firstly the cause of the physical 
underlying disorder needs to be identified and treated. Diagnosis and treatment work side 
by side so regular progress reviews are good practice and can also help detect and treat 
any additional risk factors that may appear at later stages[182].  
Keeping the family as well as the patient up to date on the progress is beneficial. Delirium 
can be a terrifying experience so adequate information, reassurance that the symptoms are 
temporary and should resolve and clear effective communication can help both the patient 
and their families. Reorientation should be facilitated by the presence of relatives, 
consistency in staff members, familiar possessions, frequent verbal reminders and multiple 
cues with regards to their settings and circumstances. 
Furthermore good communication within teams from primary healthcare (home) or general 
medical team (hospital) is a key component to successful management[166]. The mental 
health team can help to clarify differential diagnosis patients, deal with problem behaviours 
and assess symptoms competency. Studies have found that there is a referral bias towards 
hyperactive patients who are seen as having severe delirium and so benefit from a higher 
rate of psychiatric consultations and pharmacological interventions[32]. Hypoactive cases 
should also receive the same level of treatment and it is suggested that psychiatry services 
could contribute their skills in identifying these cases[32]. Often the involvement of the mental 
health team occurs much later in the treatment process and it has been suggested that an 
earlier involvement could be advantageous[25, 166].  
 
1.4.1 Environmental measures 
Efforts should be made to provide a safe environment and minimise the potential for 
complications (e.g. falls). A good therapeutic environment should maintain good nutrition 
and fluids intake, maintain mobility, avoid under and over stimulation, ensures surroundings 
are bright, well lit, quiet and comfortable, correct sensory deficits (e.g. glasses, hearing 
aids, dentures), promote adequate levels of sleep with sedation, avoid use of physical 
restraints where possible. The environmental strategies such as a ‘delirium room’[83, 183, 184] 
or those described above[185, 183] are underutilised despite being free from adverse 
reactions. Studies have found that these strategies are not applied in response to changes 
in cognition but rather in response to disruptive behaviour (hyperactive delirium)[27, 186, 187]. 
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The literature reports that there have been some positive responses with regards to 
delirium prevention[188, 82, 80, 189-191] but the effectiveness of these measures remains mixed[77, 
192]. For example a recent RCT of the use of a specialist delirium/ dementia ward concluded 
that even though patient and carer satisfaction was improved, there was no convincing 
benefit in health status or service use[193].  
 
1.4.2 Pharmacological intervention  
Medication as a cause has been implicated in a large number of delirium cases (>30%) so 
excessive medication use or compounds that may aggravate delirium are best 
minimised[194, 195]. Certain antipsychotics can modify neurotransmitter dysfunction[196] and 
there have been trials to treat delirium using cholinesterase inhibitors such as 
rivastigmine[197]. Medications are often used to alleviate delirium symptoms by controlling 
disruptive or distressing behaviour such as hallucinations or agitation. Consideration should 
be given to severity of symptoms, the clinical setting, dose and administration, patient age 
and risk of side effects[198]. Timely intervention, regular review using the Richmond Agitation 
and Sedation Scale (RASS)[199, 200] and input from psychiatry regarding the appropriateness 
of the treatment plan are considered good practice.  
There are a range of medications used to manage delirium symptoms and their use is 
briefly discussed. The use of psychotropic drugs should be stopped as it can interfere with 
the patient’s cognitive status[201]. Sedatives can be used to control agitation and 
restlessness but again they can worsen cognitive function. Antipsychotics are the most 
frequently used as they help to control agitation and psychosis but also help to improve 
attention and orientation[202]. It has been suggested treatment should continue until the 
symptoms are fully resolved as initial improvements may just be a fluctuation of the 
delirium[203, 204]. When the patient does stabilise, then the dosing of antipsychotics should be 
gradually tapered and discontinued rather than an abrupt stop. Antipsychotics such as 
haloperidol are the most studied[205, 206] but atypical antipsychotics such as risperidone and 
olanzapine are also being evaluated for use in delirium[207]. Benzodiazepines such as 
lorazepam (also known as tranquillisers) are the first choice of drug to mitigate delirium 
associated with alcohol withdrawal symptoms. There are also studies looking at the use of 
procholinergic drugs  to help in the treatment of delirium[208]. 
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1.4.3 Follow up treatment  
Symptoms of delirium can persist beyond the acute phase of treatment and this must be 
accounted for when planning a patient’s discharge from hospital. Follow up visits are 
recommended following hospital discharge as they can help to identify residual cognitive, 
functional or social problems as well as reducing the risk of delirium reoccurring[133]. Simple 
education and clear communication with the patient and their families is important as 
delirium can be a distressing experience for both.  
Communication with the patient’s family can help explain the delay period that often occurs 
between the acute treatment of the underlying physical disorder and the return to normal 
mental function which can take days, weeks or even months to normalise[41]. Careful 
explanation of the diagnosis can help avoid families misinterpreting delirium as evidence of 
brain damage. Disorientation and inattention can be persistent problems and carers can 
help provide reorientation cues for patients[43]. In addition to this, families can prevent future 
episodes of delirium by early recognition of the signs and possible causes such as sensory 
impairment which can easily be corrected at home[209].  
Many patients do not feel comfortable discussing their experience of delirium. Some 
patients may feel that the delirium is a sign of future events and could be an indication of a 
psychiatric disturbance. As a result patients undergo ‘silent delirium’ where they suffer in 
silence and are afraid or ashamed to acknowledge their symptoms and ask for help[210]. The 
psychological aftermath of delirium is understudied[32], but depression and post-traumatic 
stress disorder has been associated with delirium[211]. The development in geriatric 
neuroscience and the accessibility of psychiatry services, both in the community as well as 
the hospital means that psychiatrists can remain involved with the patient’s treatment and 
facilitate future research. Delirium may also be an indicator of dementia[211]. It has therefore 
been suggested as good practice to utilise the multidisciplinary teams in the hospital and 
the community and request referrals for continued social support or further 
assessments[133].   
 
1.4.4 Future emerging therapies 
Given that delirium may be a disturbance of brain function some studies are investigating 
patients with hypoglycaemia[212] and hypoxia[65]  associated with cholinergic metabolism 
whilst other groups have investigated traumatic brain injury[213] and stroke[214, 215, 38, 46, 216-218].  
46  
 
There is also the possibility of using medication to help treat rather than just manage the 
effects of delirium e.g. using procholinergic medication to normalise acetylcholine levels in 
the brain[196]. Other medication classes have also been tested such as using low doses of 
antidepressants (e.g. trazodone[219] and mianserin[220]) to help alleviate cognitive symptoms 
as well as alterations in mood.  Oddly, smoking has been identified as a possible protective 
factor against the risk of developing delirium [221]. However a trial testing nicotine 
replacement therapy is lacking.  
Other studies have reported the application of light therapy[222] and more recently music 
therapy[223, 224] can help prevent under and over stimulation of noise levels. However both of 
these potential therapies need to be correctly evaluated before routine use. If regularly 
used, then prevention interventions and standardised detection and management protocols 
can help to improve delirium care by reducing severity, duration and recurrence of 
episodes. Therefore efforts are being made to introduce a common delirium screening 
method in clinical settings as part of the regular admissions process. All these interventions 
have the ultimate aim of improving patient outcomes which will now be discussed.  
 
1.5 Effect of delirium outcomes 
Delirium has been associated with an overall poor prognosis. An increased mortality risk 
has been reported among older adults both during, and after, hospitalisation with estimates 
ranging from 22 to 76%[225, 226]. High mortality rates have also been reported at one month, 
six months and one year with a reported mortality rate of 35 to 40%[227-229, 226, 230]. This high 
rate is most likely due to the severe underlying medical pathology. However, once illness 
severity and confounding variables have been adjusted for, the rate of mortality directly 
attributed to delirium may actually be lower. 
Significant independent co-morbidity has been strongly associated with delirium[231, 232], 
especially in certain populations such as post-operative patients[233, 234, 28, 235]. In the elderly 
population overall high morbidity levels were associated with risk of falls, pressure sores, 
incontinence, malnutrition, dehydration and pneumonia[236, 237]. This increase in 
complications means that the average length of stay in hospital is significantly longer for 
patients with delirium (21 days) compared to those without delirium (9 days)[19]. Although 
there is a lag phase between acute treatment and return to normalised mental function, 
most patients do experience complete resolution of their delirium symptoms. However 
certain groups such as the elderly are less likely to make a full recovery[238, 239].  
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Studies have found that, post-discharge delirium has a strong independent impact on 
functional ability and cognitive decline[18]. Studies have shown that at the time of discharge, 
patients still had significant cognitive decline which then persisted for many months leading 
to long term memory impairment[40, 41, 240]. It is thought that delirium may actually highlight 
patients that have a decreased brain reserve making them more susceptible to long term 
cognitive illnesses. Therefore it is possible that delirium could actually be used as an 
indicator for evolving dementia[241, 150]. Patients with delirium have an increased need for 
institutionalisation at one and six months and overall have a higher rate (47%) compared to 
non-delirium patients (18%)[40].  
Inyoue et al[55, 53, 242], reported that there is a seven fold increase in mortality risk for 
delirious patients discharged from the emergency department. Delirium present at 
discharge was associated with a 2.6 fold increase in risk of death or nursing home 
placement. Delirium that persisted beyond discharge from acute treatment was highly 
associated with rehospitalisation, prolonged institutionalisation and death[40]. For almost a 
third of cases delirium was persistent after discharge and as delirium can last for several 
months, the long term prognosis has shown to be worse for this group of patients[41]. 
Another study reported that almost two years post-discharge, the risk of mortality, functional 
decline and institutionalisation was almost double in patients diagnosed with delirium[243]. 
Some studies suggest that delirium results in prolonged hospitalisation which leads to an 
indirect decline in functional ability[18, 19, 244], whilst others believe that irreversible brain 
damage is caused as a direct result of delirium[241, 245]. There is also a psychological and 
social impact[145, 246, 113] associated with the distress that delirium causes for patients and 
their families. However this has been severely understudied and so the full effect post-
discharge is unknown.  
Delirium places a large strain on patients, their families and social and health services. The 
cost of delirium to the NHS is substantial and healthcare costs are typically doubled in 
delirious patients[78]. Delirium is associated with higher hospital costs due to prolonged 
hospitalisation. There is the cost of increased nursing time per patient due to the frequency 
of more medical complications as a result of delirium[247]. The total estimated additional cost 
is £1500 for every delirious patient[78]. Additional costs still continue to accrue after hospital 
discharge due to; increased need for institutionalisation, rehabilitation, follow up visits, 
home care and rehospitalisation due to high remission rates in delirium[247]. Inyoue and 
colleagues estimated that 2.3 million older people each year have their hospital stay 
complicated by delirium, resulting in 17.5 billion hospital days and medical expenditure of 
over $6.9 billion[56]. The economic cost of delirium in a US study has been shown to range 
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from $38 to $152 billion each year[78]. It is estimated that people with delirium have a 
greater than two fold increase in costs than for people without delirium and its economic 
impact is similar to the cost of diabetes mellitus[248], hip fracture[249] and falls[250] in older 
people. Despite high morbidity and mortality and economic burden, delirium is still a poorly 
recognised syndrome.  
 
1.5.1 Considerations for prognostic studies 
The present knowledge base of delirium is lacking in many areas, but there are many 
opportunities for important research. Issues with delirium have included poor rates of 
recognition and detection, identifying causation and appropriate treatment, the presence of 
disruptive behaviour and dealing with the aftermath of a delirium episode. As a result there 
are wide variations in clinical practice (e.g. geriatricians compared to psychiatrists) and 
inconsistent treatment guidelines. In order to produce good quality evidence, future studies 
require careful consideration of issues such as: informed consent which may be 
problematic due to the nature of delirium[251-253], the methodologies employed and 
identification of a suitable study population.  
When planning a prognostic study, study sample, case ascertainment and case definition 
should be clearly defined with justification of the selection criteria used. From the onset, 
studies should have well defined clinically significant outcomes, the results of which should 
be clearly documented. This also includes taking into consideration important confounding 
variables when measuring outcomes (e.g. accounting for the presence and relevance of 
dementia in a study sample). With regards to confounding variables, a suitably 
representative number should be chosen in accordance to the size of the study sample and 
these should be recorded at the time of assessment in order to minimise error. When 
examining the possible effects of confounding variables on the chosen study outcomes, 
appropriate statistical techniques (e.g. multivariate approach) should be applied and results 
should be presented in a clinically relevant context (e.g. use of confidence intervals and 
odds ratios). Considering the association between delirium and mortality, survival analysis 
(e.g. Cox proportional hazards model) would also be an appropriate statistic test to consider 
conducting.  
With regards to methodology, any follow up period should be clearly defined and justified. 
For example, would one month post-discharge be suitable to assess dementia or would a 
six month period be better suited. Assessment tools should be carefully selected with 
consideration given to what will the instrument be used for, who will conduct the 
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assessments, in what time frame and how often and is the tool suited to the population 
being studied.  
Other areas to consider include increasing knowledge of phenomenonology and its impact 
on outcomes as well as the long term psychological impact on patients after a delirium 
episode. Currently the pharmacological management of delirium is based on theoretical 
knowledge as opposed to well designed efficacy studies. Due the fluctuating nature of 
delirium, it is important to evaluate the efficacy of interventions using a placebo controlled 
study. However problems of consent (patient may be incapacitous during certain periods) 
and withholding treatment in a clinical situation would be the ethical sticking points. 
Outcome predictors need to be identified to assess the effectiveness of delirium 
interventions. With this in place, pharmacological interventions can then be tailored to treat 
the clinical presentations of delirium and their psychological impact, in order to be most 
effective and efficient. The combination of pharmacological treatment with environmental 
therapies also needs to be evaluated, in order to identify what treatments are most 
effective.  
 
1.6 Conclusion 
Delirium is an understudied neuropsychiatric condition that is associated with significant 
morbidity, increased need for hospitalisation and long term institutionalisation and a 
subsequent decline in cognitive and physical function. Delirium also carries a serious risk of 
mortality that is much higher in comparison to an illness like dementia. The management of 
delirium is primarily dictated by the setting and the population in which it occurs. However 
issues of non-detection, under diagnosis, misdiagnosis and lack of management and 
treatment experience are a cause for concern. No single speciality has assumed 
responsibility for the clinical management or study of delirium. This has subsequently 
resulted in inconsistent definitions, wide variation in research methodologies, inadequate 
consideration of confounding variables and heterogeneity of the populations studied making 
it difficult to interpret and compare findings. Fundamentally it has resulted in the under 
appreciation of delirium as a serious clinical indicator of significant morbidity and mortality. 
One study population that needs further investigation regarding its association with delirium 
is acute stroke. Chapter two will now provide a brief overview of stroke and its associated 
outcomes. 
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1.6.1 Key points  
 Delirium is a neuropsychiatric disorder that is accompanied by an underlying physical 
illness. 
 It is a common occurrence in the elderly; however delirium is often overlooked or 
misdiagnosed in clinical practice.  
 Undetected delirium can delay patient recovery and have an adverse effect on 
outcomes due to increased rates of morbidity and mortality.    
 Better staff awareness, efficient and effective detection methods and early 
interventions may help patients at high risk of delirium, but basic research is lacking.  
 A possible high risk group that has been identified as needing further investigation is 
the acute stroke population.  
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2 Stroke 
In more economically developed countries, stroke has been reported as one of the most 
important causes of ill health, disability and death and it was ranked as the third most 
common cause of death worldwide. Stroke has recently transitioned to the fourth leading 
cause of death globally, demonstrating the healthcare improvements and commitment to 
decrease cerebrovascular illnesses[254]. The World Health Organisation (WHO) defined 
stroke as; ‘rapidly developing clinical signs of focal (at times global) disturbance of cerebral 
function, lasting more than 24 hours or leading to death with no apparent cause other than 
that of vascular origin’[255, 256].  
The current data indicates that in developed countries; the economic burden of stroke is 
responsible for 2 to 4% of the total health expenditure[257] and it has the highest cost to 
society in the Western Hemisphere[258]. This economic burden includes both direct and 
indirect costs such as; the cost of hospitalisation, specialised care staff, rehabilitation, 
treatment/ management of subsequent medical complications, lost productivity and the 
caregiver burden and costs associated with loss of independence[259, 260]. Due to differences 
in the use of resources and units cost, the cost of stroke, length of stay and the survival rate 
varies across countries[261-263]. 
Considering the significant burden caused by stroke, research expenditure for stroke is 
comparatively less than the amount spent on heart disease and cancer research[264]. 
Awareness and recognition of stroke symptoms was found to be low in the general 
public[265], however the launch of recent media campaigns such as ‘FAST’ aimed to change 
this[266]. Stroke is strongly associated with an increase in age and with an impending ageing 
population, this disease requires more attention. The following chapter aims to give a brief 
overview of the epidemiology, risk factors and outcomes associated with stroke. This 
provides some context for the work conducted in this thesis.  
 
2.1 Clinical symptoms and subtypes  
Stroke is a clinical syndrome and can be caused by the interruption of blood supply to the 
brain due to a blood vessel ruptured (intracerebral haemorrhage), or an occluded blood 
vessel (cerebral infarction). Transient ischaemic attacks (TIA’s) are sometimes referred to 
as ‘mini strokes’ and are caused by temporary occlusions such that symptoms resolve 
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within 24 hours. A series of TIA’s can increase the likelihood of an acute stroke occurring 
and treatments such as thrombolysis[267] are administered to avoid future poorer outcomes 
for patients. Adverse outcomes post-stroke can vary between patients and may include 
increased mortality risk, prolonged hospitalisation or a decrease in cognitive function[268, 269]. 
A stroke can be identified by sudden numbness or weakness in one half of the body or a 
single limb, incoherent/ slurred speech, confusion, changes in gait, problems with balance 
or coordination and blurred or double vision[270, 271, 216]. Non-specific presentations such as 
confusion, immobility, incontinence or falls may also be present but these can also be 
attributed to conditions other than stroke[272, 273]. The symptoms of stroke can have a similar 
presentation to features of a delirium, which were previously described in Chapter one. 
Thrombi 
[255]
 Damage area 
[274]
 MCA occur 
[255] 
 
 
Image obtained from aurorahealthcare.com 
 
Figure 2.1: Types of stroke. 
An ischaemic stroke is caused by a lack of blood flow to certain brain areas due to 
hypoperfusion, the presence of emboli or the formation of thrombi[255]. A decrease or lack 
in blood flow means that certain brain areas become deprived of oxygen. If there is a 
lack of oxygen for approximately 60 to 90 seconds, the brain will cease to function and a 
lack of oxygen for over three hours can lead to irreversible brain damage[273]. 
Haemorrhagic strokes on the other hand, are caused by weakened blood vessels which 
can rupture causing blood to accumulate in certain brain areas. In these types of 
strokes, the brain area is damaged by tissue compression due to the accumulation of 
blood in that area. The site and severity of the damage determines the fatality of the 
stroke and whether the subsequent disabilities are temporary or more permanent. The 
territory supplied by the middle cerebral artery (MCA) is where most strokes usually 
occur[255].   
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Clinical subtypes of stroke include intracerebral bleeding, subarachnoid haemorrhage 
(SAH) and infarctions. An infarct can be further divided between large vessel disease, small 
vessel disease (lacunar), cardioembolism and rare causes such as venous infarction, 
vasculitis, and infective endocarditis[275]. Subarachnoid haemorrhages are consistent with 
the clinical definition for a stroke, but are regarded as a separate entity due to the different 
clinical presentation and distinctive management[276]. Vascular dementia, silent infarctions 
and TIA’s are examples of cerebrovascular conditions that do not readily fit the WHO 
definition of stroke[277, 278]. This is an especially common problem in the elderly population 
for whom the diagnosis of an acute stroke may be more problematic[279]. Correct 
characterisation of the stroke using classification scales[280] can help determine information 
such as treatment plans, risk of recurrence and long term prognosis.  
 
2.2 Epidemiology of stroke   
Stroke is a debilitating disease with significant long term consequences. Its high prevalence 
indicates that it is accompanied by significant economic and social burden[260]. 
Approximately 150,000 people suffer from stroke each year in the UK[281] and 200,000 
deaths per annum in the USA and Europe can be attributed to stroke[281].  
Over 80% of strokes occur in people aged over 65 years and the annual incidence of stroke 
rises 1% with each year in this group of people[282]. After the age of 85 years, 25% of men 
and 20% of women can be expected to suffer a stroke[283, 284]. According to estimates from 
The National Service Framework for Older People, each year over 100,000 people in 
England and Wales people suffer a first stroke[285, 286]. Based on a review of epidemiological 
study data, it was estimated that in a population of one million people, 1800 patients will 
present with a first stroke, 600 patients with a recurrent stroke and 500 patients will present 
with a TIA[287].  
In 1999 data from the Fourth National Morbidity Survey[288] in England and Wales was 
analysed for stroke incidence, workload and pattern of disease in general practice in 
relation to the patient’s age, sex, socioeconomic status and aetiological contribution of 
identified risk factors for stroke. The one year prospective cohort study (1991-1992) 
surveyed 502,482 patients across 60 general practices in England and Wales. It was 
estimated that there were 87,700 people with a first ever stroke and 53,700 with a recurrent 
stroke, giving a total number of 133,700 strokes overall.  
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Although there has been a steady decline in stroke mortality over the past three decades, 
other measures of disease burden are needed[289, 290]. Incidence rates can help to identify if 
the case fatality is changing over time and measure the true burden of the disease[291, 292, 
286]. National incidence data are limited due to the large amount of data, cost and time 
involved with such research[257]. Instead incidence studies are often localised to specific 
areas or communities[293-295, 283, 296, 297], which may not be an accurate representation of the 
general population[298, 299]. Such data are important for policy makers and health 
organisations e.g. Department of Health (DoH), National Institute for Health and Clinical 
Excellence (NICE), to plan for and organise stroke care nationally. Important considerations 
for economic studies for stroke include standardisation of stroke reporting[298] and 
maintaining stroke registers[300], longer duration of patient follow ups, inclusion of a broad 
range of services for patients post-discharge and social care and support provision[301, 302].  
 
2.3 Aetiological causes of stroke 
The causes of stroke include heart disease, small and large vessel disease, hypertension 
and venous thrombosis[303]. There are numerous risk factors that can also accumulate over 
time and contribute to the onset of a stroke but preventative treatment of these factors can 
help to reduce the risk of a stroke occurring[304-306].  
Previous studies[307, 308] have identified a large number of possible risk factors, the 
evidence[309, 310] for which has been summarised in various reviews of the literature. Risk 
factors include; increasing age[311], male gender[312], certain ethnicities[313], cardiovascular 
disease[314], ischaemic heart disease[315], atrial fibrillation[316], carotid artery stenosis[317], 
diabetes mellitus[318], hypertension[319], hypercholesterolemia[320], hyperlipidaemia[321], sickle 
cell disease[322], previous TIA’s or strokes[323], smoking[324], alcohol[325], drugs[326], 
inappropriate diet lacking fruit and vegetables[327], lack of exercise[328, 329] and social 
status[330].  
The incidence of stroke increases with age and the risk of having a stroke are doubled 
every 10 years after 55 years of age[284]. Although stroke is more prevalent in the older 
population, 10% of strokes occur in younger adults under the age of 50 years[331]. Studies 
have found that males are more prone to strokes than females, but women have a higher 
risk of stroke mortality of over 60%[281]. Those with a family history of stroke may also be 
more susceptible to stroke. For example the presence of a genetic disorder such as 
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Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and 
Leukoencephalopathy (CADASIL)[332] can increase the risk.  
People in the African-Caribbean and South Asian communities have a much higher risk of 
death from stroke and are twice as likely to have suffer a stroke compared to people who 
are Caucasian[333, 334]. A study found that after adjusting for age, the prevalence of stroke 
was 40% for African-Caribbean and 70% for South Asian men[335]. These groups are at a 
higher risk partly due to the high incidence of obesity, diabetes and hypertension. Other 
factors such as geographical location seem to increase the likelihood of having a stroke i.e. 
more common in south-eastern United States[336, 337]. Social status also seems to be a 
possible risk factor as analysis has shown that unskilled manual workers (low income 
socioeconomic group) have a 60% higher stroke risk in comparison to professionals (more 
affluent socioeconomic group). The mortality is also 50% in the low income group 
compared to the more affluent[338]. However these findings seem to vary between levels of 
economic development of specific  countries[339].  
As mentioned previously, TIA’s are often seen as strong predictors of an impending stroke 
(ten times more likely than someone who has not had a TIA). Similarly history of a previous 
stroke also increases the chances of having another stroke in the future. The association 
between first strokes and recurrent strokes against the known risk factors was reviewed[303]. 
It was reported that increasing age, atrial fibrillation, diabetes, heart failure, ischaemic heart 
disease, hypertension, smoking and previous TIA’s were strongly associated with first time 
strokes[303]. Similarly with recurrent strokes, there were strong associations with again 
increasing age, diabetes, hypertension and also a history of TIA’s and previous stroke[340, 
341].  
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2.3.1 Prevention strategies 
The phrase ‘prevention is better than cure’ is certainly appropriate for stroke when the 
economic and social burden and the long term impacts are considered. There is a 
significant effort being made to educate the general population and put preventative 
measures in place that address stroke risk factors[304, 305, 342, 306]. Government campaigns 
involving the promotion of a healthier lifestyle consisting of a better diet, regular exercise, 
decreased intake of alcohol and cessation of smoking are recommended and encouraged. 
Studies have shown that increasing age, male gender and previous TIA’s or stoke are 
important factors but these are unmodifiable. However some of the important modifiable 
risk factors and their effectiveness are as follows.  
 Cardiovascular disease – This includes peripheral artery disease which is a 
narrowing of the blood vessels in the limbs, due to atherosclerosis. Peripheral artery 
Prevalence of stroke in England among minority ethnic groups in 
the year 1999 
 Male % Female % 
Black 3.2 0.8 
Indian 2.5 0.7 
Pakistani 0.7 0.6 
Bangladeshi 1.2 0.4 
Chinese 0.7 0.2 
Irish 2.0 2.0 
General population 2.3 2.1 
Image obtained from The Stroke Association 
 
Figure 2.2: Prevalence of stroke according to ethnic groups. 
The figure above lists the percentages of men and women that suffered a stroke, 
according to their ethnicity.   
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disease can increase the risk of carotid artery disease/ stenosis. In this condition, the 
carotid arteries that supply blood to the brain can develop atherosclerotic plaques from 
which a thrombus forms and may embolise within the cerebral circulation. Other 
conditions that increase stroke risk include coronary heart disease, heart failure, heart 
valve disease, dilated cardiomyopathy and possibly even congenital heart defects.  
 Diabetes mellitus – In England, 4% of men and 3% of women suffer from diabetes 
which is an independent risk factor for stroke[309, 310]. People with diabetes are also 
often found to have hypertension and hypercholesterolemia which again further 
increases the level of stroke risk. The presence of diabetes means that sufferers are 
two to three times more likely to have a stroke than those without diabetes[343].  
 Atrial fibrillation – An irregular heart rhythm means that the heart does not beat 
effectively and allows blood to pool and clot which can lead to the formation of emboli 
that travel in the blood and cause blockages in the arteries supplying blood to the brain. 
Atrial fibrillation is often found in 15% of stroke patients and increases risk of stroke[344].  
 Hypercholesterolemia – Also known as hyperlipidemia. A typical blood reports the 
amount of total cholesterol, high density lipoproteins (HDL), low density lipoproteins 
(LDL) and triglycerides. LDL’s sometimes referred to as ‘bad’ cholesterol can build up 
to form blockages on the inside of artery walls and have been reported as a risk factor 
for stroke. On the other hand HDL’s, sometimes referred to as ‘good’ cholesterol are 
thought to lower risk stroke but the effects are not as clear and further investigation is 
needed in this area. However lowering the overall circulating levels of cholesterol in the 
blood is recommended[345]. Cholesterol target levels may differ for individuals and the 
level of risk can be affected by the addition of illnesses and other contributing factors.  
 Hypertension – In England, 34% of men and 30% of women suffer from high blood 
pressure, however not everyone receives active treatment[343] for it (78% of men and 
67% of women) despite it being the most controllable risk factor! 50% of ischaemic 
strokes are caused by hypertension and so it is important that blood pressure is 
maintained at a suitable level.  
Some risk factors require no active medication or treatment and can be modified by simple 
life changes such as; 
 Smoking – Studies have shown that the nicotine and carbon monoxide in cigarettes 
can cause significant damage to the cardiovascular system[346], leading to the 
conditions previously described. Smokers have a two to four time greater risk of stroke 
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compared to non-smokers[343]. 10% of stroke deaths are attributed to smoking and it is 
estimated that in the UK there approximately 12.5 million smokers[281]. However 
cessation of smoking decreases the level of risk back to a level that is comparable to 
that of a non-smoker[343]. As a result there number of services and recommendations 
available to the public to help them give up smoking.  
 Diet – Food intake that is high in fat and salt content can lead to hypertension and 
hypercholesterolemia and excessive intake can lead to obesity, all of which can 
contribute to an increased risk of stroke. A healthy balanced diet with the 
recommended five portions of fruit and vegetables a day can help to decrease stroke 
risk by 6%[343, 327]. A healthy diet can also help decrease obesity which is a risk factor 
not just for stroke but for many other health issues such as heart disease and diabetes.  
Currently 25% of men and 24% of women have a BMI of over >30, which makes them 
clinically obese and puts them at an increased risk of stroke[329].  
 Physical activity – Moderate exercise such as 30 minutes of activity a day can help 
with a healthy lifestyle and decrease the occurrence of health issues such as 
hypertension, hypercholesterolemia and obesity. Moderate physical exercise has been 
shown to reduce the risk of stroke by up to 27%[328].  
 Substance abuse – Alcohol abuse can lead to a number of complications and there is 
a strong association between heavy drinking and stroke. A study showed that males 
who drank over 35 units per week doubled their risk of mortality from stroke[325]. 
Similarly drug abuse can lead to a number of health and social problems and drug 
abuse is often reported as a cause for stroke in younger adults[326]. Drugs such as 
heroin[347], amphetamines and cocaine[348] have been reported as a stroke risk. 
Medications such as oral contraceptives when combined with smoking have also been 
shown to be a possible stroke risk[349].  
There are also a number of environmental aspects and confounding variables that can 
impact on these risk factors, influencing the incidence and outcomes post-stroke, which will 
be discussed later in the chapter.  
 
2.4 Hospital management of stroke 
A person suspected of stroke is commonly admitted to the Accident and Emergency 
Department either by GP referral[350] or brought in by the Ambulance Service. An initial 
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assessment is then conducted in the Emergency Department. The diagnosis of stroke 
involves taking a careful history either from the patient or a family member or carer. 
Information about the events, symptoms, time onset and duration and past medical and 
family history help to determine the path of the diagnostic process[351, 352].  
In 10 to 20% of suspected strokes are found to have an alternative diagnosis, although this 
can vary[353]. Stroke ‘mimics’ can include an old stroke with an increase in weakness due to 
a current illness, subdural haematomas, cerebral tumours, cerebral abscesses, 
encephalitis, venous thrombosis, cerebral vasculitis, hypoglycaemia or fits[354, 353, 277]. The 
cardiovascular system is examined to identify possible aetiological causes. Neurological 
deficits after a stroke are time dependent and are often unstable prone to sudden 
improvements or deterioration in the first few hours after a stroke. Beyond 6 to 10 hours, 
these deficits do not change as suddenly as the effects of the injury have increased. Due to 
potential beneficial effects of early neuroplasticity, some patients may experience modest 
improvements in the neurological deficits in the sub-acute period (12 hours to 7 days) post-
stroke[355]. The clinical stroke syndrome can be identified using descriptors such as the 
National Institute of Health Stroke Scale (NIHSS), ICD 10[138] (codes 430-434 and 436-438) 
or the Bamford stroke classification scale[280]. Confirmation of diagnosis and pathology 
(infarct or haemorrhage) is often confirmed by brain imaging scans such as a Computerised 
Tomography (CT) or Magnetic Resonance Imaging (MRI) (Figure 2.3). The aim is to 
perform CT scans for suspected strokes within 24 hours of admission to hospital, to exclude 
the possibility of a haemorrhage which presents itself as white areas on the scan image. 
Further tests may be conducted to identify other causes[134] and an MRI scan may be done 
to identify an ischaemic stroke and/ or old stroke sites. Time is critical factor in the 
management of stroke and often the stroke patient are seen within 10 to 15 minutes upon 
hospital arrival, the CT scan is performed and interpreted in less than one hour and the 
patient is transferred to the appropriate inpatient ward within four hours from the point of 
hospital admission.  
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Chalela
[356]
  CT
[357, 358]
  PET
[356]
  SPECTaeitiology 
[137]
 
It is beneficial to conduct a simple cognitive test to determine baseline cognition post-
stroke. Often the AMTS is administered upon hospital admission to determine the patient’s 
orientation to time and place. This is then subsequently followed up by tests such as the 
MMSE and/ or the MoCA to gain a better understanding of the patient’s cognitive level. 
Tests can also help to identify any special issues that require attention such as dysphasia. 
As secondary deterioration is common in the first week post-stroke, the neurological exam 
can help to document a baseline activity for the patient so that any subsequent deterioration 
can be detected. Given that stroke is a disease that is prevalent in the older population, the 
significant co-morbidity associated with this group should be considered when making a 
stroke diagnosis[358, 359, 279]. Differential diagnoses in the elderly include; Parkinson’s 
disease, dementia, psychiatric illness, metabolic disturbances and intoxication[278].  
Patients are often transferred to stroke units[360] for further management which might 
include thrombolysis treatment to dissolve blood clots causing cerebral infarction. In clinical 
practice, despite a comprehensive work-up, sometimes the cause of the stroke can remain 
undetermined. This is true of 20 to 40% of cases[307]. Once an accurate diagnosis of stroke 
has been made, clinicians are able to tailor treatments to each individual patient and 
estimate the patient’s long term prognosis. All this can have an impact on the post-stroke 
outcomes will now be discussed.  
 
 
Type of Stroke CT scan MRI scan 
Sensitivity Specificity Sensitivity Specificity 
Ischaemic stroke  16% 96% 83% 98% 
Haemorrhagic stroke   89% 100% 81% 100% 
Image adapted from the paper by Chalela et al
[354]
. 
 
Figure 2.3: The sensitivities and specificities of CT and MRI scans. 
Studies have shown that MRI scans are a far more sensitive technique compared to CT 
scans[355, 356]; however they do have some limitations. For example MRI’s do not tolerate 
patient movement well and so a successful scan requires the patient to co-operate for a 
longer period of time. Also those patients that have pacemakers cannot have an MRI. 
Techniques such as Positron Emission Tomography (PET) scans which when combined 
with certain isotopes (FDG) can track the metabolic activity of specific neurons[354]  whilst 
Single Photon Emission Computed Tomography (SPECT) scans can monitor the 
cerebral blood flow (CBF) which can help to determine the aetiology[135].  
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2.4.1 Outcomes linked to stroke  
With an impending ageing population, the improvement of geriatric medicine is an important 
consideration for future healthcare[359] and this includes the development of stroke 
medicine. Studies have shown that once a stroke has occurred, admission to a stroke unit 
is associated with improved outcomes compared to general wards[361, 362]. Studies have 
found that the earlier rehabilitation is started after a stroke, the better the functional 
outcomes for the patient in the long term[363, 361, 364].  
Over the last decade or so, there have been a number of initiatives that have helped to 
make the stroke treatment and rehabilitation process more efficient[365-367]. These include; 
the introduction of acute and (more recently) Hyper Acute Stroke Units (HASU) and 
dedicated rehabilitation stroke units, speedier transfers to and between the stroke units, 
provision of thrombolysis treatment and CT scans within a few hours of stroke, specialised 
stroke teams, use of multidisciplinary teams to plan patient care across the hospital, 
adequately trained staff, implementation of nursing ‘critical care pathway’ systems and 
standardised stroke protocols, reducing length of stay by efficient diagnostic evaluation and 
good communication and discharge planning with the patient’s future care providers. 
Overall this has led to the delivery of good individual patient care and the overall care 
package for stroke is continually being improved[361, 368, 369, 342, 370, 371]. 
In a general hospital serving a population of 250,000 people, 4% of beds of the general 
medical beds will be occupied by stroke patients (25 to 35 individuals)[281]. As strokes are a 
common occurrence, a large proportion of the NHS financial budget is spent on providing 
prevention interventions, acute treatment and long term care associated with stroke. 
Mortality is the worst outcome of stroke and over 60,000 deaths in the UK are due to 
stroke[281], the detailed results of which can be seen in Figure 2.4a and 2.4b. Although 
stroke mortality and incidence has declined in recent years, the risk of mortality has 
remained constant. It is reported that in the first year after a stroke 30% of patients will die, 
usually within the first 10 days post-stroke[372]. Of those that survive, a third are likely to 
make good recovery progress within one month and a third will be left with significant 
disabilities that require long term care[260, 373, 374].  
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Breakdown of the number of deaths caused by stroke in the 
UK, by age and gender, in the year 2004  
 Males Females Total 
Under 35 109 100 209 
35 to 44 years 263 207 470 
45 to 54 years 613 530 1,143 
55 to 64 years 1,434 1,085 2,519 
65 to 74 years 3,955 3,289 7,244 
Over 75 years  16,596 32,277 48,873 
Total 22,970 37,488 60,458 
Image obtained from The Stroke Association 
 
Figure 2.4a: Stroke mortality according to age and gender. 
The figure above lists the number of men and women that suffered a stroke, according 
to their age and gender.   
 
 
Breakdown of deaths from stroke by country, in the year 2004  
 Males Females Total 
England 18,940 30,621 49,561 
Wales 1,195 2,112 3,307 
Scotland 2,294 3,861 6,155 
Northern Ireland 541 894 1,435 
UK 22,970 37,488 60,458 
Image obtained from The Stroke Association 
 
Figure 2.4b: Stroke mortality according to geographical location. 
The figure above lists the number of men and women that suffered a stroke, according 
to their location.   
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With regards to patient outcomes, studies have shown that several complications can 
develop interfering with common stroke complications such as pneumonia, Deep Vein 
Thrombosis (DVT), Pulmonary Embolism (PE) with neurological features, after a stroke. 
Figure 2.5 illustrates the frequency of some of the post-stroke patient outcomes.  
 
 
 
Aside from the significant mortality risk post-stroke, other medical complications[374] include: 
the onset of dementia[375-381], depression[382-386], epilepsy [387], seizures[388], increased risk of 
falls[389], fatigue[390] and changes in attention[391], cognition[392, 393, 214, 394, 395], emotional 
behaviour[396, 397], mood[398] and affective disorders[161, 399, 400] and self esteem[401-404].  One 
year on and 65% of patients will be living independently whilst the remaining 35% will need 
help with activities of daily living[405, 406, 301]. This specialised care and attention can be in the 
form of, moving in with family members, requesting home help, using rehabilitation centres 
and some may require long term institutionalisation[368]. Statistics show that of the post-
 
Image produced from data from The Stroke Association. 
 
Figure 2.5: Post-stroke patient outcomes. 
The figure above lists the frequency of some of the outcomes patients experience after a 
stroke. Percentages given are the maximum values of the ranges provided in the data. 
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stroke survivors at twelve months; 80% are back home, 12% live in a residential/ nursing 
home whilst 8% are totally dependent on others[281].  
 
2.5 Considerations for further stroke research  
Evidence based medicine is essential both for clinical practice but also as the course and 
outcomes related to stroke can be used by policy makers (e.g. GMC, NICE, WHO) to 
standardise and organise future stroke care[407-409]. The design of an audit means that there 
is no adjustment for potential bias and so aetiological and prognostic studies are needed 
Important considerations for economic studies for stroke[298, 299] include standardisation of 
studies reporting on stroke, larger incidence studies and maintenance of stroke registers 
globally, longer duration of patient follow ups, standardisation of outcome measures, 
inclusion of a broad range of services for patients post-discharge and social status and 
support provision[410, 290, 301, 411].  
Studies in stroke (both aetiological and prognostic) have variable methodologies. 
Aetiological studies use different definitions and measures to record risk factors, which 
makes the results between studies difficult to compare. Many aetiological studies are also 
retrospective in design and rely on data that has been collected for other purposes such as 
mortality. This means that the subsequent data collected is susceptible to recall error as a 
significant amount of patients may be suffering from memory impairment and hospital data 
records are not always reliable. Also figures for stroke mortality and incidence have 
declined over the last few decades, but the risk of mortality remains constant which 
indicates that mortality may not be a suitable measure due to changes in other factors (e.g. 
case fatality).  
Some studies do not account for confounding variables in their statistical analysis, which 
makes their results questionable. Some studies do not have case matched controls again 
leading to possibly questionable findings. Consideration must also be given to selection 
bias when recruiting participants for research[412]. Studies with low recruitment rates may 
lack adequate power, as to identify any meaningful confounders large patient groups are 
needed[413]. Studies that do not present findings within a clinical context and fail to provide 
odds and/ or relative risk ratios make comparisons between studies more difficult.  
Despite this there have been a number of studies upon which successful stroke prevention 
measures have been based. However the evaluation of the effectiveness of these 
measures is another matter. The care process in stroke is full of variables such as different 
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stroke protocols, the training of the team members and variations in the standard of care 
they provide, the type of stroke and the physical and psychological condition of each 
individual patient all need to be taken into account. Many studies also fail to account for 
confounding variables by not including them in their analysis, using very few variables for 
analysis or using inappropriate statistics to analyse the effect of the variables.  
For prognostic studies, well defined outcome measures that are clinically relevant need to 
be decided upon and defined at the beginning of the research. The duration of follow up 
and the justification for this time period should be made clear and not be a burden on the 
patient. Studies based across different institutions can also have an effect on the outcomes 
as there can be differences in the population specific to that geographic location, 
differences in stroke protocols and care pathways and differences in service provision (e.g. 
not all hospitals have acute stroke units or a certain number of beds allocated to stroke 
patients). These variables need to be considered when designing a study and prospective 
designs are most well suited as it decreases errors such as information recall as previously 
mentioned. Furthermore the majority of studies tend to focus on outcomes such as mortality 
and although this is clearly important, it may not be the best indicator. A better indicator 
would be the significant co-morbidity associated with stroke and the impact it has on patient 
outcomes. However challenges over how to quantify this, the effect of confounding 
variables and how this can be interpreted for clinical use needs to be considered so that the 
findings can be of use to the general population. In addition to the smaller population based 
studies, consideration should also be given to more large scale international studies that 
pool together global resources and data[409]. 
 
2.6 Conclusion 
Stroke is an important cause of mortality and morbidity for the older population. Stroke 
diagnosis can be difficult due to other presence of other illnesses. Although stroke care has 
improved significantly over the last decade, further research is required into the aetiology 
and long term outcomes for patients post-stroke. In stroke the addition of complications in 
the older population can hinder rehabilitation and one such complication is delirium. 
Chapter one discussed the adverse effects delirium can have on patient outcomes and that 
certain patient groups may be at a higher risk of delirium. Stroke was identified as one such 
patient population that requires further investigation. In Chapter three the published 
literature available will be analysed by a systematic review to evaluate the incidence, 
patient outcomes and risk factors that arise when these two conditions concurrently occur.  
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2.6.1 Key points  
 Stroke is an interruption of the brain’s blood supply caused by an occlusion or a bleed 
in the blood vessels of the brain.  
 It is now the fourth largest cause of death in the world, with the risk of dying at 12% in 
the first seven days, 19% at one month and 30% within one year from a first time 
stroke.  
 Stroke has many complications and around half of stroke survivors will be dependent 
on long term care for day to day activities.   
 It is common over 65 years of age and due to an ageing population, the number of 
stroke survivors and cost of care will also increase in the future.  
 Delirium is a complication that when combined with stroke can have an adverse effect 
on patient recovery and this requires further investigation.  
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3 Delirium and acute stroke 
3.1 Introduction: The clinical problem 
Previous studies indicate that patients who develop delirium tend to have worse outcomes 
which include increased risk of complications, mortality, morbidity and worse physical, 
cognitive and psychological outcomes[228, 414, 230]. Delirium has also been associated with 
increased healthcare costs, which include longer hospital stays and the increased need for 
institutionalisation post-discharge[415, 164, 78, 186].  
The patient populations observed in these previous studies included; surgical[234, 416, 84] and 
medical patients[417, 66, 418, 419, 153], hip fracture patients[420, 49, 421, 422] and people suffering from 
terminal illnesses[70, 423, 162]. In these studies, the clinical importance of delirium in patient 
care was highlighted and almost all of the studies concluded that further research on 
delirium was required. Recommendations were also made for the detection, prevention or 
management of delirium for those specific study populations. In comparison there is limited 
research on the epidemiology, prevention, management or outcomes of delirium in the 
stroke population.  
 
3.1.1 The detection of delirium 
The standardised research tools often employed to diagnose delirium have been developed 
and validated based on the DSM-IV and ICD-10 assessment criteria. However screening 
for delirium is not a routine procedure[56] and the hospital wards that do so, often use 
assessment tools that focus on cognitive function rather than the specifically designed 
delirium detection tools[424]. Furthermore, the research diagnostic tools developed for 
delirium often vary in sensitivity and specificity[142], thus affecting the reliability of delirium 
detection. This variation in results may also be due to lack of staff awareness[425], training or 
inexperience in detecting delirium[426], resulting in low inter-rater reliability. In addition to 
this, the temporary and fluctuating nature of delirium, and the different delirium subtypes, 
can make it difficult to detect[27]. Misdiagnosis may also occur as the symptoms of disorders 
such as dementia, depression and anxiety can overlap with the features of a delirium 
episode and so making a correct diagnosis can become challenging[145, 427, 428]. The early 
detection of delirium is recommended[429] and it is clear that more needs to be done to 
improve the detection and management of delirium[430].  
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3.1.2 The complications of stroke 
Due to the multifactorial nature of delirium, a single case may have several risk factors 
contributing to the presence of delirium[431]. Stroke in itself can be a challenging diagnosis to 
make due to the presence of stroke mimics. The presentation of stroke symptoms is also 
variable dependent on the brain territory affected by the stroke[278, 432, 433]. Many stroke 
patients are often physically unwell due to a number of complications post-stroke. These 
complications are shared factors linking the stroke and delirium. Increased age is thought to 
be a risk factor for delirium[434, 113] and the majority of stroke patient tend to be over 65 years 
of age. It is known that stroke is a predisposing factor for the onset and/or development of 
delirium[228, 435] and yet few studies have been conducted in the stroke population to 
investigate delirium.  
Symptoms of a stroke can include changes in mobility, blurred or double vision, slurred/ 
incoherent speech and confusion as described in Chapter two. These symptoms can 
overlap with the features of delirium, making the detection of delirium in stroke patients 
more challenging as is it difficult to ascertain whether the true nature of the patient’s 
symptoms have been caused by the stroke itself or if in fact they are features of a possible 
delirium.   
In addition to this when using tools to detect delirium, certain symptoms such as slurred or 
incoherent speech caused by the stroke may make the delirium instrument unreliable. 
Recent guidance issued by the National Institute for Clinical Excellence (NICE)[133] clearly 
stated the importance of identifying delirium as soon as possible, especially in patients over 
the age of 65 with significant illness. However at present, there are no clear guidelines 
being implemented regarding recommendations for multidisciplinary treatments, the best 
method to screen for delirium and if stroke patients should have a standard screening 
method in place for delirium detection.  
 
3.2 Justification for further investigation  
It is clear that further research is required to investigate the presence of delirium within the 
acute stroke population[436, 171, 120, 173, 38, 46, 175] and processes need to be put into place to 
help alleviate some of the aforementioned problems[112]. For possible interventions to be 
effective, a number of points need to be considered which include: the wide range of 
aetiology factors associated with delirium, the used of standardised diagnostic tools that are 
accurate and reliable, fixed measures to improve and evaluate delirium management in 
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order to improve patient outcomes and the quality of patient care and delivery of a standard 
and effective protocol. 
In order to develop a standard screening protocol to manage delirium post-stroke, it is 
important to determine the occurrence and outcomes within the stroke population, which in 
turn will have an effect on the planning, delivery and evaluation of any future intervention. 
The occurrence of delirium post-stroke will influence the cost per case and the predictive 
value of screening for the syndrome. The type of intervention offered will also be affected 
by how common the syndrome is within the specific patient population. The patient 
outcomes associated with delirium post-stroke will determine whether it is feasible to plan a 
screening protocol or intervention strategy and whether its economic implications will make 
it cost effective in the long term. 
 
3.2.1 Objectives of the systematic review  
In contrast to traditional or narrative reviews, systematic reviews use a well defined rigorous 
approach to collect and analyse the available literature in a specific subject area[437]. 
Systematic reviews use strict criteria to identify a complete list of all published and 
unpublished studies. The literature is critically evaluated and synthesised in the least biased 
way to answer well focused questions about clinical practice.  
Prior to planning any new investigations, a better understanding was required of the 
relationship between delirium and acute stroke and its impact on patient recovery. In order 
to do this, a systematic review was undertaken to investigate delirium and acute stroke. The 
aims of the review were to identify gaps in the available literature and to use the findings to 
help design new work. At the time of the original search conducted in June 2010, no 
systematic reviews on delirium after acute stroke had been published, to my knowledge. 
The objectives of this systematic review were to determine the following: 
1) The occurrence of delirium. To analyse the incidence rates of delirium in stroke and 
determine the periods during which delirium screening is conducted.  
2) Evaluating the related outcomes. To determine what outcome measures were 
chosen, the assessment tools employed and what were the durations of the follow up 
periods for the participants.  
3) Identify confounding variables and/or associated risk factors. By highlighting key 
variables and their clinical utility risk on outcomes, future study designs could be 
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altered in order to avoid potential sources of bias and/ or producing inadequately 
powered studies.  
The three key aims of the systematic review would help to plot a ‘natural history’ of delirium 
in order to identify when best to test for delirium onset and plan a predictive pathway with 
suitable time points for intervention and evaluation.   
 
3.3 Points to consider when critically analysing studies   
In order to inform discussion, a comprehensive search needs to be made of the topic areas 
to identify suitable studies. These studies are critically analysed to identify any limitations 
that could be potentially be improved upon in future investigations. During the process of 
critical analysis, the following general points should be considered.  
a) Composition of the cohort. The study sample can greatly affect the outcomes of a 
study and attention should be given to how the sample was constructed. In this review, 
the age of the sample population should be generalisable to the elderly population, 
which for most studies is stated as 65+ years but a minimum age limit of 55+ years can 
be considered in this review. Those with a significantly young sample population may 
not be as representative. How were the participants recruited (consecutive or non-
consecutive admissions), what sampling techniques were employed to reduce 
selection bias (systematic or random) and did the setting from which the sample was 
extracted have any unusual features that may prevent its generalisability to other 
similar settings? Were the inclusion and exclusion criteria clearly stated, were they 
applied uniformly to all potential participants and were all potential participants 
included? Did the sample size remain consistent throughout the study or where there 
fluctuations indicating that the sample may not have been treated in the same manner? 
And finally was there a high recruitment rate provided, indicating a comprehensive and 
inclusive study sample? If recruitment rates were low, was an adequate explanation 
given.  
b) Identifying the case (ascertainment). Although there may be a number of 
instruments available, attention must be paid to the suitability and use. Were the 
chosen assessment tools suitable for detecting the cases intended/ specified, 
appropriate for the setting they were used in and had they been validated for use in 
that specific population?  
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c) Defining the case (diagnosis). Did the chosen diagnostic tools have a high sensitivity 
and specificity, good inter-rater reliability and test-retest accuracy? Were the tools rated 
against ‘gold standard’ reference criteria or other similar assessment tools? Do the 
tools require any specialist training or administration by a trained medical professional? 
Was the administration of the tool done by one investigator, multiple investigators or by 
the participant themselves, which may also introduce variation in the assessment 
scores? Were the tools administered on a regular basis or just at one specific time 
point as a single test can only provide a snapshot at a specific time point whereas 
repeat tests can build up a more accurate diagnosis? Furthermore certain scales may 
not be suitable to assess the outcomes in elderly and may require alterations in order 
to capture usable data. Are the chosen tools part of a larger test battery and do they 
work well together and are the selection of tools well tolerated by the elderly 
participant?  
 
3.4 Methodological considerations  
3.4.1 Definitions of search terms  
Case ascertainment and case definition are of key importance when analysing 
epidemiology studies. For example the frequency of delirium detection assessments 
recorded could have a significant impact on the findings due to the fluctuating nature of 
delirium. Therefore it is important to determine whether incidence or prevalence was 
reported when interpreting the study findings, as there is a significant difference between 
the two terms. Incidence is defined as the frequency of new cases recorded within a certain 
time period e.g. during the follow up of a cohort over a one year period. In contrast, the term 
prevalence is used to define the number of existing cases recorded at a specific point in 
time for the cohort being studied. Essentially prevalence is the burden of a disease, where 
the numbers of new cases are added to the old cases to give a cumulative total at that time. 
Not all of the studies selected in the systematic review clearly defined whether they were 
recording incidence or prevalence and so a technique previously used in another 
systematic review was employed. For the purposes of this review, the term occurrence, as 
described by Siddiqi et al[121], was used to record the rates of delirium and a description and 
frequency of the recordings was also noted in the data extraction.  
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3.4.2 Inclusion criteria  
The following types of studies were included; prospective cohort studies, longitudinal 
studies, case control studies and controlled trials. All adult participants over 18 years of age 
with a clear diagnosis of stroke and subarachnoid haemorrhage were included. As the 
patient population being investigated was acute stroke, studies in hospital general medical 
inpatients, stroke units, accident and emergency and intensive care units were considered. 
Articles that were written in languages other than English were included, provided that a 
suitable translation of the article could be obtained.  
 
3.4.3 Exclusion criteria  
The following types of studies were excluded;  
a) Retrospective studies – Ward registers are regarded as poor sources of information 
as they are not regularly updated and so the recorded data may be unreliable. It is also 
unlikely that delirium will have been identified upon admission and often other 
conditions such as the stroke itself are given higher diagnostic priority. Therefore 
studies where the cohort data collection was done retrospectively were excluded.    
b) Specific patient case studies and small case series – These were excluded as they 
were unlikely to provide any incidence data and such small sample numbers would be 
insufficient to draw conclusions that would be generalisable to the population under 
investigation.    
c) Review papers, editorials, opinion articles/ letters and conference proceedings – 
These were unlikely to provide any new incidence data or provide statistical analysis or 
critical analysis of the available literature, to promote further understanding.  
d) Descriptions of service pathways, new technological detection methods, 
management/treatment techniques and investigations into the pathophysiology – 
These were rejected as again they were unlikely to provide any new incidence data.  
e) Study samples derived from community and hospice settings, psychiatric units 
and surgical units – The selected cohorts needed be generalisable to the chosen 
population. As the study population was acute stroke, the sample population would 
most likely be hospital based to reflect this and so any atypical settings were excluded.    
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f) Study samples recruited solely based on a diagnosis of delirium – The population 
should be relevant to the topic under investigation. Therefore studies where subjects 
were recruited only based on their delirium diagnosis with no attention given to their 
stroke diagnosis were excluded.  
g) Participant groups diagnosed with other conditions – Subjects diagnosed with 
delirium tremens, neurological brain damage (e.g. neurodegenerative disorders) and 
brain injury were excluded as these may impact on the progression of the symptoms 
under investigation.  
h) Studies where the definition of delirium did not match the current consensus for 
delirium – cases where the definition of delirium were not clear. Ideally cases should 
be identified and diagnosed using the DSM III R[22] or DSM IV[23] or ICD-10[138] criteria 
or standard scales and interviews. Those that did not were excluded.  
i) Articles not written in the English language – Steps were taken to obtain 
translations of these papers. However in the event that no suitable translations could 
be obtained, then these papers were also excluded.  
 
3.5 Systematic review methodology  
3.5.1 Initial search  
In June 2010, a general search on related terms for 'delirium' and 'acute stroke' (appendix 
1) was performed in the selected databases which included; AMED, BIOSIS, Biological 
Sciences, CINAHL, Cochrane, CSA neurosciences, EMBASE, Global Health, MEDLINE, 
PsychINFO, TRIP and Web of Science/ Knowledge. This produced a broad set of results 
that were then analysed and the systematic data extraction and assessments of quality 
were carried out by one reviewer. A decision was made as to not narrow the search by 
using specific terms such as 'incidence', 'outcomes' and 'confounding variables and/or risk 
factors' as it was felt that this would compromise the sensitivity of the search. A complete 
list of the search terms used can be found in the appendix (see appendix 1 for search terms 
used). 
Titles and abstracts were checked for their relevance to the chosen topic and a search for 
full text articles was conducted on all available databases for the citations that met the 
inclusion criteria, previously described in Section 3.4. A search for English translations was 
made and for those studies not written in the English language, attempts were made to 
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obtain suitable translations where possible. The bibliographies of each article were also 
checked to identify other studies that may not have been highlighted by the electronic 
searches. In addition to this, the authors of the selected studies were contacted for 
additional information not stated in articles, or for further clarification of the information 
presented. In April 2014, the systematic review search was subsequently refreshed for the 
purposes of publication and a meta-analysis was also performed, the details of which will 
be discussed in Chapter nine (Section 9.4). 
 
3.5.2 Study selection  
All the results identified by the database searches were reviewed by one reviewer (S. 
Ahmed). Titles and abstracts were identified from electronic database searches and any 
irrelevant studies were excluded by the reviewer. The reviewer sorted the citations into one 
of the following three groups; 'included', 'excluded' and 'possible'. The division of the 
citations into the groups and the reasons for the allocation were recorded on a paper form.  
 
3.5.3 Data extraction  
A paper form was used to extract data from the studies which met the inclusion criteria. The 
sections on the form were as follows;  
a) Author, year of publication, country of origin and study design.  
b) Sample size, characteristics of the sample, inclusion/ exclusion criteria applied and the 
number of people not recruited or included and the reasons why.  
c) Assessment tools used to screen and diagnose delirium, frequency of assessments, 
suitability of the assessor, suitability of the tool and any subsequent adaptations that 
may have been made for any possible communication issues that may have been 
present in this study population.     
d) Occurrence of delirium, the severity and duration of delirium episodes, reversibility of 
delirium and the time period over which the episodes were recorded.  
e) Outcome measures including immediate, short term and long term outcomes. Up to 
discharge: mortality, length of stay, requirement for institutionalisation post-discharge 
and complications during stay i.e. infections, changes in functional capacity and 
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cognitive function and psychological distress. At one, six and twelve months: presence 
of delirium, mortality, changes in functional capacity and cognition, psychological 
distress and the requirement for institutionalisation.  
f) Predictors for developing delirium, confounding variables and risk factors.  
 
3.5.4 Quality assessment  
The quality of the studies were assessed and compared to see if they were of a similar 
standard[438, 439]. Several checklists designed to assess methodological rigour against a set 
criteria were reviewed[437, 440-442]. These assessment criteria vary according to the type of 
study and so a range of checklists have been designed to produce a consistent approach to 
assessment and reporting. The Clinical Appraisal Skills Programme (CASP)[440, 441] has a 
number of checklists for the following study types; trials, systematic reviews, case control, 
cohort, qualitative research, economic evaluations, diagnostic test study and clinical 
predication rule. These checklists are easy to use, consistent and similar lengths of 
assessment questions are employed. Each selected study was scored using 'yes', 'no' or 
'unclear' using the CASP checklist questions summarised in figure 3.1.   
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The score allocations were as follows; 1-4 low quality, 5-8 medium quality and 9-12 high 
quality. Studies that scored highly were of high quality with a minimally biased 
methodology, making the outcomes of the study more reliable. Studies that did not score as 
Trial Cohort Case control 
1. Did the trial address a clearly 
focused issue? 
1. Did the study address a 
clearly focused issue? 
1. Did the study address a clearly 
focused issue? 
2. Was the assignment of patients 
to treatment randomised?  
2. Was the cohort recruited in 
an acceptable way? 
2. Did the authors use appropriate 
method to answer their question?   
3. Were all of the patients who 
entered the trial properly 
accounted for at its conclusion?  
3. Was the exposure 
accurately measured to 
minimise bias? 
3. Were the cases recruited in an 
acceptable way?  
4. Were patients, health workers 
and study personnel ‘blind’ to 
treatment?  
4. Was the outcome 
accurately measured to 
minimise bias? 
4. Were the controls selected in an 
acceptable way?  
5. Were the groups similar at the 
start of the trial?  
5a. Have the authors 
identified all important 
confounding factors?  
5b. Have they taken account 
of the confounding factors in 
the design and/ or analysis? 
5. Was the exposure accurately 
measured to minimise bias?  
6. Aside from the experimental 
intervention, were the groups 
treated equally?  
6a. Was the follow up of 
subjects complete enough? 
6b. Was the follow up of 
subjects long enough?  
6a. What confounding factors have 
the authors accounted for? 
6b. Have the authors taken account 
of the potential confounding 
factors in the design and/ or in 
their analysis?  
7. How large was the treatment 
effect?  
7. What are the results of this 
study?  
7. What are the results of this 
study?  
8. How precise was the estimate 
of the treatment effect?  
8. How precise are the results?  8. How precise are the results? 
How precise is the estimate of risk? 
9. Can the results be applied in 
your context? (or to the local 
population?)  
9. Do you believe the results?  9. Do you believe the results?  
10. Were all clinically important 
outcomes considered?  
10. Can the results be applied 
to the local population?  
10. Can the results be applied to 
the local population?  
11. Are the benefits worth the 
harms and costs?  
11. Do the results of this study 
fit with other available 
evidence?  
11. Do the results of this study fit 
with other available evidence?  
  12. What are the implications 
of this study for practice?  
 
Image adapted from casp.co.uk 
  
Figure 3.1: CASP quality assessment checklist.  
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highly indicated that the methodology and outcomes may not be as reliable as compared to 
the other studies. 
 
3.6 Results of the systematic review  
In comparison to other clinical situations, the association between delirium and acute stroke 
has not been as thoroughly investigated which means that there were few studies available 
for analysis. The use of specific terms such as 'incidence', 'outcomes' and 'confounding 
variables and/or risk factors' would have further narrowed the search and so a broad search 
strategy was employed. Furthermore studies that reported occurrence did not always report 
outcomes. The reported outcomes also differed between the different cohorts and there 
was little consistency in the measures used. For the purposes of this review, the searches 
for occurrence and outcomes were combined together to make best use of the information 
available.   
The initial search produced 1255 citations and after examination of the titles and abstracts 
by the reviewer, 188 articles were retrieved for further consideration. Of these articles, 174 
were excluded as they did not meet the inclusion criteria specified for this systematic 
review. No new studies were highlighted from the bibliographies of the selected studies and 
so a total of fourteen reports/ studies[61, 443-447, 111, 448, 47, 449, 450, 197, 451, 452] that met the 
inclusion criteria were further examined. The schematic diagram in Figure 3.2 summaries 
the number of studies that were excluded in this review and the reasons why.   
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Fourteen reports/ studies[61, 443-447, 111, 448, 47, 449, 450, 197, 451, 452] met the inclusion criteria and 
these were further examined. Within this sample of selected studies, two of the research 
groups (McManus[449, 450] and Dostovic[446, 447]) used the same patient population for more 
than one paper. This means that although there are fourteen papers examined in this 
review, there were in fact only twelve distinct patient cohorts studied. Figure 3.3 and 3.4 
summarise the specifics of each of the selected studies.  
 
 
 
  
 
Figure 3.2: Schematic diagram of the systematic review conducted in June 2010.  
. 
 Author and 
country 
Study design 
and setting 
Sample 
(M = male, F = female, Age = 
mean age) 
Recruitment criteria  
(I = Inclusion,  
E = Exclusion) 
Assessments  Occurrence 
of delirium 
Risk factors  
Caeiro, 2004 
(Portugal) 
Prospective case 
control 
Stroke unit 
231 admitted, 220 eligible 
218 strokes recruited  
 (131M, 87F) Age = 57.3 
50 acute coronary controls 
(38M, 12F) Age = 59.1 
I: Stroke (CI, IH, SAH), psych 
assessment within 4 days 
E: GCS score <5  
DRS, DSM-IV (4 days) 
MRS (discharge) 
13.3% 
 
Infections and stroke 
increase the risk of 
delirium 
Caeiro, 2004 
(Portugal) 
Case control 
Stroke unit 
159 eligible, 74 recruited  
22 delirium 
(14M, 8F) Age = 63.6 
52 non-delirium 
(Age/ sex match) Age = 60.9 
I: Stroke (CI, IH, SAH), psych 
assessment within 4 days 
E: GCS score <5 
DRS, DSM-IV (4 days) 
MRS (discharge) 
30% Anticholinergic 
medications increase risk 
of delirium. 
 
Caeiro, 2005 
(Portugal) 
Prospective 
cohort  
Stroke unit 
68 strokes recruited 
(28M, 40F) Age = 55.5 
11 delirium, 57 non-delirium 
I: Consecutive patients with 
SAH 
E: GCS score <5  
DSM-IV-R, DRS 
(admission) 
 
16% Older age, disturbance of 
alertness, aphasia and a 
Hunt and Hess score >2  
Dahl, 2010 
(Norway) 
Prospective 
Stroke unit 
200 admitted,178 recruited 
18 delirium  
(7M, 11F) Age = 79.4 
160 non-delirium  
(95 M, 65 F) Age = 71.65 
I: CT to confirm stroke 
E: terminally ill or unconscious  
MDAS, CAM (daily) 
MMSE, (3 days) 
ADL, MRS (3 days) 
10% Pre-stroke dementia, 
hemianopsia, apraxia, 
higher age and infection 
(UTI or pneumonia) 
Dostovic, 
2008, 2009 
(Bosnia and 
Herzegovina) 
Prospective 
Stroke unit 
561 admitted, 233 recruited 
59 delirium 
(25M, 34F) Age = 70 
174 non-delirium 
I: 1st stroke (CI, IH, SAH), 
neuropsych assessment in 4 
days 
E: GCS score <5 
DRS-R98, DSM-IV (24 
hours & 3-4 days) 
25.3% 
 
65+ years, females, right 
sided lesions in ischaemic 
and left sided lesion in 
haemorrhagic strokes  
Gustafson, 
1991 
(Sweden) 
 
Prospective 
cohort 
Stroke unit 
155 admitted, 145 recruited 
69 delirium 
(44 M, 25 F) Age = 76 
76 non-delirium 
(46 M, 30 F) Age =69 
I: Stroke (CI, IH, SAH),  
E: GCS score <5 
DSM-III-R (admission) 
MMSE, OBS scale 
(admission)  
48% Anticholinergic meds, pre-
stroke dementia, previous 
delirium, cardiovascular 
illness and left sided 
lesions 
Gustafson, 
1993 
(Sweden) 
Prospective case 
control 
Stroke unit 
83 delirious stroke 
(52 M, 31F) Age = 74.7 
72 non-stroke controls 
(43M, 29F)  
I: Dexamethasone  suppression 
test done 
E: GCS score <5 
(Sub-study of Gustafson, 1991) 
DSM-III-R (admission) 42% -  
 
Figure 3.3: The incidence of delirium in studies based on the stroke population.  
CI: Cerebral Infarction, IH: Intracerebral Haemorrhage, SAH: Subarachnoid Haemorrhage, TIA: Transient Ischaemic Attack, MMSE: Mini-Mental State 
Examination, CAM: Confusion Assessment Method, DRS: Delirium Rating Scale, DSM: Diagnostic and Statistical Manual, ADL: Activities of Daily Living, BI: 
Barthel Index, IQCODE: Informant Questionnaire on Cognitive Decline in the Elderly, GCS: Glasgow Coma Scale, MRS: Modified Rankin Scale 
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Author and 
country  
Study and 
setting  
Sample 
(M = male, F = female, Age = 
mean age) 
Recruitment criteria  
(I = Inclusion 
E = Exclusion)  
Assessments  Occurrence 
of delirium 
Risk factors 
Henon, 1999 
(France) 
Prospective 
cohort  
Stroke unit 
258 admitted, 202 recruited 
 49 delirium  
(26M, 23F) Age = 78  
153 non-delirium 
(71M, 82F) Age = 74  
 
I: Consecutive stroke (CI or IH),  
E: TIA, SAH, cerebral venous 
thrombosis stroke, head 
trauma , <40 yrs, not fluent in 
French, no informant, not local 
DSM IV, DRS (48 hours) 
MMSE, IQCODE (48 
hours) 
BI, Rankin scale 
(discharge) 
BI, MMSE,  
Rankin, Weintraub (6 
month) 
24% 
 
Old age, non-smokers, 
metabolic or infectious 
disorders, high IQCODE 
scores, severe clinical 
deficits and high 
leukoaraiosis  
 
McManus, 
2008, 2009 
(UK) 
Prospective 
observational  
Stroke unit 
110 eligible, 82 recruited  
23 delirium 
(15M, 8F) Age = 75 
59 non-delirium 
(36M, 23F) Age = 63 
I: Stroke (CI or IH), delirium 
assessment within 4 days,  
E: SAH, GCS score <8, delirium 
< 24 hrs, English speaker 
CAM (4 days & then 
weekly) 
IQCODE (admission) 
 
28% 
 
Unsafe swallow, BI score 
<10, poor vision pre-
stroke and CRP>5 
Oldenbeuving, 
2008 
(The 
Netherlands)  
Pilot study of 
intervention  
Hospital based 
527 admitted, 62 delirious 
26 recruited  
17 delirious treated  
(11M, 6F) Age = 77  
I: Consecutive stroke (CI or IH), 
delirium 1st week of admission 
E: Delirium < 24 hrs 
CAM (admission, day 2-4 
& 5-7) 
IQCODE (admission) 
 
11.8% 
 
- 
Sandberg, 
2001 
(Sweden) 
Cross sectional 
Stroke unit 
156 admitted, 133 recruited 
(55M, 78F), Age = 77 
 
I: Consecutive stroke with 24 
hrs, CT confirmed  
E: Refusal of consent  
DSM-IV, MADRS (daily) 
MMSE (daily) 
BI (daily) 
75% with 
apnoea 
56% without 
apnoea 
Risk factors related to 
sleep apnoea  not 
delirium 
Sheng, 2006 
(Australia)  
Prospective 
observational   
Hospital based 
186 admitted, 156 recruited 
39 delirium 
(17M, 22F) Age = 81.5 
117 non-delirium  
(66M, 51F) Age = 78.4  
I: stroke (CI or IH), 65yrs+ 
E: TIA, SAH, head trauma, 
neurosurgery, stroke due to 
tumour or cerebral venous 
thrombosis  
 
DSM-IV (3 days) 
FIM, MMSE (1, 6 & 12 
months) 
25% Old age, dysphagia, 
neglect, vision field loss, 
low blood pressure and 
low GCS scores  
 
Figure 3.3: The incidence of delirium in studies based on the stroke population – continued.  
CI: Cerebral Infarction, IH: Intracerebral Haemorrhage, SAH: Subarachnoid Haemorrhage, TIA: Transient Ischaemic Attack, MMSE: Mini-Mental State 
Examination, CAM: Confusion Assessment Method, DRS: Delirium Rating Scale, DSM: Diagnostic and Statistical Manual, ADL: Activities of Daily Living, BI: 
Barthel Index, IQCODE: Informant Questionnaire on Cognitive Decline in the Elderly, GCS: Glasgow Coma Scale, MRS: Modified Rankin Scale 
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Author Occurrence Outcomes Confounding variables Quality of study  
Caeiro, 2004 
(Portugal) 
13% delirium  
  
52% hypoactive and 48% hyperactive 
High unfavourable outcome e.g. death or 
dependency (76% Vs 33%) 
 
Education, medical complications, right sided infarcts and 
haemorrhagic strokes all contribute to delirium onset. 
High  
Caeiro, 2004 
(Portugal) 
 
 
30% delirium Use of anticholinergic medications highly 
associated with delirium onset 
Risk prediction model produced 
Hospitalisation medical complications, anticholinergic 
medication taken before stroke and intracerebral haemorrhage 
are all independent predictors of stroke. 
Medium  
Caeiro, 2005 
(Portugal) 
16% delirium  Pathology affects attention, memory and 
emotional behaviour 
Older age, increased disturbance of alertness, and a Hunt and 
Hess score >2 were linked to high DRS scores. Intraventricular 
bleeding, hydrocephalus and basofrontal haematomas linked to 
pathology of delirium. 
 
Medium  
Dahl, 2010 
(Norway) 
10% delirium  Longer hospital stays (12.28 days Vs 8.5 
days) 
Increased stroke severity and dysfunction. 
 
- High 
Dostovic,  
2008, 2009  
(Bosnia and 
Herzegovina) 
25.3% delirium 
 
29.2% still delirious at discharge 
Delirium duration (mean 4 days, range 1 – 
18 days) 
Higher mortality (18.6% Vs 1.7%) 
 
Overall delirium more common in haemorrhages. Left sided 
lesions common in haemorrhagic stroke and right sided lesions in 
ischaemic stroke. Ischaemic strokes more common in the 
anterior circulation. 
 
High 
Gustafson, 
1991 
(Sweden) 
48% delirium  Longer hospital stays (19 days Vs 13 days) 
Higher institutionalisation (43.5% Vs 
15.8%) 
Higher mortality (15.9% Vs 2.6%) 
 
Post-stroke myocardial infarctions, pneumonia, urinary tract 
infection, urinary retention and pulmonary embolism all linked 
to delirium. Extremity paresis, previous delirium, older age and 
anticholinergic meds all independent predictors for delirium 
development.  
High 
Gustafson, 
1993 
(Sweden) 
42% delirium Higher basal plasma cortisol levels  
Longer hospital stays (23.1 days Vs 15.6 
days) 
 
Hypercortisolism may be connected to the pathophysiology of 
delirium in acute stroke. High cortisol levels, severe motor 
impairment and left sided lesions were independent predictors 
of delirium. Old age had borderline significance.  
High  
 
Figure 3.4: The outcomes of stroke patients with delirium.  
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Author Occurrence Outcomes Confounding variables  Quality of study  
Henon, 1999 
(France) 
24% delirium   Decreased functional outcome at 
discharge and at 6 months 
Longer hospital stays (13 days Vs 12 days)  
Higher institutionalisation (61.2% Vs 
43.8%) 
Higher mortality as inpatient (14.3% Vs 
13.1%) and at 6 months (40.5% Vs 32.3%) 
 
Metabolic or infectious disorders as independent variables.  
Right superficial lesions, cerebral atrophy, leukoaraiosis and pre-
existing cognitive decline associated with delirium.  
 
High 
McManus, 
2008, 2009 
(UK) 
 
28% delirium   
 
Delirium common post-stroke and 
remains for up 1 month 
Longer hospital stays (62.2 days Vs 28.9 
days) 
Higher institutionalisation (43.7% Vs 5.2%) 
Higher mortality (30.4% Vs 1.7%)  
 
25.6% African group delirious compared to 29.2% non-African.  
Poor vision, poor hearing, high IQCODE scores, small vessel disease, 
atrial fibrillation, previous stroke/TIA and TACI stroke associated 
with delirium. Pre-cognitive decline independent predictor. 
Delirium may be a predictor of stroke. Low MMSE scores 
associated with delirium.  
High 
Oldenbeuving, 
2008 
11.8% delirium 
 
Severity of delirium decreased in 94% of 
cases with Rivastigmine treatment 
 
- Medium  
Sandberg, 2001 
(Sweden) 
75% delirium with 
sleep apnea 
56% delirium 
without sleep 
apnea 
 
52% of patients had sleep apnoea post-
stroke 
75% were delirious with sleep apnoea and 
56% were delirious without sleep apnoea  
 
Delirium is independently associated with vision impairment and 
minimal oxygen saturation.  
Delirium, depression, latent reactions to verbal stimuli and an 
impaired ADL linked to sleep apnoea.  
 
Medium  
Sheng, 2006 
(Australia) 
25% delirium  Increased disability and decreased 
cognition post-stroke 
Longer hospital stays (33.2 days Vs 25.3 
days) 
Higher institutionalisation (38.5% Vs 12%) 
Higher mortality at 6 months (29.7% Vs 
12.8%) and at 1 year (41% Vs 17%) 
  
Older age, haemorrhagic stroke, pre-stroke dementia and 
GCS<15 independent predictors for delirium. TACI stroke and 
cardioembolic stroke highly associated with delirium. Delirium 
patients more likely to have complications such as urinary tract 
infections, urinary or faecal incontinence and metabolic 
disorders. Transient delirium had better long term outcomes 
compared to delirium lasting over 24 hours.  
 
High 
 
    
Figure 3.4: The outcomes of stroke patients with delirium – continued. 
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3.6.1 Differences in sampling and methodology  
All the studies included in this review were based in a hospital setting e.g. general medical 
wards or stroke units and sampled consecutive stroke admissions. The inclusion and 
exclusion criteria were broadly similar. Most studies excluded subjects who were severely 
unwell and had a low GCS score or patients with TIA's, subarachnoid haemorrhages, head 
trauma, neurosurgery and those not competent in the English language. A less common 
exclusion criterion was the exclusion of patients below 40 years of age[47]. The majority of the 
studies sampled a cohort with an average age of over 65 years of age. However, there were 
exceptions. Studies by Caeiro et al,[61, 443, 444] had an average age of 55 to 65 years which 
meant that this study population was much younger in comparison to the other cohorts. 
Another less common exclusion criterion was the exclusion of patients who were not local or 
did not have an informant or carer[47].  
Regarding the ethics of consent in delirium research, it is preferable to obtain the informed 
consent of a participant with capacity. If the participant lacks capacity, then the proxy 
consent of a carer is sought. If neither of these options is viable, then the consent of a 
professional is sought, as they would be appointed as a temporary consultee on the patient’s 
behalf. With the exception of two studies[197, 452], the remaining cohorts did not specify how 
consent was taken.  
The studies were prospective cohort studies with the exception of three studies[61, 197, 451]. 
Caerio et al, 2004 produced a preliminary study of the role of anticholinergic medications 
using a case control study with age and sex matched controls. Sandberg et al, 2001 used a 
cross sectional study to investigate the link between sleep apnoea, stroke and delirium. 
Finally, Oldenbeuving et al, 2008 used a subset of patients within a large epidemiological 
study to conduct a smaller pilot study looking at the effects of rigvastigmine in the treatment 
of delirium after stroke.   
Screening and diagnostic methodology for delirium ascertainment varied greatly between 
cohorts. With regards to the use of diagnostic tools, previous studies and reviews have 
shown that the sensitivity and specificity of the tools used is dependent on the training and 
experience of the assessor[142, 424] and many of the studies varied with the use of qualified 
clinicians and/ or researchers. There were significant differences in the assessment tools 
used to measure delirium occurrences as well as processes of consent and the quality of the 
study data. The majority of the research groups relied on using the DSM III R, DSM-IV or 
ICD-10 criteria, alongside the CAM or DRS scales which are based on the aforementioned 
criterion. There were some exceptions such as the use of the Organic Brain Syndrome 
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(OBS) Scale[453], cognitive assessments such as the MMSE or relying on diagnoses based 
on clinical observation of the patient’s behaviour. The CAM and DRS have been shown to 
have good sensitivity and specificity in detecting delirium. However it is worth noting that the 
screening tools employed in the studies had not been tested for use in the stroke population. 
Furthermore no pilot studies were conducted to assess the suitability of the selected tools 
within the chosen population.  
With regards to delirium assessments, the timing and frequency of the assessments are of 
key importance. Incorrect timing of the assessments could result in missing potential cases 
of interest, as delirium often occurs near the time of admission. Similarly with regards to 
frequency, regular screening could help detect subsequent cases of delirium after the initial 
assessment. From the systematic review the majority of delirium assessments were 
conducted within a week of admission, with the timing of the delirium measurements ranging 
from less than 24 hours up to within 3 to 4 days of admission. These studies then repeated 
delirium assessments on a weekly basis dependent, on what time period they had specified 
for their follow up long term outcomes. The reporting of delirium rates varied between 
studies as Dahl et al,[445] and McManus et al,[449, 450] clearly stating the term prevalence whilst 
the remaining studies avoided using ‘incidence’ and ‘prevalence’ and opted for terms such 
as frequency instead. It was thought that the differences in the reporting procedures (i.e. 
variations in assessment timing and frequency) could alter the findings of the study; however 
this does not seem to be the case.   
With regards to the outcomes and confounding variables, several different primary outcomes 
were recorded and many studies had clearly defined outcomes from the onset of the study. 
The reporting of co-morbidity, length of stay, discharge destination, duration of delirium and 
functional outcomes varied between cohorts. Nearly all studies reported some sort of 
confounding variables, but these were not always consistent as the methodological and/ or 
statistical adjustments for relevant confounding variables varied.  
 
3.6.2 Results: Occurrence of delirium in acute stroke   
The papers generated from the systematic review reported delirium occurrence rates of 
between 10 to 48%, details of which can be found in Figure 3.2 and 3.3. Two cohorts 
reported delirium occurrence within 24 hours or less[444, 446, 447], whilst the majority of studies 
reported delirium occurrence within 2 to 4 days. Two of the studies focused on evaluating 
medications that may contribute to the onset of delirium[61] and medications that could be 
used to decrease the severity of delirium[197]. Both of these studies[61, 197] analysed the 
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incidence, severity and duration of delirium in stroke patients but without any follow up on 
outcomes or associated risk factors. The purpose of the study by Gustafson et al,[448] was to 
determine if the pathology of delirium might be related to cortisol levels and so no follow up 
outcomes were recorded. Sandberg et al,[451] described the methods that they used to record 
the incidence of delirium in relation to sleep apnoea in stroke, however the frequency or 
timing of assessments was not described.  
 
3.6.3 Results: Outcomes associated with delirium in acute stroke  
Mortality rates were reported in four cohorts[443, 445-447, 47] with the data indicating that patients 
with delirium had an increased risk of mortality at discharge. A fifth cohort, Sheng et al,[452]  
reported that although there was not a significant difference in mortality at discharge or at 
one month, this became more distinct at six and twelve months. Sheng et al reported the 
rate of mortality at six months for the delirious patient group was 30% in comparison to the 
13% reported in the group of non-delirious patients. Similarly at twelve months, mortality for 
the delirious group increased to 41% compared the non-delirious group which increased only 
slightly to 17% mortality.  
The duration of delirium was recorded in four cohorts[446, 447, 449, 450, 197, 452] and the length of 
stay was also reported in four cohorts[445, 47, 449, 450, 452]. The studies that reported length of 
stay[445, 47, 449, 450, 452] showed that those with delirium had a longer period of hospitalisation, 
with an average stay of 30.3 days in comparison to non-delirious patients who only stayed 
an average of 18.7 days. Lastly data on discharge destination or the need for 
institutionalisation upon hospital discharge was only reported in four of the cohorts[448, 47, 449, 
450, 452].  
With regards to subsequent follow up periods, there was only one study[452] which explored 
the outcomes of delirium twelve months post-stroke. Henon et al,[47] conducted a six month 
follow up, whilst McManus et al,[449, 450] followed up till one month post-discharge. The 
remaining cohorts recorded outcomes at patient discharge but not all had consistent 
outcome measures. Subsequent cognitive decline or pre-stroke dementia was recorded in 
two studies[47, 452] and various functional outcomes such as changes in cognition (MMSE) or 
activities of daily living (ADL) scores were recorded for six cohorts[445-448, 47, 449, 450, 452].  
Once discharged, four cohorts[448, 47, 449, 450, 452] suggested that the presence of delirium 
eventually led to the need for institutionalisation post-discharge. Dostovic et al,[446, 447] 
reported that a third of patients were still delirious at discharge and the average duration of 
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delirium was 3 to 4 days. Similarly Sheng et al,[452] reported that those with delirium that 
lasted for longer than 24 hours had worse outcomes at six months and an increased 
mortality risk at one and twelve months. Various functional outcomes were recorded for six 
cohorts, where two[449, 450] indicated a decrease in cognitive function as evidenced by 
changes in MMSE scores and four recorded a decrease in functional ability as evidenced by 
lower ADL scores[446-448, 47, 452]. 
In the study by Sandberg et al,[451] only follow up outcomes associated with the occurrence 
of sleep apnoea as opposed to the presence of delirium, were recorded and so this data was 
not included.  
 
3.6.4 Results: Confounding variables/ risk factors for developing delirium in 
acute stroke  
Five of the studies indicated that an increase in age increased the chance of developing 
delirium post-stroke[444-448, 452], whilst two cohorts identified that women were at higher risk of 
developing delirium[446, 447, 452]. Medical complications such as urinary infections and 
pneumonia were identified as key predictors for delirium[443, 445, 448, 47, 449, 450, 452] and 
subsequent cognitive decline or pre-stroke dementia was recorded in two studies[445, 47]. Of 
the studies that indicated that the presence of delirium was linked to the type of stroke, four 
cohorts suggested it was more common in haemorrhagic strokes[443, 446-448, 452] and three 
suggested that right sided lesions were better predictors for delirium onset[443, 446, 447, 47]. Only 
Gustafson et al[448] suggested that delirium was more common in left sided lesions.  
As mentioned previously the study by Sandberg et al,[451] only recorded the occurrence of 
delirium in stroke patients that had sleep apnoea and follow up outcomes were associated 
with sleep apnoea as opposed to the presence of delirium. However this was the only study 
to assess the psychological impact on patients, an area which had not been reported in the 
remaining studies. Due to different assessment methodologies used in these cohorts and the 
low number of data sets, it was not feasible to pool together the results from the various 
studies for a combined meta-analysis.  
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3.7 Discussion of the systematic review  
The results of the systematic review indicate that delirium after acute stroke has serious 
consequences for patient outcomes such as increased risk of mortality, length of stay and 
the need of institutionalisation. The studies in the systematic review reported an occurrence 
rate ranging between 10 to 48%. The findings of this review are in line with the previous 
literature reviews[120, 38, 46] that focused on giving an overall view of delirium in acute stroke 
whereas this systematic review focused purely on occurrence and outcomes with an aim to 
pool together the data for meta-analysis.   
It is worth noting that the studies selected by this review included a number of heterogenic 
study populations. These populations were due to the considerable degree of variation 
between the selection criteria employed for each of the individual studies. The exclusion of 
certain patient subgroups could be source of bias. For example excluding those with a 
history of dementia means eliminating possible cases of delirium as dementia has been 
shown to be a risk factor for delirium onset[48, 454, 15]. Similarly excluding patients with aphasia 
or communication difficulties could have been avoided by considering the use of assessment 
tools that have been adapted for use in patients with communication issues. Furthermore the 
consent process for participants was not always described and this should have been clearly 
described for all studies[251, 252]. These amendments could have significantly decreased 
variations in participant selection and could have reduced or eliminated selection bias within 
the study population. For this systematic review it should also be noted that two of the 
research groups (McManus et al and Dostovic et al) used the same patient population for 
more than one paper. This means that although there are fourteen papers examined in this 
review, there were in fact only twelve different patient populations studied.  
 
3.7.1 Occurrence of delirium in acute stroke   
The studies included in the review reported the incidence of delirium in acute stroke which 
were consistent with delirium rates in other medical settings. These groups as previously 
mentioned included vascular surgery[234, 84], hip fracture patients[420, 49] and terminal illness[70, 
423, 162]. The reported incidences of delirium varied greatly within the stroke population and so 
study findings may not allow for reliable comparisons to be made between studies. These 
variations could be due to a number of reasons. Consideration should be given to the 
variation in study methodologies when interpreting study findings and the impact it could 
have on the reported data. The frequency of the delirium assessments could have affected 
88  
 
the study findings as some groups conducted assessments daily[445], some weekly[449, 450] 
and some studies did not clearly state the frequency of assessments[451]. Whether the 
assessments were conducted on a busy ward or in a private side room should be 
considered, as any distractions could have affected the test subject and in turn the 
diagnostic outcome. The background of the assessors; ranging from clinical psychiatrists to 
those with very little psychiatry training[425], could also have affected the diagnostic process. 
It could also simply be attributed to geographic location or the variation in the sensitivity and 
specificity of the range of diagnostic tools that were employed in the studies.  
The majority of studies used tools based on the DSM-IV or ICD-10 criteria such as the CAM 
or DRS scale. However it should be noted that these delirium tools have been validated for 
use in general medical patients and not specifically for use within the stroke population. 
None of the studies in the review stated that the tools were not designed to be used for 
delirium detection in the stroke population and no pilot studies were conducted to assess 
their validity. Some studies modified the scoring of their chosen assessment tools to 
accommodate the stroke patients. For example, applying their own cut off points[47], scoring 
‘not applicable’ in certain sections due to patient communication issues[443] or excluding 
patients altogether if they were aphasic or had a reduced level of consciousness or 
alertness[47]. However it should be noted that McManus et al,[449, 450] was the only group that 
compared the use of CAM and DRS in the stroke population and stated the advantages and 
disadvantages of each method. They reported a high level of agreement between the two 
diagnostic tools and an association between the presence of delirium and a low MMSE 
score. The fluctuation of cognitive function and the associated language difficulties in acute 
stroke were also highlighted. The research group concluded that the CAM was more 
appropriate for use as it was easier to use, but it did require adequate training before use.  
Other studies also used additional tools such as the OBS scale or the MMSE, rather than 
relying purely on clinical assessments based on the DSM or ICD criteria or by focusing on 
specific delirium features such as decreased consciousness or confusion. It should also be 
noted that scores of assessments such as the MMSE can be influenced by language, motor 
function and mood. By reviewing these studies it is clear that a standardised assessment 
protocol is required for the detection of delirium in acute stroke. The review also showed that 
the severity of delirium was only reported in selected studies[445-447], although this could have 
easily been analysed and recorded once the study sample had been selected. This is 
important because the severity and duration of delirium may be related to other issues and 
long term outcomes such as the risk of developing dementia[66, 172].   
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3.7.2 Outcomes associated with delirium and confounding variables/ risk 
factors for developing delirium in acute stroke 
The outcomes associated with delirium after a stroke, are in line with the published literature 
in other clinical situations[41, 121, 230]. It is consistent with the conclusion that delirium after 
stroke is highly associated with an increased mortality, morbidity and length of stay in 
hospital. Regarding follow ups, out of the twelve populations studied, eight studies only 
reported short term hospital discharge outcomes. It is surprising that this short term follow up 
was omitted in the other four studies as information such as length of stay, mortality and 
discharge destination could have been easily obtained from the ward registers.  
For long term outcomes, McManus et al, conducted a one month follow up for length of stay, 
mortality and discharge destination and Henon et al, conducted a six month follow up for 
functional measures, but both studies collected no other further data. It would have been 
advantageous to conduct additional tests for outcome measures such as the Informant 
Questionnaire on Cognitive Decline in the Elderly (IQCODE) or Activities of Daily Living 
(ADL), to see if these had changed since discharge. The study by Sheng et al was the only 
study which conducted a thorough patient follow up at one, six and twelve months and 
reported a delirium incidence of 25%, placing this cohort in the middle of the reported 
incidence range.  
Some of the confounding variables identified, are in line with the confounding variables 
found within the general medical literature for delirium. There are many risk factors for 
delirium but old age, severe illness and visual impairment are just three of the established 
risk factors that were mentioned in the included studies. The location and type of lesion was 
also mentioned in several of the included studies, as well as other stroke specific factors but 
these varied considerably between the different cohorts.  
This review indicates that delirium in stroke patients is a cause for concern and further 
research is needed to improve the management and possible prevention of delirium post-
stroke. Further information specifically on post-discharge patient follow ups and long term 
outcomes is required. Measures such as mortality risk, length of hospital stay and the need 
for institutionalisation post-discharge need to be recorded and analysed to determine the 
level of impact they may have on a patient’s recovery. In order to conduct more informative 
long term studies, it is important that we produce more reliable incidence data sets with 
minimal variation, providing an improved foundation for better patient outcome studies. 
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3.7.3 Clinical implications 
The research suggests that in order to improve the management and treatment of patients 
with delirium in stroke, better detection methods are needed. The routine use of diagnostic 
tools for delirium might increase detection rates thus improving the clinical management of 
the syndrome. It is worth mentioning that in order to use the existing delirium tools 
alterations or adaptations may need to be made so that they may be used within the stroke 
population. This systematic review reported that the occurrence of delirium ranged from 10 
to 48%, therefore it would be safe to assume that this would increase the workload of the 
clinical staff. This would mean relying heavily on services such as psychiatry and / or the 
mental health team to deal with the large number of referrals, something which is not 
feasible for a prolonged period of time. Although the diagnostic tools require adequate 
training and experience for reliable use, the psychiatry services/ mental health team could 
provide the necessary training and advice needed for the ward staff to be trained in delirium 
detection. It would be particularly advantageous to train the nursing staff, as they interact 
with patients on a daily basis and would be able to pick up on any subtle changes in the 
patient's behaviour, thus leading to more efficient detection. Consequently in the long term, it 
would be more efficient and effective to train the clinical staff on the ward to screen, detect 
and manage delirium whilst allowing the psychiatry/ mental health team to deal with the 
more complex cases. 
The use of a standard screening protocol which could be implemented across hospitals 
would help with the detection of delirium cases. Due to the multifactorial nature of delirium, a 
number of different disciplines may be involved in order to give a good inclusive overview of 
the case, but this can be a time consuming process. It is therefore essential to have a 
balance between having a detailed insight but at the same time the protocol needs to be 
quick and easy to administer. A protocol that is less time consuming would be more 
appealing to the staff as it would not significantly increase their workload and so the staff 
would be more likely to incorporate and adhere to the protocol in their daily routine. The 
introduction of delirium screening protocols on stroke units and the training of clinical staff 
could make a significant improvement and the regular screening procedures on stroke units 
would also help to trigger a more prompt and timely search for underlying causes. In some of 
the studies it was noted that delirium already present at admission was more common than 
delirium occurring after being admitted. Other studies have shown that admission from an 
institution is a risk factor for delirium in hospital and some studies have shown that delirium 
is common in nursing homes. It may be worth considering a preventative intervention that 
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could be used in institutions such as nursing homes and this in turn may help to possibly 
reduce the number of admissions.  
 
3.7.4 Research implications 
The variation in delirium occurrence could be attributed to a number of reasons and one of 
the reasons to consider are the study methodologies employed. The articles analysed in this 
review found that a number of studies varied with regards to how patients were recruited, the 
assessment methods that were used and the differences in applying the DMS-IV and ICD-10 
diagnostic criteria. These issues suggest that a standardised screening and assessment 
protocol needs to be put into place, so that reliable cross comparisons can be made 
between studies. As it has been mentioned previously, the studies included in this 
systematic review did not employ delirium tools validated for use within the stroke population 
and no pilot studies were conducted to check the suitability of the tools for the chosen 
population. A follow up systematic review analysing how best to screen for delirium would 
highlight the tools available and specifically focus on the feasibility of the screening tools and 
their sensitivity and specificity in relation to assessing stroke patients. Following on from this, 
a validation study could be conducted to assess the use of these delirium tools in the stroke 
population. Consideration should also be given to the development and validation of a new 
delirium tool specifically for use in the stroke. This could be a future avenue of research and 
would help to overcome this particular methodological challenge in delirium research.  
Due to fluctuating nature of delirium, it is important to clearly state whether study groups are 
reporting incidence or prevalence rates as the frequency of the results recorded could have 
a significant impact on the cohort findings. This would also limit cross comparisons between 
different studies making the reliability of results not comparable. In addition to this the study 
populations recruited in these cohorts varied in age, gender and stroke types. Many studies 
had strict exclusion criteria regarding stroke types, existing illnesses, patient capacity, 
language/ communication issues and specific age limits. Due to the nature of delirium it also 
meant that a significant number of patients may have lacked the capacity to consent to the 
study or indeed they may have even struggled to communicate or complete the 
assessments required to participate. As a result there is a possibility that a significant 
number of people who may have had delirium would not have been recruited and analysed 
as part of the study cohort. The excessive exclusion criteria in these studies therefore 
produced research that was based on a group of people that were not truly representative of 
the stroke population, which leads to issues of generalisability of results and other ethical 
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considerations. The increased mortality rates associated with the presence of delirium post-
stroke means that any future long term outcomes studies may need to factor the mortality 
rate into their recruitment targets in order to have an adequately powered study. 
Furthermore there were many single case reports about the psychological aspect of delirium 
in stroke patients but ignored in the larger cohort studies, as there was no follow up on the 
patient’s psychological status and this is something which may need to be considered for 
future studies.   
 
3.7.5 Limitations of the review 
The original systematic review was completed in June 2010 to identify gaps in the literature 
and help inform the design of a study for further investigation. However the search was 
subsequently refreshed and reviewed in April 2014 so that it was up to date for publication 
and the addition of new data meant that a meta-analysis could be performed. A summary of 
the April 2014 search is provided in the discussion chapter (Section 9.4). For the original 
review conducted in June 2010, studies that that involved surgical intervention or those that 
were primarily focused on developing methods based on biochemical markers for delirium 
were excluded. Studies where the definition of delirium was not made clear were also 
excluded as case ascertainment would be unreliable. Delirium tremens was also excluded 
from this review as it was considered to be a distinct condition that was not as closely related 
to acute stroke as the other subtypes.  
The primary aim was to identify studies that investigated the incidence and outcomes of 
delirium post-stroke, which is why a broad search strategy was used in order to increase the 
sensitivity of the search thus compromising on search specificity. A secondary systematic 
review focused on investigating how best to screen for delirium, specifically the feasibility of 
the screening tools and their sensitivity and specificity in the stroke population was 
considered. However this second review was subsequently eliminated due to limitations in 
time and resources. Furthermore the data that had been collated from the published 
literature included information about the assessor background, types of assessments used 
and their timing and frequency, as summarised in Figure 3.3 and 3.4. It was decided that this 
information was sufficient to inform the study planning and design.  
As resources were limited, studies not written in English were also excluded if the 
translations of the paper obtained were not of adequate quality. Furthermore the citations 
and abstracts produced by the initial search were not reviewed by an independent assessor. 
Ideally a second review would have been conducted by a separate author. The second 
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author would have independently screened for relevance and fulfilment of the inclusion 
criteria to see if the results were in agreement. However due to limitations in time and 
resources, this was not possible. Overall, I consider that this systematic review was sufficient 
to highlight the key findings in the area of delirium and acute stroke.   
 
3.7.6 Implications for the proposed study  
The results of the systematic review showed that there were very few studies that have 
investigated the effects of delirium in stroke and the studies that did, reported a wide 
variation in delirium incidence. Out of the twelve research groups highlighted by the 
systematic review, only one study[452] followed patients long term for twelve months and 
another research group[449, 450] investigated a UK based cohort.  
The results of the systematic review indicated a need for the following; a UK based study, 
assessing long term outcomes study, employing reliable diagnostic tools (e.g. CAM and 
DRS) as well as a less strict exclusion policy so that the study sample is more representative 
of the general stroke population. Fulfilling these requirements would help in allowing 
comparisons to be made with other incidence studies and the research questions and design 
of the proposed study were developed to meet these requirements.   
 
3.8 Conclusion 
Delirium and acute stroke when combined have serious consequences for patient outcomes 
such as in increased risk of mortality, length of stay and the need of institutionalisation. To 
date, studies researching the association between acute stroke and delirium have been 
limited and the cross comparisons between the existing studies are not reliable, due to a 
number of various methodological and ethical considerations. The rate of delirium 
occurrence in the published literature ranges from 10 to 48%, with the meta-analysis 
producing an average incidence of 23.7%, suggesting that the presence of delirium and its 
impact is significant. The clinical importance of delirium in acute stroke has been highlighted 
by many studies suggesting that appropriate action needs to be taken.  
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3.8.1 Key points  
 Delirium in acute stroke has been linked to increased mortality, length of stay and the 
need for future institutionalisation. 
 Due to its high occurrence rate, delirium in acute stroke is of significant clinical 
importance and better detection methods need to be implemented. 
 Clinical staff should be educated in delirium awareness and trained in how to detect and 
manage delirium rather than relying on the psychiatry/ mental health team.  
 The number of studies conducted within the area of delirium and acute stroke is limited 
due to a range of ethical and methodological variations.  
 Future studies need to employ a standardised delirium screening and assessment 
methodology so that more reliable cross comparisons can be made between studies.  
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4 Aims and hypotheses 
4.1 Aims and objectives  
The primary aim of this study was to investigate the association of delirium with patient 
mortality within the acute stroke population. Fulfilling the primary aim would also identify the 
incidence, severity and duration of delirium within this population of patients. This UK based 
prospective cohort study was designed with the following secondary aims:  
1. To investigate the association of delirium with length of hospital stay in acute stroke 
patients. 
2. To investigate the association of delirium with a patient's discharge destination after a 
stroke. 
3. To investigate the association of delirium with a patient's physical functional capacity 
post-stroke. 
4. To investigate the association of delirium with memory impairment in stroke patients. 
5. To determine whether the type of stroke predicts the onset of delirium.  
6. To identify possible key confounding variables or outcome predictors that may protect 
against the onset or decrease the duration of delirium in stroke.  
7. To evaluate the accuracy and reliability of the delirium instruments, the CAM-ICU and 
the DRS-R98, for use in the stroke population.  
 
4.2 Hypotheses 
In a prospective sample of stroke patients admitted to the acute stroke units within West 
Yorkshire, the following hypothesis was investigated: 
Compared to those patients without delirium, patients with delirium will have a worse 
outcome in terms of an increased risk of mortality.  
For the prospective cohort study of stroke patients admitted to the Leeds Teaching Hospitals 
Trust, the following additional hypotheses were: 
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1. Compared to patients without delirium, those patients with delirium will have a poorer 
outcome in terms of a longer length of stay in hospital. 
2. Compared to patients without delirium, those patients with delirium will have a poorer 
outcome in terms of an increased need for institutionalised care post-stroke.  
3. Compared to patients without delirium, those patients with delirium will have a poorer 
outcome in terms of a decreased physical functional capacity post-stroke. 
4. Compared to patients without delirium, those patients with delirium will have a poorer 
outcome in terms of decreased cognitive function in the long term. 
5. The onset of delirium is dependent on the type of stroke, specifically the size, type and 
location of the stroke lesion.  
6. There are certain key confounding variables or outcome predictors which when altered 
affect the onset or duration of a delirium episode.  
7. The delirium instruments selected for this study, the CAM-ICU combined with the DRS-
R98, are suitable for use within the stroke population. 
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5 Methodological considerations 
Several important aspects need to be considered when designing and conducting a study, to 
investigate the effects of delirium in an acute stroke population. These important aspects are 
discussed in this chapter and include the following: the type of study, avoidance of bias in 
the study sample[455, 456], the inclusion and exclusion criteria applied to potential participants, 
unambiguous case definitions, a stringent case selection procedure during recruitment, the 
complete follow up of participants once recruited, clear definition and measurement of key 
confounding variables or outcome predictors, clinically relevant outcome measures and the 
selection of statistical methods used to analyse the study data.   
 
5.1 Type of study 
There are a number of study methodologies available, each with their own advantages and 
disadvantages. The types of study that were considered for this investigation are described 
below.  
 
5.1.1 Cross sectional study 
Cross sectional studies[457] are observational study designs which describe the absence or 
presence of a clinical feature. They observe a collection of different individuals (a cross 
section of the population) at a specific time point or interval. Exposure and outcome can be 
determined simultaneously, so the prevalence of an illness and the odds ratio or the relative/ 
absolute risks from an illness can be calculated. Cross sectional studies are advantageous 
in that they are shorter in length, quicker and easier to conduct in comparison to other 
methodologies. However this type of study does have disadvantages, as it usually relies on 
data collected for other purposes and the recall of events may be unreliable. Furthermore as 
the outcome and risk factors are identified at the same time, the direction of any effect 
cannot be easily determined as it can be a problem identifying which came first. A cross 
sectional design for the purposes of this study would not be suitable as it would not allow for 
the long term monitoring of delirium duration and the follow up assessment of outcomes after 
discharge. 
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5.1.2 Case control study  
Case control studies[458] are retrospective study designs that avoid the problem of cause and 
effect as the disease is the outcome of interest and they are often used for the study of rare 
diseases. People with the disease (case) are matched to people without the disease 
(control) in order to compare their exposure to its associated risk factors. These types of 
studies are advantageous as they can be conducted by an individual researcher, are 
inexpensive and shorter in duration compared to other methodologies and can be completed 
without waiting for the outcome to develop. However a disadvantage is that participants can 
be prone to recall error, due to the recollection of past events. This may cause difficulties in 
obtaining reliable information about an individual's exposure over a certain time period, in 
order to establish the timeline of exposure to the disease outcome.   
Case control studies are beneficial in that individuals in both groups can be matched for 
factors such as age or sex in order to minimise bias in the sample. Participant recruitment 
may take longer as each of the case and control participants have to be matched 
appropriately, but it does mean that a lower power can be sufficient to detect any exposure 
effects. As with any investigation, larger numbers would increase the statistical power of the 
study findings. However identifying and recruiting these cases may prove difficult as it is 
often easier to recruit controls rather than cases. This type of study is often used to study 
rare conditions.  
For the purposes of this study, recruiting stroke participants as controls may be relatively 
straight forward, but finding delirium cases in the stroke group that were matched in terms of 
age and gender may be difficult, as it could be time consuming. A potential solution to 
overcome this issue would be to recruit many controls to one case, but choosing a suitable 
control group can also be problematic. Although there is no list of suitable or unsuitable 
controls, sound justification is required for choosing a specific control group. Unsuitable 
controls can also make findings hard to interpret, which is why researchers tend to use more 
than one type of control group to overcome this problem. Furthermore a case control design 
would not be suited to this study as there is more than one outcome proposed for this 
investigation. In order to assess the selected outcomes, a separate sub-study would need to 
be implemented for each outcome to determine the effect it may have on the participants. A 
study design of this nature would be time consuming and unnecessarily complicated.  
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5.1.3 Retrospective cohort study 
For a retrospective methodology[459], the outcome is defined at the start of the study and the 
researcher looks at the data already collected to examine the exposure to certain risk factors 
linked to the chosen outcome. In effect the event or illness has already passed and the data 
is simply collected to analyse the relative risk or odds ratio. Retrospective cohort studies are 
less time consuming, allow multiple outcomes to be analysed and can be used to study rare 
occurrences. However they may require unfeasibly large numbers for rare outcomes and 
often rely on analysing data collected for other purposes.  
A retrospective approach in this study could lead to an underestimation of delirium 
incidence. For example in this study, the study data analysed would be derived from ward 
based registers and medical notes which may contain incomplete entries or incorrect data. 
Also the use of diagnostic tools after a delirium episode has passed could introduce an 
element of error, as the assessments would rely on the information recorded in the ward 
registers. This information may not be the most accurate diagnosis of delirium as it would not 
be the primary focus of ward care. The aim of the ward register is to record information on 
the primary cause of admission, which is a stroke and not on the detection of delirium. This 
means that accurate comparisons may not be made as there may be uncertainty over the 
presence of delirium due to doubts over the diagnostic process and the data records. 
Furthermore any patient input regarding the case would be questionable as their recall of 
events may differ from what actually took place, again making the data unreliable.  
 
5.1.4 Prospective cohort study  
A prospective cohort study[460] involves recruiting, observing and assessing a sample of 
people over a certain period of time for a common outcome. As well monitoring the 
development of a disease, prospective studies can help to determine risk factors and 
uncover unanticipated outcomes. Compared to the other methodologies, prospective studies 
are expensive, time consuming and have a large workload as they require a large number of 
participants to be monitored over a long period of time. This methodology can also be prone 
to attrition bias depending on what outcome is being studied. For example in the case of 
stroke, an increased mortality rate could contribute to a steady decrease in participants over 
the length of the study. Cohort studies are also greatly susceptible to the effect of 
confounding variables and this is discussed in further detail later on in this chapter (Section 
5.6). Prospective studies are valuable in that they tend to have fewer potential sources of 
bias as participant exposure is assessed at the start of the study and then regular repeat 
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observations are made using a standard protocol. This means that the use of retrospective 
data collection is avoided, potential participant errors are lower and the data collected is 
consistent and completed to the same standard for every participant. Furthermore 
comparison groups do not have to be selected in advance, as the assessment of risk 
exposure produces a good selection of exposed and unexposed groups for comparison. This 
type of study design seems to be the most suitable for this study to produce an accurate, 
reliable and representative data set.  
 
5.1.5 Implications for the proposed study 
For the purposes of this study, a prospective cohort study was selected as it allowed direct 
comparisons to be made between stroke patients with and without delirium. It would also 
ensure that all participants are subjected to the same procedure from the start, thus 
producing a consistent data set for analysis. The diagnostic criteria used for case 
ascertainment could be determined prior to the commencement of the study. Also time can 
be taken to ensure that the assessment tools used in the determination of the cases are 
valid and reliable for that chosen patient population.  
 
5.2 Construction of the study sample  
When designing a study, consideration should be given to the construction of the sample. It 
is important that the sample produced is representative of the population being studied and 
that steps have been taken to avoid or reduce error and improve the generalisability of the 
sample. The following section discusses certain aspects that were considered.  
 
5.2.1 The study setting  
The study was set to recruit patients from stroke units based in National Health Service 
(NHS) hospitals within West Yorkshire, specifically hospitals based in Leeds and Bradford. 
Prior to study commencement, the stroke services within the Leeds Teaching Hospitals Trust 
(LTHT) were distributed between two hospitals in Leeds; the Leeds General Infirmary (LGI) 
and St James University Hospital (SJUH). In December 2010, the elderly stroke ward at 
SJUH was relocated to the LGI (Ward 44 and 46 were subsequently renamed L26 and L27) 
to form the Acute Stroke Unit (ASU) and the Stroke Rehabilitation Unit was relocated to 
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SJUH (Ward 30) for patients over 65 years of age and Chapel Allerton Hospital (CAH) (Ward 
1) for patients under 65 years of age. In December 2011, the Hyper Acute Stroke Unit 
(HASU) was set up at the LGI (Ward L21) increasing the number of stroke beds.   
At the Bradford Foundation Hospitals Trust (BFHT), the combined HASU and ASU were 
originally based at the Bradford Royal Infirmary (BRI) with the Stroke Rehabilitation Unit 
situated at St Luke's Hospital (SLH) (Ward 6D). The BRI also relocated their combined 
HASU and ASU from Ward 24 to Ward 9 at the BRI, increasing the number of acute stroke 
beds in the process. In both hospitals, almost all the stroke patients arrived at the hospital’s 
Accident and Emergency (A&E) Department either by the ambulance paramedics, or via a 
referral from their general practitioner and from there they were transferred to the stroke 
units. Due to the recent reallocation of stroke services, almost all stroke cases are now 
admitted directly to the stroke units.   
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As these hospitals have larger stroke units, it is possible that patients from other districts 
may be referred. The sample was limited to stroke services within Leeds and Bradford, with 
hospitals in Harrogate and Calderdale selected as additional recruitment sites if the need 
arose. The use of more than one hospital ward increased the number of beds available and 
thus increasing the number of potential participants. By recruiting from more than one 
hospital ward, any procedural differences such as screening or discharge pathways, 
potential sources of bias or any other affecting factors specific to a particular ward will also 
have been reduced.  
 
 
Hospital Trust 
 
 
Acute stroke unit Rehab stroke unit 
Ward no Beds Ward no Beds 
LEEDS  
Consultants: 
P. Wanklyn 
J. Cooper 
S. Limaye 
Hassan 
J.Bamford 
Chandran  
 
 
LGI (Brotherton level B) 
Ward L26 (male) 
Ward L27 (female)  
 
LGI (Brotherton level G) 
Ward 21 (HASU)   
 
 
16  
18  
 
 
10  
 
SJUH (Beckett Wing) 
Ward J30 (mixed)  
Older stroke patients  
 
Chapel Allerton 
Ward 1 (mixed)  
Younger stroke patients  
 
 
24 
 
 
 
22 
BRADFORD  
Consultants: 
C. Patterson 
S. Maguire  
 
 
BRI (Neuro/ Stroke) 
Ward 9 (mixed)  
N.B. Includes HASU 
 
 
24 
 
SLH (Horton wing) 
Ward F6 
N.B. Includes neuro-rehab 
 
 
24 
HARROGATE 
Consultants: 
S. Brotheridge 
 
 
 
Strayside wing 
Oakdale ward (mixed) 
N.B. No HASU 
 
 
4 
 
Strayside wing 
Oakdale ward (mixed) 
N.B. Includes neuro-rehab 
 
 
22 
CALDERDALE 
Consultants: 
I. Shakir 
P. Rana 
R. Mir  
 
 
HDU 
Ward 6D (male) 
Ward 6D (female) 
Side rooms  
 
4 
4 
4 
3 
 
Ward 7A stroke (mixed) 
Ward 7B stroke (mixed) 
Ward 7C neuro (mixed) 
Ward 7D general (mixed) 
 
14 
12 
14 
12 
YORK 
Consultants: 
J. Coyle  
W. Iverson  
 
 
Ward 36 (mixed) 
Side rooms 
 
 
14 
5 
 
Ward 39 (mixed) 
 
19 
WAKEFIELD 
Consultants: 
M. Carpenter  
A. Stanners 
P. Dhatta  
 
Gate 2 
Stroke/ neuro ward 
(mixed) 
Pinderfields stroke unit 
 
 
34 
 
10 
 
Gate 2 
Stroke/ neuro-rehab ward 
 
Pinderfields rehab unit  
 
 
28 
 
12 
 
 
Figure 5.1: Stroke services available in Yorkshire in 2011-2012.  
The number of stroke beds available in hospitals within West Yorkshire in 2011 to 2012.  
 
103  
 
In the hospitals chosen, there is a ward clerk assigned to each ward who is responsible for 
the data input into the ward registers and electronic databases. The stroke units have good 
links with the stroke rehabilitation units, physiotherapy and occupational teams, community 
stroke team (CST), intermediate care team (ICT), mental health teams, clinical psychology, 
neuropsychiatry and liaison psychiatry. The admission rates for the chosen wards are 
illustrated in Figure 5.2 below. Information about stroke patient care during hospital 
admission is helped by national audit registers as stroke is a very well audited clinical 
condition. An example of such a register is the Sentinel Stroke National Audit Programme 
(SSNAP) which builds on the work of the National Sentinel Stroke Audit (NSSA) and the 
Stroke Improvement National Audit Programme (SINAP). These registers demonstrate that 
stroke has a high level of interest and is a worthwhile area for further investigation.  
 
 
 
 
 
 
Location Beds Admissions Deaths No. of potential 
participants 
Per year Per 
month 
Per year Per 
month 
Ward 37 –  
LGI 
relocated to 
ward L27 
18 480 40 92 8 480 – 92 =  
388 per year 
Average of 32 a 
month 
Ward 34 –  
SJUH 
relocated to 
ward L26  
15 480 40 33 3 480 – 33 =  
447 per year 
Average of 37 a 
month 
Ward 24 –  
BRI 
relocated to 
ward 9 
14 400 35 56 5 400 – 56 =  
344 per year 
Average of 29 a 
month 
 
 
Figure 5.2: Admission statistics for stroke units in Leeds and Bradford in 2011.  
The stroke units predominately cater for patients over 65 years of age. They currently 
have an average of 2 admissions per day and an average of 40 new admissions per 
month, not including weekends. The average number of deaths per stroke unit has also 
been taken into account, producing a cumulative total of approximately 1179 admissions 
over a one year period. Since December 2010, the elderly stroke wards have undergone 
significant relocation and restructuring, but it was assumed that the wards will generate 
similar admission numbers.  
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5.2.2 Identifying potential participants 
Patients with a suspected stroke were admitted to the hospital Accident and Emergency 
Department where they were seen by the clinicians and nursing staff.  Stroke diagnosis was 
made by clinical assessment and a Computer Tomography (CT)[357] or Magnetic Resonance 
Imaging (MRI) [356] scan of the head. Patients with a confirmed stroke diagnosis were then 
transferred to HASU or an ASU depending on the time of stroke onset. Details of the stroke 
unit admissions recorded in the ward registers by the ward clerk were checked, as well as 
consulting with clinical staff to accurately identify patients with an acute stroke.  
  
5.2.3 Recruitment of the participants  
Once potential participants were identified, the following issues were considered with 
regards to the recruitment of the study sample.  
a) The recruitment window (occurrence bias)[456]. Delirium is a clinical syndrome that has 
an acute onset and a fluctuating nature. If the participants are not recruited within a 
specific time period after admission, then certain cases may be missed. This may alter 
the study outcomes as not all possible cases are included and in effect this would not be 
a true representation of the occurrence.  
b) The refusal of participants (non-respondent/ volunteer bias)[456]. The population who 
refused to participate in the study may differ from those who did participate and this 
could have a significant impact on the study outcomes e.g. cognitive impairment and 
communication problems. Patients with delirium may be unwilling to participate as they 
are already going through a traumatic time. Similarly patients without delirium may deem 
the assessment as unnecessary as the study is voluntary and they may not wish to 
undergo any additional investigations. This may mean that the recruited population may 
be more motivated or willing to complete assessments as they are more able or more 
concerned about their health. 
 
5.3 Study participant criteria   
The impact of recruitment is important, in order to produce a reliable and consistent data set 
from which accurate findings can be reported. To produce this it is necessary to set certain 
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guidelines for the recruitment of the patients. For potential participants to be involved in this 
study, the following criteria needed to be fulfilled.  
 
5.3.1 Inclusion criteria  
The inclusion criteria for the study were as follows: 
a) New diagnosis of a stroke as confirmed by clinical and imaging assessment within 72 
hours of admission to the acute stroke unit. The time period of 72 hours was chosen as 
it increased the maximum number of participants that could be recruited, without having 
to miss any potential participants or interfere in the clinical assessments that the patient 
would require upon admission. Patients diagnosed with Transient Ischaemic Attack 
(TIA), Subarachnoid Haemorrhage (SAH) and other neurological conditions and stroke 
‘mimics’ were not included. 
b) Aged 55 years and over. Age has been shown to be significant risk factor for delirium, 
when investigated in other patient populations[76].  
 
5.3.2 Exclusion criteria  
The exclusion criteria for the study were as follows: 
a) Patients who are severely ill. The decisions were made in consultation with the clinical 
staff and the use of the MEWS and GCS scores. Those with a Modified Early Warning 
Score (MEWS)[461, 462] of 5 or more and a Glasgow Coma Scale (GCS)[463, 464] score of 8 
or lower were excluded. Patients that initially had a high MEWS score or low GCS score 
but improved within the recruitment window were considered for participation. There is a 
possibility that some severely ill patients that were excluded may have had delirium, but 
it would not have been appropriate to include them due to the state of their health.  
b) Patients whose first language was not English and where appropriate arrangements for 
translation could not be made.  
c) Patients who did not have capacity to consent and did not have a carer or consultee to 
look after the participant’s best interests and wellbeing, and provide consent to take part 
in the study. 
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d) Patients who had a home address outside of West Yorkshire were classed as non-
residents. The non-residents were included in the analysis of the incidence data but 
excluded for the analysis of the prognostic outcomes if follow up proved to be difficult.  
e) Patients that were already enrolled in other research studies. If these other studies did 
not allow for co-recruitment of patients, then the patients were excluded.   
 
5.4 Case definition and selection process  
As described in Chapter two, the onset of a stroke can be identified using a number of 
warning signs but the actual diagnosis of a stroke is made by a medical professional[465, 351]. 
Once within the care of a medical professional, the onset of a stroke is identified quickly so 
that the patient can receive the prompt treatment they need. The process of stroke diagnosis 
is well documented[466] and every hospital has a stroke care pathway in place. However this 
is not the case for the screening, diagnosis and treatment of delirium. There are no clinical 
tests or investigations used routinely for the detection of delirium.  
With regards to delirium, previous studies have used a range of different assessment tools to 
detect delirium within a stroke population, as discussed in Chapter three. It is important that 
the instruments used to identify the study cases are easy to use and interpret, well tolerated 
by the participants and have a good sensitivity and specificity to detect delirium. The 
Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV)[23], recently updated to 
DSM 5[26] and the International Classification of Diseases 10 (ICD-10)[138], are considered the 
international standards in the diagnosis of delirium and provide an accurate definition of the 
syndrome. Subsequently other diagnostic methods for delirium have been developed and 
validated based on these criteria. The following section discusses the measures used in the 
study for the identification of both stroke and delirium.  
 
5.4.1 Classification of stroke 
The diagnosis of stroke was made by the clinical staff on the stroke units. These 
assessments were supplemented by CT and/ or MRI scans which clarified the pathology of a 
stroke in relation to an infarct or a haemorrhage. In addition to this, the Bamford stroke 
classification[280] was used as clinical descriptor, to provide a prognostic grouping of the 
stroke subtypes, as illustrated in Figure 5.3. 
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Bamford
[280]
 thrombosis 
[281]
 
The Bamford classification is also known as the Oxford Stroke Classification[467, 280, 468]. The 
patient’s clinical signs are used to classify the stroke into one of four possible categories and 
this relatively simple bedside method[469] can give the assessor[470] useful information on 
mortality risk, dependence outcome and risk of reoccurrence. During patient examinations, 
MEWS readings are often used to monitor physiological status and the GCS score is used to 
assess the patient's level of consciousness. In this study both the MEWS and GCS scores 
were used to assess the potential participant’s state of health to determine if they were well 
enough to participate in the study, in addition to the clinical assessment of the stroke.  
 
Stroke type Features 
 
Total Anterior 
Circulation Stroke 
(TACS) 
 
 
1. New higher cerebral function dysfunction: 
dysphasia/dyscalculia/apraxia/neglect/visuospatial problems plus 
2. Homonymous visual field defect, plus 3. Ipsilateral motor and/or 
sensory deficit of at least two areas of face, arm and leg. In the 
presence of impaired consciousness, higher cerebral function and 
visual fields deficits are assumed.  
 
 
Partial Anterior 
Circulation Stroke 
(PACS) 
 
 
Two of the three components of TACS, or isolated dysphasia or 
other cortical dysfunction, or motor/sensory loss more limited than 
for a LACS. 
 
 
Lacunar Stroke 
(LACS) 
 
 
Pure motor or pure sensory deficit affecting two of three of face, 
arm, and leg, or sensorimotor stroke (basal ganglia and internal 
capsule), or ataxic hemiparesis (cerebellar-type ataxia with 
ipsilateral pyramidal signs—internal capsule or pons); or dysarthria 
plus clumsy hand, or acute onset movement disorders (hemi-
chorea, hemiballismus—basal ganglia).  
 
 
Posterior 
Circulation Stroke 
(POCS) 
 
 
Cranial nerve deficit with contralateral hemiparesis or sensory 
deficit, or bilateral stroke, or disorders of conjugate eye movement, 
or isolated cerebellar stroke, or isolated homonymous hemianopia.  
 
Image adapted from the paper by Bamford et al
[279]
 
 
 
Figure 5.3: The Bamford stroke classification. 
The Bamford stroke classification scale is based on the four key clinical features of stroke; 
brainstem signs, hemiparesis, hemianopia and higher cortical dysfunction which include 
language problems. PACS are mostly embolic, whilst LACS are mostly thrombotic 
occlusions of small deep end arteries.  POCS and TACS however are spilt - 80% of 
POCS are thrombotic and 20% are embolic compared to LACS which are two thirds 
embolic and one third of them are due to in-situ thrombosis[280]. 
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5.4.2 Detection of delirium  
As previously mentioned, several diagnostic methods have been developed to operationalise 
the DMS-IV and ICD-10 criteria[471-475, 130, 476-481]. From the systematic review and other review 
articles[142, 33, 424], several tools that screen for and diagnose delirium were shortlisted, which 
had varying degrees of sensitivity and specificity when used in the general medical 
population. However, these tools were not designed to detect delirium in a stroke population. 
These shortlisted measures as illustrated in Figure 5.4a and 5.4b, were previously 
mentioned in Chapter one and will now be further discussed.  
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Figure 5.4a: A summary of the assessment tools available to diagnose delirium. 
Many delirium diagnostic methods have been developed and validated based the DSM-IV 
or ICD-10 criteria, which are considered the reference "gold standard" in delirium. 
However they are not routinely used in clinical settings. 
 
Delirium assessment tools Features 
Confusion Assessment Method (CAM)  Sensitivity: 94% 
Specificity: 89% 
CAM for Intensive Care Unit (CAM-ICU)  Sensitivity: 94 - 100% 
Specificity: 90 - 95% 
Cognitive Capacity Screening Examination 
(CCSE)  
Sensitivity: 94 - 100% 
Specificity: 83 - 100% 
Cognitive Test for Delirium (CTD)  Cut off 22; Sensitivity: 72%, Specificity: 71% 
Delirium Observation Screening (DOS)  Sensitivity: 94.4% 
Specificity: 76.6%   
Delirium Rating Scale (DRS)  
 
Cut off 10; Sensitivity: 82%, Specificity: 94% 
Cut off 8; Sensitivity: 90%, Specificity: 82% 
DRS – Revised 98 (DRS-R98)  Sensitivity: 91 - 100% 
Specificity: 85 - 100% 
Intensive Care Delirium Screening (ICDS)  Sensitivity: 99% 
Specificity: 64%   
Memorial Delirium Assessment Scale (MDAS)  Sensitivity: 68%  
Specificity: 94% 
NEECHAM Confusion Scale  Sensitivity: 87% 
Specificity: 95% 
Image adapted from the paper by Meagher et al
[31]
 
 
 
Figure 5.4b: The sensitivity and specificity of delirium diagnostic tools.  
Furthermore, many of these delirium tools vary in sensitivity and specificity in non-stroke 
settings, making the comparison of results between cases unreliable and problematic.   
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Diagnostic methods for delirium have been developed and validated based on the DSM-IV 
or ICD-10 criteria and one such tool is the Confusion Assessment Method (CAM)[130]. The 
CAM was originally developed in 1988-1990 to help non-psychiatrically trained clinicians to 
identify cases of delirium quickly and accurately. The CAM has the highest sensitivity and 
specificity in comparison to the other tools. Due to its ease of use and good validation 
results, the CAM is the mostly widely used tool for delirium detection[482] both in clinical and 
research settings. The tool includes two parts; firstly the screen for cognitive impairment and 
secondly the focus on the four core features of delirium that distinguish it from other forms of 
cognitive impairment. The four core features are acute onset or fluctuating nature, 
inattention, disorganised thinking and an altered level of consciousness. Each core feature is 
rated as positive if present or negative if absent and an overall score of three positive 
features indicates that delirium is present.  
The Confusion Assessment Method for Intensive Care Units (CAM-ICU)[483] was further 
developed for use with patients in intensive care units who were unable to communicate 
verbally due to artificial ventilation or intubation. It is a well validated and frequently used 
tool. It requires minimal training, is quick to administer and has been translated into ten 
languages. The ability to translate the test was important in our study as the hospitals serve 
diverse communities and some of our participants may not be fluent in English. In addition to 
this, some of the study population may not be able communicate verbally due to the effects 
of stroke and so the use of the CAM-ICU may help to overcome this problem[484].  
As the CAM-ICU does not determine the severity of a delirium episode, another measure 
was needed to meet this requirement. There are only a few tools that assess severity of 
delirium such as the Delirium Rating Scale – Revised 98 (DRS-R98)[485], the Memorial 
Delirium Assessment Scale (MDAS)[474] and the Delirium Index (DI)[476]. The DI depends 
solely on the observation of the patient without any input from other sources such as staff or 
carers[486]. The use of information from other sources would strength the diagnosis of 
delirium by decreasing potential sources of error and so the use of the DI was excluded on 
this basis. The MDAS showed a good specificity (94%) but lower sensitivity (68%) for the 
detection of delirium. Furthermore the MDAS had only been tested with one patient 
population consisting of cancer patients, whereas the Delirium Rating Scale (DRS)[481] had 
been tested in a range of different patient groups. The DRS also incorporates information 
from staff, carers and the medical notes as well as patient observations. Upon comparison of 
the sensitivity and specificity of the tools, the DRS also had a higher sensitivity and 
specificity compared to the MDAS and DI.  
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The DRS[481, 487] assesses 16 domains which include: sleep wake cycle, perceptual 
disturbances, delusions, lability of affect, language, thought process, motor agitation, motor 
retardation, orientation, attention, short and long term memory, visuospatial ability, temporal 
onset of symptoms, fluctuation of symptom severity and physical disorder. Each domain is 
allocated a score and the test has an overall maximum score of 32. The assessment tool 
also requires input from the staff involved with the patient's care.  
The 1998 revised edition of the DRS, the DRS-R98[485] is based on 13 severity ‘symptoms’ 
and three ‘diagnostic’ items and is able to determine the severity of a delirium episode[488]. It 
is a well validated tool that is simple to administer, has a high inter-rater reliability, is ideal for 
longitudinal studies and has been translated into seven languages. The updated version of 
the DRS was chosen as the tool to assess delirium severity. From examining the literature 
and conducting the systematic review, it was considered that the combination of the CAM-
ICU and the DRS-R98 was sufficient for the purposes of detecting the presence and 
assessing the severity and duration of delirium in this study.  
 
5.4.3 Selection of the study cases 
As delirium can be of a transient nature and the published literature has also shown a 
common inception point between 24 and 72 hours after admission[489], it is essential that the 
patients should be identified and recruited as quickly as possible. In the initial protocol, it was 
decided that patients should be recruited within 24 hours of hospital admission so that no 
potential cases were missed. Prior to the start of the study, a pilot study was conducted on 
the stroke units in which; the assessments tools, the Case Report Forms (CRF) and the 
study protocol were tested. The pilot study allowed the researcher to gain experience using 
the selected assessment tools, practice scoring and make protocol amendments.  
The pilot study highlighted that the chosen recruitment window of 24 hours might prove 
problematic for the study recruitment. This is because as potential participants had suffered 
a stroke, they would be undergoing various clinical assessments upon their admission to the 
hospital within the first 24 hours. Therefore trying to conduct the study assessments correctly 
in amongst the initial clinical assessments would be difficult. As a result of this a recruitment 
window of 72 hours was chosen within which the diagnosis of stroke and initial delirium 
assessment would be made. The extension of the recruitment period meant there was less 
pressure in terms of assessments, on the participant during their first few days of hospital 
admission. This also meant that participant would be much more likely to consent once they 
had settled into the hospital environment.   
112  
 
5.5 Measurement of outcomes  
This following section discusses the aspects related to the outcome measures, which were 
considered during the design of the study. These aspects include: selection of outcomes, the 
measurement of the selected outcomes, avoiding bias and error, and finally the follow up 
process. 
 
5.5.1 Mortality 
The risk of dying from a stroke is about 12% at seven days, 19% at one month and 30% at 
one year for a first-ever stroke[340, 490]. Studies indicate that delirium has also been 
associated with an increased risk of mortality[491] and so the combination of stroke and a 
delirium episode may greatly increase the mortality risk for patients.  
It should also be considered that by extending the life of the patient, this could further 
increase costs associated with additional patient care and deplete already limited resources. 
In England alone, stroke is estimated to cost the economy £7 billion per year, of which £2.8 
billion are direct costs to the NHS[331]. This indicates that stroke will become increasingly 
expensive as the number of people living with stroke increases. The stroke burden can be 
assessed by commonly applied health measures such as the gain of Life Years (LYs), 
Quality Adjusted Life Years (QALYs) and Disability Adjusted Life Years (DALYs)[492, 493]. 
However in determining priorities between individuals for limited resources, the General 
Medical Council (GMC) states that clinicians should have regard for three duties of care; to 
protect life and health, to respect autonomy and to treat justly. Therefore priority is given to 
the need to protect life and health and give priority to those who healthcare needs are 
greatest or most urgent.  
Mortality is recorded by the issue of a death certificate by a clinician registered with the 
General Medical Council. For deaths that occur in the hospital, the death certificates are 
issued by one of the attending doctors and recorded in the Ward Register. The procedure is 
the same for deaths that occur once the patient has been discharged; however the 
procedure to access this data becomes less straightforward. Outside the hospital, the 
confirmation of death is made by the patient's general practitioner or any qualified and 
registered medical professional that may be on call. If the patient is in institutional care, then 
the staff at the institution can be contacted to confirm the patient's status. Similarly if the 
patient returns home, then the patient's local health authority or general practitioner can be 
contacted to confirm the patient's status.  
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Patients have their medical information stored in databases which are recorded using an 
NHS number that is unique to every patient. A request can be made to check these records 
to confirm the patient's survival status. An example of such a database is the Official 
National Statistics (ONS) which collects data on large scale studies using automatic tags for 
each patient, for which patient consent is required. For this study, mortality was monitored 
for up twelve months after the patient had suffered a stroke. The data was collected from 
ward registers, contacting staff based at the patient's institution or general practitioner. This 
procedure avoided the need for any further contact with patient's family, especially during a 
period of recent bereavement.  
 
5.5.2 Length of hospital stay 
According to the Hospital Episode Statistics (HES) for 2011 to 2012, stroke patients stay an 
average of 18.4 days in a general hospital ward after a stroke[494]. Over 2.6 million beds per 
year are occupied by stroke patients, which is the largest number of any patient population. 
26% of patients do not spend any time in a dedicated stroke unit as not all hospitals have 
dedicated acute stroke units[365, 366]. In 2001, the average length of hospital stay in a general 
ward was around 34 days, however this has now significantly decreased[365]. In 2012 to 2013 
the average length of stay in a dedicated stroke unit was calculated to be approximately 21 
days but this can vary across hospitals[72, 73]. Research has shown that patients that have 
received care from a specialist stroke unit have a 50% reduced risk of death[364], better long 
term recovery and a decreased need for long term hospital or institutional care[495, 361, 366].  
In addition to the resources and cost implications[367, 496], longer hospital stays also have an 
impact on the patient's health and may increase the risk of complications post-stroke. Longer 
hospital stays have been associated with an increased risk of hospital acquired infections[497] 
which would impact on the patient's prognosis. Studies in non-stroke populations have 
shown that delirium may independently increase the length of stay[19, 244], which would place 
increased pressure on NHS resources as well as impacting on the patient's health. 
Furthermore research has shown that early discharge for stroke care patients may aid a 
quicker recovery rate. Community stroke teams can help to decrease the length of stay and 
bridge the gap between hospital and home by continuing to provide vital rehabilitation 
services for patients after hospital discharge. From a psychological point of view, many 
patients are motivated to return to their own homes and limit their stay in hospital, as the 
hospital stay is most likely associated with an unfortunate event in their health.  
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The length of stay is defined by the combined time spent on the acute stroke unit, the 
rehabilitation unit and any other wards that the patient may have been transferred to for 
treatment during their stay in hospital. A patient's length of stay can be affected by a number 
of different factors such as post-stroke care needs, family support and NHS support 
services. In addition to being medically fit, the patient's degree of disability, their home 
environment and the needs of the carer are also taken into consideration. Some patients 
may need the help of Intermediate Care Teams (ICT) or spend some time in Community 
Intermediate Care (CIC) beds after hospital discharge. A patient's discharge from hospital 
can also be affected by future long term care arrangements not being put in place such as 
allocation of a place in institutional care, funding for home care nursing or contacting local 
authorities to arrange additional community support services for patients. In this study, 
length of stay was determined by monitoring the dates of admission and discharge or death 
as recorded in the Ward Registers.  
 
5.5.3 Discharge destination  
Upon hospital discharge, patients who are medically fit and independent are able to return to 
their homes as before or with care packages to provide additional support once they are 
home. However for some patients after a stroke, institutional care may have to be 
considered by the patient, the carers and the clinical staff responsible for the patient. In 
certain cases, patients may even request residential care in order to relieve pressure on their 
carers. At present, the cost of informal care after a stroke is £2.4 billion[331, 2]. The type of 
care required varies depending on the level of input a patient requires but approximately 20 
to 40% of residents in care homes are there as a result of a stroke[2].  The average long term 
cost per patient ranges from £15,000 over the first five years after a stroke, but this can 
increase to £29,000 when informal care costs are added[498].  
The presence of delirium can have an impact on a patient's need for institutionalisation post-
discharge. Studies in populations such as hip fracture patients show that delirium increases 
the need for institutionalisation[499, 49]. Studies also estimate that the prevalence of delirium 
within a care home setting ranges from 6 to 60%[500] and these groups have NICE identified 
risk factors for delirium. An increase in the number of people with stroke coupled with 
delirium would mean that more patients would require some form of long term institutional 
care. This would impact on the costs, the patient's recovery rate and place more strain on 
care facilities.  
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Placement into an institutional care facility can be local authority means tested or privately 
funded by the patient. In order to secure placement, the needs of the patient are assessed 
by the staff and then matched to the appropriate institutions, so that the patient receives the 
best care possible for their specific needs[501]. The placement is then confirmed either 
through social services or directly by the patient and/ or their carers. However many patients 
and/ or their carers would prefer to avoid the use of an institutional care facility until it is 
absolutely necessary. This may be because in the past and at this moment in time, concerns 
have been raised about the quality of care provided for older people in long term care[502, 503]. 
These included factors such as; financial costs, care staff attitudes, poor living conditions 
and the mental wellbeing and health of other residents in care[503]. This is not an ideal 
situation to have, but changes are being made to improve the standards within care homes.  
In this study, the patient's discharge destination and date of discharge were recorded in the 
ward registers. Discharge destinations included patients returning to their own home, moving 
in with a family member, sheltered housing, residential care homes, nursing homes and 
temporary Care in the Community (CIC) beds. Any other different destinations not listed 
were also noted. These patients were then further monitored for up to six months post-stroke 
to detect any changes in their residence, by contacting the patient's general practitioner or 
the local health authority.  
 
5.5.4 Physical function 
Up to 70% of stroke patients survive but are left with significant disability[281]. Stroke is the 
largest cause of adult disability in the UK[281]. Lost productivity and disability from strokes 
cost the economy around £1.8 billion[270]. After a stroke people lack independence and 
require more help with their needs and a longer recovery rate[405]. This increase in the 
patient's physical dependence will create a greater need for more institutionalised care 
placements, thus increasing the burden on community services provided by the local health 
authority as well as the care homes.  
Studies in other patient populations have shown that delirium is linked to an increased risk of 
mortality and significant morbidity[38, 491]. An increase in morbidities means that patients may 
not be able to return to their pre-stroke functional ability and will therefore be more 
dependent on carers. The effect of delirium on the recovery process after a stroke can be 
assessed by measuring the patient's physical functional capacity as one of the outcomes. By 
monitoring functional capacity, it can be determined whether the presence of delirium delays 
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the patient's recovery and return to their pre-stroke functional capacity or if a complete 
recovery is no longer feasible.  
In order to measure functional capacity, a suitable assessment tool needed to be selected 
that fulfilled a number of requirements. As patients will be undergoing a range of other 
assessments during their time in hospital, a tool that would be quick and easy to administer 
was required to decrease the burden on the participants. The tool should have good 
sensitivity to detect subtle function changes and be well tolerated by participants. Patient 
tolerance is crucial as any participants that do not react well to the assessments may 
withdraw from the study or refuse to participate at all.  
From the systematic review conducted, it was apparent that several measures have been 
used, which have been summarised in Figure 5.5. Reviews have also been conducted to 
assess the feasibility of using these measures in the stroke population, but have provided no 
clear answer as to which was the best suited to measure functional ability outcomes[504, 410, 
290, 505, 301, 506, 507]. The reason for this is not clear. It may be due to differences in the range of 
areas the different tools assess, the methodology of how the tool is administered to the 
patient or perhaps influenced by the profession and experience of the person employing the 
assessment tool.    
One of the most commonly used measures in these studies is the Barthel Index[508], which 
measures activities of daily living. It is routinely used in clinical settings to measure functional 
ability, has also been used in many stroke based studies[509-511] and also has a postal 
version[512].  It is easy to administer and is based on 10 activities which are given a score of 1 
to 4 to describe how well each activity is done. Although the basic functional tasks are 
covered, higher order functions are not assessed and the Barthel Index is not sensitive 
enough to detect subtle changes from normal function because there are only 2-4 categories 
per item. In addition to this, it has been shown to have inherent floor and ceiling effects[513, 
514]. This means that the Barthel Index’s sensitivity to change is limited at extremes of 
disability and those with a mild or moderate stroke have are likely to achieve a high score in 
activities of daily living, whilst still suffering from significant disability post-stroke.  
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Functional 
Measure 
Features Advantages and 
disadvantages 
Barthel Index 
(BI)   
Assesses: activities of daily living and 
mobility.  
Structure: 10 items  
Scoring: Scored 1 to 4 
Time: 2-5 minutes self report or 20 
minutes direct observation.  
Advantages: 6 languages  
 
Disadvantages: significant 
ceiling effects 
Modified Rankin 
Scale 
Assesses: activities of daily living, 
post-stroke independence 
Structure:  
Scoring: scored 1 to 5 
Time: 5-15 minutes 
Advantages: adequate floor 
effect 
 
Disadvantages: Poor at 
detecting change. Categories 
are broad, poorly defined and 
left open to rater interpretation 
Functional 
Independence 
Measure (FIM) 
Assesses: physical and cognitive 
disability 
Structure: 18 items (13 physical 
domains, 3 cognition domains) 
Scoring: Scored 1 to 7  
Time: 30 - 45 minutes 
Advantages: developed in 
response to BI sensitivity 
issues. 
10 languages 
 
Disadvantages: has ceiling 
effects with cognitive 
subscale. 
National 
Institute of 
Health Stroke 
Scale (NIHSS)  
Assess: level of consciousness, 
muscle function,  
Structure: 15 items 
Scoring: Scored 1 to 7  
Time: 10 minutes 
Advantages: 11 languages 
 
Disadvantages: low 
sensitivity. some scale items 
cannot be tested due to stroke 
severity  
 
Subjective 
Index for 
Physical and 
Social Outcome 
(SIPSO) 
Assess: functional ability post-stroke  
Structure: 10 items 
Scoring: Scored 1 to 4  
Time: 15 minutes  
Advantages: self report, can 
be administered quickly and 
cheaply 
 
Disadvantages: all subscales 
not fully validated  
 
Nottingham 
Extended 
Activities of 
Daily Living 
(NEADL) 
Assess: activities of daily living  
Structure: 16 items (4 domains) 
Scoring: Scored 1 to 4  
Time: 15 minutes  
Advantages: can be used as 
a postal questionnaire 
 
Disadvantages:  
 
Image adapted from rehabmeasures.org 
 
 
Figure 5.5: Summary of the tools used to measure functional capacity. 
There are a number of functional measures used both in clinical settings and for research 
purposes. However there is no consensus on the instrument best suited to measure 
functional ability outcomes in the stroke population. Many of these tools vary in sensitivity 
and specificity and the table above summaries the features of some of these functional 
measures.  
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From the systematic review conducted and the reviews available, the Nottingham Extended 
Activities of Daily Living (NEADL)[515] was selected. Reviews[516, 517] have shown that it has 
good responsiveness and validity in comparison to other methods[518]. It is a more 
comprehensive measure, has better score representation, is easy to administer and is 
suitable for stroke patients[519]. The NEADL can also be used as a postal questionnaire[520], 
which may be completed by the patient and/ or the carer. For the purposes of this study, a 
measure of pre-stroke functional ability was obtained by extraction from the patient's medical 
admission notes and input from the patient's carers. The pre-stroke score was a 
retrospective assessment which may be susceptible to recall error from both the patients 
and/ or the carers. The NEADL was administered to the patient during their stay in hospital 
as part of the baseline assessments. It was then repeated at the one and six month post-
stroke to assess changes in functional capacity. 
 
5.5.5 Cognitive function  
Cognitive impairment is common after a stroke[521, 522] and an increased age of 75 years and 
older has been shown to be significant risk factor, with an odds ratio of 2.5[435].  The 
combination of delirium after a stroke has the potential to significantly increase the later risk 
of dementia[376, 523]. Dementia currently costs the UK economy around £23 billion per year 
and one dementia patient costs about £27, 647 per year[524]. It is thought that up to one 
quarter of hospital beds are taken up by people with dementia, as they end up staying twice 
as long as other people who go in for the same procedure. Social care costs account for 
about 40% of this figure, due to the need for community care services and institutionalised 
care placements. The onset of dementia would mean a poorer prognosis for the patient due 
to the changes in quality of life, physical health, mental wellbeing and ultimately death[379, 525]. 
Dementia would also have a significant impact on the patient's family and their quality of life 
as well as increasing the burden on the NHS[526].  
Initiatives such as the National Dementia Strategy (NDS) have promoted better diagnosis, 
management and support for people with dementia. Although currently there is no cure, it is 
estimated that delaying the onset of dementia by five years could help to reduce deaths 
directly linked to dementia by 30,000 a year[527, 528]. Assessing cognitive impairment is 
clinically relevant, as changes in cognitive impairment could be an early indicator for 
dementia[526]. There are a number of assessment tools[146, 147] that can be used to measure 
cognitive impairment which will now be discussed.  
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The Mini Mental State Examination (MMSE)[10] has been a commonly used instrument to 
detect cognitive problems. It focuses on the domains of language, immediate, short and long 
term memory, processing, attention and orientation and praxis. The scores are split into four 
bands from none; mild; moderate and severe cognitive impairment. The MMSE has a 
specificity of 80-100% and a sensitivity of 82-87% in detecting cognitive impairment. 
However it does have some disadvantages as the test can be influenced by the patient’s age 
and education levels[529, 530]. This can create a variation in scores and as a result the 
standardised MMSE (SMMSE)[531, 532] was introduced to reduce inter-rater variability. The 
Telephone Interview for Cognitive Status (TICS)[533] is another cognition test that has been 
shown to have a high correlation with the MMSE and can be administered face to face as 
well, despite being designed to be administered over the phone[534]. The opportunity to test 
cognition using this method is advantageous when arranging follow up assessments for a 
large group of patients. Certain patients within the study sample may not want the 
researchers to come to their homes for further assessment. Furthermore some stroke 
patients may still be experiencing problems with their vision and reading and writing post-
stroke. As a result they may not be able to fill out postal questionnaires but can still complete 
the TICS exam as it does not rely on visual clues.  
The Addenbrooke’s Cognitive Examination - Revised (ACE-R)[535] is a test that incorporates 
the MMSE. There are five subdomains that are tested: attention and orientation, memory, 
fluency, language and visuospatial. The ACE-R is a well validated and brief test that takes 
an average of 16 minutes to administer and score in a clinical setting. It is a sensitive and 
specific tool and the five sub-domain scores provide further details on which specific 
cognitive functions are affected. Another similar cognitive exam that is increasingly being 
used clinically in the UK is the Montreal Cognitive Assessment (MoCA)[536]. This is a shorter 
one page test that is scored out of 30, takes approximately 10 minutes to administer and is 
ideal for longitudinal studies. It has been translated into 35 languages and assesses the 
following domains: memory, attention and orientation, visuospatial abilities, language, 
fluency and executive function.  
The ACE-R was chosen for this particular study population as it is sensitive to early cognitive 
dysfunction, which may be indicative of the early stages of dementia[537]. The ACE-R was 
administered during the patient's stay in hospital and then administered again at six months 
to investigate for changes in cognition. Consideration was given to the inevitable probability 
that a significant number of study sample may suffer from visual problems and difficulties 
with reading and writing post-stroke. Obviously this would be unavoidable, but if these 
problems affected the completeness of the data collected from the ACE-R exam, then an 
alternative method would be needed. The first option would be to eliminate specific parts of 
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the ACE-R that relied upon visual clues or reading or writing so that analysis was the same 
for each participant. A second option would be to extract the MMSE data from the ACE-R 
exam or use the much shorter SMMSE during hospital admission followed by the TICS at 
the six month follow up stage to obtain a measurement for cognitive impairment.  
In addition to testing for cognitive impairment using the ACE-R, the addition of a specific 
dementia assessment tool was considered beneficial to detect dementia related changes at 
baseline and follow up. For the assessment of dementia, methods considered included the 
Clinical Dementia Rating (CDR)[538] which is able to detect mild impairment. However it is 
prone to subjective assessment. It also takes a long time to administer and it is not efficient 
at detecting changes over a longer period of time. Another commonly used method 
considered was the Cambridge Mental Disorder of the Elderly Examination (CAMDEX)[539] 
which consists of three separate sections: a structured patient clinical interview; a range of 
cognitive tests known as the CAMCOG; and a structured interview for the patient’s 
informant. 
The CAMDEX has a high inter-rater reliability and the CAMCOG has a good sensitivity and 
specificity, especially for a post-stroke assessment[540]. However the main disadvantage of 
this method was the time taken to complete the test, as the original version takes 60-90 
minutes to administer whilst the shortened version takes 30 minutes. This would clearly 
increase the burden on the patient and may deter them from participating in the study. An 
alternative assessment tool was the Cambridge Neuropsychological Test Automated Battery 
(CANTAB)[541] which is based on the CAMCOG and is administered using a touch screen 
computer. However the use of a computer aided test was not be feasible for our chosen 
population, many of whom would be disabled due to their recent stroke. The presence of 
delirium may also impact their ability to understand and follow instructions on how to 
complete the computer based assessment. 
Reviews have highlighted a number of interview methods as an alternative way of assessing 
dementia[542, 427, 543, 544]. These included the Short Portable Mental Status Questionnaire 
(SPMSQ)[545] which measures intellectual impairment. However, its sensitivity for detecting 
moderate and severe impairment is low[546]. Furthermore, the SPMSQ is similar to the 
Abbreviated Mental Test Score (AMTS)[11]. The AMTS is routinely administered on the wards 
and a more extensive assessment was considered necessary for this study. The Informant 
Questionnaire for Cognitive Decline in the Elderly (IQCODE)[547] And the short form of the 
IQCODE[548] were also considered as they are easy to administer, culturally accepted and 
are not influenced by education or hearing or visual impairments[549, 550]. The IQCODE can 
give an impression of general decline rather than specific cognitive changes[551-553]. However, 
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it may be susceptible to informant bias depending on the carer-patient relationship[554]. 
Another assessment tool considered was the Ascertain Dementia-8 (AD-8)[555] which is a 
dementia interview that has a good sensitivity (>84%) and specificity (>80%)[556]. The AD-8 is 
advantageous in that, if the carer is not available for the interview, it can be administered 
solely to the patient[557] and can also be combined with a word list recall task[558].  
For the purposes of this study, the AD-8 was used to assess for dementia as it is much 
shorter in length compared to the IQCODE and can be completed by either the informant or 
patient. If a carer was available, then the short form of the IQCODE was given to the carer to 
complete in order to compare comparisons between the different viewpoints between the 
carer and the patient. Again both the AD-8 and short form of the IQCODE were administered 
during the patient's stay in hospital and then repeated again at six months to monitor any 
changes that may predict the onset of dementia.  
 
5.5.6 Assessment of mood  
Mood disorders are common after a stroke[161, 451]. The Geriatric Depression Scale (GDS)[559] 
was used to monitor any changes in the patient’s mood as it is easy to administer, requires 
very little training or prior psychiatric knowledge and is well validated[560, 561]. The GDS is a 30 
item self-report assessment that is used to identify mood symptoms of depression but the 
formal diagnosis of depression requires a comprehensive clinical assessment. There are 
shorter versions of the scale that can be used to screen and exclude the presence of 
depression[562] but are of little clinical value in monitoring the severity of the depression. If 
depression is present then the longer list of questions can be used to determine the exact 
severity of the episode. The GDS was administered during the patient's stay in hospital and 
then repeated at six months to detect any possible changes in mood.  
 
5.5.7 The follow up process 
In order for reliable comparisons to be made for the outcome measures, the data set needed 
to be as complete as possible for every participant. During the participant's stay in hospital 
data was collected from medical notes, ward registers, databases and direct contact with the 
patient and carers. Once discharged from hospital, data was collected by contacting general 
practitioners and staff at institutionalised care facilities and local health authorities. Patients 
were also monitored by follow up assessments which were administered by home visits, 
telephone interviews or postal questionnaires, according to the participant's convenience.  
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5.5.8 Avoiding bias in the outcome measures  
To avoid systematic errors in data collection, potential sources of bias should be considered 
when measuring outcomes[563, 455, 456].   
a) The tools (instrument and insensitive measure bias)[456]. If the chosen assessment tools 
are not able to detect the presence of an illness (sensitivity) or the absence of the illness 
(specificity), then important differences in the chosen outcome may be missed. To avoid 
insensitive measure bias, the assessments chosen for this study e.g. the delirium tools, 
the activities of daily living and so forth, were selected after careful consideration and 
analysis of all available resources. The tools were chosen with the requirements of this 
study in mind to ensure that they were the best suited tools for this population of stroke 
patients. Following on from this point, if the carefully chosen assessment tools are not 
administered correctly, then this is also a potential source of error. If the researcher is 
not adequately trained in administering the various tests and assessment tools chosen, 
then this would lead to inaccurate data being collected and an incorrect representation 
of the sample population. For the purposes of this study, the tests were conducted by 
only one researcher to avoid differences in skill or training procedures so that all 
participants were assessed and scored in the same manner.  
b) The protocol (verification bias or proficiency bias)[456]. If the measurement tool is 
restricted to test only those who have the illness, or is not applied equally to all 
participants, then this can lead to overestimations. For the purposes of this study, all 
participants had the same set of assessments conducted at exactly the same intervals, 
regardless of their diagnosis and whether they were delirium positive or negative.  
c) The diagnoses (attention and expectation bias)[456]. Participants that are more aware of 
their involvement in a study, may be more motivated and give more positive responses 
compared to those participants that are unaware of their involvement in the study. In this 
study, some of the patients may lack capacity, which would impact on their 
understanding of why the assessments were being conducted. This lack of capacity may 
be due to confusion from the stroke, the presence of delirium or pre-existing long term 
conditions such as dementia. Although some variables such as lack of capacity cannot 
be controlled, for this study the researcher made an effort to keep the participants 
equally informed as to the purpose of these assessments with reminders and prompts 
given when necessary. With regards to expectation bias, researchers that are aware of 
a participant’s diagnosis may unknowingly make a mistake in measuring outcomes 
towards the outcome they expect and in effect reinforce the diagnosis made. For 
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example a delirium positive person may be expected to score more poorly on cognitive 
assessments compared to someone without delirium. This may impact on the way the 
tests are administered as delirium negative patients may be given an opportunity to 
correct any mistakes they may have made, whereas a delirium positive patient may not 
receive a similar opportunity as it is assumed that they will score poorly in any case due 
to the presence of delirium. In this study, only one researcher conducted and scored all 
the assessments in the same manner to avoid potential differences in the methodology 
and thereby increasing the reliability of the scoring process. However this may also have 
been a potential source of bias, as the researcher was not blinded to the patient’s 
diagnosis. Awareness of the patient’s diagnosis may have influenced the scoring of the 
assessment and it is possible that this could have affected the generalisability of this 
study.  
d) The participants (recall bias)[456]. Participants with delirium, or due to the effect of a 
stroke, may be confused. This may impact on their ability to recall events during the 
follow up assessments, especially if the events during their stay in hospital were of a 
negative nature. On the other hand, some participants may remember their involvement 
in the study and their previous responses or may be subjected to similar assessments 
from care teams in the community. Therefore when the assessments are repeated, the 
participants may no longer be unaware of the nature of the assessments as they may 
have the opportunity to 'learn' their responses. In this study, the researcher made an 
effort to contact community care teams post-discharge to determine if any similar 
assessments had been conducted and during which time period. If assessments were of 
a similar nature and the time period matched those stated in the protocol, then these 
results were used for the follow up assessments. This helped to avoid the problem of 
'learned' responses from participants and it also meant that the participants did not have 
to undergo any unnecessary or additional assessments.  
e) The outcomes (significance bias)[456]. In a prospective study, measuring outcomes that 
are not clinically significant would be waste of time and resources. Therefore time must 
be taken to ensure that the chosen outcomes are of clinical significance and the 
conclusions of the prospective study can be used to possibly make changes and 
develop strategies that can be employed in clinical practice. It is also important to have 
adequate participant numbers in order to avoid studies that are inadequately powered. 
Underpowered studies can lead to important effects not being detected whilst 
overpowered studies can be considered as unethical and a waste of resources. The 
appropriate power calculations for this study are discussed in further detail in Section 
5.10. For this study, the outcomes chosen such as mortality, length of hospital stay, the 
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need for institutionalisation, physical functional capacity, cognitive function and changes 
in mood were chosen as they were of clinical significance and these have been 
discussed in detail earlier in this chapter at the start of Section 5.5.  
f) The follow up (incomplete or withdrawal bias)[456]. Loss of follow up is a cause for 
concern in prospective studies. During their stay in hospital, the participants are a 
captive audience and so it is easier to complete the assessments. However once 
discharged, it is harder to contact participants and so it is better to maximise the use of 
resources that do not require as much patient contact such as using general 
practitioners and hospital databases. It is worth mentioning that these resources may 
not be as accurate or up-to-date as possible and the researchers have no way of 
checking each and every patient detail. However the use of these resources would allow 
for the completeness of data collection. It is also possible that once discharged from 
hospital, patients may no longer want to participate in the study and may withdraw from 
any further assessments. For the purposes of this study, the data collected in hospital 
was a combination of information extracted from the medical records as well as directly 
from the patients themselves. Once discharged from hospital, resources such as 
information from hospital databases, general practitioners and community care teams 
were employed to maximise the collection of data to ensure completeness of follow up. 
With regards to minimising loss to follow up, participants were given a range of options 
through which the follow up assessments could be conducted, at their convenience. The 
options included home visits, telephone interviews or postal questionnaires.  
 
5.6 Potential confounding variables/ outcome predictors and risk 
factors 
The literature suggests that delirium is associated with a number of confounding variables 
and risk factors such as age, gender and the patient's state of health and these are 
illustrated in Figure 5.6. From the research groups included in the systematic review in 
Chapter three, a list of confounding variables and risk factors was produced. These variables 
have also been discussed in further detail in certain reviews[120, 38, 46] investigating the 
occurrence of delirium in the acute stroke population.  
Risk factors are variables that increase the risk of a certain outcome occurring[563]. For 
example in this study a risk factor such as age would increase the chances of a patient 
suffering from an episode of delirium. On the other hand, confounders are variables that may 
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have an effect on both the exposure and the outcomes in a prospective study in addition to 
the main risk factor being studied[563].  
Confounders can cause problems in data analysis as it may seem that certain variables 
have a direct association with the outcome when they do not (positive confounding) or hide a 
genuine association with the outcome when they do (negative confounding). A solution to 
confounding variables would be to match each participant from the exposure group 
(delirium) to a participant from the non-exposure group (non-delirium) to account for this or 
to take a random sample of participants and adjust for the effects of confounders in the 
analysis phase of the study.  
 
 
Van Rompaey
[564]
 
 
 
Image adapted from Van Rompaey et al
[561]
 
 
 
Figure 5.6: Confounding variables/ risk factors that affect delirium in acute stroke. 
There are a number of variables that are associated with delirium onset in the acute 
stroke population. Some variables such as age and sex are not modifiable and whilst 
other such as patient environment can be modified to a certain extent. The association 
between these variables and delirium in stroke patients requires further investigation.   
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In addition to the outcomes, supplementary data for confounding variables and/or risk factors 
was also collected to determine whether they had any effect on the outcomes. Patients 
recruited into the study were interviewed and a detailed medical history was collected that 
included social background, educational levels and type of employment. The medical history 
included information on prescribed medications, chronic illnesses, recent surgical 
procedures and previous mental health problems.  
The variables investigated in this study were: incontinence, constipation, malnutrition, 
dehydration, electrolyte imbalance, infections, hypoxia, surgery and physical illness, number 
of medications, smoking, alcohol and changes in cognitive impairment. It is anticipated that 
these confounding variables and/ or risk factors may act as delirium predictors for 
outcomes[188]. The presence or absence of each variable was noted and then recorded 
according to various measurement scales used for the specific variable. Further details of 
these chosen measures are provided in the methodology (Section 6.6.2) which will be 
discussed in Chapter six.  
 
5.7 Assessment of the delirium instruments  
The delirium instruments chosen for this study are the CAM-ICU and DRS-R98 to screen for 
and assess the severity and duration of a delirium episode. Both of these instruments have 
been validated against the DSM-IV or ICD-10 criteria which are considered the "reference 
standard" for delirium diagnoses. Both the CAM-ICU and DRS-R98 have been tested and 
validated for use in populations such as general medical and surgical patients, patients with 
hip fracture and patients in intensive care. The instruments have shown good sensitivity and 
specificity in detecting delirium, are easy to administer and are well tolerated by patients.  
The stroke population however differs significantly from the other populations previously 
tested. It should be noted that many of the features of delirium overlap with the symptoms of 
a stroke, which makes the detection of delirium more challenging. The accuracy and 
reliability of the CAM-ICU and DRS-R98 should be tested for use within the stroke 
population.  
For this study, the source population were the stroke patients admitted to the stroke unit 
whilst the study population consisted of stroke patients with delirium. As the CAM-ICU and 
DRS-R98 had not been validated for use within the stroke population a few points needed to 
be considered, in order to make the study findings generalisable to the extended population. 
Firstly both assessment tools should be applied to all the stroke patients recruited regardless 
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of whether they had delirium or not. Secondly, the CAM-ICU and DRS-R98 should be 
administered at the same time points so that same set of symptoms are examined, as 
delirium has an acute onset and is susceptible to fluctuating symptoms. These points are 
worth mentioning to avoid any selection bias and ensure that it was a comprehensive 
exercise in testing the delirium instruments within an acute stroke population. 
 
5.8 Ethical considerations 
5.8.1 Identification of potential participants 
The study protocol was reviewed and approved by certain consultants on the stroke units (Dr 
P. Wanklyn in Leeds and Dr C. Patterson in Bradford) based in West Yorkshire. Patients 
admitted to the stroke units were approached to participate in the study, after a consultation 
with clinical staff. The consultation with the clinical staff was necessary in order to correctly 
identify suitable participants and as well as safeguarding the interests of the patients, 
particularly as this study was based on a vulnerable population[252, 565]. Patients with delirium 
were expected to be in a poorer state of health as delirium is usually a sign of an underlying 
physical illness. Due to their vulnerable state, the researcher was careful not to approach 
patients where it was not appropriate, in order to avoid any additional distress to the patient 
and their families.  
Potential participants were screened to see if they matched the recruitment criteria. A 
statistical power calculation, which is discussed in further detail in Section 5.10, was 
conducted to identify the recruitment numbers needed for this study. The aim was to screen 
339 patients for the prospective cohort study, divided into 68 patients with delirium and 271 
patients without delirium. These numbers also allowed for 15% contingency in both groups, 
to account for those who chose to withdraw from the study without affecting the feasibility of 
the study. The inclusion and exclusion criteria for this study had been carefully thought out in 
order to include as many patients and minimise recruitment bias[251]. For participants who did 
not match the study criteria or refused to participate, the exclusion CRF was completed 
detailing the reasons for exclusion. 
 
5.8.2 Capacity assessment  
Once the patients had satisfied the study criteria, the researcher assessed the capacity of 
the patient to obtain informed consent, according to the Mental Capacity Act 2005[566]. This 
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statutory framework aims to protect vulnerable people should they lose capacity to make 
their own decisions. When assessing capacity, consideration should be given to whether the 
patient has an impairment of the brain or disturbance of mental function and whether this 
impairment/ disturbance affects their ability to make decisions. A person with capacity should 
be able to understand, retain and process information that is relevant to the decision and 
then communicate their decision by speech, writing or any other means. The researcher 
received training from the LGI liaison psychiatry team and attendance at Comprehensive 
Clinical Research Network (CLRN) workshops. Assessing the patient's capacity was 
important in this study in order to identify the more vulnerable patients in the recruitment 
process. Gaining fully informed, voluntary consent is essential to all research.  
The requirements are that the patient should be able to understand the information and 
without any coercion from the researcher, provide voluntary agreement to participate as a 
self-ruling agent. Where patients are not able to fully understand the situation, then rather 
than excluding them, proxy consent or assent is sought from someone who is appointed to 
safeguard the patient's interests. This is a legal requirement to avoid any unnecessary 
physical and mental suffering and/ or injury to the patient. For the purposes of this study the 
protocol stated that if the patient had capacity and could provide written consent, then they 
were included in the study. If the patient could not physically write as a result of their stroke, 
then verbal consent was obtained in the presence of a clinical staff member or the patient's 
carers. The patient's carers were also approached for written consent so that they could be 
interviewed as part of the study.  
In cases where the patient lacked capacity, then proxy consent was sought from an 
appointed consultee for the patient. The appointed consultee was asked to sign a 
declaration form and kept informed of the patient's involvement in the study. Due to the 
nature of delirium, it was expected some of the patients would lose capacity after the initial 
consent process during the study. If this happened, then the patient would still be included 
provided that the appointed consultee was happy to continue. If the consultee refused proxy 
consent, then the patient would be excluded. It should be noted that regarding patient 
capacity, it is possible that the study findings could be susceptible to bias. Patients who 
lacked capacity or had been excluded from the study may have been suffering from delirium. 
This means that the final sample may not have included all the possible cases of delirium 
and therefore it may not be a true representation of the population being studied.  
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5.8.3 Consent and recruitment process  
The participants that satisfied the study criteria were given a verbal explanation of the study 
and an opportunity to ask any questions they had. Both the patients and their carers were 
provided with information sheets describing the details of the study and the reasons as to 
why it was being done. The participants were then given adequate time to decide whether 
they would like to take part, without any coercion from the researcher. This time would allow 
them to appreciate the relevance of the study to their situation, use their own reasoning to 
make a decision and then make and communicate a choice based on this process. However 
it is important to remember that delirium is a temporary condition and it has an acute onset 
and fluctuating nature. Therefore it was crucial that the delirium baseline assessments 
should be conducted quickly, preferably within 72 hours of admission.  
Once the participants understood the study information and had an opportunity to ask 
questions, they were then approached for written consent and asked to complete the 
appropriate consent forms according to their capacity. The researcher tried to build a rapport 
with the patients to develop a feeling of trust and minimise any unnecessary pressure. It was 
made clear to the participants that their involvement in the study was entirely voluntary and 
that they were free to withdraw from the study at any time. Furthermore, any information that 
they disclosed would be kept confidential and would not be shared with any unauthorised 
persons. Upon completing the consent forms and the baseline assessments, the participants 
were allocated a study number. The study number was used to anonymise the data 
collected by separating the study assessment data from any patient identifiable data.  
In order to avoid any further feelings of being pressured, the consent forms were also 
structured in such a way that the patient and/ or their carers/ appointed consultee could 
choose the length of their participation in the study. At each assessment point during their 
stay in hospital, the participant was verbally re-consented prior to any assessments being 
administered. During the follow up stages of the study, the capacity of the participant was 
again re-assessed. All participants whether they previously lacked capacity or not, were 
requested to sign a second consent form, provided that they were happy to continue. 
Patients with delirium can display symptoms such as hallucinations or feelings of insecurity 
or not feeling safe. By regularly checking the patient’s consent, researcher avoided any 
potential situations where the patient may have felt distressed, threatened or pressured into 
completing the study assessments.  
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5.8.4 Risk, benefits and burdens  
In order to conduct the study, ethical approval was acquired from the local research ethics 
committee. It was unlikely that the participants would have been harmed in any way during 
the study as the assessments being conducted by the researcher would not have interfered 
with the patient’s existing clinical care. If the participants were unhappy or wished to make a 
complaint, then this was reported to the chief investigator and the research manager at the 
University of Leeds.  
In terms of study numbers, between October 2009 and September 2010, approximately 200 
patients were recruited to various stroke research studies on the LGI ward alone and many 
of these studies had strict exclusion criteria. In order to lessen the burden on patients and to 
help decrease any "research fatigue" for participants, patients recruited to other studies that 
did not allow for co-recruitment were not included in the study. Despite this, it was believed 
that the recruitment targets in this study were still achievable due to the large number of 
patients being admitted to the stroke units and the unrestrictive entry criteria for this study. 
The feasibility of recruitment numbers will be discussed further in Section 5.10.  
During their stay in hospital, the patients had supplementary assessments administered as 
part of this study, in addition to their normal clinical care. The combination of assessments 
amounted to approximately 60 minutes of direct patient contact. This duration of assessment 
could potentially have added to the patient‘s stress of being in hospital. As a result, the 
various baseline assessments were staggered over the first 72 hours of hospital admission, 
to decrease the participant burden. It was expected that some participants would have 
severe communication disturbances. This may have affected their responses on certain 
assessments and so suitable assessment tools had been chosen to account for this. In 
addition to this, the researcher provided visual response/ cue cards to be used as 
communication aids during the assessment, for patients with communication difficulties. 
Nevertheless, there were participants who were unable to complete all parts of the 
assessments and so they were classed as ‘unable to score’ and analysed accordingly.  
Once the patient had been discharged, the researcher completed the follow up assessments 
by contacting the patient to arrange a home visit, conduct a telephone interview or send out 
postal questionnaires. Prior to arranging the follow up assessments, the patient's general 
practitioner was contacted to determine the survival status of the participant. This was done 
in order to reduce any distress to carers that may be caused if the patient had died since 
their discharge from hospital. The data collected during the study consisted of the CRFs 
containing assessments results, clinical data, past medical history and patient and carer 
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interviews. The paper based documents were stored in a locked filing cabinet in the Charles 
Thackrah Building at the University of Leeds and were only accessible to the researcher and 
the supervisors. Two separate electronic databases were stored on a secure password 
protected server; one to pool the data together for analysis and the other to retain patient 
contact details.  
The study data were analysed anonymously and confidential data kept to a minimum which 
was shredded if no longer required. Once recruitment and all follow up assessments had 
been completed, the data were analysed and a summary of the research findings were sent 
to the participants as well as thanking them for their involvement in the study. Although there 
was no immediate benefit to the participant in this study, it was anticipated that the research 
would lead to a better understanding in the area of stroke and delirium.  
 
5.9 Financial considerations 
The study was funded through a scholarship provided by the National Institute for Health 
Research (NIHR) Collaboration for Leadership in Applied Health Research and Care 
(CLAHRC) for the Leeds, York and Bradford Research Association (LYBRA). The 
scholarship covered tuition fees, living allowances for the researcher and research costs 
which included; travel costs, conference fees, training, printing of the study material and so 
forth.  
Aside from financial support, training and support was provided from a number of sources 
which included; academic support and training from the University of Leeds, training from the 
Liaison psychiatry team at the LGI and support from the clinical staff based at the acute and 
rehabilitation stroke units at the LGI and SJUH.  
 
5.10 Statistical considerations 
The largest loss to patient follow is often due to death and the combination of a stroke and 
delirium significantly increased the risk of mortality according to the literature reviewed 
previously. The sample size calculations for this study were generated using statistical 
power calculations and were based on mortality figures for patients with delirium in the 
stroke population. The prospective cohort study involved a comprehensive six month follow 
up and in essence would analyse two separate patient cohorts; delirium positive against 
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delirium negative. The patients were classed as independent meaning that they were not 
specifically age or sex matched for analysis. The type I error probability for this study was 
set at 0.05 with a power of 80%. The power calculation was calculated using the exact 
Fisher’s test, where the alternative hypothesis was expressed as two proportions. The 
incidence figures for mortality were based on a paper by Sheng et al,[452] (2006) who 
investigated the effect of delirium on the stroke population and these figures are illustrated in 
Figure 5.7.   
 
Based on the information in Figure 5.7, the minimum number of participants required was 59 
people for the delirium positive group, and 236 people for the delirium negative group, giving 
a core total of 295 patients. Upon advice from a statistician (T. Munyombwe) a 15% 
contingency was included and so a minimum of 339 participants (68 delirium positive and 
271 delirium negative) would need to be screened. Figure 5.8 illustrates the rate of patient 
turnover at the chosen study sites.  
 
 
Recruitment  
period 
Potential participants  People per month People per week 
Per site Total 
sites 
Per site Total sites Per site Total sites 
6 months 240 720 (16.4)  
17 
(49.2) 
50 
(4.1) 
4 
(12.3) 
12 
9 months 360 1080 (10.9) 
11  
(32.8) 
33 
(2.7) 
3 
(8.2) 
8 
12 months 480 1440 (8.2) 
8 
(24.6) 
25 
(2.0) 
2 
(6.1) 
6 
 
 
Figure 5.8: Breakdown of the study recruitment targets. 
The figure above illustrates the number of potential participants available at the chosen 
study sites and the rate at which participants would need to be recruited in order to reach 
the study recruitment targets.  
 
 
Cumulative mortality  
 
Overall 
(n= 156) 
With delirium 
(n = 39) 
Without delirium 
(n = 117) 
1 month mortality  9 (5.8) 4 (10.3) 5 (4.3) 
6 month mortality  25 (17.1) 11 (29.7) 14 (12.8) 
12 month mortality  34 (23.8) 16 (41.0) 18 (17.0) 
Image adapted from the paper by Sheng et al
[450]
 
 
 
Figure 5.7: Delirium incidence statistics for power calculations. 
Sheng et al,[450] reported the incidence of delirium as 25%, which gives a ratio of 3:1, four 
delirium negative patients for every one delirium positive patient. The incidence of 6 
month mortality was reported as delirium [29.7] against non-delirium [12.8]. The power 
calculations for this study were based on these figures given.  
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The recruitment schedule had originally been set out to a six month time scale. A review was 
conducted at the six month stage to see if interim recruitment targets had been met. Any 
issues or delays with the recruitment would mean that the recruitment period could be 
extended to twelve months with a review done every three months. This meant that there 
would be a six month overlap in the researcher’s work schedule. During this six month 
period, the researcher would have split the weekdays equally between recruitment and 
follow up assessments to stay on target. Although this was a large workload, there are a few 
points that should be noted. 
Firstly, it was anticipated that there would be a significant number of drop outs due to deaths 
and this in turn would result in a considerable drop in patient follow up visits. This decrease 
in follow up visits would allow the researcher to spend more time on the wards recruiting new 
patients. Secondly, the researcher only recruited during the weekdays and not at the 
weekends. This meant that the new stroke admissions admitted at the weekend would be 
added to start of the new week, thus increasing the number of potential participants that the 
researcher could screen. Based on these reasons and the numbers (Figure 5.7 and 5.8), it 
was believed that the patient recruitment figures were achievable in the allocated time 
frames.  
 
5.11 Conclusion 
There were a number of methodological and ethical issues to consider when designing the 
study to fulfil the chosen research aims. Poorly chosen study designs that are not suitable 
for the data being collected can create bias and errors in the data set. For example in this 
study choosing a retrospective cohort would mean relying on the patient’s version of events 
which may be susceptible to recall error. This may produce inaccurate and unreliable 
findings which would also be a waste of time and resources. Due to the nature of conditions 
being investigated, a number of key issues were highlighted that that needed to be factored 
into the study design in order to avoid problems later in recruitment and assessment 
process. Details of the finalised study protocol will be discussed in Chapter six.  
 
5.11.1 Key points  
 Investigating clinical conditions such as delirium and stroke requires careful designing 
and planning.  
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 The study methodology of a prospective cohort was suitable for the type of data being 
collected and efforts were made to reduce potential sources of bias.  
 The use of a pilot study helped to identify potential flaws in the proposed methodology 
and allowed for corrections to be made before active recruitment began.  
 Eliminating potential flaws and reducing sources of bias and systematic errors would 
help to produce a completed data set that would be accurate and reliable.  
 Due to the nature of the clinical conditions being studied, ethical considerations were of 
key importance when working with a vulnerable patient population.  
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6 Methodology  
The following chapter discusses the detailed aspects of the methodology. These aspects 
include the following: study design, the study setting, the sample of participants recruited, 
the materials used, the baseline assessments, the time scale, the outcome measures and 
the data collection and analysis.  
 
6.1 The study design 
A prospective cohort study was conducted with stroke patients admitted to stroke units in 
West Yorkshire with a twelve month follow up period. Figure 6.1 summarises the study 
design.  
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Figure 6.1: Study design for the prospective cohort study.  
137  
 
6.2 The study setting 
The study was conducted at the Leeds Teaching Hospital Trust (LTHT) in the Acute Stroke 
Unit (ASU) based at the Leeds General Infirmary (LGI) and the stroke rehabilitation unit at St 
James University Hospital (SJUH) in Leeds, West Yorkshire. In addition to the acute stroke 
units for the male and female patients, patients were also recruited from the Hyper Acute 
Stroke Unit (HASU) based at the LGI after it was established in January 2012.   
 
6.3 The study population  
Patients were admitted to the LGI’s Accident and Emergency Department either by 
ambulance or by referrals from their general practitioner. Stroke patients were then 
transferred to the HASU or the ASU depending on what was appropriate. As there was only 
one researcher with limited time and resources, patients that were not admitted to the stroke 
units were not approached for participation. The population for this study compromised 
consecutive stroke patients aged 55 years and over that were admitted to the stroke units at 
the LGI and SJUH, with a confirmed diagnosis of stroke. 
 
6.4 The study materials used 
Potential participants and carers that were interested in being involved with the study were 
provided with information sheets to read through. Examples of the information sheets 
distributed to the patients, carers and consultees are provided in the appendices 3, 4 and 5.  
Once the patients and their carers indicated that they had understood the information, the 
participants were asked to provide written consent by completing the consent forms for the 
patients, carers and/ or consultees. Examples of the consent and declaration forms are 
provided in the appendices 7, 8 and 9.  
Participants were also asked to consent to the researcher contacting their general 
practitioner in order to obtain any additional information that may be relevant to the research. 
The general practitioner was also sent an information sheet, as shown in appendix 6, 
informing them of their patient's involvement in the study.  
The patient's initial diagnosis was augmented using the Bamford stroke classification, 
MEWS and GCS scores, as shown in appendix 11. Those participants who did not match 
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the recruitment criteria had an exclusion case report form completed to provide further 
details of the reasons for exclusion. The exclusion form is shown in appendix 10.  
The study assessments administered in the study at baseline included the following; 
1. Confusion Assessment Method for Intensive Care Unit (CAM-ICU) - appendix 12 
2. Delirium Rating Scale - Revised 98 (DRS-R98) - appendix 13 
3. The Nottingham Extended Activities of Daily Living (NEADL) - appendix 14 
4. Geriatric Depression Scale (GDS) - appendix 15 
5. Addenbrookes Cognitive Exam - Revised (ACE-R) - appendix 16 
6. Ascertain Dementia (AD-8) - appendix 17 
7. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) - appendix 18 
8. Standardised Mini Mental State Examination (SMMSE) – appendix 19 
 
6.5 The recruitment of the sample 
The researcher was based on the stroke units at the LGI where the ward registers were 
monitored to identify potential participants, with consultation from clinical staff on the ward. 
The source population were stroke patients aged 55 years and over, that had a confirmed 
diagnosis of stroke. The stroke diagnosis was confirmed using the CT/ MRI scans and 
classified using Bamford stroke classification. The MEWS and GCS scores along with input 
from the clinical staff were used to determine if it was clinically appropriate to approach the 
patient.  
Once these criteria had been satisfied, the researcher approached the patient and their 
carers to introduce herself and provide a verbal explanation of the study and its purpose. 
This was done at the patient's bedside for the patients, or in the relatives’ room for the 
carers. Both the patients and the carers were provided with information sheets about the 
study and left to read through the information in their own time. Patients who fulfilled the 
study inclusion criteria were asked to provide written consent in order to participate in the 
study. Participants who did not fulfil the inclusion criteria or who did not wish to take part 
were thanked for their time and the exclusion CRF was completed detailing the reasons for 
exclusion.   
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An assessment of capacity was made by the doctors on the Ward and recorded in the 
medical notes. Patients who lacked capacity and were not considered able to provide 
informed written consent were still included in the study, provided that proxy consent could 
be sought from an appointed consultee. Although this type of consent was not a replacement 
for the patient's written consent, it was felt that an appointed consultee could oversee the 
patient's involvement in the study and safeguard the patient's interest. A consultee could be 
the patient's family member, legal carer or, if no one else was available, then the patient's 
consultant during their stay in hospital. If the consultee declined to provide written consent, 
then the patient was not included in the study.  
Patients that were recruited into the study were allocated a study number so that the data 
analysed would be done so anonymously. The study assessments were then administered 
to the patient within the first 72 hours of admission to the stroke unit. 
 
6.6 The study assessments administered  
The initial baseline assessments were conducted within 72 hours of hospital admission by 
the researcher. As the patients had suffered a recent stroke, the majority of the assessments 
were done at the patient’s bedside. However attempts were made to conduct the 
assessments in private where possible. Prior to starting the assessment, patients were 
asked if they usually wore glasses or a hearing aid so that the patient was not at a 
disadvantage during the assessment. The patient protocol for the study is illustrated in 
Figure 6.2 and is described in the following sections.  
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Figure 6.2: Patient protocol for the prospective cohort study.  
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6.6.1 Introductory interview  
During an introductory interview, patient information on the following areas was collected 
and recorded in the patient’s CRF. Data on physical variables was also collected and this 
information was extracted from the patient's medical notes and clerking information. The 
information collected was as follows: 
1. Age 
2. Date of birth 
3. NHS number 
4. Contact details for their general practitioner 
5. Contact details for the patient 
6. Contact details of the patient's carer 
7. Patient's medical history  
8. Patient’s social background  
9. Hospital location and place of referral 
10. Data and time of admission to the stroke unit 
11. Date and time of CT/ MRI scan if performed 
12. Assessment of mental capacity 
13. Pre-stroke functional capacity  e.g. pre-stroke Modified Rankin score 
14. Clinical examination results e.g. power and tone of limbs, changes in gait and vision, 
examination of all systems, nutritional status, clinical observations, blood results 
Patients were thanked for their time at the end of the interview and reminded that they would 
be contacted at a later stage for their follow up assessments.  
 
6.6.2 Measurement of the confounding variables and risk factors 
Clinical data were collected to assess the effects of specific confounding variables, which 
were previously described in Chapter five. The confounding variables or predictors were 
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measured and recorded throughout the patient's stay in hospital. The variables were as 
follows: 
1. Incontinence – defined as the involuntary excretion of urine or inability to control the 
bowel. Confirmation of incontinence was made by monitoring the nursing observations 
and any episodes that lasted more than 5 days were classed as positive for 
incontinence. Details of the type of incontinence, the aids use and the duration were 
recorded.  
2. Constipation – defined as infrequent bowel movements of which there are two types; 
obstructed defaecation or colonic slow transit (hypomobility). Confirmation of 
incontinence was made by monitoring the nursing observations and any episodes that 
lasted more than 5 days were classed as positive for constipation. The Bristol stool 
chart[567] was used to record the type, severity and duration of the episode.  
3. Malnutrition – defined as the incorrect intake of nutrients which can be too low, high or 
not in the correct proportions, due to an unbalanced diet. Confirmation of malnutrition 
was made by monitoring the Malnutrition Universal Screening Tool (MUST)[568] scores 
recorded in the nursing observations. Upon admission, the patient's height and weight 
were measured by the nursing staff. The Body Mass Index (BMI)[569] readings were 
calculated and recorded in the nursing notes and a MUST score of 1 and above was 
classed as positive for malnutrition. The duration of the episode, total weight loss during 
this period and the need for additional supplements were also recorded.  
4. Dehydration – defined as the excessive loss of body water of which there are three 
types; hypotonic (loss of electrolytes e.g. Sodium), hypertonic (loss of water) and 
isotonic (equal loss of water and electrolytes). Confirmation of dehydration was made by 
monitoring the blood results and any electrolyte imbalances, changes in the urea to 
creatinine ratio or the need for paraenteral fluids (intravenous or subcutaneous) that 
lasted for longer than 5 days were classed as positive for dehydration. The duration, 
cause (e.g. poor intake, rapid loss rate) of the episode as well as the need for additional 
supplements were also recorded.   
5. Infections – defined as a clinically evident illness that arises from infection, presence or 
growth of pathological biological agents. Confirmation of an infectious disease was 
made by monitoring the blood results and changes in the CRP or white cell count. The 
cause and duration of the episode as well as any previous history of infectious diseases 
were also recorded.  
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6. Hypoxia – defined as when the whole body or a specific region of the body is deprived 
of an adequate oxygen supply. Confirmation of hypoxia was made by monitoring the 
oxygen saturation results recorded in the nursing observations and the need for 
supplementary oxygen for longer than 5 days was classed as positive for hypoxia. The 
changes in oxygen saturation and duration of the episode were also recorded.  
7. Physical illness – delirium onset has been to specific chronic pathology which includes; 
cardiac disease, pulmonary disease, cognitive impairment and any recent surgical 
procedure preceding their admission to hospital, as well as mental health problems and 
changes in the patient's memory. The number of physical illnesses were recorded.  
8. Stroke - the pathology (infarct or haemorrhage) was established by the CT/ MRI scans 
and the Bamford classification was used as a clinical descriptor to classify the type of 
stroke into one of the four categories previously mentioned in Chapter five.  
9. Medication - the details of medications taken were recorded. Details included the 
number of medications, types and dosages of drugs taken.  
10. Smoking – the frequency (e.g. per day) and years spent smoking was recorded.  
11. Alcohol – the frequency (e.g. unit per week) and type of drinking (e.g. casual, heavy), 
were recorded.  
12. Social background – the marital status of the patient, living arrangements, type of 
accommodation, level of social care and support the patient receives such as home care 
or placement in an institutional care facility were recorded. The information was 
extracted from the responses for the Modified Rankin Score and background information 
recorded in the nursing notes.  
13. Education – the patient's level of education was recorded by interviewing the patient or 
their carer. The responses were classed according to the scale in appendix 21. 
14. Employment – the patient's first job and main occupation, type of employment and 
duration was recorded by interviewing the patient or their carer. The responses were 
classed according to the scale in appendix 22.  
Once these details had been extracted, the study assessments were administered to the 
patient at the following time points: 
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6.6.3 Within 72 hours of admission (baseline assessments) 
Patients were screened using the CAM-ICU to detect whether they had prevalent delirium 
and were then assessed using the DRS-R98 to determine the severity of delirium. The 
following baseline assessments were also conducted:  
1. The Nottingham Extended Activities of Daily Living (NEADL)  
2. Geriatric Depression Scale (GDS)  
3. Addenbrookes Cognitive Exam - Revised (ACE-R)  
4. Standardised Mini Mental State Examination (SMMSE)  
5. Ascertain Dementia (AD-8)  
Only one of the cognitive tests, either the ACE-R or the SMMSE, was administered 
depending on the patient’s communication abilities and compliance. In addition to this, the 
patient's carers were also interviewed and asked to complete the Informant Questionnaire 
on Cognitive Decline in the Elderly (IQCODE) as well verify the information provided by the 
patient during the interview.  
 
6.6.4 Day four and day seven 
On day four and day seven, the CAM-ICU was repeated on all patients to determine if any 
new cases of delirium had occurred and the DRS-R98 was used to determine the severity of 
the episode. If incident delirium was detected, then the patient’s care team were informed. 
Any clinical investigations that had been carried out during the patient’s stay in hospital were 
also recorded in their CRF’s.   
 
6.6.5 Weeks two and three 
The CAM-ICU was repeated for all patients regardless of whether they had been delirium 
positive or negative in past assessments and the DRS-R98 was used to assess the severity 
of the episode. The use of the CAM-ICU, DRS-R98 and the recording of any new clinical 
investigations was done weekly. If any patients were discharged from hospital before the 
one month stage, then a pre-discharge delirium screen of both the CAM-ICU and DRS-R98 
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was administered before the patient was discharged. The date of hospital discharge and 
their discharge destination was also recorded in their CRF's. 
 
6.6.6 One month 
As we anticipated a high mortality rate at one month, the survival status of all patients’ was 
reviewed after four weeks of recruitment. If the patient had been discharged prior to the one 
month stage, then the patient's general practitioner or care institution was contacted to 
determine survival status. If the patient had not survived, then the cause of death was 
recorded in the patient’s CRF.  
The remaining patients had their length of hospital stay, including additional NHS care 
recorded. Those patients that were still in hospital either at the acute stroke unit or at the 
stroke rehabilitation unit underwent assessments for the following: delirium (including both 
the CAM-ICU and DRS-R98), activities of daily living using the NEADL and the SMMSE 
(appendix 19) or the ACE-R to test their cognition.  
A pre-discharge delirium screen of both the CAM-ICU and DRS-R98 was administered to 
patients due to be discharged at or before the one month stage. The date of hospital 
discharge and their discharge destination was also recorded in their CRF's. They were then 
contacted by telephone to review their activities of daily living using the NEADL and their 
cognitive function was tested using the Telephone Interview for Cognitive Status (TICS) 
assessment, as shown in appendix 20.  
 
6.6.7 Six months 
Patient outcomes were assessed at six months via home visits, telephone interviews or 
postal questionnaires as previously described. Prior to contacting the participants, general 
practitioners were contacted to confirm any patient deaths. This was done to avoid potential 
distress to the patient's families and carers. If the patient had been discharged to a care 
institution, then the appropriate staff members were contacted to confirm the patient's 
survival status.  
The patient's length of stay in hospital was recorded by regularly monitoring the ward 
registers. Length of stay included the time spent in the acute stroke unit, the stroke 
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rehabilitation unit and any other NHS wards that the patient may have been transferred to, 
for subsequent treatment.  
The discharge destination was also recorded along with the date of discharge. Discharge 
destination included patients returning to their homes, moving to a residential home or being 
placed in institutional care such as a nursing home or a hospice.  
Where it was appropriate, the researcher arranged to meet with the participant and conduct 
the follow up interviews and assessments. Patients were assessed to determine how they 
were coping post-stroke and hospital discharge. The assessments administered during their 
stay in hospital were repeated and the scores were recorded in the patient's CRF. The 
assessments included the following;  
1. Confusion Assessment Method for Intensive Care Unit (CAM-ICU)  
2. Delirium Rating Scale - Revised 98 (DRS-R98)  
3. The Nottingham Extended Activities of Daily Living (NEADL)  
4. Geriatric Depression Scale (GDS)  
5. Addenbrookes Cognitive Exam - Revised (ACE-R)  
6. Telephone Interview for Cognitive Status (TICS) 
7. Ascertain Dementia (AD-8)  
8. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) 
Again, the carers were also interviewed to verify the information provided by the patient. The 
six month assessments marked the end of the participant's study involvement and the 
participants were thanked for their co-operation.  
 
6.6.8 One year 
The final stage of the study was to determine the survival status of all stroke patients one 
year after their first initial admission to hospital. The patient's general practitioner or care 
institution was contacted to determine survival status. If the patient had not survived, then 
the cause of death was recorded in the patient’s CRF. The one year stage marked the end 
of data collection for the study.  
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6.7 Data handling and analysis 
The participant data collected was coded for anonymity and was entered into two separate 
electronic databases; one to pool the data together for analysis and the other to retain the 
participant contact details. The data was analysed using Microsoft Office Excel, IBM SPSS 
version 15 and STATA version 13.  
 
6.8 Statistical analysis 
For this study, the aim was to compare outcomes for stroke patients with delirium and stroke 
patients without delirium. For the analysis it was decided that the study cohort would be 
further divided into the following subgroups: delirium positive patients with and without 
dementia and delirium negative patients with and without dementia. However after careful 
consideration it was decided that this would not be suitable for reliable comparisons, as 
there were insufficient numbers in each subgroup. Therefore the analysis focused on the 
comparisons between the delirium and non-delirium groups. The specific areas of interest 
were; 
1. The incidence and duration of delirium within the stroke group selected for the study. 
2. The incidence of mortality in the delirium group compared to the non-delirium group. 
3. The evaluation of outcomes such as; length of hospital stay, discharge destination, 
functional capacity, cognitive function and risk of dementia. These individual values 
would then be compared between delirium and non-delirium groups.  
4. To analyse whether there is a relationship between the type of stroke and/or potential 
confounding variables and the duration of a delirium episode.  
For the statistical analysis of the data, Microsoft Office Excel, IBM SPSS version 15 and 
STATA version 13 were used to analyse the data as follows; 
1. The incidence of mortality for both the delirium and non-delirium groups was conducted 
using the Pearson chi-squared test and the Log Rank test.  
2. For continuous variables, an independent samples t-test was used to compare 
differences between the delirium group and the non-delirium group. 
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3. For the categorical data, the Pearson chi-squared test was used to compare differences 
between the delirium group and the non-delirium group.  
4. The mean difference and P values for continuous variables for both delirium and non-
delirium groups were calculated using binary logistic regression. 
5. Odds ratios and confidence intervals for categorical data associated to delirium were 
calculated using binary logistic regression. 
6. The comparison between the outcomes at baseline and six months were analysed using 
the Wilcoxon Signed Ranks test. The difference between the delirium and non-delirium 
outcome scores were then further analysed using the Mann Whitney U test.  
7. Factors that showed a significant association with delirium were subjected to binary 
logistic regression analysis to identify independent predictors for delirium.  
 
6.9 Conclusion 
A prospective cohort study was used to recruit stroke patients from the stroke units based at 
the Leeds Teaching Hospitals Trust. Patients with and without delirium were recruited into 
the study and followed up for a one year period. During their initial stay in hospital, all 
patients underwent a delirium screen and the data for a selection of confounders was also 
recorded. The study data generated were stratified according to the participant’s delirium 
diagnosis. Participants also underwent a number of assessments to establish a baseline 
score so that a comparison of outcomes could be made at the six month follow up. 
Admission outcomes were also compared and checks for participant mortality were made 
throughout the study up until the one year stage.   
 
6.9.1 Key points  
 A prospective cohort study was used to recruit and assess stroke patients over a one 
year follow up period. 
 All stroke patients recruited were screened for delirium using the assessment tools 
CAM-ICU and DRS-R98.  
 Data for a selection of confounders was recorded and adjusted for in the analysis.   
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 Admission outcomes included mortality, length of stay and discharge destination.  
 Six month outcomes included assessment of physical function, mood, risk of dementia 
and cognitive impairment.  
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7 Results 
7.1 The study sample  
The study recruitment was carried out in two separate phases (period one: 18th July 2011 to 
23rd Dec 2011, period two: 23rd Feb 2012 to 18th November 2012), producing a cumulative 
14 month recruitment period. During this period 1,253 patients were admitted to the stroke 
unit at the LGI either through transfer from A&E, other hospital wards or direct admission via 
a GP referral. Figure 7.1 illustrates the admissions and exclusions of the participants at each 
stage of the study.  
 
 
 
  
Figure 7.1: Schematic diagram of the number of admissions and exclusions. 
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Of the 1,253 admissions, 17% (219 patients) were clinically not an acute stoke consisting of 
TIA’s, SAH, stroke mimics or other neurological conditions that have similar stroke type 
symptoms. Due to the restructuring of the stroke services within Leeds and the addition of a 
HASU unit in January 2012, the stroke unit no longer separated stroke patients according to 
age. All acute stroke cases were admitted solely to the LGI regardless of age and therefore 
a further 10% (121 patients) were not eligible for study participation as they were found to be 
less than 55 years of age. 
Of the remaining stroke unit admissions, 173 were clinically too ill to participate, 7 died 
before they could be assessed, 87 were discharged from the stroke unit before the 
researcher could screen them, 43 were outside of the 72 hour recruitment window, and 2 
were excluded for other reasons such as being a non-resident of this area/ visiting from out 
of the country and/ or language issues. A further 303 patients were not interested, the 
patient and/ or carer did not provide consent or the participants initially consented but later 
changed their mind and withdrew consent refusing to participate. Therefore their details and 
study data were removed from sample.  
This produced a final sample size of 298 patients, producing a recruitment rate of 33%. The 
graded consent forms allowed participants to choose how long they wanted to stay in the 
study. All the patients decided to participate for the full length of the study (one year), but a 
small minority (three participants) withdrew their consent during the follow up period 
choosing only to allow the use of their inpatient data for the study. Of the 298 participants, 
293 had a Caucasian background and less than 2% of the study sample had a non-
Caucasian background. The mean age of the sample was 79 years (SD 9.0, range 57–101) 
which consisted of 128 males and 170 females and this is illustrated in Figure 7.2.  
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For comparative purposes, the excluded patient group had 386 males and 569 females with 
a mean age of 83 years. There were no significant differences between the excluded patient 
groups and the selected study sample. All 298 participants were assessed by one 
researcher at the acute stroke unit at the LGI, with rehabilitation follow up at the SJUH or 
CAH stroke units.  
 
7.2 The physical clinical factors 
In the study sample, 271 patients suffered an infarct which accounted for 91% of the sample 
and 27 patients (9%) suffered a haemorrhage. 131 (44%) were diagnosed as having a left 
sided lesion and 167 (56%) were diagnosed as having a right sided lesion. The Bamford 
Classification scale was used as a clinical descriptor and the distribution of the types of 
stroke (TACS, PACS, LACS and POCS) are shown in Figure 7.3.  
 
 
Figure 7.2: The age distribution of the study sample. 
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As Figure 7.3 shows 34 participants (14%) were classed as TACS, 108 (36%) as PACS, 101 
(34%) as LACS and 46 (15%) as POCS. All 298 subjects were assessed within 24 hours of 
a suspected stroke with a CT head to exclude any bleeds and 15% required further MRI or 
repeat CT scans to assist with the diagnosis. Of the stroke patients 90% were admitted to 
HASU or the ASU with 24 hours of a suspected stroke, with 8% admitted to the stroke unit 
within 48 hours and less than 2% were admitted to unit over 48 hours later. Upon admission 
the patients experienced the following clinical symptoms; 58 (20%) had sensory loss, 55 
(19%) had sensory inattention, 172 (58%) had communication difficulties such as dysphasia 
or dysarthria, 89 (30%) had an unsafe swallow, 167 (56%) had a change in gait and 51 
(17%) exhibited evidence of visuospatial disorders.  
In addition to the presentation of a stroke, the majority of patients also had existing 
significant physical illness as derived from the patient’s medical history. These were classed 
as nil conditions, less than 3 clinical conditions as mild illness, 3 to 5 conditions as moderate 
illness and over 5 clinical conditions as severe illness. According to this grouping, 8 (3%) 
had nil physical illness, 77 (26%) as mild, 150 (50%) as moderate and 63 (21%) as severe 
physical illness. A note of the number of medications regularly taken for physical illness was 
also made at the time of admission. The number of medications for the study sample ranged 
from 0 to 23 medications with a mean of 7 + 4.3 SD (interquartile range 4 to 10, median 7). 
Only 18 patients (6%) had no regular medications prior to having a stroke, 64 (22%) were 
 
 
Figure 7.3: The distribution of the Bamford stroke types within the sample. 
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recorded as taking less than 5 medications, 144 (48%) were recorded as taking between 5 
to 10 medications and 72 patients (24%) were recorded taking over 10 medications. In the 
sample 67 patients (22%) were recorded as having a history of a previous stroke prior to 
their current admission. The study sample had 165 patients (55%) that were found to be 
smokers (current and past) and 108 (36%) also consumed a moderate amount of alcohol in 
their regular routine, with only 2 drinking alcohol excessively over the recommended amount. 
Other physical factors that were listed as confounders were also recorded. The patients that 
recorded as positive for these factors were as follows; 106 (36%) incontinence, 143 (48%) 
constipation, 56 (19%) malnutrition, 106 (36%) dehydration, 95 (32%) infection, 31 (10%) 
hypoxia, 88 (30%) electrolyte imbalance and 12 (4%) recent surgery. On the whole, the data 
collected for these factors was well recorded and will be discussed later in this chapter.  
 
7.3 The non-clinical and psychosocial factors 
The marital status of the sample compromised of; 47 (16%) single, 122 (41%) married, 25 
(8%), divorced and 104 (35%) widowed. 151 (51%) were recorded as living alone and 147 
(49%) lived with their partner or a family member. Accommodation prior to discharge was 
classed as either living at home/ in sheltered housing or as an institutional placement in 
nursing homes, care homes or residential homes. Prior to admission 287 (96%) were 
recorded as living at home, in sheltered housing or religious accommodation and were 
mostly independent in their daily living. 11 participants (4%) were admitted from care homes, 
residential homes or nursing homes. The patient’s history of mental health prior to admission 
was also recorded where 26 patients (9%) patients were diagnosed with pre-existing 
dementia and 23 patients (8%) with clinical depression.  
English was the primary language for 295 participants, with only three participants (1%) 
recorded as non-English speakers but had a sufficient level of English for the assessments. 
184 patients (62%) required some sort of aids such as glasses or hearing aids. 27 patients 
(9%) were left handed, 205 (69%) were right handed and for 66 patients (22%) this data was 
not recorded. The education and occupation of the participants were recorded according to 
the scales described in Chapter five (appendix 21 and 22). With regards to the education in 
the sample (Figure 7.4), only one participant was recorded as illiterate. 248 (83%) were 
educated to primary/ secondary school, 38 (13%) attended college, army or completed an 
apprenticeship and 11 participants (4%) attended university. There was a wide range of 
occupations across the study sample as shown in Figure 7.5, with only 63 patients (21%) 
that were recorded as not stated or ‘retired’.  
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Figure 7.4: The education levels across the sample. 
 
 
 
  
Figure 7.5: The types of occupation across the sample. 
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7.4 Delirium diagnosis  
7.4.1 Assessing the presence of delirium using the CAM-ICU and DRS-R98 
The CAM-ICU was used to detect the presence of delirium where a positive score is needed 
for 3 out of the 4 features. The MEWS score was initially used to screen for potential 
participants. Once enrolled into the study, the GCS or the RASS were used to assess the 
patient’s mental status/ altered level of consciousness as part of the CAM-ICU screening 
tool. All patients were assessed at the same time point regardless of whether they displayed 
any symptoms of delirium. 200 patients exhibited no signs of delirium during their stay in 
hospital. 78 patients tested positive for delirium either during their stay or in the subsequent 
follow up periods producing an incidence of 26.2%. However there were a further 20 cases 
that displayed some signs of delirium, despite testing negative for the CAM-ICU, producing a 
combined total of 98 cases of delirium and cumulative incidence of 32.9%. The delirium 
diagnosis was made in conjunction with the DRS-R98.   
All 298 patients were assessed using the DRS-R98, which had a total score of 39. 
Categories were created for the DRS-R98 scores which were as follows; 0 to 14 no delirium 
present, 15 to 23 mild delirium, 24 to 32 moderate delirium and 31 to 39 severe delirium. 
Patients were assessed at days one and four, weeks two and three and months one and six.  
 
7.4.2 Assessing the duration of delirium and association with other factors 
For patients that were delirium positive, the duration of delirium was recorded as the 
cumulative number of delirium positive days. The range of delirium positive days was 1 to 33 
days with a mean of 9.5 days + 6.9 SD (interquartile range 4 to 13, median 8).  
The relationship between delirium diagnosis and the other variables was calculated using 
the Pearson chi-squared test for categorical variables and the independent samples t-test for 
continuous variables. The results are shown in Figure 7.6.  
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Characteristic 
n + SD or n (%) 
Total 
n=298 
Delirium 
n=98 
No Delirium 
n=200 
P value OR* 
 
95%  CI 
Lower Upper 
Patient details 
Age, mean + SD 
Male 
Caucasian 
English speaker  
Living at home 
Living alone 
Marital status 
Single 
Married  
Divorced 
Widowed  
Left handedness 
Education  
None
+
 
School 
College 
University 
Occupation 
Unskilled 
Semi skilled 
Skilled manual 
Skilled non-manual 
Intermediate 
Professional 
Unemployed  
Not stated/ ‘Retired’ 
 
79+9.0 
128 (42.9%) 
293 (98.3%) 
295 (98.9%) 
287 (96.3%) 
151 (50.7%) 
 
47 (15.8%) 
122 (40.9%) 
25 (8.4%) 
104 (34.9%) 
27 (9.1%) 
 
1 (0.3%) 
248 (83.2%) 
38 (12.8%) 
11 (3.7%) 
 
9 (3%) 
37 (12.4%) 
67 (22.5%) 
39 (13.1%) 
47 (15.8%) 
27 (9.1%) 
9 (3%) 
63 (21.1%) 
 
83.2+8.1 
38 (38.8%) 
96 (97.9%) 
96 (97.9%) 
92 (93.9%) 
55 (56.1%) 
 
15 (15.3%) 
37 (37.8%) 
6 (6.1%) 
40 (40.8%) 
8 (8.2%) 
 
0 (0%) 
83 (84.7%) 
12 (12.2%) 
3 (3.1%) 
 
5 (5.1%) 
13 (13.3%) 
15 (15.3%) 
7 (7.1%) 
13 (13.3%) 
6 (6.1%) 
3 (3.1%) 
36 (36.7%) 
 
77.5+8.9 
90 (45%) 
197 (98.5%) 
199 (99.5%) 
195 (97.5%) 
96 (48%) 
 
32 (16%) 
85 (42.5%) 
19 (9.5%) 
64 (32%) 
19 (9.5%) 
 
1 (0.5%) 
165 (82.5%) 
26 (13%) 
8 (4%) 
 
4 (2%) 
24 (12%) 
52 (26%) 
32 (16%) 
34 (17%) 
21 (10.5%) 
6 (3%) 
27 (13.5%) 
 
<0.0001 
0.308 
0.733 
0.211 
0.119 
0.188 
 
0.877 
0.434 
0.323 
0.134 
0.605 
 
0.483 
0.643 
0.445 
0.686 
 
0.142 
0.756 
0.038 
0.033 
0.406 
0.216 
0.977 
<0.0001 
 
1.08 
0.77 
0.73 
0.24 
0.39 
1.39 
 
0.95 
0.82 
0.62 
1.47 
0.69 
 
- 
1.17 
0.72 
0.76 
 
2.63 
1.12 
0.51 
0.40 
0.75 
0.56 
1.02 
3.72 
 
1.05 
0.47 
0.12 
0.02 
0.12 
0.85 
 
0.49 
0.50 
0.24 
0.89 
0.26 
 
- 
0.61 
0.31 
0.20 
 
0.69 
0.54 
0.27 
0.72 
0.37 
0.22 
0.25 
2.09 
 
1.12 
1.27 
4.45 
2.69 
1.32 
2.25 
 
1.85 
1.35 
1.61 
2.42 
1.81 
 
- 
2.27 
1.68 
2.92 
 
10.04 
2.31 
0.97 
0.95 
1.49 
1.43 
4.17 
6.63 
Medical history  
Medications 
Physical illness 
Smoker 
Drinker 
Dementia 
Depression 
Previous stroke 
 
7.3+4.3 
3.9+2.4 
165 (55.4%) 
108 (36.2%) 
26 (8.7%) 
23 (7.7%) 
67 (22.5%) 
 
7.2+3.8 
4.2+2.3 
45 (45.9%) 
27 (27.6%) 
18 (18.4%) 
7 (7.1%) 
28 (28.6%) 
 
7.4+4.5 
3.8+2.4 
120 (60%) 
81 (40.5%) 
8 (4%) 
16 (8%) 
39 (19.5%) 
 
0.790 
0.178 
0.022 
0.029 
<0.0001 
0.795 
0.078 
 
0.99 
1.07 
0.57 
0.56 
5.40 
0.89 
1.65 
 
0.94 
0.97 
0.35 
0.33 
2.26 
0.35 
0.94 
 
1.05 
1.19 
0.92 
0.95 
12.92 
2.23 
2.89 
Stroke details  
Bamford type 
TACS 
PACS 
LACS 
POCS 
Infarct 
Right lesion 
 
 
43 (14.4%) 
108 (36.2%) 
101 (33.9%) 
46 (15.4%) 
271 (90.9%) 
167 (56%) 
 
 
21 (21.4%) 
41 (41.8%) 
24 (24.5%) 
12 (12.2%) 
85 (86.7%) 
57 (58.2%) 
 
 
22 (11%) 
67 (33.5%) 
77 (38.5%) 
34 (17%) 
186 (93%) 
110 (55%) 
 
 
0.016 
0.160 
0.016 
0.286 
0.077 
0.605 
 
 
2.21 
1.43 
0.52 
0.68 
0.49 
0.88 
 
 
1.15 
0.87 
0.30 
0.34 
0.22 
0.54 
 
 
4.25 
2.35 
0.89 
1.38 
1.09 
1.43 
Clinical symptoms 
Sensory inattention 
Sensory loss 
Communication  
Unsafe swallow 
Gait changes 
Visuospatial  
 
55 (18.5%) 
58 (19.5%) 
172 (57.7%) 
89 (29.9%) 
167 (56%) 
51 (17%) 
 
22 (22.4%) 
18 (18.4%) 
65 (66.3%) 
34 (34.7%) 
57 (58.2%) 
28 (28.6%) 
 
33 (16.5%) 
40 (20%) 
107 (53.5%) 
55 (27.5%) 
110 (55%) 
23 (11.5%) 
 
0.214 
0.738 
0.035 
0.202 
0.605 
<0.0001 
 
1.47 
0.90 
1.71 
1.40 
1.14 
3.08 
 
0.80 
0.49 
1.04 
0.83 
0.70 
1.66 
 
2.68 
1.67 
2.83 
2.35 
1.85 
5.71 
Complications 
Incontinence 
Constipation 
Malnutrition 
Dehydration 
Infection 
Hypoxia 
Electrolyte imbalance 
Surgery  
 
106 (35.6%) 
143 (47.9%) 
56 (18.8%) 
106 (35.6%) 
95 (31.9%) 
31 (10.4%) 
88 (29.5%) 
12 (4%) 
 
55 (56.1%) 
60 (61.2%) 
23 (23.5%) 
49 (50%) 
59 (60.2%) 
12 (12.2%) 
46 (46.9%) 
5 (5.1%) 
 
51 (25.5%) 
83 (41.5%) 
33 (16.5%) 
57 (28.5%) 
36 (18%) 
19 (9.5%) 
42 (21%) 
7 (3.5%) 
 
<0.0001 
0.001 
0.148 
<0.0001 
<0.0001 
0.466 
<0.0001 
0.509 
 
3.74 
2.23 
1.55 
2.51 
6.89 
1.33 
3.33 
1.48 
 
2.24 
1.36 
0.85 
1.52 
4.01 
0.62 
1.97 
0.46 
 
6.22 
3.65 
2.82 
4.14 
11.85 
2.86 
5.61 
4.80 
 
Figure 7.6: Delirium diagnosis and association with other factors. 
 
* Odds ratio (OR) for the incidence of delirium. 
+ 
Small sample size, analysis not performed. 
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With regards to patient details, the age of the participant and the occupation subgroups of 
skilled manual and skilled non-manual were shown to be significantly associated with the 
delirium diagnosis, as shown in Figure 7.6. The ‘not stated/ retired’ subgroup was also 
significant, but this was most likely a proxy marker for an increase in age. For medical 
history smoking, drinking, dementia, the TACS and LACS stroke subtypes and the clinical 
symptoms of communication and visuospatial disorders showed a significant association 
with delirium. A significant association was also seen for complications such as 
incontinence, constipation, dehydration, infection and electrolyte imbalance.   
 
7.4.3 The combined use of the CAM-ICU and the DRS-R98 
The CAM-ICU and DRS-R98 tools were administered by one researcher and the completion 
rates for these assessments were 98%. Some patients did not stay in hospital till the 
allocated time points and so a pre-discharge delirium assessment was done where possible. 
There were certain assessments that were missed due to the patient discharges or deaths at 
the weekend, when the researcher was not present. The assessments using the CAM-ICU 
and DRS-R98 were conducted by the researcher (S. Ahmed) who had been trained in use of 
the delirium assessments tools. The tools were well tolerated by the patients and the 
combined use of the CAM-ICU and DRS-R98 produced results that were in agreement 
which reinforced the diagnosis, as shown in previous studies.  
Once experience had been gained, the assessment tools were quick to administer but in a 
busy stroke unit this may prove difficult. Use of the DRS-R98 requires experience and the 
staff may not be able to spend as much time assessing patients for delirium as compared to 
the researcher whose primary aim was to assess delirium occurrence. The time taken to 
train the staff on the stroke unit may be a point to consider if a delirium screening/ 
assessment tool was introduced to the stroke care pathway.   
 
7.4.4 Possible confounders for delirium 
The following confounders were also analysed for possible associations with the delirium 
diagnosis; incontinence, constipation, malnutrition, dehydration, electrolyte imbalance, 
infection, hypoxia, recent surgery, smoking and alcohol intake. Analysis of these factors in 
relation to delirium diagnosis was calculated using binary logistic regression and the results 
are shown in Figure 7.7.  
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Figure 7.7 showed that certain specific patient variables had an association with the 
participant’s delirium diagnosis. The presence of infection, an electrolyte imbalance and the 
presence of dementia had a significant association with a delirium positive diagnosis.  
 
7.5 Post-admission outcomes 
7.5.1 Mortality over one year post-stroke   
With regards to mortality, all patients were followed up for one year after their admission to 
the stroke unit. A total of 15 patients died before the one month stage, 38 deaths were 
recorded between one to six months and 19 deaths were recorded between six months and 
the one year stage. The sample had a total of 72 deaths (24.2%) during the twelve month 
period after their admission to hospital, as shown in Figure 7.8a.  
The log rank test demonstrated a significant effect on mortality for the delirium group 
compared to the non-delirium group (P<0.002). The unadjusted effect of delirium diagnosis 
Characteristic 
n (%) 
Total 
n=298 
Delirium 
n=98 
No Delirium 
n=200 
P value OR* 
 
95%  CI 
Lower Upper 
Incontinence 106 (35.6%) 55 (51.9%) 51 (48.1%) 0.256 1.52 0.74 3.11 
Constipation 143 (48.0%) 60 (42.0%) 83 (58.0%) 0.139 1.58 0.86 2.90 
Malnutrition 56 (18.8%) 23 (41.4%) 33 (58.9%) 0.434 0.74 0.35 1.57 
Dehydration 106 (35.6%) 49 (46.2%) 57 (53.8%) 0.922 0.96 0.45 2.06 
Infection 95 (31.9%) 59 (62.1%) 36 (37.9%) <0.0001 4.72 2.38 9.35 
Hypoxia 31 (10.4%) 12 (38.7%) 19 (61.3%) 0.148 0.47 0.17 1.31 
Electrolyte imbalance 88 (29.5%) 46 (52.3%) 42 (47.7%) 0.014 2.26 1.18 4.32 
Surgery 12 (4.0%) 5 (41.7%) 7 (58.3%) 0.382 1.87 0.46 7.62 
Smoking 165 (55.4%) 45 (27.35) 120 (72.7%) 0.240 0.70 0.39 1.26 
Alcohol 108 (36.2%) 27 (25.0%) 81 (75.0%) 0.353 0.74 0.38 1.41 
Dementia 26 (8.7%) 18 (69.2%) 8 (30.8%) 0.009 4.01 1.41 11.43 
Depression 23 (7.7%) 7 (30.4%) 16 (69.6%) 0.419 0.62 0.19 1.99 
Previous stroke 67 (22.5%) 28 (41.8%) 39 (58.2%) 0.507 1.26 0.64 2.46 
Physical illness 
(mean) 
3.9 4.2 3.8 0.183 1.09 0.96 1.24 
Medications (mean) 7.3 7.2 7.4 0.247 0.96 0.88 1.03 
Figure 7.7: Analysis of factors in relation to delirium diagnosis.  
 
* Odds ratio (OR) for the incidence of delirium. The relationship between the delirium diagnosis 
and each variable was analysed using a generalised linear model.  
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on survival is shown in Figure 7.8b. The group was not split further into dementia subgroups 
for the delirium diagnosis as it was felt that there were too few numbers for a significant 
difference.  
 
 
Cumulative 
mortality, n (%) 
Total 
n=298 
Delirium 
n=98 
No Delirium 
n=200 
P value OR* 
 
95%  CI 
Lower Upper 
1 month 15  
(5%) 
9 
(9.2%) 
6 
(3%) 
0.022 3.27 1.13 9.47 
6 months 53  
(17.8%) 
29 
(29.6%) 
24 
(12%) 
0.006 2.59 1.30 5.17 
12 months 72 
(24.2%) 
34 
(34.7%) 
38 
(19%) 
0.529 0.71 0.25 2.04 
 
Figure 7.8a: Cumulative mortality over a one year period. 
 
* Odds ratio (OR) for the incidence of delirium. All study participants were followed up for one year 
after discharge from hospital. The study sample had a total of 72 deaths (24.2%) over this period.  
 
 
Log rank test P<0.002 
 
Figure 7.8b: Survival in relation to delirium diagnosis. 
 
The unadjusted effect of delirium diagnosis on survival is shown above.  
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7.5.2 Length of hospital stay 
The length of stay for the study sample ranged from 1 day to 152 days with mean of 27 days 
+ 26.0 SD (inter quartile range 9 to 40 days, median 16). The total amount of time spent in 
hospital included any time spent in A&E, the hyper acute stroke unit, the acute stroke unit, 
the stroke rehab unit and time spent in any other hospital ward. The delirium group had a 
mean of 38.5 days + 27.9 SD compared to the non-delirium group which had a mean of 21.5 
days + 23.0 SD. The difference in length of stay between groups was calculated using the 
independent samples t-test (P<0.0001). The log rank test demonstrated a significant effect 
on length of stay for the delirium group compared to the non-delirium group (P<0.0001). 
Figure 7.9 shows the Kaplan-Meier curve for the unadjusted effect of delirium diagnosis on 
the length of stay for the study sample.   
 
 
 
Log rank test P<0.0001 
 
Figure 7.9: Length of stay in relation to delirium diagnosis. 
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7.5.3 Discharge destination  
The discharge destination of the study sample is shown in Figure 7.10. In the study sample, 
15 participants died before the one month stage and a cumulative total of 22 participants 
died during their stay in hospital. Of the remaining patients 222 were discharged home and 
54 were discharged to an institutionalised placement such as a nursing home, care home or 
residential home. The difference in discharge destination between the delirium and non-
delirium group was calculated using the Pearson chi-squared test. The presence of delirium 
had a significant effect on discharge destination (P<0.0001).  
 
 
 
7.6 Outcomes six months post-stroke 
7.6.1 Physical function 
With regards to the assessment of long term outcomes at the six month follow up, three 
participants declined any further follow up assessments. In addition to this a further 56 
participants had passed away, leaving a total of 239 participants at the six month stage. All 
298 patients had their pre-stroke function recorded by the nursing staff upon admission to 
the stroke unit. The nursing staff used the Rankin scale/ Oxford handicap scale with input 
from the patient’s medical notes, family and carers and the patient themselves and also a 
Barthel score was conducted by nursing staff upon hospital discharge. As part of the study 
protocol, the NEADL was carried out during the patient’s admission to hospital to estimate 
their pre-stroke function. With a possible total score of 66, the item scores range from 0 
indicating that they could not manage this activity at all compared to a max item score of 3 
indicating that they were fully independent in that particular activity. The NEADL was 
administered to 297 participants during their stay in hospital. Only one participant did not 
 
Discharge 
destination, n (%) 
Total 
n=298 
Delirium 
n=98 
No Delirium 
n=200 
P value OR* 95%  CI 
Lower Upper 
Home 222 (74.5%) 49 (50.0%) 173 (86.5%) <0.0001 0.16 0.09 0.28 
Institutionalisation 54 (18.1%) 36 (36.7%) 18 (9.0%) <0.0001 5.87 3.11 11.08 
Died in hospital  22 (7.4%) 13 (13.3%) 9 (4.5%) 0.007 3.25 1.34 7.88 
 
Figure 7.10: Discharge destination in relation to delirium diagnosis. 
 
* Odds ratio (OR) for the incidence of delirium.  
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complete the assessment due to a sudden deterioration in their health. For those patients 
who survived and consented to participate for the full duration of the study, the NEADL was 
then repeated at the six month stage. The range of NEADL scores at baseline and six 
months are shown in Figure 7.11.  
 
 
The median NEADL scores were 63 at admission and 55 at six months. There was a 
significant difference in NEADL scores between admission and at six month post-stroke 
(Wilcoxon Signed Ranks Test Z= -10.45, P<0.0001). The changes in the NEADL scores 
were analysed according to delirium diagnosis, which indicated there was a significant 
decrease in physical function (Mann Whitney U Test, P<0.0001) associated with delirium.  
 
7.6.2 Risk of dementia  
All 298 patients had the AD-8 dementia screen administered by the researcher upon 
admission to the stroke unit. The AD-8 has a total possible maximum score of 8, where an 
item score of 2 or more indicates a change in certain behaviours over the specified time 
 
 
 
Figure 7.11: Comparison of NEADL scores at admission and at six months. 
 
As there were no predefined categories for the NEADL scores, the following scoring categories 
were created in order to group patients together for comparison. The scoring categories 
employed for the NEADL were as follows; a score of 66 to 50 indicates little or no change, 49 to 
34 indicates mild disability, 33 to 18 indicates moderate disability and a score of 17 to 0 indicates 
severe disability.   
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period and indicative of possible risk of dementia. The IQCODE was also administered to all 
carers for their input, where each item is scored as 1/2 to indicate improvement, 3 to indicate 
no change, 4 to indicate slight deterioration and 5 to indicate significant deterioration, giving 
a total possible maximum score of 80. The total score is then divided by the number of items 
(in this case 16) to give the final score. A final score of 4 or 5 was considered indicative of 
dementia risk. The nursing staff did not used any screening tools for dementia, but a note for 
pre-existing dementia was made in the patient’s medical history as part of the stroke care 
pathway. Upon admission the median scores for the AD-8 and the IQCODE were 0 and 3 
respectively. All AD-8 and IQCODE scores were completed at admission. For those patients 
who survived and consented to participate for the full duration of the study, the AD-8 and 
IQCODE were repeated at the six month stage. At the follow up stage, three participants 
declined any further assessments. A further 56 participants died by the follow up stage, 
leaving a total of 239 participants that completed the AD-8 and IQCODE. At six months, the 
median scores for the AD-8 and the IQCODE were 1 and 3 respectively. The range of AD-8 
and IQCODE scores at baseline and six months are shown in Figure 7.12a and 7.12b. 
There was a significant difference in dementia scores upon admission and at six month post-
stroke for both the AD-8 (Wilcoxon Signed Ranks Test Z= -8.00, P<0.0001) and the 
IQCODE (Wilcoxon Signed Ranks Test Z= -7.29, P<0.0001). The changes in the dementia 
screening scores, both the AD-8 and IQCODE were analysed according to the delirium 
diagnosis. There was a significant increase in dementia risk for both the AD-8 (Mann 
Whitney U Test, P<0.0001) and the IQCODE (Mann Whitney U Test, P<0.0001) associated 
with delirium. 
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Figure 7.12a: Comparison of AD8 scores at admission and at six months. 
 
The scoring categories for the AD-8 were as follows; a score of 0 or 1 indicates no risk of 
dementia whereas a score between 2 to 8 indicates risk of dementia.  
 
 
 
 
 
Figure 7.12b: Comparison of IQCODE scores at admission and at six months. 
 
The scoring categories for the IQCODE were as follows; an average score of 1 to 3 indicates no 
change, an average score of 4 indicates the change is a bit worse and an average score of 5 
indicates that the change is much worse.  
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7.6.3 Assessment of mood 
As part of the study protocol, the GDS was to be administered to all participants upon 
admission to the stroke unit. However 19 participants did not complete the GDS due to 
severe communication difficulties and/ or a sudden deterioration in their health. As a result 
only 279 participants were able to complete the GDS assessment in full upon admission to 
hospital. The GDS assessment has a maximum score of 30 which is split into categories of 
no depression, mild depression and severe depression. The nursing staff did not use any 
screening tools for depression, but a note of depressive episodes was made in the patient’s 
medical history as part of the stroke care pathway. Those that were thought to be at high risk 
had a mood screen administered by the nurses and then referred to the psychiatrist/ OT for 
further assessment using the Wimbledon score.  
At the six month stage, three participants declined to participate for the full duration of the 
study and so the GDS was not repeated. Also a further 56 participants had died by the follow 
up stage, leaving a total of 239 participants who were able to complete the GDS at six 
months. There were only 233 participants that had completed the GDS assessment upon 
admission and at six months. The median GDS scores at both admission and at six months 
were 4 and the range of GDS scores is shown in Figure 7.13.  
 
 
 
 
Figure 7.13: Comparison of GDS scores at admission and at six months. 
 
The scoring categories for the GDS were as follows; a score between 0 to 9 indicates no 
depression, 10 to 19 indicates mild depression and a score between 20 to 30 indicates severe 
depression.  
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There was a significant difference in the GDS scores upon admission and at six month post-
stroke (Wilcoxon Signed Ranks Test Z= -2.08, P<0.04). The changes in the GDS scores 
were then analysed according to delirium diagnosis. Although there was a difference in 
depressive symptoms between admission and at six months in relation to the delirium (Mann 
Whitney U Test, P<0.09), the results did not reach statistical significance.  
 
7.6.4 Cognitive impairment  
As part of the study protocol, the ACE-R was chosen to assess cognitive impairment due to 
its shorter duration compared to other assessment tools. In addition to this, the MMSE was 
also incorporated into the ACE-R exam which was advantageous. The ACE-R had a 
maximum total score of 100, testing domains such as attention and orientation, memory, 
fluency, language and visuospatial abilities. A cut off score of 88 (94% sensitivity, 89% 
specificity) was used to indicate cognitive impairment. Upon hospital admission, the AMTS 
with a maximum score of 10 was often administered to assess the patient’s orientation to 
time and place. This was then subsequently followed up by an SMMSE or ACE-R by the 
occupational therapy staff on the stroke unit, depending on how compliant the patient was, 
and the results were recorded in the medical notes.  
During the recruitment phase however, the occupational therapy team switched to the MoCA 
due to payment issues with the ACE-R/ MMSE. The MMSE and MoCA are shown to have 
good concordance so this was not an issue, however subsequently the team later switched 
back to using the MMSE. For the purposes of this study, the ACE-R was administered to the 
participants regardless of changes on the stroke unit. It was found that patients, and often 
those that were found to be showing signs of cognitive impairment, often refused to continue 
the assessment after starting the ACE-R exam. Further to this many of the patients 
experienced changes in vision and motor ability after their stroke and so they were not able 
to adequately answer all the questions on the exam. The changes in the patient’s ability 
post-stroke had been anticipated prior to starting the study and alternative arrangements had 
been made should the need arise.  
Of the 298 patients, only 164 patients completed the ACE-R in full. Since the data relating to 
ACE-R score was incomplete, no further analysis of this measure was undertaken. It was 
decided early on in the study that the SMMSE would be used upon admission as an 
alternative cognitive assessment if the need arose. The TICS had been shown to correlate 
highly with the MMSE and so it was decided that the TICS could be used as an alternative 
measure of cognition at the six month stage if required.   
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7.6.4.1 The SMMSE and the TICS 
Of the 298 participants in the study sample, 42 participants did not complete the SMMSE 
upon admission. The incomplete assessments were due to the following reasons; 15 had 
severe dysphasia, 18 were not responsive and 9 refused or were unable to complete the 
assessment. This left a total of 256 participants who completed the SMMSE in full upon 
admission.  The SMMSE has a total maximum score of 30, which is split into categories of 
normal cognition, mild cognitive impairment, moderate cognitive impairment and severe 
cognitive impairment.  
For the patients that survived and consented to participate for the full duration of the study, 
the TICS assessment was administered at the six month stage. Of the study population, 
three participants declined any further assessments at the follow up stage.  A further 56 
participants had died by the six month stage, leaving a total of 239 participants who were 
able complete the TICS assessment. Of the total study population, there were only 197 
participants that had completed the SMMSE at admission and the TICS at six months. The 
range of SMMSE and TICS assessment scores are shown in Figure 7.14. 
 
 
 
 
 
Figure 7.14: Comparison of SMMSE at admission and TICS at six months. 
 
The SMMSE scores were split into the following categories; 27 to 30 indicates normal cognition, 
21 to 26 indicates mild cognitive impairment, 11 to 20 indicates moderate cognitive impairment 
and 0 to 10 indicates severe cognitive impairment. These scoring categories were also the same 
for the TICS assessment administered at the six month stage.  
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Although two different exams were used, the TICS had similar scoring categories, had high 
correlation with the SMMSE and could be administered over the phone as well as face to 
face. There was a significant difference in cognition scores upon admission and at six 
months post-stroke (Wilcoxon Signed Ranks Test Z =-3.67, P<0.0001). The changes in the 
cognitive screening scores were analysed according to delirium diagnosis but did not 
indicate a change in cognitive impairment (Mann Whitney U Test, P<0.97) associated with 
the presence of delirium, that was statistically significant.  
 
7.7 Conclusion 
The stroke population investigated for this study was based in Leeds, West Yorkshire. Over 
a cumulative 14 month period, 1,253 new patients were admitted to the stroke units at the 
Leeds Teaching Hospitals Trust. Of this total, 298 stroke patients were recruited into this 
study by the researcher, producing a recruitment rate of 33%. These patients were then 
followed up for a one year period and during the follow up stages, only three participants 
refused any further assessments. There were a total of 72 deaths over the one year period. 
The study sample had a total delirium incidence of 32.9% and delirium positive patients were 
associated with higher mortality rates, a longer stay in hospital and increased requirements 
for some form of institutional care placements after discharge. The long term outcome 
measures such as physical function and risk of dementia were comparatively worse in the 
delirium group than the non-delirium group. Assessment of mood and change in cognitive 
impairment did not have a strong association with delirium diagnosis, the reasons for which 
are discussed in Chapter eight.  
 
7.7.1 Key points  
 Out of the 1,253 admissions, 298 patients were recruited for the stroke sample 
producing total incidence of delirium of 32.9%. 
 Delirium positive patients were associated with a higher mortality rate compared to their 
non-delirium counterparts. 
 Delirium patients were also found to have a longer length of hospital stay and increased 
need for institutionalisation. 
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 The study also identified a number of confounding variables that may impact on the 
presence of delirium. However it should be noted this was exploratory study only. 
 Long term outcomes such as poorer physical function and increased risk of dementia 
were associated with a delirium positive diagnosis. 
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8 Discussion: Potential flaws  
8.1 The systematic review 
The systematic review was performed in June 2010 by a comprehensive search of the 
relevant medical literature databases as described in Chapter three. The search strategy 
(appendix 1) was developed by the researcher (S. Ahmed) with training and guidance from 
staff members at the University of Leeds Health Sciences library who specialised in 
systematic reviews. The search was conducted using the maximum number of medical 
databases that were relevant to the search topics of ‘delirium’ and ‘acute stroke’ in order to 
avoid missing any potentially relevant articles. However there is always the possibility that 
some articles may be missed as they have been not have been covered by the selected 
search terms or they may have been recently published. Furthermore in order to avoid 
compromising the sensitivity of the search, a decision was made not to narrow the search by 
using specific terms such as 'incidence', 'outcomes' and 'confounding variables and/or risk 
factors'. This produced a broad set of results, which were then analysed by the reviewer.  
A possible second systematic review was considered in order to investigate which tools 
would be best suited to screen for delirium. This second systematic review would specifically 
focus on the feasibility of the screening tools with the possibility of rating the sensitivity and 
specificity of the tools currently available. However this was not done due to time restrictions 
and it was decided that the aims initially selected for the systematic review would be 
sufficient to inform the research questions and study design. Subsequently a systematic 
review analysing the suitability of the delirium tools currently available was published in 2013 
by another research group[570]. All the abstracts identified by the database searches were 
reviewed by one reviewer (S. Ahmed) and ideally a second review would have been 
conducted by a separate independent reviewer. The second reviewer would have 
independently screened for relevance and fulfilment of the inclusion criteria to determine if 
the results were in agreement with the original reviewer. However due to limitations in time 
and resources, this was not possible.  
The authors of the selected studies identified by the review were contacted by the reviewer 
(S. Ahmed) for clarification or additional information not stated in articles. An attempt was 
also made to obtain suitable translations for those studies not written in the English 
language. Furthermore the bibliographies of each article were checked to identify other 
studies that may have been missed by the electronic searches. Grey literature and thesis 
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materials were excluded from the review and it is possible that inclusion of these materials 
may have strengthened the search. A final step to strengthen the search would have been to 
conduct a manual hand search of journals relevant to the topics of delirium and acute stroke. 
Again due to limited time and resources this was not done, which may make the systematic 
review prone to publication bias by primarily relying on published journal articles. 
Subsequently the systematic review search was conducted again for publication in April 
2014, which highlighted the journal articles[571-573, 226, 574-579, 243] that had been published since 
the last search in June 2010. This produced a further six distinct new study populations in 
addition to the twelve populations previously identified in June 2010. A meta-analysis was 
also performed for the April 2014 search as there was more data to analyse the findings in 
this topic area. A summary of the April 2014 search is discussed in Chapter nine (Section 
9.4). Given the aforementioned explanations, I believe that this systematic review was 
adequate for the purposes of this thesis in providing information on which to base the 
research questions and study design.  
 
8.2 The study sample and setting  
As with any research, it is good practice to eliminate bias in the study design where possible 
and some of these sources of bias were discussed in Chapter five.  
 
8.2.1 Composition of the sample  
The composition of the study sample was of consecutive stroke patients admitted to the LGI 
over the age of 55 years. As discussed in Chapter seven, the primary reasons for exclusion 
were patients that were clinically unwell and therefore unable to complete the required 
assessments and patients that refused consent to participate in the study. Refusal of 
consent occurred for a number of reasons such as; patients did not want to be disturbed and 
wanted to be left alone during their stay in hospital stating ‘it was not for them’, patients that 
felt it would be too much of a burden considering their recent stroke diagnosis, patients that 
learned of the voluntary nature of the study and refused as they felt they would not gain any 
benefit from participating and finally patients that were wary of the research topic and what 
the results of certain assessments such as the cognitive exams could mean for them in the 
future. Regarding the last point, it is possible that certain patients that were suffering from 
delirium or dementia may have refused consent in the belief that they may have been 
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treated differently once assessed. Therefore by not participating in these assessments they 
avoided situations in which they may have felt isolated or uncomfortable.  
The recruitment rate of 33% for this study may seem low in comparison to other published 
studies in this area. However, in addition to the comments made above, there are a number 
of other reasons that may explain this figure. The sample population consisted of very ill 
stroke patients with multiple co-morbidities who were often too physically ill to participate, 
some participants has severe communication problems and found it too difficult or tiring to 
participate, the voluntary nature of the study meant that the study was not given preference 
amongst the other ongoing research studies on the ward and many of the larger stroke 
based research studies did not allow for co-recruitment in order to avoid research fatigue in 
participants, participant recruitment was only conducted at one hospital site (LTHT) and 
lastly there was only one researcher (S. Ahmed) on the ward to screen, recruit and assess 
potential participants with very little input from the staff on the stroke unit staff as they were 
busy with their own day to day duties, which was as expected. Upon consideration of these 
factors, although the recruitment rate may not be as high as other published studies, it is 
understandable given the circumstances described.  
With regards to previously published studies, the mean age of this study sample (79 years) 
is in keeping with published studies that were of a similar design. With regards to ethnicity, 
only 5 people (less than 2% of the study sample) were not Caucasian. The overall admission 
figures are in keeping with the published data that had a similar stroke services set up and 
the similar mortality rates are a likely indication that there were no differences in physical 
health between this study sample and the data of previously published studies.  
The age and gender of the included study sample when compared to potential participants 
that were excluded showed no significant differences. This indicates there was no selection 
bias present as there was homogeneity between the excluded source population and in the 
included study population. As no other data were collected for the excluded population, a 
further analysis determining the homogeneity of the included and excluded populations could 
not be made.  
It is possible that some potential patients may have been unintentionally missed due to 
reasons such as;  
a) Potential misdiagnosis. Stroke is a medical emergency that requires immediate 
attention and with the recent stroke awareness campaigns it seems highly unlikely that a 
stroke could remain undetected. However it may be possible that certain patients with 
severe multiple co-morbidities as well as dementia and/or delirium could be missed by 
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staff as they may not be able to detect a significant change in their behaviour due to pre-
existing conditions. Symptoms may also be mistaken for other neurological conditions 
and delays in CT and/or MRI scans may further delay the correct diagnosis, although 
these possibilities remain highly unlikely.   
b) The researcher. Potential participants may have been missed as the researcher was 
primarily based on the acute stroke unit at the LGI, with regular visits to HASU to screen 
new patients as they arrived. With specialist stroke units set up at the LGI and the 
restructuring of the stroke services across both the LGI and SJUH sites, it is hospital 
policy that once a stroke diagnosis is confirmed, the patient is made a priority and is 
transferred to the stroke unit as soon as possible for specialist treatment. Therefore the 
ward registers on the stroke units were monitored on a regular basis to reflect this. It is 
possible however that a potential participant may have already been an existing 
inpatient being treated for another condition on another ward, where they remained for 
the duration of their stay and then subsequently discharged from that ward. It is also 
possible that the potential participants may have had a stroke after a surgical procedure 
which may have led to death or a possible transfer to the intensive care unit. As a result 
such cases may have been missed as they would not have been admitted to the stroke 
unit. 
c) Physical illness. Potential participants were excluded if they had severe 
communication difficulties such as severe dysarthria, dysphasia, deafness or problems 
with their vision that prevented them from completing the study assessments. In some 
cases, where consent was obtained, these patients were included in the analysis of the 
incidence data but excluded in the analysis of the prognostic outcomes for the study as 
there were no baseline assessment scores for comparison. With regards to presence of 
delirium, certain cases also had to be excluded as these patients became emotionally 
distressed, not co-operative and in some cases patients displayed aggressive and 
threatening behaviours which made it inappropriate to approach them.  
There is always a possibility that the delirium incidence in this study may have been 
underestimated. For example certain episodes of delirium may have been presented 
themselves in between the assessment timings specified in the study protocol and these 
episodes could have resolved by the time the researcher made the next repeat assessment. 
It is also possible that there may have been potential delirium cases in the excluded study 
population that were not screened and did not participate due to illness severity or refusal of 
consent. Overall, the admissions figures for the stroke unit in the year 2011 to 2012 were 
similar to the admissions figures supplied by the research stroke network for the year 2010 
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to 2011, as discussed in Chapter five. Bearing in mind the multiple co-morbidities associated 
with the stroke population and the limited resources available to the researcher, the selected 
study sample seems to be as inclusive as possible, thus suggesting a low recruitment bias.  
 
8.2.2 The study setting  
The study sample was acquired from only one site at the Leeds Teaching Hospitals Trust 
(LTHT). Acute stroke admissions were based at the Leeds General Infirmary (LGI) with 
further stroke rehabilitation services provided at St James University Hospital (SJUH) and 
Chapel Allerton Hospital (CAH). Although the use of only one study site could possibly affect 
the generalisability of study findings, the LTHT did offer a specialised stroke service. 
Currently emphasis is being placed on setting up specialised stroke services across the UK 
and efforts to raise the awareness of stroke amongst the general public is proving to be 
effective. The stroke policy at the LTHT is as follows. The Brain Attack Team (BAT) is led by 
Dr John Bamford and consists of a nurse specialist and a stroke nurse that are based in the 
A&E department at the LGI. Once the BAT team have assessed the stroke patients, those 
that are eligible for thrombolysis are typically recruited within the hour. If patients are not 
eligible for thrombolysis then they are transferred within four hours, to either the HASU or the 
ASU depending on the severity of their symptoms. If patients are admitted at the weekend or 
during the night and there is no senior registrar available, then they are seen by the on call 
SHO and transferred. A CT head scan is usually done with 24 hours of admission to exclude 
any signs of a haemorrhagic stroke and later a follow up MRI scan may be used to identify 
the site of the stroke or exclude other causes. As the patient recovers, they are either 
discharged accordingly or sent to stroke rehabilitation at either SJUH or CAH for further 
treatment, with follow ups with the community based rehabilitation teams if required after 
discharge. The setup at the LTHT is similar to many other hospital stroke services.  
It is likely that models of care, specific stroke pathways and the management of stroke 
patients may differ slightly between hospitals. As the study recruitment only took place at 
one study site, it is difficult to determine what these differences in care provision may have 
been. With regards to recruitment at the Leeds Trust, there was a clear stroke pathway in 
place for the treatment and management of stroke patients, both for acute and rehabilitation 
purposes. As well as having communication with the physiotherapy and occupational 
therapy departments, the stroke team also had good communication with the 
neuropsychiatry and old age liaison psychiatry teams as well. This indicates that the staff 
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was aware of certain issues post-stroke and submitted referral requests as and when they 
were needed.  
Originally two hospital trusts had been listed for study recruitment with the LTHT as the 
primary site and the BFHT as the secondary site. A number of back up sites had also been 
selected at Calderdale and Harrogate should they be needed if recruitment fell short of the 
specified target numbers. However once the study began, there were certain issues with 
recruitment at the BFHT site. The stroke units at the BFHT had a fewer number of beds 
which catered to a mix of conditions that included strokes, TIA’s and other neurological 
conditions, whereas the LTHT had a separate neurology ward and a larger number of stroke 
beds available, as discussed in Chapter five. To add to this, there were a large number of 
research studies ongoing at the BFHT which meant that in many cases co-recruitment of 
patients was not possible and the stroke researchers were very cautious not to over burden 
patients by recruiting them into numerous studies.  
Furthermore, the researcher had a better familiarity with the stroke protocol and an 
established network with the staff and departments at the LTHT where the initial pilot studies 
and researcher training took place. As there was only one researcher, there was a limit to 
how much could be done within a certain time period and it would have taken more time to 
develop this network at the BFHT. There would also have been an associated increase in 
the travelling time taken to commute back and forth between the two sites, a decrease in 
resources such as money (for parking) and time that would have been allocated to active 
recruitment, patient follow ups, admin and data analysis. The same reasoning would have 
applied to any of the backup sites based at Calderdale, Harrogate and Wakefield. A possible 
solution would have been to hire a research assistant to conduct some of the assessments 
but again this would cost in terms of time and money to train them. The introduction of a 
second assessor for the research could also have led to differences in patient interaction, 
variation in the screening and assessment protocols and the potential for variation in the 
results recording procedure, thus decreasing the reliability of the scoring process. However it 
has also been acknowledged previously in Section 5.5.8 that the use of only one assessor 
(S. Ahmed) may be a potential source of bias as the researcher would not have been 
blinded to the participant’s diagnosis. It is possible that the presence or absence of certain 
conditions such as delirium may have influenced the scoring of the assessments and the 
generalisability of this study. Overall in order to avoid the aforementioned issues, a decision 
was made to concentrate solely on the primary site at the LTHT, where more time could be 
spent at the LGI to increase the study progress.  
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Each hospital serves specific areas and as the entire study sample was acquired from one 
site, the difference in certain variables could be significant between hospital catchment 
areas. If two or more study sites had been used, then differences in certain variables such 
as such as ethnicity or socioeconomic background could have been analysed to see if they 
had any effect on the results. However of the published studies, 12 of the research groups 
all recruited from only one site and so the recruitment practices of this study were in keeping 
with the published literature. The case mix of stroke type, time of assessment, scans and 
diagnosis, use of medications and the physical illness of the study sample were similar to the 
previously published data. It is therefore assumed that the results of this study can be 
generalised to other stroke service settings.  
 
8.3 Recording the physical clinical factors 
The data on the confounding variables based on physical clinical factors were well monitored 
and recorded. The CRF’s designed for the study were based on the LTHT stroke proforma 
so much of the data could be extracted relatively easily from the medical notes. The date 
and time of scans, stroke type, onset of symptoms, past medical history specifically listing 
physical illness and recent surgery, number of medications, pre-stroke function, details of the 
clinical exam and current physical condition of the patients were completed in all the cases 
when the patient was clerked in. Less than 2% of the sample consisted of inpatient transfers 
from others wards and so although they did not have a completed stroke proforma, most of 
the information could be extracted from the medical notes, nursing notes and by accessing 
the scans and reports on the hospital server.  
Where the patient was not a good historian, then alternative sources of information such as 
the patient’s family or the staff at the institution placement were consulted for further 
information. As part of the admissions procedure, the patient’s general practitioner was also 
contacted to obtain a complete medical history and an up to date list of medications. 
However it should be noted that in some cases although certain drugs were listed as regular 
medications, some of the patients admitted to not taking them as regularly or had stopped 
them altogether without consulting their GP. The reasons for this ranged from the presence 
of conditions such as dementia where the patient had been confused, to patients knowingly 
stopping their medications through their own personal choice. An effort was made to record 
the correct number of medications being taken, but this may not have always been accurate.  
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Other physical factors that were listed as confounders included; incontinence, constipation, 
malnutrition, dehydration, electrolyte imbalance, infection and hypoxia. Again these were 
generally well recorded and could be obtained from the nursing notes and from the hospital 
results server. Confounders such as malnutrition, incontinence and constipation were 
routinely monitored and recorded for the majority of patients whereas variables such as 
dehydration, electrolyte imbalance, infection and hypoxia were monitored and recorded 
according to the patient’s needs. In Chapter six, the recording procedure for the presence of 
certain factors was categorised as positive if the cumulative time period lasted five days or 
more. It should be noted that for certain patients their total length of hospital stay was much 
shorter that the specified five day period. Upon checking the data, it was found that this was 
only true for less than 6% of the study sample and those that did have a shorter hospital stay 
often did not suffer from the confounding variables listed. The accurate monitoring and 
recording of the confounders was important in determining the relationship between the 
presence of delirium and confounding variables.  
 
8.4 Recording the non-clinical and psychosocial factors 
The data on the confounding variables based on non-clinical and psychosocial factors were 
again well monitored and recorded. Details of the patient’s marital status, education, 
employment and history of mental health including pre-existing dementia and delirium were 
again routinely recorded in the LTHT stroke proforma. Dementia, depression and anxiety 
were often classed as a physical illness in the stroke proforma as well as in the mental 
health section. Details of the patient’s education, employment and social support/ 
background were obtained during the patient interview and recorded for analysis using the 
scales described in Chapter six (appendix 21 and 22).  
Details of the patient’s accommodation were recorded in both the stroke proforma and the 
nursing notes. For analysis the data was divided into two main categories, which consisted 
of; living alone, with a partner or family or in sheltered housing as category one and living in 
an institutional placement such as a care home, residential home or nursing home as 
category two. An effort was made to determine whether certain institutional placements were 
classed as a nursing home or a residential home by contacting the staff. However this was 
not always straight forward as many institutional placements now provide patients with both 
nursing and residential care needs from the same placement site. It is due to this reason that 
all care homes, residential homes or nursing homes were classed as one category for 
analysis, a decision that could be criticised as being incorrect. Although the classification of 
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these confounding variables may not have been considered acceptable, every effort was 
made to make sure that the data was as accurate as possible.  
 
8.5 Recording the delirium diagnosis  
The diagnostic process of identifying delirium within this study population may have had 
some limitations. For example although the doctors on the ward did provide some diagnostic 
input, there were no independent evaluations carried out by specialist staff to assess 
delirium diagnosis. Furthermore a ‘gold standard’ diagnostic tool was not employed as a 
reference standard for comparison with the delirium tools chosen for this study. With regards 
to the detection and diagnosis of delirium, the CAM-ICU was used to screen for delirium 
whilst the DRS-R98 was used to assess the severity of delirium cases. These tools have 
been shown to have good sensitivity and specificity for delirium detection, as discussed in 
Chapter five. However it must be noted that these tools had not been specifically tested for 
use in the stroke population and prior to study recruitment no suitable tools had been tested 
and validated for this purpose[449, 450]. From the data and tools available during the design 
stage of the study, the CAM-ICU was chosen as the most suitable as it had been designed 
not to rely on verbal communication. When using the CAM-ICU firstly a check is made to 
determine the patient’s response level by gently squeezing their hand. If they respond, then 
the test can continue but if they are unresponsive it is better try later on to see if there is any 
change in response levels.  
With certain items of the tool, alternative approaches could be used in the screening process 
according to the patient’s abilities. For example in the CAM-ICU feature two to test 
inattention (appendix 12), if the patient has limited speech then this item can be scored using 
the hand squeeze. Alternatively if the patient has limited movement post-stroke, then this 
item can be scored using the picture sets. Care was taken to use assessment aids that were 
printed in a large size, on buff coloured paper with a non-shiny finish in order to minimise 
any potential issues with vision. However there were still issues, as the CAM-ICU feature 
three to test disorganised thinking proved to be the hardest item to assess in non-verbal 
patients.  
There will always be a certain number of patients where a complete assessment may not be 
possible. Furthermore a certain number of severely ill, non-testable patients may have had 
delirium but assessing this was difficult. Severely ill patients should be monitored regularly 
and in some cases during the night as delirium is a fluctuating condition and certain patients 
180  
 
display signs of delirium at night. However this was not possible due to limitations in 
resources. Furthermore a certain number of participants may not score positively on the 
CAM-ICU, as it is feasible that the cut off points for a positive diagnosis may have been set 
too high, making it harder to reach diagnostically. Despite not scoring highly positive on the 
CAM-ICU, these participants still exhibited signs of delirium and were included in the 
incidence figures. This is classed as sub-syndromal delirium, which was discussed 
previously in Chapter one (Section 1.1.2). In this study this was true for 20 patients who 
exhibited signs of sub-syndromal delirium, accounting for less than 7% of the study sample.  
The DRS-R98 was completed for all participants as it relied on the information from the 
medical notes, staff on the stroke unit and the researcher’s own observations. According to 
the literature, patients with the hypoactive type of delirium have the worst prognosis and are 
missed in about 75% of cases[27], as discussed in Chapter one. This is often due to similar 
presentations of hypoactive delirium, dementia and depression. In some cases delirium can 
be found super imposed on pre-existing dementia[157], making it difficult to make a diagnosis. 
In addition to this, the literature suggests that people with dementia may be much more 
susceptible to developing delirium, as previously discussed in Chapter one. Multiple 
diagnoses do exist in clinical practice but the primary focus of this study was to determine 
the level of delirium present in the study population. Only one researcher was used to 
administer the assessment tools which ensured that the assessments were conducted in 
exactly in the same manner. All four parts of the CAM-ICU were performed on all patients 
regardless of delirium diagnosis, at the same time points in the study in order to avoid bias. 
The assessment tools were well tolerated by the patients in this study.  
For this study the CAM-ICU was administered by the researcher. However the fact that it is 
quick and easy to administer and is well tolerated by patients makes the CAM-ICU a good 
candidate to be incorporated into a possible standardised protocol for delirium detection, for 
which further research would be required. However the CAM-ICU on its own is not sufficient 
to provide further detailed information and so it is suggested that the combined use of the 
DRS-R98 with the CAM-ICU, would be a better use of the diagnostic tools. Although the 
DRS-R98 does not require much interaction with the patient, it does require the staff to take 
some time out to complete the assessment by examining the medical notes and nursing 
notes in more detail. There are many specialities within the medical profession and so not all 
staff will have been trained to detect subtle changes in psychiatric behaviour. This can be 
further demonstrated by examining the medical notes where often phrases such as ‘remains 
pleasantly confused’ or ‘signs of disorientation/ confusion noted’ are used to describe 
episodes of confusion with little indication regarding the onset or duration of the episode or 
very little or more often no further details or descriptions being recorded in the notes. With 
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this in mind, the introduction of a delirium screening and assessment tool as part of the 
admissions procedure would require a certain level of training in delirium detection for all 
staff. For the purpose of this study, the combined use of the CAM-ICU and DRS-R98 was 
sufficient for delirium detection in the stroke population and was in keeping with the types of 
assessment tools used in similar studies.   
 
8.6 Post-admission outcomes  
8.6.1 Mortality over one year  
Of all the outcomes measures, mortality was the least susceptible to bias as it was 
unaffected by the study design. The date of death was easily derived from medical notes, 
contacting the patient’s general practitioner or searching the hospital database which tracks 
the location of the patient’s case notes, details of their admission to hospital and their 
survival status.  
 
8.6.2 Length of stay 
Inclusion of the patient into the study did not affect the clinical care received by the patients 
and the study did influence the treatment or management of patients in any way. The 
diagnosis of delirium was often made after consulting the staff who decided what course of 
action to take and whether any referrals needed to be made. Therefore the length of stay 
was independent of the study’s primary aims. It was noted that the presence of delirium, pre-
existing dementia or depression upon admission did increase the length of hospital stay, 
which in turn also impacted on the patient’s possible need for an institutionalised placement 
in the future.   
 
8.6.3 Discharge destination 
Again similar to length of stay, the discharge destination of the participants was independent 
of the study’s aims. An assessment of the patient’s current state of health is often made with 
input from the patient’s themselves, their family and the medical staff looking after them, in 
order to determine whether a patient requires an institutionalised care placement. The length 
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of stay is sometimes negatively affected in some cases, as patients may spend a longer time 
in hospital whilst waiting for confirmation of their care placement.  
 
8.7 Outcomes six months post-stroke 
8.7.1 Physical function  
A pre-stroke score of physical function was recorded using the Rankin scale/ Oxford 
handicap scale in the stroke proforma with input from the patient and/ or the patient’s carers. 
This method of retrospective data collection could be susceptible to recall error, especially in 
cases where the patient may be confused in which case, the input from the carer or staff 
from the care placements was used instead. The Barthel score was also used by staff upon 
admission to and discharge from the hospital. However, this assessment has a strong ceiling 
effect, which was previously discussed in Chapter five. An independent assessment of 
physical function was made prospectively by the researcher by administering the NEADL 
upon admission and then repeating the assessment at the six months after the stroke. 
Although the NEADL was an extra assessment to be administered to the patient, it was 
found to be well tolerated by the study participants and was completed by all but one 
participant.  
 
8.7.2 Risk of dementia  
According to the literature reviewed in Chapter one, patients with the hypoactive type of 
delirium have the worst prognosis and are missed in about 75% of cases. This is often due 
to similar the presentations of hypoactive delirium and dementia and in some cases delirium 
can be found super-imposed on pre-existing dementia, making it difficult to make a 
diagnosis. The literature also suggests that people with pre-existing dementia are much 
more susceptible to develop delirium. The nursing staff did not used any screening tools for 
dementia, but a note for pre-existing dementia was made in the patient’s medical history as 
part of the stroke care pathway. For the purposes of this study, the dementia assessment 
was made using both the AD8 for patients and IQCODE for the carers. Both assessments 
were well tolerated and completed by all the participants.  
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8.7.3 Assessment of mood 
Although the nursing staff did not use any screening tools for depression, a note of 
depressive episodes was made in the patient’s medical history as part of the stroke 
proforma. Those that were thought to be at high risk were further assessed using mood 
screens such as the Wimbledon score[580], Signs of Depression Score (SODS) or Stroke 
Aphasic Depression Questionnaire Hospital version (SADQH)[581, 582]. During the study if a 
patient was showing signs of depression, a note of this was made in the nursing notes using 
phrases such as ‘anxiety’ or ‘low mood’ where no further details were given and perhaps 
further questioning may have been required. However referrals were made by the stroke 
team for these patients to be seen by clinical neuropsychology or the mental health team. 
For the purposes of this study, the GDS was administered upon admission to hospital and 
then repeated at the six month stage.  
Only 6% of the study participants did not complete the GDS assessment at baseline as they 
were either unable due to illness, tiredness or were no longer interested in completing the 
assessment. This may have been due to length of the assessment and in hindsight the 
shorter version of the GDS, the GDS-15[583] may have been better tolerated. It is also 
possible that the nature of questions may have been upsetting for some participants and so 
they refused to answer any further questions at that time. Rating scales are effectively 
symptom checklists that are well tolerated, quick to administer and often used for research 
purposes. These scales can only provide a snapshot of how the participant is feeling at that 
point in time and not a complete in depth and accurate diagnosis. It is possible that a certain 
number of cases that scored positively for depression may not have been clinically 
depressed. Most likely these participants may have been temporarily suffering from an 
adjustment disorder after being diagnosed with a life changing event such as a stroke[584, 585]. 
As the patient’s rate of recovery improves post-stroke, the depressive symptoms may also 
be short lived. However there may be true cases of clinical depression and so the study 
sample may have been a mixture of depression as well as short term depressive episodes 
related to the stroke.  
 
8.7.4 Cognitive impairment  
Upon hospital admission, the AMTS which has a maximum score of 10 was often 
administered by hospital staff to assess the patient’s orientation to time and place. Further in 
depth assessment was then followed up by either an SMMSE or ACE-R depending on how 
compliant the patient was, and the results were recorded in the medical notes.  
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The use of the ACE-R was the measure that was the least well tolerated by patients in this 
study. This was often due to communication difficulties or visual issues that the patients 
were suffering from after having a stroke and therefore they were not able to complete the 
exam. On the other hand, a certain number of participants once the assessment had begun 
decided they no longer wanted to continue. Certain patients found to be showing signs of 
cognitive impairment, often refused to continue the assessments any further and asked the 
researcher to come back later as a way of avoiding any further questioning.  
In addition to these issues, during study recruitment the occupational therapy team at the 
LTHT switched from using the ACE-R assessment to the MoCA[536] due to recent copyright 
and payment issues with the ACE-R/ MMSE[586]. The MMSE and MoCA have been shown to 
have good concordance[536] so this was not an issue. However, subsequently the team 
switched back to using the ACE-R/ MMSE after two to three months.  
Changes in patient’s ability post-stroke had been anticipated during the study design and 
there was a possibility that some measures such as the ACE-R assessment may not be fully 
completed during hospital admission for many participants. A measure of cognitive 
impairment that was independent of the delirium and dementia assessment tools was 
needed and so a backup assessment had been selected should the need arise. The 
SMMSE and the TICS assessments were used as alternatives in order to salvage some sort 
of measure of cognitive impairment for analysis. An issue with the SMMSE is that the test 
scores can be influenced by the patient’s age and education levels, which can cause a 
variation in the scores[530].  
Out of a study population of 298, only 66% (197 participants) completed the cognitive 
assessments in full both at admission and at the six month stage. This was clearly a smaller 
group of scores for the SMMSE/ TICS assessment analysis when compared to the other 
outcome measures analysed and could be a possible explanation for the lack of significant 
results for this outcome measure. An alternate explanation may also be that due to the 
significant degree of cognitive impairment post-stroke in the whole study group, any possible 
significant associations with the delirium diagnosis may be have been masked.  
 
8.8 Conclusion 
Efforts were made to minimise the effects of bias in the study during recruitment and data 
collection. However there were still some potential sources which may or may not have had 
an impact on the data collected and analysed in the study. This chapter described the 
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possible sources of bias and error and what was done before, during and after the data 
collection and analysis to minimise its effect on the results. The next chapter will look at the 
results in the context of the wider population and whether these results are generalisable to 
similar study settings and services.  
 
8.8.1 Key points  
 Taking into consideration the limited time and resources, the results of the systematic 
review were sufficient for the purposes of this thesis.  
 The recording of the data for the physical clinical, non-clinical and psychosocial factors 
was relatively straight forward and was completed in full for the majority of participants.  
 Mortality was the outcome that was least susceptible to bias.  
 Measures for physical function, dementia risk and to some extent assessment of mood 
were generally well tolerated. 
 Measures for cognitive impairment were not as well tolerated by study participants and 
an alternative measure had to be used in order to obtain usable data for this outcome.  
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9 Discussion: Study findings  
9.1 Diagnosis of delirium  
This prospective cohort study was the first UK based one year follow up study to investigate 
delirium incidence in acute stroke. The study employed patient and carer interviews with 
standardised diagnostic tools to determine the incidence of delirium and its impact on long 
term outcomes for patients, in the acute stroke population. With a study sample of 298 
patients, the delirium incidence of 32.9% was in keeping with the incidence rates found in 
the published literature of delirium and acute stroke which ranges from 10 to 48%[61, 443-447, 
111, 448, 47, 449, 450, 197, 451, 452] and including the newer studies which have been published since 
this study began[571-573, 226, 574-579, 243]. The meta-analysis performed for the April 2014 search 
results, gave an average incidence of 23.7%.    
The combined use of the CAM-ICU and DRS-R98 was not specifically tested and validated 
for use in the stroke population when this study started recruitment in July 2011. However 
the majority of the newly published studies in this area employed similar tools for delirium 
detection. Upon reviewing the literature, this study found that the use of the CAM-ICU for 
screening and the DRS-R98 for further diagnosis, proved to be an effective combination to 
determine delirium incidence in the stroke population. With regards to the use of the CAM-
ICU in the stroke population, some adjustments such as the use of assessment aids e.g. 
visual response/ cue cards, were employed as communication aids in order to assess 
patients as effectively as possible after a stroke.  
Although the CAM-ICU and DRS-R98 have shown good sensitivity and specificity for 
delirium detection in other non-stroke settings, it must be noted that this study was not a 
validation study. Therefore no analysis of the tools was made in this regard for use in the 
stroke population. Since this study began, a systematic review has been published analysing 
the suitability of the range of delirium tools available for use in stroke[570], concluding that the 
CAM and the DRS were the most commonly used research tools. The same research group 
also conducted a survey investigating the delirium screening practices in stroke amongst 
hospital staff in Scotland[587]. The survey highlighted inconsistencies in delirium screening in 
the Scottish stroke services and the uncertainties of the staff regarding the most suitable 
delirium tools for use in stroke. Lees et al, reviewed a number of screening tools in a sample 
of 111 stroke patients[588]. Their analysis concluded that the 4AT[589] was a suitable choice for 
delirium and cognitive screening, however it should be noted that the comparisons were 
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based on the standard MOCA diagnostic threshold and may not be applicable to the stroke 
population.  
Subsequently the CAM-ICU has been validated for use in stroke, exhibiting high sensitivity 
and specificity with good inter-rater reliability and accuracy[575]. Recommendations were 
made by the research group to conduct serial screenings for delirium and preferably starting 
screening much earlier e.g. the day after stroke onset. In addition to this, a new variant of the 
CAM has been developed by Inouye et al. The CAM-S[590] has strong psychometric 
properties and can now measure the severity of a delirium episode, in comparison to the 
previous versions of the CAM that could only be used for delirium screening.   
 
9.2 Admission outcomes  
9.2.1 Mortality  
Although no difference was seen at the twelve month follow up, the mortality rates at the one 
and six month follow up period were significantly higher in the delirium group compared to 
the non-delirium group. There was a difference between groups at twelve months (34.7% 
delirium, 19% non-delirium), but this difference did not reach significance. The only other 
one year follow up study data for comparison was published in 2006[452], although the total 
percentage of deaths in this study (72 out of 298 participants, 24.2%) was similar to the 
study by Sheng et al (34 out of 156 participants, 23.8%). Since then subsequent studies, 
which have previously been highlighted in Chapter eight, have published data that also 
follow a similar trend regarding mortality with similar confidence intervals[443, 446-448, 47, 571, 449, 
450, 226, 574-577, 452]. This will be discussed further in Section 9.4.  
 
9.2.2 Length of hospital stay 
Patients with delirium spent a significantly longer period of time in hospital (38.5 days) when 
compared to their non-delirium counterparts (21.5 days). The presence of delirium had a 
negative effect on the length of stay. Again, this is in keeping with the published literature in 
this area and of the research groups[445, 111, 448, 47, 449, 450, 575-577, 452] that recorded length of stay 
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9.2.3 Discharge destination  
When compared to the existing living arrangements prior to hospital admission, the delirium 
positive group of patients were less likely to return to their original accommodation and the 
presence of delirium increased the likelihood that the patient would require some form of 
institutional care placement. Furthermore the measures of physical function were linked to 
the need for future care placements, as patients that scored lower on the ADL scales were 
highlighted with an increased need for care than previously provided. Despite its strong 
ceiling effect, a Barthel score was often administered by the hospital staff prior to hospital 
discharge in order to identify the care needs of the patient. Again this was in keeping with 
the majority of the published literature[448, 47, 449, 450, 576, 452] which also recorded discharge 
destination. 
 
9.3 Outcomes six months post-stroke 
Despite the number of deaths (72 in total), and the dropouts, and graded participation 
chosen by three participants (1%), the remaining study sample was sufficiently large to form 
reliable conclusions. Although there were valid reasons provided for the slightly lower 
recruitment rates (33%) when compared to other published studies, steps had been taken to 
reduce any potential bias and there is evidence that the recruited patient group was 
representative of the larger stroke population.  
The confounding factors were not adjusted for when analysing the outcomes between 
delirium positive and delirium negative groups. The primary hypothesis that delirium patients 
had an increased risk of mortality was supported by the study data. The secondary 
hypotheses regarding increased length of stay and an increased need for a future 
institutionalised care placement again were both supported by the study data. For this study, 
long term outcomes such as physical function, future risk of dementia, assessment of mood 
and changes in cognitive impairment were also analysed. This study aimed to provide a 
comprehensive long term follow up of outcomes at six months. At the time of commencing 
this study,  good quality data on long term outcomes in the published literature were lacking, 
with only a select few studies providing a comprehensive follow up after discharge such as 
Henon et al[47], McManus et al[449, 450] and Sheng et al[452].  
There are several ways in which the presence of delirium could affect patient outcomes post-
stroke. In this study sample, poorer physical function was associated with the presence of 
delirium. Physical function was also often used as an indicator for the need for future 
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placement in institutionalised care. The presence of delirium suggests an underlying physical 
illness which if left untreated can add to existing co-morbidities in the patient. The symptoms 
of delirium can also interfere with the treatment of stroke, leading to poorer long term 
outcomes for delirium positive patients.  
The risk of dementia did increase with the presence of delirium and this finding was 
statistically significant for both of the tools used. Although there was a significant difference 
between scores at baseline and at six months, the presence of cognitive impairment was not 
significantly higher in the delirium group compared to the non-delirium group. Patients with 
delirium can display behaviours such as inattention, disorganised thought processes and 
memory impairment which can interfere with their recovery and rehabilitation. Unfamiliar 
surroundings and people can also increase levels of confusion and in cases of hyperactive 
delirium; aggressive or violent behaviours can act as a barrier and prevent staff from aiding 
the patient’s recovery process.  
Regarding the assessment of mood, although there was significant difference between 
scores at baseline and at six months, delirium positive patients were not associated with 
higher GDS scores. As discussed in Chapter eight, it is possible that some patients may be 
displaying signs of a short term adjustment disorder after as stroke as opposed to clinical 
depression. The impact of a stroke coupled with poor physical health and the presence of 
delirium can cause a lack of motivation which may affect the patient’s mental and physical 
recovery. 
With regards to the confounders, a number of variables were taken into account when 
analysing the differences between the delirium positive and delirium negative groups. With 
regards to assessing risk factors independently, the study sample may be seen as 
inadequate due to the number (n = 298). However this part of the study was always 
regarded as an exploratory study rather than a definitive risk factor study aimed at producing 
a delirium risk factor predictor model. A number of confounders were found to associated 
with the presence of delirium and it is possible that certain confounders could combine 
together to increase the likelihood of certain outcomes such as poor physical function or 
cognitive impairment. As delirium is an indicator of underlying physical illness, by alleviating 
and improving certain confounding variables upon admission, there may be a possibility to 
improve the long term prospective outcomes for patients with delirium.  
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9.4 Comparisons with the published literature 
The systematic review in Chapter three identified a need for a UK based study that recruited 
a prospective cohort of stroke patients, representative of the population being studied with a 
long term follow up period and the use of suitable diagnostic instruments. At the time of 
designing this study, no delirium instruments had been validated for use in the stroke 
population. This was reflected in the published literature as the majority of research groups 
used tools such as the DSM criteria, the DRS or the CAM with some studies opting to the 
use the MMSE. The MMSE as mentioned previously is not an appropriate screening tool for 
delirium. McManus et al[449, 450], used the CAM to screen for delirium whilst Sheng et al[452] 
used the DSM, with no groups assessing severity. A systematic review of the published 
literature concluded that it would be better to use two tools in combination with each other. 
The addition of DRS-R98 would be used to measure severity whilst CAM-ICU as a screening 
tool would be better suited for this study as it did not rely on verbal responses and so it could 
accommodate stroke patients. Both tools had shown good concordance with each other in a 
general medical setting and as mentioned previously, the CAM-ICU has now been validated 
for use in stroke[575].  
Of the studies included in the systematic review, the majority of the research groups only 
assessed outcomes up until discharge. With regards to long term outcomes, very few 
studies provided a comprehensive long term follow up after discharge. These included 
McManus et al[449, 450] at one month, Henon et al[47] at six months with Sheng et al[452] as the 
only research group to provide a full one year follow up. For this study although a full twelve 
month follow up was planned in the initial stages, time restrictions meant that a compromise 
had to be made in the study design. Therefore a comprehensive assessment of outcomes 
was made at six months, with only a mortality check being performed at twelve months. Had 
there been sufficient time, then a full follow up of physical function, mood assessment, 
dementia risk and cognitive impairment could have been conducted at the one year stage.  
The systematic review search conducted in April 2014 highlighted eleven new papers that 
had been published since the last search conducted in June 2010. A summary of these 
recently published studies can be found in Figure 9.1 and Figure 9.2. In certain research 
groups, further analysis had been conducted using the same stroke populations previously 
identified in the June 2010 search. This was true of the research groups McManus et al[449, 
450, 226] and Oldenbeuving et al[577, 578, 197, 579, 243]. As a result the April 2014 search identified 
six new study populations in addition to the twelve previously identified in June 2010.   
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Author and 
country 
Study design 
and setting 
Sample 
(M = male, F = female, Age = 
mean age) 
Recruitment criteria  
(I = Inclusion,  
E = Exclusion) 
Assessments  Occurrence 
of delirium 
Risk factors  
Oldenbeuving, 
2011 
(The 
Netherlands)  
Prospective 
cohort  
Stroke unit 
 
630 admitted, 527 recruited  
62 delirium 
(38M, 24F) Age = 78  
465 non-delirium  
(250M, 215F) Age = 71  
I: Consecutive stroke (CI or IH)  
E: SAH, TIA, <18 years of age 
(Oldenbeuving, 2008 cohort) 
CAM (admission, day 2-4 
& 5-7) 
DRS (daily for delirium) 
NIHSS (admission) 
IQCODE (admission) 
11.8% 
 
IQCODE> 50, right sided 
lesion, anterior circulation 
large vessel strokes, 
infection and NIHSS score, 
cortical atrophy 
McManus, 
2011 
(UK) 
Prospective 
observational  
Stroke unit 
 
110 eligible, 82 recruited  
23 delirium 
(15M, 8F) Age = 75 
59 non-delirium 
(36M, 23F) Age = 63 
I: Stroke (CI or IH), delirium 
assessment within 4 days,  
E: SAH, GCS score <8, delirium 
< 24 hrs, English speaker 
(Follow up for McManus, 2008, 
2009 cohort) 
CAM (4 days & then 
weekly) 
IQCODE (admission) 
 
28% 
 
-  
Van 
Rijsbergen, 
2011 
(The 
Netherlands) 
Retrospective 
case control  
Hospital based 
527 original cohort, 50 recruited 
(62 delirium, 465 non-delirium) 
22 delirium  
(11M, 11F) Age = 75.8  
28 delirium  
(18M, 10F) Age = 74.6 
I: cohort 2 year follow up, age, 
sex and stroke matched  
E: death, poor health 
(Sub -study of  
Oldenbeuving, 2011 cohort) 
Delirium assessments 
already conducted 
CDR and Rotterdam 
CAMCOG (upon sub-
study recruitment) 
11.8% 
 
- 
Kostalova, 
2012 
(Czech 
Republic) 
Prospective 
observational 
Stroke unit  
275 admitted, 197 screened, 
119 recruited, 100 assessed  
43 delirium 
(24M, 19F) Age = 80 
57 non-delirium  
(30M, 27F) Age = 73 
I: Stroke (CI or IH), delirium 
assessment within 24 hrs,  
E: SAH, head trauma, brain 
tumour, neurosurgery, 
comatose, psychosis, non-
Czech speaker  
DSM-IV (daily in 1st week) 
CAM-ICU and RASS (daily)  
NIHSS (admission) 
 
43% Older, pre-stroke 
dementia, ICH, lesions> 
40cm, anticholinergic 
meds, TACI strokes and 
metabolic disorders (RF’s 
for poor CI at follow up) 
Melkas, 2011 
(Finland) 
Prospective 
cohort 
Hospital based 
1622 admitted, 642 eligible, 
486 recruited, 263 assessed 
50 delirium 
(26M, 24F) Age = 72.5 
213 non-delirium 
(109M, 104F) Age = 70.4 
I: Stroke (CI only) 
E: SAH, IH, incomplete 
assessments 
DSM-IV (days 1 to 7)  
MMSE, ADL, IADL, BI, 
Blessed functional activity 
scale (admission)  
19% Pre-stroke cognitive 
decline, severe stroke and 
low education  
 
Figure 9.1: The incidence of delirium in stroke populations identified in the April 2014 search.  
CI: Cerebral Infarction, IH: Intracerebral Haemorrhage, SAH: Subarachnoid Haemorrhage, TIA: Transient Ischaemic Attack, MMSE: Mini-Mental State 
Examination, CAM: Confusion Assessment Method, DRS: Delirium Rating Scale, DSM: Diagnostic and Statistical Manual, ADL: Activities of Daily Living, BI: 
Barthel Index, IQCODE: Informant Questionnaire on Cognitive Decline in the Elderly, GCS: Glasgow Coma Scale, MRS: Modified Rankin Scale 
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Author and 
country 
Study design 
and setting 
Sample 
(M = male, F = female, Age = 
mean age) 
Recruitment criteria  
(I = Inclusion,  
E = Exclusion) 
Assessments  Occurrence 
of delirium 
Risk factors  
Mitasova, 
2012 
(Czech 
Republic) 
Prospective 
observational 
Stroke unit 
331 admitted, 236 screened, 
151 recruited, 129 assessed  
55 delirium, 79 non-delirium 
(72M, 57F) Age = 71.2   
I: Stroke (CI or IH), delirium 
assessment within 24 hrs  
E: SAH, head trauma, brain 
tumour, neurosurgery, 
comatose, psychosis, non-
Czech speaker 
CAM-ICU, DSM-IV (daily)  
NIHSS, SOFA, Blessed 
dementia rating scale and 
Mississippi aphasia 
screen test (admission) 
BI  (week 1 and 6 months)  
42.6% -  
Miu, 2013  
(China) 
Prospective 
cohort 
Stroke unit 
314 recruited 
86 delirium, Age = 78.8 
228 non-delirium, Age = 70.7 
I: Stroke (CI or IH) 
E: TIA, stroke due to cerebral 
venous thrombosis, severe 
trauma, neurosurgery, age <50 
years, GCS <5 
CAM (daily day 1 to 5) 
Charlson Comorbidity 
Index (CCI), NIHSS, 
IQCODE (admission) 
MRS and BI (admission 
and 6 months)  
27.4% Stroke aetiology/location, 
medical complications, 
pre-existing cognitive 
impairment, visual neglect 
and dysphagia 
Oldenbeuving, 
2013 
(The 
Netherlands)  
Prospective 
cohort  
Stroke unit 
 
527 original cohort,  
(62 delirium, 465 non-delirium) 
353 recruited  
 
I: Existing cohort, patients with 
genomic DNA isolation data   
E: death, poor health 
(Sub -study of  
Oldenbeuving, 2011 cohort) 
Delirium assessments 
already conducted 
 
11.8% 
 
-  
Kara, 2013 
(Turkey)  
Prospective 
cohort 
Hospital based 
 
150 recruited  
42 delirium 
(30M, 12F) Age = 68 
108 non-delirium 
(75M, 33F) Age = 61.2 
I: Stroke (any type) 
E: Comatose, severe aphasia  
DSM-IV, DRS (daily 5 day) 
NIHSS, IQCODE 
(admission)  
 
28% Ischaemic heart disease, 
anticholinergic meds, 
haemorrhagic, TACI and 
cardioembolic strokes 
Kutlubaev, 
2013 
(Russia) 
Prospective 
cohort 
Neurovascular 
unit  
271 admitted, 96 recruited 
22 delirium 
(8M, 14F) Age = 74 
74 non-delirium  
(42M, 32F) Age = 66 
I: Stroke (CI or IH), delirium 
assessment within 3 days 
E: SAH, TIA, comatose, history of 
psychiatric illness  
DSM-IV (within 3 days) 
NIHSS, MRS (admission)  
22.9% Old age, severe stroke, 
chronic cerebral changes, 
fever, catheterisation 
and positive snout reflex 
Oldenbeuving, 
2013 
(The 
Netherlands) 
Prospective 
cohort  
Hospital based 
 
527 original cohort,  
(62 delirium, 465 non-delirium) 
273 validation set, 15% delirium 
(131M, 142F) Age = 72  
I: Consecutive stroke (CI or IH)  
E: SAH, TIA, <18 years of age 
(Sub -study of  
Oldenbeuving, 2011 cohort) 
Delirium assessments 
already conducted 
 
11.8% 
 
-  
 
Figure 9.1: The incidence of delirium in stroke populations identified in the April 2014 search – continued.  
CI: Cerebral Infarction, IH: Intracerebral Haemorrhage, SAH: Subarachnoid Haemorrhage, TIA: Transient Ischaemic Attack, MMSE: Mini-Mental State 
Examination, CAM: Confusion Assessment Method, DRS: Delirium Rating Scale, DSM: Diagnostic and Statistical Manual, ADL: Activities of Daily Living, BI: 
Barthel Index, IQCODE: Informant Questionnaire on Cognitive Decline in the Elderly, GCS: Glasgow Coma Scale, MRS: Modified Rankin Scale 
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Author Occurrence Outcomes Confounding variables Quality of study  
Oldenbeuving, 
2011 
(The 
Netherlands)  
11.8% delirium 
 
Lower BI scores and unfavourable 
outcomes (death or low BI) at 1 month  
Longer hospital stays (23.7 days Vs 13.9 
days) 
High inpatient mortality (19.4% Vs 6.5%) 
 
Age, NIHSS score, TACI and PACI strokes, right sided lesion, high 
IQCODE, cortical atrophy, infection and metabolic disorders 
associated with delirium.  
High  
McManus, 
2011 
(UK) 
28% delirium 
 
Inpatient mortality (30.4% Vs 1.7%) 
1 year mortality (25% Vs 7.4%) 
2 year mortality (8.3% Vs 10.2%)  
 
Age and delirium significantly associated with inpatient 
mortality. Age and pre-stroke cognitive decline significant for 1 
year mortality and only cognitive decline for 2 year mortality.     
High  
Van 
Rijsbergen, 
2011 
(The 
Netherlands) 
11.8% delirium 
 
Delirium is an independent predictor of 
dementia onset 2 years post stroke 
Delirium patients have 5 to 7 fold 
increased risk of dementia   
CDR: delirium, metabolic disorders, infection, cerebral atrophy, 
and white matter changes associated with dementia and 
delirium and cerebral atrophy were independent predictors.  
CAMCOG: Delirium, females and lower education associated 
with dementia and delirium and female independent predictors.  
 
Medium  
Kostalova, 
2012 
(Czech 
Republic) 
43% delirium Delirium duration 5 days (range 1-28)  
Risk prediction model produced 
Older, pre-stroke dementia, chronic alcoholism, elevated GGT, 
thrombocytopenia associated. Hyponatremia, high creatinine 
and high bilirubin more frequent in delirium. ICH, NIHHS >10, 
lesion >40cm, TACI strokes, SOFA score and metabolic disorders.  
 
High 
Melkas, 2011 
(Finland) 
19% delirium  Delirium increases onset of post-stroke 
dementia at 3 months 
Shorter survival (6.1 years Vs 9.1 years)  
Low education, severe stroke and pre-stroke cognitive decline 
associated with delirium. Age, post stroke dementia and stroke 
severity associated with poor survival.  
 
High 
 
Figure 9.2: The outcomes of post-stroke delirium studies identified in the April 2014 search.  
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Author Occurrence Outcomes Confounding variables Quality of study  
Mitasova, 2012 
(Czech 
Republic) 
42.6% delirium  BI lower as inpatient and at 6 months  
Delirium duration 4 days (range 1-28)  
Longer stay (18 days Vs 12 days) median 
High 6 month mortality (23.6% Vs 14.9%)  
Validation of CAM-ICU for use in stroke  
 
-  High 
Miu, 2013  
(China) 
27.4% delirium Poorer functional mobility and physical 
performance at discharge, 6 months and 
12 months post-stroke 
Longer stay (45 days Vs 22.1 days) 
High institutionalisation (62.3% Vs 11.2%) 
High inpatient mortality (18.8% Vs 2.2%)  
High 1 year mortality (30.2% Vs 7.4%)  
1 year survival (281.65 days Vs 348.7 days) 
 
Age, NIHSS, urinary retention, chest infection, previous cognitive 
impairment, TACI and POCI strokes as predictors for delirium.  
Age, CCI, large area of infarct, dysphagia, visual neglect, fever, 
urinary tract infection, chest infection and pre-existing cognitive 
decline associated with nursing home placement at 1 year.  
Age, CCI, dysphagia and chest infection independent predictors 
for mortality at 1 year.  
High  
Oldenbeuving, 
2013 
(The 
Netherlands) 
11.8% delirium  No association between APOEe4 allele 
and occurrence of post-stroke delirium  
No difference in duration of delirium 
 
No association with any of the variables tested.   Medium 
Kara, 2013 
(Turkey)  
28% delirium  Low BI scores 
High inpatient mortality (71.4% Vs 28.6%) 
NIHSS, pre-stroke cognitive decline, high IQCODE scores, 
advanced leukoaraiosis, high CHIPS score, ECG (high amplitude 
diffuse slow disorder), metabolic and infectious disorders all 
associated with delirium.  
 
High 
Kutlubaev, 
2013 
(Russia) 
22.9% delirium Lower MRS scores 
Chronic brain changes and stroke 
complications risk factors for delirium 
 
Old age, severe stroke, cerebral changes, fever, catheterisation, 
positive snout reflex likely to develop delirium. Severity of 
posterior leukoaraiosis independent predictor of delirium onset.  
High 
Oldenbeuving, 
2013 
(The 
Netherlands) 
11.8% delirium  Risk prediction model produced to predict 
delirium in 1
st
 week of admission based on 
age, stroke severity/ subtype and 
infection  
-  High 
 
Figure 9.2: The outcomes of post-stroke delirium studies identified in the April 2014 search – continued.  
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From the newer literature published, Kostalova et al[572] focused on producing a risk 
prediction model and therefore did not record any follow up outcomes. Kara et al[571] and 
Kutlabaev et al[573] only analysed outcomes during the participant’s stay in hospital and upon 
discharge. The groups Oldenbeuving et al[577], recorded follow up outcomes till one month, 
Melkas et al[574], investigated outcomes till three months and Mitasova et al[575], analysed 
outcomes till six months post-stroke. McManus et al[226], provided further analysis for 
mortality one to two years after a stroke using their existing cohort. Miu et al[576], was the only 
new research group to provide a full one year comprehensive follow up. Almost all the new 
studies provided data on risk factors, outcome predictors and/ or confounding variables. The 
only exception to this were the studies by Mitasova et al[575], which was primarily a validation 
study and Oldenbeuving et al[578], (a sub-study of a previous paper) which focused on 
producing a delirium risk prediction model.  
A meta-analysis was also performed to analyse mortality, institutionalisation and length of 
stay, the results of which are shown in Figure 9.3. It should be noted that certain research 
groups did not provide complete data for certain outcomes and/ or did not quantify sub-group 
sizes. As a result the data for these studies could not be included in the analysis. In order to 
make comparisons with the published literature, the data for this study (marked as Ahmed 
2014) was also included in the analysis. The funnel plots and the results of the original meta-
analysis performed on only the published literature have also been included (appendix 23).  
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Figure 9.3: Results of the meta-analysis performed for the April 2014 search. 
 
To allow comparisons with the published literature identified by the systematic review, the data 
for this study has also been included in the comparison and is marked as Ahmed 2014. 
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With regards to the composition of the sample, the mean age of previously published 
literature ranged from 55 to 79 years, with 74 years as the median age. This study had a 
mean age of 79 years which was in keeping with the published literature and representative 
of the elderly stroke population being studied. Age was a key factor in the representation of 
the sample as presentation of physical illness in the elderly is significantly different to that of 
younger adults. There are also implications regarding quality of life as the elderly population 
unavoidably have an increased incidence and prevalence of illness. Less strict exclusion 
policies were also used in this study with only age (55+ years), stroke diagnosis and 
sufficient health to participate as the main points upon which study recruitment was made. 
To conclude, every effort was made to conduct a successful long term follow up study that 
investigated the incidence of delirium in stroke using appropriate diagnostic tools suited to 
the participant’s needs, with a study sample that was representative of the stroke population.  
 
9.5 Implications for future research and clinical practice 
9.5.1 Areas of further research for delirium and stroke 
The incidence of delirium in stroke in the published literature ranges from 10 to 48% with the 
April 2014 meta-analysis producing an average incidence of 23.7%. There were, and still 
are, a number of obstacles ranging from; ethical considerations, capacity, unsuitable 
assessment tools and lack of studies, instrument suitability to variations in age, gender and 
stroke type for sample cohorts and the wide variation in exclusion criteria set by research 
groups. With regards to the confounders data analysed in this study, the results of this group 
of variables could be used as a pilot study to power a larger risk factor study with the end 
point of possibly generating a predictive delirium risk factor model such as the model by 
Inouye et al[54]. Since this study began other research groups such as Carrasco et al[63], have 
also produced delirium predictive models for use in the elderly, whilst groups such as 
Kostalova et al[591, 572], and Oldenbeuving et al,[578] have focused on producing a predictive 
model specifically for  post-stroke delirium.  
With regards to suitable assessment tools, a recent systematic review[570]  by Carin-Levy et 
al, was published listing the various delirium tools that are currently available and analysing 
their strengths and weaknesses for use in the stroke population. The review also collated 
information on incidence rates and outcome predictors as well, helping to consolidate the 
slowly growing body of literature being published on post-stroke delirium. Recently the CAM-
ICU was validated for use in stroke by the research group Mitasova et al[575]. The research 
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group tested the delirium instrument in a stroke setting and found that it had good inter-rater 
reliability, sensitivity, specificity and accuracy. The adoption of a validated stroke specific 
detection tool for delirium by research groups will help to standardise the reporting of post-
stroke delirium incidence, thus allowing better cross comparisons between future studies. 
Issues such as cohort homogeneity, possibly produced by unnecessary strict exclusion 
criteria[251, 252] are still an issue, but these may improve as better standardised incidence and 
outcome studies are published. The increased levels of mortality and morbidity associated 
with post-stroke delirium[228, 226, 574, 592] should be considered when calculating sample sizes 
so that the analysis and results of future studies are adequately powered.  
Some studies have shown that admission from an institutionalised care placement seems to 
be a significant delirium risk factor[232]. In some cases it was suggested that delirium may be 
present upon admission rather than after admission, possibly in the form of delirium 
superimposed on dementia[158]. Incidence studies based in community settings could help to 
clarify this situation[81, 593]. If incidence rates were found to be significantly high in care 
settings, then it may worth considering conducting a trial evaluating preventative delirium 
measures in the community. It may also be beneficial to collaborate with GP’s for data 
collection and relay any information on delirium diagnosis back to the community so that 
they can be continued to be monitored once discharged from hospital. Another area of 
delirium research that has been ignored in larger cohort studies is the psychological aspect 
of delirium both at admission and follow up. As discussed in Chapter two, stroke survivors 
often suffer from adjustment reaction disorders, emotional changes and depression after a 
stroke[585, 594, 218]. The after effects of stroke coupled with episodes of delirium could result in 
a significantly poorer prognosis for patients. Delirium symptoms often overlap with signs of 
dementia and depression[145]. This can make a differential diagnosis challenging as 
evidenced by the numerous single case reports examining these occurrences. It would be 
beneficial to assess and follow up the occurrence of depression as well as dementia post-
stroke[595] and delirium on a larger scale and to further explore the implications of whether 
the patient’s psychological status may have a potential effect on these outcomes.  
 
9.5.2 Delirium as an outcome measure for future studies  
In research studies outcome measures such as mortality, functional ability and cognitive 
impairment are just some of the measures that are commonly used[410, 406]. They are used as 
markers to measure a patient’s progress or deterioration and there are number of well 
validated assessments tools that facilitate this process. It may be worth considering 
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implementing delirium as an outcome measure[430, 596] that would be routinely used in 
research studies, specifically in the area of stroke. For example the incidence of delirium is 
routinely analysed in many hip fracture studies and a similar study design could be 
implemented for stroke research. Delirium is caused by an underlying physical illness and a 
significant number of these conditions are reversible. For example, avoiding malnutrition and 
dehydration[597], treating conditions such as incontinence and constipation efficiently[59] and 
quicker mobilisation strategies for patients post-stroke[363, 373] could all help improve the 
patient’s level of health. These conditions are common after stroke and are also contributing 
factors for delirium onset. Therefore by promoting better quality care in medical settings and 
treating such conditions more efficiently would also mean a decrease in the occurrence of 
post-stroke delirium. The lower delirium rates in stroke units could be seen as providing 
better care for patients. In effect measurement of delirium occurrence would no longer be the 
objective of future research studies but instead delirium would be seen as a marker of better 
good quality care in studies. In order to implement this, the use of a stroke validated delirium 
tool such as the CAM-ICU[575], would need to be adopted and employed in stroke units as 
part of the standard admissions pathway.   
 
9.5.3 Detection and treatment of delirium in stroke  
This study has shown that delirium is commonly present within the acute stroke population 
and can have an adverse effect on several patient outcomes. Delirium is regarded as an 
indicator for an underlying physical illness and by not identifying and treating the cause 
might result in poor prognosis for the patient, as evidenced by the published literature. 
Therefore it is assumed that the increased physical illness in patients can increase the 
occurrence of delirium. With regards to post-stroke complications, conditions such as 
pneumonia (due to an unsafe swallow and immobility) or pulmonary embolism (due to 
immobility) are common and have also found to be predictors of delirium[598]. Pneumonia and 
pulmonary embolism are given greater emphasis in stroke and have national programmes 
highlighting the need for efficient management of such conditions[270, 271]. It may be 
considered that the incidence of post-stroke delirium may have a higher incidence in 
comparison to other conditions such as pulmonary embolism and so it could be worthwhile 
implementing similar national programmes for delirium. However a further risk factor study 
would be required to explore these factors and investigate this topic in further detail.  
With published incidence rates ranging from 10 to 48%, as well poor outcomes, it is clear 
that delirium has the potential to increase the workload of hospital staff if left untreated.  This 
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would also lead to an increase in referrals to psychiatry and the mental health team, 
increasing their workload. Although a number of clinicians are aware of what delirium is, the 
majority of staff are still unaware and not educated in detecting the signs of delirium[169, 599]. 
This leads to many cases remaining undetected, mistaken or misdiagnosed. Even in places 
when detection is common, little action may be taken due to lack of staff understanding and 
awareness of how to treat a case of delirium[587]. As a result delirium is a common 
occurrence in many of the referrals sent to psychiatry services and approximately 10% of 
referred patients exhibited signs of delirium[600].  
Psychiatric input may involve assessing the patient’s cognition, making a differential 
diagnosis where dementia or depression may be present, identifying the symptoms and their 
cause, treatment and how best to manage the patient[600, 32]. Good communication is 
necessary between the various teams involved in the care of patient as each have their own 
area of expertise. Many reviews have indicated the need for the better systematic prevention 
and management of delirium by identifying key risk factors and how best to minimise them to 
avoid hindering patient progress[187]. There are a number trials evaluating prevention 
intervention measures in care homes’[81, 593], across various hospitals settings[131] (as 
described in Chapter one), to improve communication with the patient’s families/ carers[179] 
and to increase the awareness of clinical staff[425].  
The need to implement these measures alongside decreasing conflicting definitions, 
standardising terminology[601] and better screening procedures in clinical practice is 
evident[83]. Future research contributions to the pathophysiology of delirium[602, 109] to identify/ 
develop treatments as well as the development of risk prediction models[63, 54, 591, 572, 578] will 
help to improve the detection and management of delirium in stroke. With regards to training, 
the published literature shows that improvements in geriatric medicine translate to better 
outcomes for the elderly population and the routine use of tools such as the Comprehensive 
Geriatric Assessment (CGA) can improve patient outcomes[140, 603]. As both delirium and 
stroke have been strongly associated with an increase in age, introducing the routine use of 
an assessment such as the CGA may be beneficial. The assessment, when administered 
upon admission to the stroke unit, could help to highlight key issues earlier on facilitating the 
efficient and effective management of the patient. Suggestions have also been made for 
improvements in the geriatric medicine training provided for junior doctors[604] and a recent 
study by Jenkin et al,[605] showed a small increase in delirium knowledge and awareness 
associated with training in geriatric medicine.  
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9.5.4 Development of a standardised delirium protocol in stroke 
As discussed previously lack of staff education and awareness, misdiagnosis and the use of 
inappropriate tools have all contributed to low rates of delirium detection on the ward[425]. It 
has been suggested that earlier involvement of psychiatry service would be beneficial in 
cases of delirium[32]; however this would be time consuming for the referral service and not 
feasible in the long term. An alternative solution would be to introduce a routine screening 
protocol as part of the admissions process. Research suggests that in some situations the 
staff are informed on the importance of delirium but are using incorrect tools to identify 
potential cases[587]. Therefore it is assumed that the routine use of the correct diagnostic tool 
may increase detection rates and as a result improve the clinical management of the 
syndrome as staff awareness and familiarity increases. It should be noted that the sensitivity 
of tools such as the CAM-ICU when used in a clinical setting, may differ from that of a 
research environment. With regards to clinical implementation the research group Mitasova 
et al[575], make a good point in that the use of a tool such as the CAM-ICU would require 
calibration with ongoing monitoring and compliance checks. This would need to be done in 
order to ensure that delirium screening procedures were efficient and of good quality.  
Leentjens et al[606] conducted a survey of delirium guidelines across Europe and found there 
was a lack of evidence based guidelines for the management of delirium. Suggestions were 
made for the development of globally consistent guidelines which would help improve clinical 
and research practice. With regards to delirium in stroke, the NICE guidelines for stroke 
(CG68)[270] and for delirium (CG103)[132] are currently valid and do not require any further 
changes to be made in relation to post-stroke delirium. The existing delirium risk factor 
guidance and prevention methods from NICE are still applicable to the stroke population as 
they are for any other patient population. The presentation of delirium remains the same in 
most patient groups as delirium symptoms are clinically dominant, although there is overlap 
with the stroke symptoms. Therefore the issue does not lie with the existing guidelines. It is 
not guidelines alone that change the management of delirium, but more so the 
organisational and educational changes that are needed[607]. Further research is needed to 
determine whether education could have a preventative effect on delirium occurrence and 
whether this increased awareness could be transformed into increased rates of delirium 
detection. Trials evaluating delirium educational programs as demonstrated in other clinical 
settings[425, 131] could also be conducted in stroke units to determine their effectiveness, in 
order to implement educational and organisational changes to create better practices in 
delirium management.      
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The introduction of stroke units nationally have been found to improve patient outcomes as 
well as being cost effective[365, 495, 361, 366, 360, 367, 362]. Many stroke services have been 
restructured in order to offer more specialised care to stroke patients efficiently and 
effectively. The various teams such as physiotherapy, occupational therapy and old age 
liaison psychiatry all have their own areas of expertise and participate in the weekly 
multidisciplinary team meetings on the unit. The incidence rates of delirium in the stroke 
population are significant and cannot be ignored and it would make clinical sense to 
incorporate a regular delirium education and awareness program for the clinical staff, in 
addition to the existing care packages offered on the ward. Cases of delirium may require 
different disciplines to gain a detailed insight into the causes, but at the same time general 
medical/ stroke unit staff also need to be aware of what signs to pay attention to. This may 
include elements of delirium detection, simple screening assessments for cognitive 
impairment and behavioural changes such as depression as well as avoiding the use of 
specific drugs that may worsen a delirium episode.  
In the early stages of a delirium education and awareness program, the clinical staff would 
need to be trained in detecting cases of delirium, and once competent this training could 
then be delivered to other staff members. Training would have to be repeated on a regular 
basis as new staff members join the stroke unit. It is possible that the initial basic training 
and education on delirium could be provided by the psychiatry services. This would be 
equally beneficial to the clinical staff as well as the psychiatrically trained staff who then have 
more time and resources to tend to more complex cases that require their attention.  
In the long term training the clinical staff, specifically the nurses on the stroke unit, would be 
beneficial as it is these staff members that regularly interact with patients and are able to 
build up a rapport with them. By observing the baseline interactions of the patients, any 
subsequent subtle changes in the patient’s behaviour, mental status and routine could be 
identified much more efficiently. These cases could be treated whilst the patients remain on 
the stroke units thus avoiding the need for transfers or interactions with new people that may 
possibly increase confusion and disorientation. For more complex cases where a differential 
diagnosis may be required, the patients could be referred to the psychiatry services for more 
in-depth analysis and treatment. 
In order to produce a delirium screening protocol the assessment tool needs to be quick and 
easy to administer in a busy clinical setting such as the stroke unit. Shorter assessment tools 
are more likely to appeal to staff as they would be less time consuming, work intensive and 
the staff would be more likely to adhere to the protocol in their day to day duties. In this 
study, the CAM-ICU was a quick and easy screening tool to administer and was very well 
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tolerated by patients, although the tool may require some training and experience for reliable 
use. It has also recently been validated for use in the stroke population with good results[575]. 
The DRS-R98 could then be used to provide further details if a patient tested positive for 
delirium. Although the DRS-R98 was initially introduced for research purposes, it is now 
being using by clinical staff such as experienced psychiatrists to detect delirium. In order to 
use the DRS-R98, staff would need to be trained in its use or perhaps a simplified version of 
the DRS-R98 could be developed for use by non-psychiatrically trained staff.   
The combined use of the CAM-ICU as a one sheet assessment would hopefully be 
appealing, with a separate DRS-R98 sheet for the additional details if the patient does test 
positive. This short assessment tool could easily be incorporated into the existing stroke 
proforma currently being used at the LTHT, although stroke proformas may vary between 
different hospitals. A delirium protocol would need development, testing and subsequent 
calibration checks, but it is possible to implement a standardised screening practice for post-
stroke delirium at some point in the near future. Putting the aforementioned steps into 
practice could help to initiate a more efficient and effective management method to help treat 
the underlying causes of delirium and regular screening could make a significant 
improvement in post-stroke delirium detection rates.  
 
9.6 Conclusion 
Taking into account all the information presented, the results of this study are generalisable 
to similar stroke services. However it is fair to conclude that further data on delirium and 
acute stroke are needed. Aside from the incidence data, more prospective cohort studies 
employing similar delirium diagnostic tools validated for use in the stroke population are 
required. Studies need to be well designed, with particular being paid attention towards 
possible confounders, composition and size of samples and statistical analysis methods 
employed. There is still a need for studies with a comprehensive long term follow up that 
have regular repeated measurements in order to assess the outcomes as accurately as 
possible.  Specific outcomes of interest include; mortality, length of hospital stay, discharge 
destination, physical function, assessment of mood, risk of dementia and cognitive 
impairment. Once these data have been generated, it would provide the basis upon which a 
standardised delirium protocol could be implemented as previously described in this chapter. 
Until then, staff on stroke units can be made aware of the signs of delirium and taught 
environmental measures on how best to limit disruption to the patient’s recovery post-stroke 
and delirium, with more complex cases being referred to the mental health team.  
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9.6.1 Key points  
 For this study the incidence of delirium in the acute stroke population was recorded as 
32.9% and delirium was shown to have a significant effect on mortality figures.  
 Other outcomes that were negatively affected by delirium included; length of stay, 
discharge destination, physical function and risk of dementia.   
 More study data are required with a comprehensive follow up and repeat assessment of 
outcomes measures after discharge.   
 The collection of such data may eventually enable the introduction of a standardised 
delirium screening protocol for use in stroke units.    
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Conclusion of the thesis 
The summarised key points of the thesis are as follows: 
a) The findings of this study calculate the cumulative incidence of delirium to be at 32.9% 
suggesting that there is a significant delirium burden in the acute stroke population.  
b) Delirium has a significant association with long term mortality after a stroke.   
c) Early delirium in the immediate post-stroke onset period has an effect on adverse 
outcomes such as increased length of hospital stay and institutionalisation.  
d) Persistent delirium after one month post-stroke has an effect on physical function and 
risk of dementia for up to six months after suffering a stroke.  
e) Staff on stroke units may benefit from education about delirium, how to detect it and how 
best to manage delirium in stroke patients. The effectiveness of such a programme 
would require further research.   
f) Consideration should also be given to the development of a standardised screening 
protocol for delirium on the stroke unit that could help to improve detection rates. 
g) Delirium is a sufficiently frequent complication in acute stroke to warrant the 
development of a prevention intervention. This would require further research.  
 
206  
 
References   
 
1. Cracknell R, The Ageing Population, in Key Issues for the New Parliament 2010. 
House of Commons Library Research, www.parliament.uk, Editor. 2010 
2. The-Stroke-Association, Stroke Statistics, The Stroke Association, Editor. January 
2013 
3. Lindesay J, The concept of delirium. Dementia and Geriatric Cognitive Disorders, 
1999. 10(5): p. 310-314. 
4. Meagher D, More attention, less confusion: time to lessen the burden of delirium. 
International Review of Psychiatry, 2009. 21(1): p. 1-3. 
5. Oxford-University-Press, The Oxford English Dictionary. 2014 
6. Berrios GE, Delirium and confusion in the 19th century: a conceptual history. British 
Journal of Psychiatry, 1981. 139: p. 439-49. 
7. Bednarik J, Delirium - A new challenge for neurology. Ceska a Slovenska Neurologie 
a Neurochirurgie, 2006. 69(1): p. 18-26. 
8. Lipowski ZJ, Delirium (Acute Confusional States). JAMA, 1987. 258(13): p. 1789-
1792. 
9. Lipowski ZJ, Delirium: Acute Confusional State. 1990: Oxford University Press. 
10. Folstein MF, et al., “Mini-mental state” : A practical method for grading the cognitive 
state of patients for the clinician Journal of Psychiatric Research, 1975. 12(3): p. 189-
198. 
11. Hodkinson HM, Evaluation of a mental test score for the assessment of mental 
impairment in the elderly. Age and Ageing, 1972. 1: p. 233-238. 
12. Liptzin B and Levkoff S, An empirical study of delirium subtypes. British Journal of 
Psychiatry, 1992. 161: p. 843-5. 
13. MacSweeney R, et al., A national survey of the management of delirium in UK 
intensive care units. QJM: An International Journal of Medicine, 2010. 103 (4): p. 
243-251. 
14. Stagno D, et al., The delirium subtypes: A review of prevalence, phenomenology, 
pathophysiology, and treatment response. Palliative and Supportive Care, 2004. 2(2): 
p. 171-179. 
15. Yu K, et al., Delirium in Acute Elderly Care Unit; Prevalence, Clinical Characteristics, 
Risk Factors and Prognostic Significance.  . Journal of Korean Geriatric Society, 
2005. 9(3): p. 182-189. 
16. Meagher DJ, et al., Phenomenology of delirium. Assessment of 100 adult cases 
using standardised measures. British Journal of Psychiatry, 2007. 190: p. 135-141. 
17. Bhat RS and Rockwood K, The Prognosis of Delirium. Psychogeriatrics, 2002. 2(3): 
p. 165-179. 
18. McCusker J, et al., Delirium in older medical inpatients and subsequent cognitive and 
functional status: a prospective study. Canadian Medical Association Journal, 2001. 
165(5): p. 575-583. 
19. McCusker J, et al., The course of delirium in older medical inpatients: a prospective 
study. Journal of General Internal Medicine, 2003. 18(9): p. 696-704. 
20. Cole M, et al., The prognostic significance of subsyndromal delirium in elderly 
medical inpatients. Journal of the American Geriatrics Society, 2003. 51(6): p. 754-
60. 
207  
 
21. Cole MG, et al., Subsyndromal Delirium in Older People: A Systematic Review of 
Frequency, Risk Factors, Course and Outcomes. FOCUS, 2013. 11: p. 534-543. 
22. APA, Diagnostic and Statistical Manual of Mental Disorders III Revised (DSM III R), 
ed. American Psychiatric Association (APA). 1987. 
23. APA, Diagnostic and Statistical Manual of Mental Disorders IV (DSM IV), ed. 
American Psychiatric Association (APA). 1994. 
24. Laurila JV, et al., Predisposing and precipitating factors for delirium in a frail geriatric 
population. Journal of Psychosomatic Research, 2008. 65(3): p. 249-254. 
25. Meagher D and Leonard M, The active management of delirium: improving detection 
and treatment. British Medical Journal, 2008. 14(4): p. 292-301. 
26. APA, Diagnostic and Statistical Manual of Mental Disorders 5 (DSM 5), ed. American 
Psychiatric Association (APA). 2013. 
27. Fong TG, et al., Delirium in elderly adults: diagnosis, prevention and treatment. 
Nature Reviews Neurology, 2009. 5(4): p. 210-220. 
28. Deiner S and Silverstein JH, Postoperative delirium and cognitive dysfunction. British 
Journal of Anaesthesia, 2009. 103(suppl 1): p. i41-i46. 
29. O'Keffee ST and Lavan JN, Clinical significance of delrium subtypes in older people. 
Age and Ageing, 1999. 28: p. 115-119. 
30. Rockwood K, The occurrence and duration of symptoms in elderly patients with 
delirium. Journal of Gerontology, 1993. 48(4): p. M162-166. 
31. Kirshner H, Delirium: A focused review. Current Neurology and Neuroscience 
Reports, 2007. 7(6): p. 479-482. 
32. Meagher D, Delirium: the role of psychiatry. Advances in psychiatric treatment, 2001. 
7(6): p. 433-442. 
33. Maldonado JR, Delirium in the acute care setting: characteristics, diagnosis and 
treatment. Critical Care Clinics, 2008. 24(4): p. 657-722. 
34. Renjel R, et al., Delirium in medical inpatients: adverse outcomes. OA Medical 
Hypothesis, 2013. 1(1): p. 1-4. 
35. Vasilevskis EE, et al., Epidemiology and risk factors for delirium across hospital 
settings. Best Practice and Research Clinical Anaesthesiology, 2012. 26(3): p. 277-
287. 
36. Davis D, et al., Delirium is a strong risk factor for dementia in the oldest-old: a 
population-based cohort study. Brain, 2012. 135(9): p. 2809-2816. 
37. Gonzalez M, et al., Impact of Delirium on Short-Term Mortality in Elderly Inpatients: A 
Prospective Cohort Study. Psychosomatics, 2009. 50(3): p. 234-238. 
38. McManus J, et al., Delirium post-stroke. Age and Ageing, 2007. 36(6): p. 613-618. 
39. Rigney T, Delirium in the hospitalized elder and recommendations for practice. 
Geriatric Nursing, 2006. 27(3): p. 151-157. 
40. Anderson CP, et al., Complications in Post-Acute Care are Associated with 
Persistent Delirium. Journal of American Geriatrics Society, 2012. 60(6): p. 1122-
1127. 
41. Cole MG, et al., Persistent delirium in older hospital patients: A systematic review of 
frequency and prognosis. Age and Ageing, 2009. 38(1): p. 19-26. 
42. Levkoff SE, et al., Delirium. The occurrence and persistence of symptoms among 
elderly hospitalized patients. Archive of Internal Medicine, 1992. 152(2): p. 334-340. 
43. Burback D, Delirium: a condition of all ages. Canadian Journal of CME, 2001 p. 197-
206. 
44. Bassetti CL, Differential diagnosis and management of non-psychiatric acute 
confusional states. Archives of Neurology and Psychiatry, 2007. 158: p. 368-378. 
208  
 
45. George J, et al., Causes and prognosis of delirium in elderly patients admitted to a 
district general hospital. Age and Ageing, 1997. 26(6): p. 423-427. 
46. Oldenbeuving AW, et al., Delirium in acute stroke: a review. International Journal of 
Stroke, 2007. 2(4): p. 270-275. 
47. Henon H, et al., Confusional State in Stroke: Relation to Preexisting Dementia, 
Patient Characteristics, and Outcome. Stroke, 1999. 30(4): p. 773-779. 
48. Francis J, Delirium in Hospitalized Elderly Patients: A Meta-analysis. ACP Journal 
Club, 1993. 119(87). 
49. Holmes J and House A, Psychiatric illness predicts poor outcome after surgery for 
hip fracture: a prospective cohort study. Psychological Medicine, 2000. 30: p. 921-
929. 
50. Alagiakrishnan K and Wiens CA, An approach to drug induced delirium in the elderly. 
Postgraduate Medical Journal, 2004. 80(945): p. 388-93. 
51. Reyes-Ortiz CA, Dehydration, delirium, and disability in elderly patients. JAMA, 1997. 
278(4): p. 287-287. 
52. Miller MO, Evaluation and Management of Delirium in Hospitalized Older Patients. 
American Family Physician, 2008. 78(11): p. 1265-1270. 
53. Inouye S and Charpentier P, Precipitating factors for delirium in hospitalized elderly 
persons. JAMA, 1996. 27: p. 852-857. 
54. Inouye SK, et al., Risk factors for delirium at discharge: development and validation 
of a predictive model. American Medical Association, 2007. 167(13): p. 1406-1413. 
55. Inouye S, Delirium in older persons. New England Journal of Medicine, 2006. 354: p. 
1157-1165. 
56. Inouye SK, The Dilemma of Delirium: Clinical and Research Controversies 
Regarding Diagnosis and Evaluation of Delirium in Hospitalized Elderly Medicine 
Patients. American Journal of Medicine, 1994. 97(3): p. 278 - 288. 
57. Dilley M and Fleminger S, Advances in neuropsychiatry: clinical implications. 
Advances in psychiatric treatment, 2006. 12(1): p. 23-34. 
58. Ahmed S, et al., Risk factors for incident delirium among older people in acute 
hospital medical units: a systematic review and meta-analysis. Age and Ageing, 
2014. 43(3): p. 326-333. 
59. Hogan DB, Revisiting the O complex: urinary incontinence, delirium and 
polypharmacy in elderly patients. Canadian Medical Association Journal, 1997. 157: 
p. 1071-1077. 
60. McManus J, et al., Is the Number of Medications on Admission Predictive of the Risk 
of Developing Delirium Post-Stroke? Basic and Clinical Pharmacology and 
Toxicology, 2009. 105: p. 132-133. 
61. Caeiro L, et al., Delirium in acute stroke: a preliminary study of the role of 
anticholinergic medications. European Journal of Neurology, 2004. 11(10): p. 699-
704. 
62. Pasina L, et al., Association of anticholinergic burden with cognitive and functional 
status in a cohort of hospitalized elderly: Comparison of the anticholinergic cognitive 
burden scale and anticholinergic risk scale: Results from the REPOSI study. Drugs 
and Aging, 2013. 30(2): p. 103-112. 
63. Carrasco MP, et al., Development and validation of a delirium predictive score in 
older people. Age and Ageing, 2014 43(3): p. 346-51. 
64. Lerner V and Kanevsky M, Acute dementia with delirium due to vitamin B12 
deficiency: A case report. International Journal of Psychiatry in Medicine, 2002. 32: p. 
215-220. 
209  
 
65. Aakerlund LP and Rosenberg J, Postoperative delirium: treatment with 
supplementary oxygen British Journal of Anaesthesia, 1994. 72(3): p. 286-290. 
66. Kolbeinsson H and Jonsson A, Delirium and dementia in acute medical admissions 
of elderly pateints in Iceland Acta Psychiatrica Scandinavica, 1993. 87(2): p. 123-
127. 
67. Ely EW, et al., Delirium in the Intensive Care Unit: An Under-Recognized Syndrome 
of  Organ Dysfunction. Seminars in Respiratory and Critical Care Medicine, 2001. 
22(2): p. 115-126. 
68. McPherson JA, et al., Delirium in the cardiovascular intensive care unit: 
Implementation of a screening tool, prevalence and lessons learned. Circulation, 
2011. 4 (6 MeetingAbstracts2011). 
69. Kreisel SH, et al., Diagnosing delirium in patients with acute ischemic stroke: What's 
delirium and what's stroke? Cerebrovascular Diseases, 2013. 35: p. 190-190. 
70. Gagnon P, et al., Delirium in terminal cancer: a prospective study using daily 
screening, early diagnosis, and continuous monitoring. Journal of Pain Symptom 
Management, 2000. 19(6): p. 412-26. 
71. Lee HB, et al., Predisposing Factors for Post-Operative Delirium After Hip Fracture 
Repair Among Patients With and Without Dementia. Journal of the American 
Geriatrics Society, 2011. 59(12): p. 2306-2313. 
72. Rudolph JL, et al., Delirium: An Independent Predictor of Functional Decline After 
Cardiac Surgery. Journal of the American Geriatrics Society, 2010. 58(4): p. 643-649. 
73. Koster S, et al., Risk factors of delirium after cardiac surgery: A systematic review. 
European Journal of Cardiovascular Nursing, 2011. 10(4): p. 197-204. 
74. Tabet N and Howard R, Non-pharmacological interventions in the prevention of 
delirium. Age and Ageing, 2009. 38(4): p. 374-379. 
75. Lundström M, et al., A Multifactorial Intervention Program Reduces the Duration of 
Delirium, Length of Hospitalization, and Mortality in Delirious Patients. Journal of the 
American Geriatrics Society, 2005. 53(4): p. 622-628. 
76. Anderson D, Preventing delirium in older people. British Medical Bulletin: Oxford 
Journals, 2005. 73-74(1): p. 25-34. 
77. Cole MG, Delirium in elderly patients. American Journal of Geriatric Psychiatry, 2004. 
12(1): p. 7-21. 
78. Leslie DL, et al., One-Year Health Care Costs Associated With Delirium in the Elderly 
Population. Archive of Internal Medicine, 2008. 168(1): p. 27-32. 
79. Inouye S, Prevention of delirium in hospitalized older patients: risk factors and 
targeted intervention strategies. Annals of Medicine, 2000. 32(4): p. 257-263. 
80. Inouye SK, et al., A multicomponent intervention to prevent delirium in hospitalized 
older patients. New England Journal of Medicine, 1999. 340(9): p. 669-76. 
81. Featherstone I, et al., An intervention to reduce delirium in care homes. Nursing 
Older People, 2010. 22(4): p. 16-21. 
82. Holt R, et al., Effectiveness of a multi-component intervention to reduce delirium 
incidence in elderly care wards. Age and Ageing, 2013. 0: p. 1-7. 
83. O'Hanlon S, et al., Review: Improving delirium care through early intervention: from 
bench to bedside to boardroom. Journal of Neurology, Neurosurgery and Psychiatry, 
2013. 85(2): p. 207-213. 
84. Rudolph JL, et al., Derivation and validation of a preoperative prediction rule for 
delirium after cardiac surgery. Circulation, 2009. 119(2): p. 229-36. 
85. Siddiqi N, et al., Interventions for preventing delirium in hospitalised patients. 
Cochrane Database of Systematic Reviews, 2007. 2. 
210  
 
86. O’Keeffe ST and Lavan JN, Clinical significance of delrium subtypes in older people. 
Age and Ageing, 1999. 28: p. 115-119. 
87. Alsop DC, et al., The role of neuroimaging in elucidating delirium pathophysiology. 
Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2006. 
61(12): p. 1287-93. 
88. Marcantonio ER, et al., Review Article: Serum Biomarkers for Delirium. Journals of 
Gerontology Series A: Biological Sciences & Medical Sciences, 2006. 61(12): p. 
1281-1286. 
89. Pae C, et al., Delirium: Where Do We Stand? Current Psychiatry Reports, 2008. 10: 
p. 240-248. 
90. Soiza RL, et al., Neuroimaging studies of delirium: A systematic review. Journal of 
Psychosomatic Research, 2008. 65(3): p. 239-248. 
91. Koponen H, et al., Acute confusional states in the elderly: A radiological evaluation. 
Acta Psychiatrica Scandinavica, 1987. 76(6): p. 726-731. 
92. Koponen H, et al., Cerebrospinal fluid somatostatin in delirium. II Changes at the 
acute stage and at one year follow-up. Psyhological Medicine, 1990. 20: p. 501-505. 
93. Koponen H, et al., Cerebrospinal fluid somatostatin in delirium. Psychological 
Medicine, 1989. 19(3): p. 605-9. 
94. Koponen HJ, et al., A long-term follow-up study of cerebrospinal fluid 5-
hydroxyindoleacetic acid in delirium. European Archives of Psychiatry and Clinical 
Neuroscience, 1994. 244(3): p. 131-4. 
95. Macdonald A, et al., C-reactive protein levels predict the incidence of delirium and 
recovery from it. Age and Ageing, 2007. 36(2): p. 222-225. 
96. Fong TG, et al., Cerebral perfusion changes in older delirious patients using 99mTc 
HMPAO SPECT. Journals of Gerontology Series A: Biological Sciences & Medical 
Sciences, 2006. 61(12): p. 1294-9. 
97. van der Kooi A, et al., EEG in delirium: Increased spectral variability and decreased 
complexity. Clinical Neurophysiology, 2014 p. 1388-2457. 
98. Koponen H, et al., EEG spectral analysis in delirium. Journal of Neurology, 
Neurosurgery and Psychiatry, 1989. 52(8): p. 980-5. 
99. Cerejeira J, et al., The cholinergic system and inflammation: common pathways in 
delirium pathophysiology. Journal of the American Geriatrics Society, 2012. 60(4): p. 
669-75. 
100. Trzepacz PT, Is there a final common neural pathway in delirium? Focus on 
acetylcholine and dopamine. Semin Clin Neuropsychiatry, 2000. 5(2): p. 132-48. 
101. Sommer BR, et al., Is dopamine administration possibly a risk factor for delirium? Crit 
Care Med, 2002. 30(7): p. 1508-11. 
102. Maldonado JR, Pathoetiological Model of Delirium: a Comprehensive Understanding 
of the Neurobiology of Delirium and an Evidence-Based Approach to Prevention and 
Treatment. Critical Care Clinics, 2008. 24: p. 789-856. 
103. Ali S, et al., Insight into Delirium. Innovative Clinical Neuroscience, 2011. 8(10): p. 
25-34. 
104. Broadhurst C and Wilson KEN, Immunology of delirium: new opportunities for 
treatment and research. British Journal of Psychiatry, 2001. 179(4): p. 288-289. 
105. Cerejeira J, et al., The neuroinflammatory hypothesis of delirium. Acta 
Neuropathologica, 2010. 119(6): p. 737-754. 
106. van Gool WA, et al., Systemic infection and delirium: when cytokines and 
acetylcholine collide The Lancet, 2010. 375: p. 773-775. 
211  
 
107. Adamis D, et al., APOE and cytokines as biological markers for recovery of prevalent 
delirium in elderly medical inpatients. International Journal of Geriatric Psychiatry, 
2007. 22(7): p. 688-94. 
108. Liu P, et al., High serum interleukin-6 level is associated with increased risk of 
delirium in elderly patients after noncardiac surgery: a prospective cohort study. 
Chinese Medical Journal, 2013. 126(19): p. 3621-7. 
109. MacLullich AMJ, et al., Unravelling the pathophysiology of delirium: A focus on the 
role of aberrant stress responses. Journal of Psychosomatic Research, 2008. 65(3): 
p. 229-238. 
110. Barugh AJ, et al., Cortisol levels and the severity and outcomes of acute stroke: a 
systematic review. Journal of Neurology, 2013. 261(3): p. 533-45. 
111. Gustafson Y, et al., Acute Confusional State (Delirium) Soon after Stroke Is 
Associated with Hypercortisolism. Cerebrovascular Diseases, 1993. 3(1): p. 33-38. 
112. Fann JR, The epidemiology of delirium: a review of studies and methodological 
issues. Seminars in Clinical Neuropsychiatry, 2000. 5(2): p. 64-74. 
113. Saxena S and Lawley D, Delirium in the elderly: a clinical review. Postgraduate 
Medical Journal, 2009. 85: p. 405-413. 
114. Davis D and MacLullich A, Understanding barriers to delirium care: a multicentre 
survey of knowledge and attitudes amongst UK junior doctors. Age and Ageing, 
2009. 38(5): p. 559-63. 
115. Johnson JC, et al., Prospective versus retrospective methods of identifying patients 
with delirium. Journal of American Geriatrics Society, 1992. 40(4): p. 316-9. 
116. Bekker AY and Weeks EJ, Cognitive function after anaesthesia in the elderly. Best 
Practice and Research Clinical Anaesthesiology, 2003. 17(2): p. 259-272. 
117. Robinson TN and Eiseman B, Postoperative delirium in the elderly: diagnosis and 
management. Clinical Interventions in Aging, 2008. 3(2): p. 351-355. 
118. Cavallazzi R, et al., Delirium in the ICU: an overview. Annals of Intensive care, 2012. 
2: p. 1-11. 
119. Han JH, et al., Delirium in the Older Emergency Department Patient – A Quiet 
Epidemic. Emergency Medicine Clinics of North America, 2010. 28(3): p. 611-631. 
120. Ferro JM, et al., Delirium in acute stroke. Current Opinion in Neurology, 2002. 15(1): 
p. 51-55. 
121. Siddiqi N, et al., Occurrence and outcome of delirium in medical in-patients: a 
systematic literature review. Age and Ageing, 2006. 35(4): p. 350-364. 
122. Girard TD, et al., Delirium in the intensive care unit. Critical Care, 2008. 12(Suppl 3): 
p. s3. 
123. Kyziridis TC, Post-operative delirium after hip fracture treatment: a review of the 
current literature GMS Psycho-Social-Medicine, 2006. 3. 
124. Bartels K, et al., Neurocognitive outcomes after cardiac surgery. Current Opinion in 
Anaesthesiology, 2013. 26(1): p. 91-97. 
125. Kat MG, et al., Long-term cognitive outcome of delirium in elderly hip surgery 
patients. A prospective matched controlled study over two and a half years. 
Dementia and Geriatric Cognitive Disorders, 2008. 26(1): p. 1-8. 
126. Centeno C, et al., Delirium in advanced cancer patients. Palliative Medicine, 2004. 
18(3): p. 184-94. 
127. Stiefel F and Holland J, Delirium in Cancer Patients. Cambridge Journals University 
Press, 1991. 3(02): p. 333-336. 
128. Gonzalo LS, Delirium after cardiac surgery. Applied Cardiopulmonary 
Pathophysiology. Conference: 28th Annual Meeting of the European Association of 
Cardiothoracic Anaesthesiologists, EACTA, 2013. 17(2). 
212  
 
129. Gottesman RF, et al., Neurological complications of cardiac surgery: stroke, 
encephalopathy, and cognitive decline. Brain Disorders in Critical Illness: 
Mechanisms, Diagnosis, and Treatment, 2013: p. 410-418. 
130. Inouye S, et al., Clarifying confusion: The Confusion Assessment Method. A new 
method for detecting delirium. . Annals of Internal Medicine, 1990. 113(12): p. 941-
948. 
131. Vidán MT, et al., An Intervention Integrated into Daily Clinical Practice Reduces the 
Incidence of Delirium During Hospitalization in Elderly Patients. Journal of the 
American Geriatrics Society, 2009. 57(11): p. 2029-2036. 
132. NICE, Clinical Guideline 103 Delirium in National Institute for Health and Clinical 
Excellence (NICE) Guidelines National Institute for Health and Clinical Excellence 
(NICE), Editor. 1999 
133. NICE, Delirium: Diagnosis, prevention and management in National Institute for 
Health and Clinical Excellence (NICE) Guidelines NICE, Editor. 2010. p. 1-33  
134. Brown G, et al., Cranial computed tomography of elderly patients: an evaluation of its 
use in acute neurological presentations. Age and Ageing, 1993. 22(4): p. 240-3. 
135. Egelko S, et al., Relationship among CT Scans, Neurological Exam, and 
Neuropsychological Test-Performance in Right-Brain-Damaged Stroke Patients. 
Journal of Clinical and Experimental Neuropsychology, 1988. 10(5): p. 539-564. 
136. Ell PJ and Costa DC, The Role of Nuclear-Medicine in Neurology and Psychiatry. 
Current Opinion in Neurology and Neurosurgery, 1992. 5(6): p. 863-869. 
137. O'Connell RA, et al., The role of SPECT brain imaging in assessing psychopathology 
in the medically ill. General Hospital Psychiatry, 1991. 13(5): p. 305-12. 
138. WHO, International Classification of Diseases 10 (ICD-10), ed. World Health 
Organisation (WHO). 1992. 
139. Asplund K, et al., Geriatric-based versus general wards for older acute medical 
patients: A randomized comparison of outcomes and use of resources. Journal of the 
American Geriatrics Society, 2000. 48(11): p. 1381-1388. 
140. Ellis G and Langhorne P, Comprehensive geriatric assessment for older hospital 
patients. British Medical Bulletin: Oxford Journals, 2005. 71(1): p. 45-59. 
141. Yates C, et al., Screening instruments for delirium in older people with an acute 
medical illness. Age and Ageing, 2009. 38(2): p. 235 - 237. 
142. Adamis D, et al., Delirium scales: A review of current evidence. Aging and Mental 
Health, 2010. 14: p. 543-555. 
143. Mitchell AJ, et al., The Mini-Mental State Examination as a diagnostic and screening 
test for delirium: systematic review and meta-analysis. General Hospital Psychiatry, 
2014: p. Pages 1 - 7. 
144. Bader JP, Differential diagnosis and treatment of acute confusional states in 
psychiatric disorders. Schweizer Archiv fur Neurologie und Psychiatrie, 2007. 158(8): 
p. 379-385  
145. Downing LJ, et al., Geriatric psychiatry review: Differential diagnosis and treatment of 
the 3 D's - Delirium, dementia, and depression. Current Psychiatry Reports, 2013. 
15(6). 
146. Woodford HJ and George J, Cognitive assessment in the elderly: a review of clinical 
methods. QJM: An International Journal of Medicine, 2007. 100: p. 469 - 484  
147. Young J, et al., Cognitive assessment of older people. British Medical Journal, 2011. 
343: p. 1-7. 
148. Clarfield AM, The reversible dementias: do they reverse? Annals of Internal 
Medicine, 1988. 109(6): p. 476-486. 
213  
 
149. De Reuck J, et al., Dementia and confusional state in patients with cerebral infarcts. 
A clinicopathological study. European Neurology, 1982. 21(2): p. 94-7. 
150. Rahkonen T, et al., Delirium episode as a sign of undetected dementia among 
community dwelling elderly subjects: a 2 year follow up study. Journal of Neurology, 
Neurosurgery and Psychiatry, 2000. 69(4): p. 519-521. 
151. McKeith IG, et al., Prospective validation of Consensus criteria for the diagnosis of 
dementia with Lewy bodies. Neurology, 2000. 54(5): p. 1050-1058. 
152. Oinas M, et al., Neuropathologic findings of dementia with lewy bodies (DLB) in a 
population-based Vantaa 85+ study. Journal of Alzheimers Disease, 2009. 18(3): p. 
677-89. 
153. Ryan DJ, et al., Delirium in an adult acute hospital population: predictors, prevalence 
and detection. British Medical Journal: Open, 2013. 3(1-11). 
154. Girard TD, et al., Delirium as a Predictor of Long-Term Cognitive Impairment in 
Survivors of Critical Illness. Critical Care Medicine, 2010. 38(7): p. 1513-1520. 
155. Sampson EL, et al., Dementia in the acute hospital, prospective cohort study of 
prevalance & mortality. British Journal of Psychiatry, 2009. 195: p. 61-66. 
156. Fick D and Foreman M, Consequences of not recognizing delirium superimposed on 
dementia in hospitalized elderly individuals. Journal of Gerontology Nursing, 2000. 
26(1): p. 30-40. 
157. Fick DM and Mion LC, Delirium Superimposed on Dementia. American Journal of 
Nursing, 2008. 1008(1): p. 52-60. 
158. Morandi A, et al., Delirium Superimposed on Dementia Strongly Predicts Worse 
Outcomes in Older Rehabilitation Inpatients. JAMDA, 2014. 15(5): p. 348-354. 
159. Morandi A, et al., Tools to Detect Delirium Superimposed on Dementia: A Systematic 
Review. Journal of the American Geriatrics Society, 2012. 60(11): p. 2005-2013. 
160. Caplan LR and Ahmed I, Depression and neurological disease. Their distinction and 
association. General Hospital Psychiatry, 1992. 14(3): p. 177-85. 
161. House A, et al., Mood disorders in the year after first stroke. British Journal of 
Psychiatry, 1991. 158: p. 83-92. 
162. Minagawa H, et al., Psychiatric morbidity in terminally III cancer patients: A 
prospective study. Cancer, 1996. 78(5): p. 1131-1137. 
163. Kiloh LG, Pseudo Dementia. Acta Psychiatrica Scandinavica, 1961. 37(4): p. 336-
351. 
164. Jacobson SA, Delirium in the Elderly Psychiatric Clinics of North America, 1997. 
20(1): p. 91-110. 
165. Farrell K and Ganzini L, Misdiagnosing delirium as depression in medically ill elderly 
patients. . Archives of Internal Medicine, 1995. 155(22): p. 2459-2464. 
166. Meagher DJ, Delirium: optimising management. British Medical Journal, 2001. 
322(7279): p. 144-149. 
167. Wass S, et al., Delirium in the Elderly: a review. Oman Medical Journal, 2008. 23(3): 
p. 1-8. 
168. Andrew M, et al., Prevalence and outcomes of delirium in community and non-acute 
care settings in people without dementia: a report from the Canadian Study of Health 
and Aging. BMC Medicine, 2006. 4(1): p. 1-15. 
169. Clegg A, et al., Under-reporting of delirium in the NHS. Age and Ageing, 2011. 40(2): 
p. 283-286. 
170. Benbadis SR, et al., Acute confusion and stroke. Stroke, 1994. 25(1). 
171. Brust JC and Caplan LR, Agitation and delirium, in Stroke syndromes (2nd ed ). 
2001, Cambridge University Press; US: New York, NY. p. 222-231. 
214  
 
172. Koponen H, et al., Delirium among elderly persons admitted to a psychiatric hospital: 
clinical course during the acute stage and one-year follow-up. Acta Psychiatrica 
Scandinavica, 1989. 79(6): p. 579-85. 
173. Kumral E and Ozturk O, Delusional state following acute stroke. Neurology, 2004. 
62(1): p. 110-113. 
174. Schuurmans MJ, et al., Early recognition of delirium: review of the literature. Journal 
of Clinical Nursing, 2001. 10(6): p. 721-729. 
175. Sherman FT, Delirium: more common than stroke; it befuddles both clinicians and 
seniors. Geriatrics, 2002. 57(6): p. 5-6. 
176. Hallberg IR, Impact of Delirium on Professionals. Dementia and Geriatric Cognitive 
Disorders, 1999. 10(5): p. 420-425. 
177. Kishi Y and et al, Delirium: patient characteristics that predict a missed diagnosis at 
psychiatric consultation. General Hospital Psychiatry, 2007. 29(5): p. 442-445. 
178. Kishi Y, et al., Delirium in critical care unit patients admitted through an emergency 
room. General Hospital Psychiatry, 1995. 17(5): p. 371-379. 
179. Rosenbloom DA and Fick DM, Nurse/family caregiver intervention for delirium 
increases delirium knowledge and improves attitudes toward partnership. Geriatric 
Nursing, 2013. 
180. Yevchak A, et al., Managing delirium in the acute care setting: a pilot focus group 
study. International Journal of Older People Nursing, 2012. 7(2): p. 152-162. 
181. Silva RCGd, et al., Analysis of a health team's records and nurses' perceptions 
concerning signs and symptoms of delirium. Sci Elo Brazil, 2011. 19: p. 81-89. 
182. Collins N, et al., Detection of delirium in the acute hospital. Age and Ageing, 2010. 
39(1): p. 131-135. 
183. Van Rompaey B and et-al, The effect of earplugs during the night on the onset of 
delirium and sleep perception: a randomized controlled trial in intensive care patients. 
Critical Care, 2012. 16(R73): p. 1-11. 
184. Wahlund LO and Björlin GA, Delirium in Clinical Practice: Experiences from a 
Specialized Delirium Ward. Dementia and Geriatric Cognitive Disorders, 1999. 10(5): 
p. 389-392. 
185. Colombo R, et al., A reorientation strategy for reducing delirium in the critically ill. 
Results of an interventional study. Minerva Anestesiologica, 2012. 78(9): p. 1026-
1033. 
186. Mattoo SK, et al., Delirium in general practice. Indian Journal Medical Research, 
2010. 131: p. 387-398. 
187. Young J, et al., Systematic approaches to the prevention and management of 
patients with delirium. Journal of Psychosomatic Research, 2008. 65(3): p. 267-272. 
188. Bogardus ST, et al., The Effects of a Targeted Multicomponent Delirium Intervention 
on Postdischarge Outcomes for Hospitalized Older Adults. American Journal of 
Medicine, 2003 114: p. 383-390. 
189. Jose Tarazona-Santabalbina F, et al., Early interdisciplinary hospital intervention for 
elderly patients with hip fractures - functional outcome and mortality. Clinics, 2012. 
67(6): p. 547-555. 
190. Pitkala KH, et al., Multicomponent geriatric intervention for elderly inpatients with 
delirium: a randomized, controlled trial. Journals of Gerontology Series A: Biological 
Sciences & Medical Sciences, 2006. 61(2): p. 176-81. 
191. Rizzo JA, et al., Multicomponent Targeted Intervention to Prevent Delirium in 
Hospitalized Older Patients: What is the Economic Value? Medical Care, 2001. 
39(7): p. 740-752. 
215  
 
192. Rizzo JA, et al., Multicomponent Targeted Intervention to Prevent Delirium in 
Hospitalized Older Patients: What is the Economic Value? 2001. p. 740-752  
193. Goldberg S, et al., Care in specialist medical and mental health unit compared with 
standard care for older people with cognitive impairment admitted to general hospital: 
randomised controlled trial (NIHR TEAM trial). British Medical Journal, 2013. 347: p. 
1-13. 
194. Clegg A and Young JB, Which medications to avoid in people at risk of delirium: a 
systematic review. Age and Ageing, 2011. 40: p. 23-29. 
195. Friedman JI, et al., Pharmacological Treatments of Non-Substance-Withdrawal 
Delirium: A Systematic Review of Prospective Trials. The American Journal of 
Geriatric Psychiatry, 2014. 171(2): p. 151-159. 
196. Seitz DP, et al., Antipsychotics in the treatment of delirium: a systematic review. 
Journal of Clinical Psychiatry, 2007. 68(1): p. 11-21. 
197. Oldenbeuving AW, et al., A pilot study of rivastigmine in the treatment of delirium 
after stroke: A safe alternative. BMC Neurology, 2008. 8: p. 34. 
198. Royal-College-Of-Physicians and British-Geriatrics-Society, Number 6: The 
prevention, diagnosis and management of delirium in older people NATIONAL 
GUIDELINES, in Concise Guide to Good Practice: A series of evidence-based 
guidelines for clinical management, British Geriatrics Society Royal College Of 
Physicians, Editor. 2006. p. 1-20  
199. Ely EW, et al., Monitoring sedation status over time in ICU patients: the reliablity and 
validity of the Richmond Agitation Sedation Scale (RASS) JAMA, 2003. 289: p. 2983-
2991. 
200. Sessler C, et al., The Richmond Agitation-Sedation Scale: validity and reliablity in 
adult intensive care patients. American Journal of Respiratory and Critical Care 
Medicine, 2002. 166: p. 1338-1344. 
201. Lonergan E, et al., Benzodiazepines for delirium. 2009 
202. Boettger S and Breitbart W, Atypical antipsychotics in the management of delirium: a 
review of the empirical literature. Palliative and Supportive Care, 2005. 3(3): p. 227-
237. 
203. Lonergan E, et al., Antipsychotics for delirium. 2007 
204. Michauda L, et al., Delirium: Guidelines for general hospitals. Journal of 
Psychosomatic Research, 2007. 62: p. 371-383. 
205. Page VJ, et al., Effect of intravenous haloperidol on the duration of delirium and 
coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-
controlled trial. The Lancet Respiratory Medicine, 2014. 1(7): p. 515-523. 
206. Wang W, et al., Haloperidol prophylaxis decreases delirium incidence in elderly 
patients after noncardiac surgery: a randomized controlled trial*. Critical Care 
Medicine, 2012. 40(3): p. 731-9. 
207. Grover S, et al., Comparative efficacy study of haloperidol, olanzapine and 
risperidone in delirium. Journal of Psychosomatic Research, 2011. 71(4): p. 277-81. 
208. Campbell N, et al., Pharmacological management of delirium in hospitalized adults--a 
systematic evidence review. J Gen Intern Med, 2009. 24(7): p. 848-53. 
209. Caplan GA, et al., Does home treatment affect delirium? A randomised controlled 
trial of rehabilitation of elderly and care at home or usual treatment (The REACH-
OUT trial). Age and Ageing, 2006. 35(1): p. 53-60. 
210. Jones C, et al., Memory, delusions, and the development of acute posttraumatic 
stress disorder-related symptoms after intensive care. Critical Care Medicine, 2001. 
29(3): p. 573-580. 
216  
 
211. Davis DHJ, et al., Delirium is a strong risk factor for dementia in the oldest-old: a 
population-based cohort study. Brain, 2012. 135(9): p. 2809-2816. 
212. Aldemir M, et al., Predisposing factors for delirium in the surgical intensive care unit. 
Critical Care, 2001. 5(5): p. 265 - 270. 
213. Nakase-Thompson R, et al., Acute confusion following traumatic brain injury. Brain 
Injury, 2004. 18(2): p. 131-42. 
214. Ferro JM, Hyperacute cognitive stroke syndromes. Journal of Neurology, 2001. 
248(10): p. 841-849. 
215. Henon H and Leys D, Delirium and confusional state in stroke patients, in The 
behavioral and cognitive neurology of stroke. 2007, Cambridge University Press; US: 
New York, NY. p. 489-509. 
216. Paciaroni M, et al., Manifestations of Stroke, in Manifestations of Stroke, M. 
Paciaroni, G. Agnelli, and V. Bogousslavsky J. Caso, Editors. 2012, KARGER: 
Postfach, Ch-4009 Basel, Switzerland. 
217. Robinson RG, Neuropsychiatric disorders following stroke. Canadian Journal of 
Psychiatry - Revue Canadienne de Psychiatrie, 2010. 55(6): p. 339-40. 
218. Sinanovic O, Neuropsychology of acute stroke. Psychiatria Danubina, 2010. 22(2): p. 
278-81. 
219. Okamoto Y, et al., Trazodone in the treatment of delirium. J Clin Psychopharmacol, 
1999. 19(3): p. 280-2. 
220. Nakamura J, et al., The effect of mianserin hydrochloride on delirium. Human 
Psychopharmacology: Clinical and Experimental, 1995. 10(4): p. 289-297. 
221. Lucidarme O, et al., Nicotine withdrawal and agitation in ventilated critically ill 
patients. Critical Care, 2010. 14(2): p. R58. 
222. Chong MS, et al., Bright light therapy as part of a multicomponent management 
program improves sleep and functional outcomes in delirious older hospitalized 
adults. Clinical Interventions in Aging, 2013. 8: p. 565-72. 
223. McCaffrey R and Locsin R, The effect of music listening on acute confusion and 
delirium in elders undergoing elective hip and knee surgery. Journal of Clinical 
Nursing, 2004. 13: p. 91-96. 
224. Sarkamo T, et al., Music listening enhances cognitive recovery and mood after 
middle cerebral artery stroke. Brain: A Journal of Neurology, 2008. 131(3): p. 866-
876. 
225. Kakuma R, et al., Delirium in Older Emergency Department Patients Discharged 
Home: Effect on Survival. Journal of the American Geriatrics Society, 2003. 51(4): p. 
443-450. 
226. McManus JT, et al., Association of delirium post-stroke with early and late mortality. 
Age and Ageing, 2011. 40(2): p. 271-274. 
227. Almeida OP and Xiao J, Mortality associated with incident mental health disorder 
after stroke. Australian and New Zealand Journal of Psychiatry, 2007. 41(3): p. 274-
281. 
228. Kaplan D, Delirium in elderly stroke patients linked to mortality. Patient Care for the 
Nurse Practitioner, 2006: p. 2. 
229. Labib N, et al., Severely injured geriatric population: Morbidity, mortality, and risk 
factors. Journal of Trauma - Injury, Infection and Critical Care, 2011. 71(6): p. 1908-
1914. 
230. Witlox J, et al., Delirium in elderly patients and the risk of postdischarge mortality, 
institutionalization, and dementia: a meta-analysis. JAMA, 2010. 304(4): p. 443-51. 
231. Arinzon Z, et al., Delirium in long-term care setting: Indicator to severe morbidity. 
Archives of Gerontology and Geriatrics, 2011. 52(3): p. 270-275. 
217  
 
232. Eeles EMP, et al., Hospital use, institutionalisation and mortality associated with 
delirium. Age and Ageing, 2010. 39(4): p. 470-475. 
233. Bednarik J, et al., Delirium in stroke and surgical patients. European Journal of 
Neurology, 2008. 15: p. 287-287. 
234. Bokeriia LA, et al., Postoperative delirium in cardiac operations: microembolic load is 
an important factor. Annals of Thoracic Surgery, 2009. 88(1): p. 349-501. 
235. O'Brien D, Acute postoperative delirium: Definitions, incidence, recognition, and 
interventions. Journal of PeriAnesthesia Nursing, 2002. 17(6): p. 384-392. 
236. Dieckelmann A, et al., Acute Postoperative Delirium - Prospective-Study and 
Multivariate-Analysis of Risk-Factors. Chirurg, 1989. 60(7): p. 470-474. 
237. Rudolph JL and Marcantonio ER, Postoperative Delirium: Acute Change with Long-
Term Implications. Anesthesia and analgesia, 2011. 112(5): p. 1202-1211. 
238. Rahkonen T, et al., Delirium in the non-demented oldest old in the general 
population: risk factors and prognosis. International Journal of Geriatric Psychiatry, 
2001. 16(4): p. 415-21. 
239. Rahkonen T, et al., Delirium in Elderly People Without Severe Predisposing 
Disorders: Etiology and 1-Year Prognosis After Discharge. International 
Psychogeriatrics, 2000. 12(4): p. 473-481. 
240. Marcantonio ER, et al., Delirium Symptoms in Post-Acute Care: Prevalent, 
Persistent, and Associated with Poor Functional Recovery. Journal of the American 
Geriatrics Society, 2003. 51(1): p. 4-9. 
241. Fong TG, et al., Delirium accelerates cognitive decline in Alzheimer disease. 
Neurology, 2009. 72(18): p. 1570-5. 
242. Inouye SK, et al., Delirium in elderly people. The Lancet, 2014. 383(9920): p. 911-
922. 
243. van Rijsbergen MWA, et al., Delirium in acute stroke: A predictor of subsequent 
cognitive impairment? A 2 year follow up. Journal of the Neurological Sciences, 
2011. 306: p. 138-142. 
244. McCusker J, et al., Does delirium increase hospital stay? Journal of the American 
Geriatrics Society, 2003. 51(11): p. 1539-1546. 
245. Jones RN, et al., Aging, Brain Disease, and Reserve: Implications for Delirium. 
American Journal of Geriatric Psychiatry, 2010. 18(2): p. 117-127. 
246. Fann JR, et al., Impact of Delirium on Cognition, Distress, and Health-Related Quality 
of Life After Hematopoietic Stem-Cell Transplantation. 2007. p. 1223-1231  
247. Leslie DL and Inouye SK, The importance of delirium: economic and societal costs. 
Journal of American Geriatrics Society, 2011. 59 (Suppl 2): p. S241-3. 
248. Hex N, et al., Estimating the current and future costs of Type 1 and Type 2 diabetes 
in the UK, including direct health costs and indirect societal and productivity costs. 
Diabetes Medicine, 2012. 29(7): p. 855-862. 
249. Lawrence TM, et al., The current hospital costs of treating hip fractures. Injury, 2005. 
36(1): p. 88-91; discussion 92. 
250. Scuffham P, et al., Incidence and costs of unintentional falls in older people in the 
United Kingdom. Journal of Epidemiology and Community Health, 2003. 57(9): p. 
740-744. 
251. Adamis D, et al., Capacity, consent, and selection bias in a study of delirium. Journal 
of Medical Ethics, 2005. 31: p. 137-143. 
252. Holt R, et al., The ethics of consent in delirium studies. Journal of Psychosomatic 
Research, 2008. 65(3): p. 283-287. 
218  
 
253. The-British-Psychological-Society, Conducting research with people not having the 
capacity to consent to their participation: A practical guide for researchers, in Guides 
for Researchers. 2008, The British Psychological Society. p. 1-63  
254. Towfighi A and Saver JL, Stroke Declines From Third to Fourth Leading Cause of 
Death in the United States: Historical Perspective and Challenges Ahead. Stroke, 
2011. 42(8): p. 2351-2355. 
255. WHO, Cerebrovascular Disorders, in Offset Publications, World Health Organization 
(WHO), Editor. 1978 
256. WHO, WHO STEPS Stroke Manual: The WHO STEPwise approach to stroke 
surveillance World Health Organisation (WHO), Editor. 2005 p. 1-96  
257. Truelsen T, et al., Stroke incidence and prevalence in Europe: a review of available 
data. . Europeon Journal of Neurology, 2006. 13: p. 581-598. 
258. Truelsen T, et al., The global burden of cerebrovascular disease 2000. p. 1-65  
259. Di Carlo A, Human and economic burden of stroke. Age and Ageing, 2009. 38: p. 4-
5. 
260. Laloux P, Cost of Acute Stroke: A Review. Acta Neurologica Belgica, 2003. 103: p. 
71-77. 
261. Evers SMAA, et al., International Comparison of Stroke Cost Studies. Stroke, 2004. 
35(5): p. 1209-1215. 
262. Johnston SC, et al., Global variation in stroke burden and mortality: estimates from 
monitoring, surveillance, and modelling. The Lancet Neurology, 2009. 8(4): p. 345-
354. 
263. Wolfe CDA, et al., Variations in Stroke Incidence and Survival in 3 Areas of Europe. 
Stroke, 2000. 31(9): p. 2074-2079. 
264. Gouveia C, et al., NIH Disease Funding Levels and Burden of Disease. PLoS ONE, 
2011. 6(2): p. e16837. 
265. Greenlund KJ, et al., Low Public Recognition of Major Stroke Symptoms. American 
Journal of Preventive Medicine, 2003. 25(4): p. 315-9. 
266. Dombrowski SU, et al., The impact of the UK 'Act FAST' stroke awareness 
campaign: content analysis of patients, witness and primary care clinicians' 
perceptions. BMC Public Health, 2013. 13: p. 915. 
267. Nguyen-Huynh MN and Johnston SC, Is hospitalization after TIA cost-effective on the 
basis of treatment with tPA? Neurology, 2005. 65(11): p. 1799-1801. 
268. Pendlebury ST, et al., Acute reversible cognitive impairment after TIA and minor 
stroke: A population-based study. Cerebrovascular Diseases, 2009. 27: p. 73. 
269. Pendlebury ST, et al., Transient cognitive impairment in TIA and minor stroke. 
Stroke, 2011. 42(11): p. 3116-21. 
270. NICE, Clinical Guideline 68 Stroke in National Institute for Health and Clinical 
Excellence (NICE) Guidelines National Institute for Health and Clinical Excellence 
(NICE), Editor. 1999 
271. NICE, Stroke: Diagnosis and initial management of acute stroke and transient 
ischaemic attack (TIA) in NICE clinical guidance 68 2008. p. 1-37  
272. Bassi P and Lattuada P, The stroke in an emergency: the grey areas. Neurological 
Sciences, 2006. 27 p. 57-8. 
273. Lioutas VA, et al., Diagnosis and misdiagnosis of cerebrovascular disease. Current 
Treatment Options in Cardiovascular Medicine, 2013. 15(3): p. 276-287. 
274. O'Brien J, et al., Cerebrovascular Disease, Cognitive Impairment and Dementia. 
2004: Martin Dunitz. 
219  
 
275. Adams HP, et al., Classification of subtype of acute ischemic stroke. Definitions for 
use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke 
Treatment. Stroke, 1993. 24(1): p. 35-41. 
276. Ferro JM, et al., Update on subarachnoid haemorrhage. Journal of Neurology, 2008. 
255(4): p. 465-479. 
277. Fernandes PM, et al., Strokes: mimics and chameleons. Practical Neurology, 2013. 
13(1): p. 21-28. 
278. Nor AM and Ford GA, Misdiagnosis of stroke. Expert Review of Neurotherapeutics, 
2007. 7(8): p. 989-1001. 
279. Ryan D and Harbison J, Stroke as a medical emergency in older people. Reviews in 
Clinical Gerontology, 2011. 21(1): p. 45-54. 
280. Bamford J, et al., Classification and natural history of clinically identifiable subtypes 
of cerebral infarction. The Lancet, 1991. 337(8756): p. 1521-1526. 
281. The-Stroke-Association, Stroke Statistics, in Stroke Statistics by The Stroke 
Association, The Stroke Association, Editor. 2013 
282. Bamford J, et al., A prospective study of acute cerebrovascular disease in the 
community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, 
demography and incident cases of first-ever stroke. Journal of Neurology, 
Neurosurgery and Psychiatry, 1988. 51(11): p. 1373-1380. 
283. Rodgers H, et al., Risk Factors for First-Ever Stroke in Older People in the North East 
of England: A Population-Based Study. Stroke, 2004. 35: p. 7-11. 
284. Wolfe CDA, The impact of stroke. British Medical Bulletin: Oxford Journals, 2000. 
56(2): p. 275-286. 
285. Department-of-Health, National service framework: older people, in Guidance 
Department of Health, Editor. 2001, www.gov.uk/government/publications 
286. Sudlow C and Warlow C, First-ever stroke incidence. The Lancet, 1998. 351(9119): 
p. 1892. 
287. Hankey GJ and Warlow CP, Treatment and secondary prevention of stroke: 
evidence, costs, and effects on individuals and populations. The Lancet, 1999. 
354(9188): p. 1457-1463. 
288. Office-of-Population-Censuses-and-Surveys, Morbidity Statistics from General 
Practice. Fourth national study Office of Population Censuses and Surveys (OPCS), 
Editor. 1991-1992 
289. Baker K, et al., Outcome Measurement in Stroke: A Scale Selection Strategy. Stroke, 
2011. 42(6): p. 1787-1794. 
290. Duncan PW, et al., Outcome Measures in Acute Stroke Trials: A Systematic Review 
and Some Recommendations to Improve Practice. Stroke, 2003. 31: p. 1429 - 1438. 
291. Carroll K, Stroke incidence and risk factors in a population based prospective cohort 
study, in Health Statistics Quarterly: Winter 2001, National Statistics, Editor. 2001 
292. Kleindorfer D, The bad news: stroke incidence is stable. The Lancet Neurology, 
2007. 6(6): p. 470-471. 
293. Bonita R, et al., Stroke incidence and case fatality in Australasia. A comparison of the 
Auckland and Perth population-based stroke registers. Stroke, 1994. 25(3): p. 552-7. 
294. Kolominsky-Rabas PL, et al., A prospective community-based study of stroke in 
Germany--the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, 
and 12 months. Stroke, 1998. 29(12): p. 2501-6. 
295. Lovelock CE, et al., Change in incidence and aetiology of intracerebral haemorrhage 
in Oxfordshire, UK, between 1981 and 2006: a population-based study. The Lancet 
Neurology, 2007. 6(6): p. 487-493. 
220  
 
296. Rothwell PM, et al., Change in stroke incidence, mortality, case-fatality, severity, and 
risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). The 
Lancet, 2004. 363(9425): p. 1925-1933. 
297. Wasay M, et al., Stroke in South Asian countries. Nature Reviews Neurology, 2014. 
10: p. 135-143. 
298. Sudlow CL and Warlow CP, Comparing stroke incidence worldwide: what makes 
studies comparable? Stroke, 1996. 27(3): p. 550-8. 
299. Sudlow CLM and Warlow CP, Comparable Studies of the Incidence of Stroke and its 
Pathological Types: Results From an International Collaboration. Stroke, 1997. 28(3): 
p. 491-499. 
300. Truelsen T, et al., Standard method for developing stroke registers in low-income and 
middle-income countries: experiences from a feasibility study of a stepwise approach 
to stroke surveillance (STEPS Stroke). Lancet Neurol, 2007. 6(2): p. 134-9. 
301. Quinn TJ, et al., Functional outcome measures in contemporary stroke trials. 
International Journal of Stroke, 2009. 4(3): p. 200-5. 
302. Salter K, et al., Review 21. Outcome Measures in Stroke Rehabilitation 
http://www.ebrsr.com/uploads/Outcome-Assessment-SREBR-13.pdf, in The 
Evidence-Based Review of Stroke Rehabilitation (EBRSR) reviews current practices 
in stroke rehabilitation. , EBRSR, Editor. 2010 London, Ontario,Canada. p. 1 - 126  
303. Gorelick PB, et al., Prevention of a first stroke: A review of guidelines and a 
multidisciplinary consensus statement from the national stroke association. JAMA, 
1999. 281(12): p. 1112-1120. 
304. Javed MA, et al., Risk Factors In Stroke. Pakistan Journal of Neurology, 1998. 4(1): 
p. 55-8. 
305. Kokotailo RA and Hill MD, Coding of Stroke and Stroke Risk Factors Using 
International Classification of Diseases, Revisions 9 and 10 Stroke, 2005 36: p. 
1776-1781. 
306. Sacco RL, et al., Risk Factors Stroke, 1997. 28: p. 1507-1517. 
307. Vemmos K, et al., Stroke aetiology and predictors of outcome in patients with heart 
failure and acute stroke: a 10-year follow-up study. European Journal of Heart 
Failure, 2012. 14: p. 211-218. 
308. Vohra EA, et al., Aetiology and Prognostic Factors of Patients admitted for Stroke. 
Journal of Pakistan Medical Association, 2000. 50: p. 234-241. 
309. Lloyd-Jones D, et al., Heart disease and stroke statistics--2010 update: a report from 
the American Heart Association. Circulation, 2010. 121(7): p. e46-e215. 
310. Roger VL, et al., Heart disease and stroke statistics--2011 update: a report from the 
American Heart Association. Circulation, 2011. 123(4): p. e18-e209. 
311. Nakayama H, et al., The influence of age on stroke outcome. The Copenhagen 
Stroke Study. Stroke, 1994. 25(4): p. 808-13. 
312. Kelly-Hayes M, et al., The influence of gender and age on disability following 
ischemic stroke: the Framingham study. Journal of Stroke and Cerebrovascular 
Diseases, 2003. 12(3): p. 119-126. 
313. Ayala C, et al., Sex Differences in US Mortality Rates for Stroke and Stroke Subtypes 
by Race/Ethnicity and Age, 1995-1998. Stroke, 2002. 33(5): p. 1197-1201. 
314. Pearson TA, et al., AHA Guidelines for Primary Prevention of Cardiovascular 
Disease and Stroke: 2002 Update. Consensus Panel Guide to Comprehensive Risk 
Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular 
Diseases. Circulation, 2002. 106: p. 388-391. 
221  
 
315. Law MR, et al., Quantifying effect of statins on low density lipoprotein cholesterol, 
ischaemic heart disease, and stroke: systematic review and meta-analysis. British 
Medical Journal, 2003. 326(7404): p. 1423. 
316. Wolf PA, et al., Atrial fibrillation as an independent risk factor for stroke: the 
Framingham Study. Stroke, 1991. 22(8): p. 983-8. 
317. North-American-Symptomatic-Carotid-Endarterectomy-Trial-Collaborators, Beneficial 
effect of carotid endarterectomy in symptomatic patients with high-grade carotid 
stenosis. New England Journal of Medicine, 1991. 325(7): p. 445-53. 
318. Biller J and Love BB, Diabetes and stroke. Medical Clinics of North America, 1993. 
77(1): p. 95-110. 
319. Spence JD, Treating Hypertension in Acute Ischemic Stroke. Hypertension, 2009. 54: 
p. 702. 
320. Huxley RR, et al., Risk of Fatal Stroke in Patients With Treated Familial 
Hypercholesterolemia; A Prospective Registry Study Stroke, 2003. 34(1): p. 22. 
321. Lewis A and Segal A, Hyperlipidemia and primary prevention of stroke: does risk 
factor identification and reduction really work? Current Atherosclerosis Reports, 
2010. 12(4): p. 225-9. 
322. Powars D, et al., The natural history of stroke in sickle cell disease. The American 
Journal of Medicine, 1978. 65(3): p. 461-471. 
323. Wolf PA, et al., Preventing Ischemic Stroke in Patients With Prior Stroke and 
Transient Ischemic Attack: A Statement for Healthcare Professionals From the 
Stroke Council of the American Heart Association. Stroke, 1999. 30(9): p. 1991-1994. 
324. Bonita R, et al., Passive Smoking As Well As Active Smoking Increases the Risk of 
Acute Stroke. Tobacco Control, 1999. 8: p. 156-160. 
325. Carole LH, et al., Alcohol consumption and mortality from all causes, coronary heart 
disease, and stroke: results from a prospective cohort study of Scottish men with 21 
years of follow up. British Medical Journal, 1999. 318(7200): p. 1725-1729. 
326. Fonseca AC and Ferro JM, Drug abuse and stroke. Curr Neurol Neurosci Rep, 2013. 
13(2): p. 325. 
327. Joshipura KJ, et al., Fruit and vegetable intake in relation to risk of ischemic stroke. 
JAMA, 1999. 282(13): p. 1233-1239. 
328. Lee CD, et al., Physical activity and stroke risk: a meta-analysis. Stroke, 2003. 
34(10): p. 2475-81. 
329. Shinton R, Lifelong exposures and the potential for stroke prevention: the 
contribution of cigarette smoking, exercise, and body fat. Journal of Epidemiology 
and Community Health, 1997. 51(2): p. 138-143. 
330. Cox AM, et al., Socioeconomic status and stroke. The Lancet Neurology, 2006. 5(2): 
p. 181-188. 
331. National-Audit-Office, Reducing Brain Damage: Faster access to better stroke care, 
in National Audit Office Reports Department Of Health, Editor. 2005: London. p. 1-11  
332. Joutel A, et al., Notch3 mutations in CADASIL, a hereditary adult-onset condition 
causing stroke and dementia. Nature, 1996. 383: p. 707-710. 
333. Judith AS, et al., Ethnic differences in incidence of stroke: prospective study with 
stroke register. British Medical Journal, 1999. 318(7189): p. 967-971. 
334. Wolfe C, et al., Incidence and case fatality rates of stroke subtypes in a multiethnic 
population: the South London Stroke Register. Journal of Neurology, Neurosurgery & 
Psychiatry, 2002. 72(2): p. 211-216. 
335. Stewart J, et al., Ethnic differences in incidence of stroke: prospective study with 
stroke register. BMJ, 1999. 318(7189): p. 967-971. 
222  
 
336. Cushman M, et al., Estimated 10-year stroke risk by region and race in the United 
States: geographic and racial differences in stroke risk. Annals of Neurology, 2008. 
64(5): p. 507-13. 
337. Obisesan TO, et al., Geographic Variation in Stroke Risk in the United States: 
Region, Urbanization, and Hypertension in the Third National Health and Nutrition 
Examination Survey. Stroke, 2000. 31(1): p. 19-25. 
338. Seo SR, et al., The Incidence of Stroke by Socioeconomic Status, Age, Sex, and 
Stroke Subtype: A Nationwide Study in Korea. Journal of Preventative Medicine and 
Public Health, 2014. 47(2): p. 104-112. 
339. Grimaud O, et al., Incidence of ischaemic stroke according to income level among 
older people: the 3C study. Age and Ageing, 2011. 40(1): p. 116-121. 
340. Burn J, et al., Long-term risk of recurrent stroke after a first-ever stroke. The 
Oxfordshire Community Stroke Project. Stroke, 1994. 25: p. 333-337. 
341. Sun Y, et al., 5-year survival and rehospitalization due to stroke recurrence among 
patients with hemorrhagic or ischemic strokes in Singapore. BMC Neurology, 2013. 
13: p. 133-141. 
342. Redfern J, et al., Stop Stroke: Development of an innovative intervention to improve 
risk factor management after stroke. Patient Education and Counseling, 2008. 72(2): 
p. 201-209. 
343. Furie KL, et al., Guidelines for the Prevention of Stroke in Patients With Stroke or 
Transient Ischemic Attack: A Guideline for Healthcare Professionals From the 
American Heart Association/American Stroke Association. Stroke, 2011. 42(1): p. 
227-276. 
344. Gage BF, et al., Validation of clinical classfication schemes for predicting stroke: 
Results From the National Registry of Atrial Fibrillation. JAMA, 2001. 285: p. 2864-
2870. 
345. Yamori Y, et al., Nutritional factors for stroke and major cardiovascular diseases: 
international epidemiological comparison of dietary prevention. Health Reports, 1994. 
6(1): p. 22-7. 
346. Pittilo RM, Cigarette smoking, endothelial injury and cardiovascular disease. 
International Journal of Experimental Pathology, 2000. 81(4): p. 219-230. 
347. Brust JC and Richter RW, Stroke associated with addiction to heroin. Journal of 
Neurology, Neurosurgery and Psychiatry, 1976. 39(2): p. 194-199. 
348. Westover AN, et al., Stroke in young adults who abuse amphetamines or cocaine: a 
population-based study of hospitalized patients. Archives of General Psychiatry, 
2007. 64(4): p. 495-502. 
349. Bousser MG and Kittner SJ, Oral contraceptives and stroke. Cephalalgia, 2000. 
20(3): p. 183-189. 
350. McNeill A, How accurate are primary care referral letters for presumed acute stroke? 
Scottish Medical Journal, 2008. 53(4): p. 11-2. 
351. Hand PJ, et al., Interobserver agreement for the bedside clinical assessment of 
suspected stroke. Stroke, 2006. 37(3): p. 776-80. 
352. Mulley GP, Practical Management of Stroke. 1985: Croom Helm. 
353. Clarke B, et al., Stroke Mimics within the London Hyper-acute Stroke Unit Model of 
Care. International Journal of Stroke, 2011. 6: p. 31. 
354. Alonge O, et al., Stroke mimics in a district general hospital Hyper Acute Stroke Unit. 
International Journal of Stroke, 2013. 8: p. 1-2. 
355. Saver JL and Altman H, Relationship Between Neurologic Deficit Severity and Final 
Functional Outcome Shifts and Strengthens During First Hours After Onset. Stroke, 
2012. 43: p. Page 1537-1541. 
223  
 
356. Chalela J, et al., Magnetic resonance imaging and computed tomography in 
emergency assessment of patients with suspected acute stroke: a prospective 
comparison. The Lancet, 2007. 369(9558): p. 293-298. 
357. Davis KR, et al., Computed tomography of cerebral infarction: hemorrhagic, contrast 
enhancement, and time of appearance. Computerized Tomography, 1977. 1(1): p. 
71-86. 
358. Hardy JE and Brennan N, Computerized tomography of the brain for elderly patients 
presenting to the emergency department with acute confusion. Emergency Medicine 
Australasia, 2008. 20(5): p. 420-424. 
359. O'Neill D, et al., Developing specialist healthcare for older people: a challenge for the 
European Union. Journal of Nutrition, Health and Aging, 2004. 8(2): p. 109-112. 
360. O'Connor SE, The Development of Stroke Units: The British Experience. 
Rehabilitation Nursing, 1994. 19(4): p. 244-247. 
361. Jorgensen HS, et al., The Effect of a Stroke Unit: Reductions in Mortality, Discharge 
Rate to Nursing Home, Length of Hospital Stay, and Cost: A Community-Based 
Study. Stroke, 1995. 26(7): p. 1178-1182. 
362. Stroke-Unit-Trialists-Collaboration, How Do Stroke Units Improve Patient 
Outcomes?: A Collaborative Systematic Review of the Randomized Trials. Stroke, 
1997. 28(11): p. 2139-2144. 
363. Forster A, et al., Rehabilitation for older people in long-term care. 2009 
364. Langhorne P, et al., Do stroke units save lives? The Lancet, 1993. 342(8868): p. 395-
398. 
365. Canavan M, et al., Development of acute stroke units - a cost effective 
reconfiguration which benefits patients. QJM: An International Journal of Medicine, 
2012. 105(1): p. 99-102. 
366. Lannon R, et al., An audit of the impact of a stroke unit in an acute teaching hospital. 
Irish Journal of Medical Science, 2011. 180(1): p. 37-40. 
367. Saka O, et al., Cost-Effectiveness of Stroke Unit Care Followed by Early Supported 
Discharge. Stroke, 2009. 40(1): p. 24-29. 
368. Langhorne P, et al., Early supported discharge services for stroke patients: a meta-
analysis of individual patients' data. The Lancet, 2005 365(9458): p. 501-506. 
369. Rabadi MH, et al., Cognitively Impaired Stroke Patients Do Benefit From Admission 
to an Acute Rehabilitation Unit. Archives of Physical Medicine and Rehabilitation, 
2008. 89(3): p. 441-448. 
370. Steultjens EMJ, et al., Occupational Therapy for Stroke Patients: A Systematic 
Review. Stroke, 2003. 34(3): p. 676-687. 
371. Tilling K, et al., A New Method for Predicting Recovery After Stroke. Stroke, 2001. 
32(12): p. 2867-2873. 
372. Lukman Femi O and Mansur N, Factors associated with death and predictors of one-
month mortality from stroke in Kano, Northwestern Nigeria. Journal of Neurosciences 
in Rural Practice, 2013. 4(Supplement 1): p. S56-S61. 
373. Langhorne P, et al., Stroke rehabilitation. The Lancet, 2011. 377(9778): p. 14-20. 
374. Langhorne P, et al., Medical complications after stroke: a multicenter study. Stroke, 
2000. 31(6): p. 1223-9. 
375. Ballard C, et al., Prospective Follow-Up Study Between 3 and 15 Months After 
Stroke: Improvements and Decline in Cognitive Function Among Dementia-Free 
Stroke Survivors >75 Years of Age. Stroke, 2003. 34(10): p. 2440-2444. 
376. Censori B, et al., Dementia After First Stroke. Stroke, 1996. 27(7): p. 1205-1210. 
377. Hackett ML, et al., Management of Depression After Stroke: A Systematic Review of 
Pharmacological Therapies. Stroke, 2005. 36(5): p. 1092-1097. 
224  
 
378. Henon H, et al., Preexisting Dementia in Stroke Patients: Baseline Frequency, 
Associated Factors, and Outcome. Stroke, 1997. 28(12): p. 2429-2436. 
379. Ivan C, et al., Dementia after stroke: the Framingham Study. Stroke, 2004. 35(6): p. 
1264-1268. 
380. Schut LJ, Dementia following stroke. Clinical Geriatric Medicine, 1988. 4(4): p. 767-
84. 
381. Tang WK, et al., Impact of applying NINDS-AIREN criteria of probable vascular 
dementia to clinical and radiological characteristics of a stroke cohort with dementia. 
Cerebrovascular Diseases, 2004. 18(2): p. 98-103. 
382. Burvill PW, et al., Prevalence of depression after stroke: the Perth Community Stroke 
Study. British Journal of Psychiatry, 1995. 166(3): p. 320-7. 
383. House A, et al., Mortality at 12 and 24 Months After Stroke May Be Associated With 
Depressive Symptoms at 1 Month. Stroke, 2001. 32: p. 696-701. 
384. Kishi Y, et al., The validity of observed depression as a criteria for mood disorders in 
patients with acute stroke. Journal of Affective Disorders, 1996. 40(1-2): p. 53-60. 
385. Ng KC, et al., A study of post-stroke depression in a rehabilitative center. Acta 
Psychiatrica Scandinavica, 1995. 92(1): p. 75-9. 
386. Schwartz JA, et al., Depression in stroke rehabilitation  Biological Psychiatry, 1993. 
33(10): p. 694-699. 
387. Graham NS, et al., Incidence and associations of poststroke epilepsy: the 
prospective South London Stroke Register. Stroke, 2013. 44(3): p. 605-11. 
388. Bladin CF, et al., Seizures after stroke: A prospective multicenter study. Archives of 
Neurology, 2000. 57(11): p. 1617-1622. 
389. Tutuarima JA, et al., Risk factors for falls of hospitalized stroke patients. Stroke, 
1997. 28(2): p. 297-301. 
390. Glader E-L, et al., Poststroke Fatigue: A 2-Year Follow-Up Study of Stroke Patients 
in Sweden. Stroke, 2002. 33(5): p. 1327-1333. 
391. Garcia-Albea E, Confusional State and Cerebral Infarcts. Postgraduate Medical 
Journal, 1989. 65(763): p. 286-290. 
392. del Ser T, et al., Evolution of Cognitive Impairment After Stroke and Risk Factors for 
Delayed Progression. Stroke, 2005. 36(12): p. 2670-2675. 
393. Douiri A, et al., Prevalence of poststroke cognitive impairment: South London Stroke 
Register 1995-2010. Stroke, 2013. 44(1): p. 138-45. 
394. Lincoln NB and Tinson DJ, The Relation between Subjective and Objective Memory 
Impairment after Stroke. British Journal of Clinical Psychology, 1989. 28: p. 61-65. 
395. Myint PK, et al., Cognition, continence and transfer status at the time of discharge 
from an acute hospital setting and their associations with an unfavourable discharge 
outcome after stroke. Gerontology, 2008. 54(4): p. 202-209. 
396. Beckson M and Cummings JL, Neuropsychiatric aspects of stroke. International 
Journal of Psychiatry in Medicine, 1991. 21(1): p. 1-15. 
397. Bogousslavsky J, William Feinberg Lecture 2002: Emotions, mood, and behavior 
after stroke. Stroke, 2003. 34(4): p. 1046-1050. 
398. Kishi Y, et al., Suicidal Plans in Patients with Acute Stroke. Journal of Nervous and 
Mental Disease, 1996. 184(5): p. 274-280. 
399. Morris PL, et al., The relationship between risk factors for affective disorder and 
poststroke depression in hospitalised stroke patients. Australian and New Zealand 
Journal of Psychiatry, 1992. 26(2): p. 208-17. 
400. Parikh RM, et al., A two year longitudinal study of poststroke mood disorders: 
prognostic factors related to one and two year outcome. International Journal of 
Psychiatry in Medicine, 1988. 18(1): p. 45-56. 
225  
 
401. Vickery CD, et al., Self-esteem in an acute stroke rehabilitation sample: a control 
group comparison. Clinical Rehabilitation, 2008. 22(2): p. 179-187. 
402. Vickery CD, et al., Self-Esteem Level and Stability, Admission Functional Status, and 
Depressive Symptoms in Acute Inpatient Stroke Rehabilitation. Rehabilitation 
Psychology, 2009. 54(4): p. 432-439. 
403. Vickery CD, et al., The Association of Level and Stability of Self-Esteem and 
Depressive Symptoms in the Acute Inpatient Stroke Rehabilitation Setting. 
Rehabilitation Psychology, 2008. 53(2): p. 171-179. 
404. Vickery CD, et al., The relationship between self-esteem and functional outcome in 
the acute stroke rehabilitation setting. Rehabilitation Psychology, 2008. 53(1): p. 101-
109. 
405. Jongbloed L, Prediction of function after stroke: a critical review. Stroke, 1986. 17: p. 
765 - 776. 
406. Murray J, et al., Measuring outcomes in the longer term after a stroke. Clinical 
Rehabilitation, 2009. 23(10): p. 918-921. 
407. Feigin VL, et al., Stroke epidemiology: a review of population-based studies of 
incidence, prevalence, and case-fatality in the late 20th century. The Lancet 
Neurology, 2003. 2(1): p. 43-53. 
408. Feigin VL, et al., Worldwide stroke incidence and early case fatality reported in 56 
population-based studies: a systematic review. The Lancet Neurology, 2009. 8(4): p. 
355-369. 
409. O'Donnell M and Yusuf S, Tackling the global burden of stroke: the need for large-
scale international studies. The Lancet Neurology, 2009. 8(4): p. 306-307. 
410. Di Fabio RP, Reliability and Validity of Functional Assessment in Patients with 
Stroke. Neurorehabilitation and Neural Repair, 1990. 4(3): p. 145-152. 
411. Toyoda K, Epidemiology and Registry Studies of Stroke in Japan. Journal of 
STROKE, 2013. 15(1): p. 21-26. 
412. Appelros P, et al., Case ascertainment in stroke studies: the risk of selection bias. 
Acta Neurol Scand, 2003. 107(2): p. 145-9. 
413. Hobart JC, et al., Effect sizes can be misleading: is it time to change the way we 
measure change? Journal of Neurology, Neurosurgery and Psychiatry, 2009. 81(9): 
p. 1044-8. 
414. MacLullich AMJ, et al., Delirium and long-term cognitive impairment. International 
Review of Psychiatry, 2009. 21(1): p. 30-42. 
415. Franco K, et al., The Cost of Delirium in the Surgical Patient Psychosomatics, 2001. 
42: p. 68-73. 
416. Mitasova A, et al., Incidence and Risk Factors of Postoperative Delirium. Ceska a 
Slovenska Neurologie a Neurochirurgie, 2012. 75(5): p. 574-580. 
417. Edlund A, et al., Delirium in Older Patients Admitted to General Internal Medicine. 
Journal of Geriatric Psychiatry and Neurology, 2006. 19(2): p. 83-90. 
418. Kolbeinsson H and Jonsson A, Delirium and dementia in acute medical admissions 
of elderly patients in Iceland. Acta Psychiatric Scandinavia, 1993. 87(2): p. 123-7. 
419. Ryan D, et al., Delirium prevalence among older inpatients in a tertiary hospital. 
European Geriatric Medicine, 2010. 1: p. S65-S66. 
420. Dolan MM, et al., Delirium on Hospital Admission in Aged Hip Fracture Patients: 
Prediction of Mortality and 2-Year Functional Outcomes. Journals of Gerontology 
Series A: Biological Sciences & Medical Sciences, 2000. 55(9): p. M527-M534. 
421. Merchant RA, et al., The relationship between postoperative complications and 
outcomes after hip fracture surgery. Annals Academy of Medicine Singapore, 2005. 
34(2): p. 163-8. 
226  
 
422. Neitzel J, et al., Delirium in the Orthopaedic Patient. Orthopaedic Nursing, 2007. 
26(6): p. 354-363  
423. Lawlor PG, et al., Occurrence, causes, and outcome of delirium in patients with 
advanced cancer: a prospective study. Archives of Internal Medicine, 2000. 160(6): 
p. 786-94. 
424. Wong CL, et al., Does this patient have delirium?: Value of bedside instruments. 
JAMA, 2010. 304(7): p. 779 - 786  
425. Forsgren LM and Eriksson M, Delirium - Awareness, observation and interventions in 
intensive care units: A national survey of Swedish ICU head nurses. Intensive and 
Critical Care Nursing, 2010. 26(5): p. 296-303. 
426. Rockwood K, Need we do so badly in managing delirium in elderly patients? Age and 
Ageing, 2003. 32(5): p. 473-4. 
427. Milisen K, et al., Cognitive Assessment and Differentiating the 3 Ds (Dementia, 
Depression, Delirium) Nursing Clinics of North America, 2006. 14(1): p. 1-22. 
428. Sandberg O, et al., Prevalence of dementia, delirium and psychiatric symptoms in 
various care settings for the elderly. Scandinavian Journal of Public Health, 1998. 
26(1): p. 56-62. 
429. Cerejeira J and Mukaetova-Ladinska EB, Review Article: A Clinical Update on 
Delirium: From Early Recognition to Effective Management. Nursing Research and 
Practice, 2011. 2011: p. 1-12. 
430. Inouye SK, et al., Delirium: a symptom of how hospital care is failing older persons 
and a window to improve quality of hospital care. American Journal of Medicine, 
1999. 106(5): p. 565-73. 
431. Rudberg M, et al., The natural history of delirium in older hospitalized patients: a 
syndrome of heterogeneity. Age and Ageing, 1997 26: p. 169-174. 
432. Norris JW and Hachinski VC, Misdiagnosis of stroke. The Lancet, 1982. 1(8267): p. 
328-31. 
433. Ronning OM and Thommessen B, Stroke: when the diagnosis is wrong. Tidsskrift for 
den Norske lageforening : tidsskrift for praktisk medicin, ny rakke, 2005. 125(12): p. 
1655-7. 
434. Korevaar JC, et al., Risk factors for delirium in acutely admitted elderly patients: a 
prospective cohort study. BMC Geriatrics, 2005. 5: p. 6. 
435. Zhu L, et al., Association of Stroke With Dementia, Cognitive Impairment, and 
Functional Disability in the Very Old: A Population-Based Study. Stroke, 1998. 
29(10): p. 2094-2099. 
436. Benbadis SR, et al., Mental status changes and stroke. Journal of General Internal 
Medicine, 1994. 9(9): p. 485-487. 
437. Moher D, et al., Preferred Reporting Items for Systematic Reviews and Meta-
Analyses: The PRISMA Statement. Annals of Internal Medicine, 2009. 151(4): p. 
264-269. 
438. Mallen C, et al., Quality assessment of observational studies is not commonplace in 
systematic reviews. Journal of Clinical Epidemiology, 2006. 59(8): p. 765-769. 
439. Sanderson S, et al., Tools for assessing quality and susceptibility to bias in 
observational studies in epidemiology: a systematic review and annotated 
bibliography. International Journal of Epidemiology, 2007. 36: p. 666-676. 
440. National-Collaborating-Centre-for-Methods-and-Tools, Critical appraisal tools to 
make sense of evidence, in National Collaborating Centre for Methods and Tools 
Hamilton ON: McMaster University, Editor. 2011, 
http://www.nccmt.ca/registry/view/eng/87.html 
227  
 
441. Pearce-Smith N, A complete list (published & unpublished) of articles and research 
papers about CASP and other critical appraisal tools and approaches, Critical 
Appraisal Skills Programme (CASP), Editor. 2012, www.casp-uk.net 
442. Whiting P, et al., The development of QUADAS: a tool for the quality assessment of 
studies of diagnostic accuracy included in systematic reviews. BMC Medical 
Research Methodology, 2003. 3(1): p. 25. 
443. Caeiro L, et al., Delirium in the first days of acute stroke. Journal of Neurology, 2004. 
251(2): p. 171-178. 
444. Caeiro L, et al., Delirium in acute subarachnoid haemorrhage. Cerebrovascular 
Diseases, 2005. 19(1): p. 31-8. . 
445. Dahl MH, et al., Delirium in acute stroke - prevalence and risk factors. Acta 
Neurologica Scandinavica, 2010. 122(suppl. 190): p. 39-43. 
446. Dostovic Z, et al., Delirium after Stroke. Acta Medica Saliniana, 2009. 38(1): p. 26 - 
29. 
447. Dostovic Z, et al., Duration of delirium in the acute stage of stroke. Acta Clinica 
Croatica, 2008. 48(1): p. 13-7. 
448. Gustafson Y, et al., Acute Confusional States (Delirium) in Stroke Patients. 
Cerebrovascular Diseases, 1991. 1(5): p. 257-264. 
449. McManus J, et al., The course of delirium in acute stroke. Age and Ageing, 2009. 
38(4): p. 385-389. 
450. McManus J, et al., The evaluation of delirium post-stroke. International Journal of 
Geriatric Psychiatry, 2009. 24(11): p. 1251-1256. 
451. Sandberg O, et al., Sleep apnea, delirium, depressed mood, cognition, and ADL 
ability after stroke. Journal of the American Geriatrics Society, 2001. 49(4): p. 391-
397. 
452. Sheng AZ, et al., Delirium within three days of stroke in a cohort of elderly patients. 
Journal of the American Geriatrics Society, 2006. 54(8): p. 1192-1198. 
453. Bjorkelund KB, et al., The Organic Brain Syndrome (OBS) scale: a systematic 
review. International Journal of Geriatric Psychiatry, 2006. 21(3): p. 210-22. 
454. Jitapunkul S, et al., Delirium in newly admitted elderly patients - a prospective study 
QJM: An International Journal of Medicine, 1992. 83(300): p. 307-314. 
455. Gerhard T, Bias: Considerations for research practice. American Journal of Health 
System Pharmacy, 2008. 65: p. 2159-2168. 
456. Sackett DL, Bias in analytic research. Journal of Chronic Diseases, 1979. 32(1-2): p. 
51-63. 
457. Schulz KF and Grimes DA, Case-control studies: research in reverse. The Lancet, 
2002. 359(9304): p. 431-434. 
458. Kopec JA and Esdaile JM, Bias in case-control studies. A review. Journal of 
Epidemiology and Community Health, 1990. 44(3): p. 179-186. 
459. Hess DR, Retrospective Studies and Chart Reviews. Respiratory Care, 2004. 49(10): 
p. 1171-1174. 
460. Bookwala A, et al., The three-minute appraisal of a prospective cohort study. Indian 
Journal of Orthopaedics, 2011. 45(4): p. 291-293. 
461. Burch VC, et al., Modified early warning score predicts the need for hospital 
admission and in-hospital mortality. Emergency Medicine Journal, 2008. 25: p. 674-
678. 
462. Subbe CP, et al., Validation of a modified Early Warning Score in medical 
admissions. QJM: An International Journal of Medicine, 2001. 94(10): p. 521-526. 
463. Rowley G and Fielding K, Reliability and accuracy of the Glasgow Coma Scale with 
experienced and inexperienced users. The Lancet, 1991. 337 (8740): p. 535-538. 
228  
 
464. Teasdale G and Jennett B, Assessment of Coma and Impaired Consciousness: A 
practical Scale The Lancet, 1974. 304(7872): p. 81-84. 
465. Goodstein RK, Overview: Cerebrovascular accident and the hospitalized elderly: A 
multidimensional clinical problem. American Journal of Psychiatry, 1983. 140(2): p. 
141-7. 
466. Goldstein LB, Improving the clinical diagnosis of stroke. Stroke, 2006. 37: p. 754-755. 
467. Anderson CS, et al., Validation of a clinical classification for subtypes of acute 
cerebral infarction. Journal of Neurology, Neurosurgery and Psychiatry, 1994. 57: p. 
1173-1179. 
468. Iłzecka J and Stelmasiak Z, Practical significance of ischemic stroke OCSP 
(Oxfordshire Community Stroke Project) classification. Neurol Neurochir Pol, 2000. 
34(1): p. 11-22. 
469. Mead GE, et al., How well does the Oxfordshire Community Stroke Project 
classification predict the site and size of the infarct on brain imaging? Journal of 
Neurology, Neurosurgery and Psychiatry, 2000. 68: p. 558-562. 
470. Dewey H, et al., Inter-rater reliability of stroke sub-type classification by neurologists 
and nurses within a community based stroke incidence study Journal of CLinical 
Neuroscience, 2001. 8(1): p. 14-17. 
471. Albert M, et al., The delirium symptom interview: an interview for the detection of 
delirium symptoms in hospitalized patients. . Journal of Geriatric Psychiatry and 
Neurology, 1992. 5(1): p. 14-21. 
472. Bergeron N, et al., Intensive Care Delirium Screening Checklist: evaluation of a new 
screening tool. Intensive Care Medicine, 2001. 27(5): p. 859-64. 
473. Bettin K, et al., Measuring delirium severity in older general hospital inpatients 
without dementia. The Delirium Severity Scale. American Journal of Geriatric 
Psychiatry, 1998. 6(4): p. 296-307. 
474. Breitbart W, et al., The Memorial Delirium Assessment Scale. Journal of Pain 
Symptom Management, 1997. 13(3): p. 128-37. 
475. Hart R, et al., Validation of a cognitive test for delirium in medical ICU patients. 
Psychosomatics, 1996. 37(6): p. 533-546. 
476. McCusker J, et al., Reliability and validity of a new measure of severity of delirium. 
International Psychogeriatrics, 1998. 10(4): p. 421-433. 
477. O’Keeffe S, Rating the severity of delirium: the delirium assessment scale. 
International Journal of Geriatric Psychiatry, 1994. 9(7): p. 551-556. 
478. Otter H, et al., Validity and reliability of the DDS for severity of delirium in the ICU. 
Neurocritical Care, 2005. 2(2): p. 150-158. 
479. Schuurmans MJ, et al., The Delirium Observation Screening Scale: a screening 
instrument for delirium. Research and Theory for Nursing Practice, 2003. 17(1): p. 
31-50. 
480. Schwamm LH, et al., The Neurobehavioral Cognitive Status Examination: 
comparison with the Cognitive Capacity Screening Examination and the Mini-Mental 
State Examination in a neurosurgical population. Annals of Internal Medicine, 1987. 
107(4): p. 486-91. 
481. Trzepacz P, et al., A symptom rating scale for delirium. . Psychiatry Research, 1988. 
23(1): p. 89-97. 
482. Wei LA, et al., The Confusion Assessment Method (CAM): A Systematic Review of 
Current Usage. Journal of the American Geriatrics Society, 2008. 56(5): p. 823-830. 
483. Ely EW, et al., Evaluation of delirium in critically ill patients: Validation of the 
Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Critical Care 
Medicine, 2001. 29(7): p. 1370-1379. 
229  
 
484. Van Rompaey B, et al., A comparison of the CAM-ICU and the NEECHAM Confusion 
Scale in intensive care delirium assessment: an observational study in non-intubated 
patients. Critical Care, 2008. 12(1): p. 16. 
485. Trzepacz PT, et al., Validation of the Delirium Rating Scale-Revised-98: Comparison 
With the Delirium Rating Scale and the Cognitive Test for Delirium. Journal of 
Neuropsychiatry and Clinical Neuroscience, 2001. 31: p. 229-242. 
486. McCusker J, et al., The delirium index, a measure of the severity of delirium: new 
findings on reliability, validity, and responsiveness. Journal of the American Geriatrics 
Society, 2004. 52(10): p. 1744-9. 
487. Trzepacz PT, The Delirium Rating Scale: Its Use In Consultation-Liaison Research. 
Psychosomatics, 1999. 40: p. 193-204. 
488. Andrew MK, et al., Inter-rater reliability of the DRS-R98 in detecting delirium in frail 
elderly patients Age and Ageing, 2009. 38: p. 241-244. . 
489. Mariz J, et al., Risk and Clinical-outcome Indicators of Delirium in an Emergency 
Department Intermediate Care Unit (EDIMCU). BMC Emergency Medicine, 2013. 
13(2). 
490. Hankey GJ, et al., Five-Year Survival After First-Ever Stroke and Related Prognostic 
Factors in the Perth Community Stroke Study. Stroke, 2000. 31(9): p. 2080-2086. 
491. Rockwood K, et al., The risk of dementia and death after delirium. Age and Ageing, 
1999. 28(6): p. 551-556. 
492. Johnston C and Slowther A, Introduction to ethical considerations and QALYS. 
March 2004 
493. Robberstad B, QALYs vs DALYs vs LYs gained: What are the differences, and what 
difference do they make for health care priority setting? Norsk Epidemiologi, 2005 
15(2): p. 183-191. 
494. HSCIC, Hospital Episode Statistics (HES) in Medical Statistics, Health and Social 
Care Information Centre (HSCIC), Editor. 2012, http://www.hscic.gov.uk/hes 
495. Govan L, et al., Organized Inpatient (Stroke Unit) Care for Stroke. Stroke, 2008. 
39(8): p. 2402-2403. 
496. Saka RO, et al., Economic burden of stroke in England, University of London  King's 
College London, Editor. 2005. p. 1-29  
497. Hassan M, et al., Hospital length of stay and probability of acquiring infection. 
International Journal of Pharmaceutical and Healthcare Marketing, 2010. 4(4): p. 324 
- 338. 
498. NICE, Quality Standards Programme. NICE cost impact and commissioning 
assessment: quality standard for stroke, National Institute for Health and Clinical 
Excellence (NICE), Editor. 2010. p. 1-10  
499. Bond J, et al., Predicting place of discharge from hospital for patients with a stroke or 
hip fracture on admission. Journal of Health Services and Research Policy, 2000. 
5(3): p. 133-9. 
500. Siddiqi N, et al., Educating staff working in long-term care about delirium: the Trojan 
horse for improving quality of care? . Journal of Psychosomatic Research, 2008. 
65(3): p. 261-266. 
501. Challis D and Hughes J, Frail old people at the margins of care: some recent 
research findings. British Journal of Psychiatry, 2002. 180(2): p. 126-130. 
502. Black D and Bowman C, Community institutional care for frail elderly people. British 
Medical Journal, 1997. 315(7106): p. 441-442. 
503. Bowman CE, et al., Acute hospital admissions from nursing homes: some may be 
avoidable. Postgraduate Medical Journal, 2001. 77(903): p. 40-42. 
230  
 
504. Brott T, et al., RCMAR Measurement Tools: National  Institutes of Health Stroke 
Survey (NIHSS). 1989 SC Cooperative for Healthy Aging in Minority Populations. 
Resource Centers for Minority Aging Research (RCMAR) 
505. Kersten P, et al., The Subjective Index for Physical and Social Outcome (SIPSO) in 
Stroke: investigation of its subscale structure. BMC Neurology, 2010. 10: p. 26-35. 
506. Trigg R and Wood VA, The Subjective Index of Physical and Social Outcome 
(SIPSO): a new measure for use with stroke patients. Clinical Rehabilitation, 2000. 
14(3): p. 288-299  
507. Vida S, et al., An 18-month prospective cohort study of functional outcome of delirium 
in elderly patients: activities of daily living. International Psychogeriatrics, 2006. 
18(4): p. 681-700. 
508. Mahoney FI and Barthel DW, Functional Evaluation: the Barthel Index. Maryland 
State Medical Journal, 1965. 14: p. 61-5. 
509. Granger CV, et al., Stroke rehabilitation: analysis of repeated Barthel index 
measures. Archives of Physical Medicine and Rehabilitation, 1979. 60(1): p. 14-7. 
510. Hsueh IP, et al., Comparison of the psychometric characteristics of the functional 
independence measure, 5 item Barthel index, and 10 item Barthel index in patients 
with stroke. Journal of Neurology, Neurosurgery and Psychiatry, 2002. 73: p. 188 - 
190  
511. Rouillard S, et al., Functioning at 6 months post stroke following discharge from 
inpatient rehabilitation. South African Medical Journal, 2012. 102(6): p. 545-548. 
512. Gompertz P, et al., A postal version of the Barthel Index. Clinical Rehabilitation, 
1994. 8(3): p. 233-239. 
513. Kwon S, et al., Disability Measures in Stroke: Relationship Among the Barthel Index, 
the Functional Independence Measure, and the Modified Rankin Scale Stroke, 2004 
35(4): p. 918 - 923  
514. Shah S, et al., Improving the sensitivity of the Barthel Index for stroke rehabilitation. 
Journal of Clinical Epidemiology, 1989. 42(8): p. 703-709. 
515. Nouri FM and Lincoln NB, An extended activities of daily living scale for stroke 
patients. Clinical Rehabilitation, 1987. 1(4): p. 301-305. 
516. Sarker S, et al., Comparison of 2 extended activities of daily living scales with the 
Barthel Index and predictors of their outcomes: cohort study within the South London 
Stroke Register (SLSR). Stroke, 2012. 43(5): p. 1362-1369. 
517. Wu CY, et al., Responsiveness and validity of two outcome measures of instrumental 
activities of daily living in stroke survivors receiving rehabilitative therapies. Clinical 
Rehabilitation, 2011. 25(2): p. 175-183. 
518. Lincoln NB and Gladman JRF, The Extended Activities of Daily Living scale: a further 
validation  Disability & Rehabilitation, 1992. 14(1): p. 41-43. 
519. Wu C-y, et al., Responsiveness, Minimal Detectable Change, and Minimal Clinically 
Important Difference of the Nottingham Extended Activities of Daily Living Scale in 
Patients With Improved Performance After Stroke Rehabilitation. Archives of Physical 
Medicine and Rehabilitation, 2011. 92: p. 1281-1287. 
520. Sutton CJ, et al., Postal and Face-to-Face Administration of Stroke Outcome 
Measures: Can Mixed Modes Be Used? Stroke, 2013. 44: p. 217-219. 
521. Dong Y, et al., Brief screening tests during acute admission in patients with mild 
stroke are predictive of vascular cognitive impairment 3-6 months after stroke. 
Journal of Neurology, Neurosurgery and Psychiatry, 2012. 83(6): p. 580-585. 
522. Patel M, et al., Natural history of cognitive impairment after stroke and factors 
associated with its recovery. Clinical Rehabilitation, 2003. 17(2): p. 158-166. 
231  
 
523. Tatemichi TK, et al., Clinical determinants of dementia related to stroke. Annals of 
Neurology, 1993. 33(6): p. 568-575. 
524. Albanese E, et al., A report into the prevalence and cost of dementia prepared by the 
Personal Social Services Research Unit (PSSRU) at the London School of 
Economics and the Institute of Psychiatry at King’s College London, for the 
Alzheimer’s Society, in Dementia UK - Full report The Alzheimer’s Society, Editor. 
2007 p. 1-189  
525. Mukadama N and Sampson EL, A systematic review of the prevalence, associations 
and outcomes of dementia in older general hospital inpatients. International 
Psychogeriatrics, 2011. 23 (3 ): p. 344-355. 
526. NICE, Clinical Guideline 42 Dementia in National Institute for Health and Clinical 
Excellence (NICE) Guidelines National Institute for Health and Clinical Excellence 
(NICE), Editor. 1999 
527. Alzheimer's-Association, 2010 Alzheimer's disease facts and figures. Alzheimers 
Dementia, 2010. 6(2): p. 158-94. 
528. Jorm AF, et al., Projections of future numbers of dementia cases in Australia with and 
without prevention. Australian and New Zealand Journal of Psychiatry, 2005. 39(11-
12): p. 959-63. 
529. Agrell B and Dehlin O, Mini mental state examination in geriatric stroke patients. 
Validity, differences between subgroups of patients, and relationships to somatic and 
mental variables. Aging-Clinical and Experimental Research, 2000. 12(6): p. 439-44. 
530. Nys GM, et al., Restrictions of the Mini-Mental State Examination in acute stroke. 
Archives of Clinical Neuropsychology, 2005. 20(5): p. 623-9. 
531. Molloy DW, et al., Reliability of a Standardized Mini-Mental State Examination 
compared with the traditional Mini-Mental State Examination. American Journal of 
Psychiatry, 1991. 148(1): p. 102-5. 
532. Molloy DW and Standish TI, A guide to the standardized Mini-Mental State 
Examination. International Psychogeriatrics, 1997. 9(1): p. 87-94; discussion 143-50. 
533. Brandt J, et al., The Telephone Interview for Cognitive Status. Neuropsychiatry, 
Neuropsychology and Behavioral Neurology, 1988. 1(2): p. 111-118. 
534. Ferrucci L, et al., Is the telephone interview for cognitive status a valid alternative in 
persons who cannot be evaluated by the Mini Mental State Examination? Aging 
(Milano), 1998. 10(4): p. 332-8. 
535. Mioshi E, et al., The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief 
cognitive test battery for dementia screening. International Journal of Geriatric 
Psychiatry, 2006. 21: p. 1078 - 1085  
536. Nasreddine ZS, et al., The Montreal Cognitive Assessment, MoCA: A Brief Screening 
Tool For Mild Cognitive Impairment. Journal of the American Geriatrics Society, 
2005. 53(4): p. 695-699. 
537. Dudas RB, et al., The Addenbrooke’s Cognitive Examination (ACE) in the Differential 
Diagnosis of Early Dementias Versus Affective Disorder. American Journal of 
Geriatric Psychiatry, 2005. 13: p. 218-226. 
538. Morris JC, Clinical Dementia Rating: A Reliable and Valid Diagnostic and Staging 
Measure for Dementia of the Alzheimer Type. International Psychogeriatrics, 1997. 9: 
p. 173-176. 
539. Roth M, et al., CAMDEX. A standardised instrument for the diagnosis of mental 
disorder in the elderly with special reference to the early detection of dementia. 
British Journal of Psychiatry, 1986. 149: p. 698-709. 
540. Koning ID, et al., The CAMCOG: A Useful Screening Instrument for Dementia in 
Stroke Patients Stroke, 1998. 29: p. 2080-2086. 
232  
 
541. Robbins TW, et al., Cambridge Neuropsychological Test Automated Battery 
(CANTAB): a factor analytic study of a large sample of normal elderly volunteers. 
Dementia, 1994. 5(5): p. 266-281. 
542. Burns A, et al., Rating scales in old age psychiatry. British Journal of Psychiatry, 
2002. 180: p. 161-7. 
543. Pendlebury S and Rothwell P, Prevalence, incidence, and factors associated with 
pre-stroke and post-stroke dementia: a systematic review and meta-analysis. The 
Lancet Neurology, 2009. 8(11): p. 1006-1018. 
544. Sheehan B, Assessment scales in dementia. Therapeutic Advances in Neurological 
Disorders, 2012. 5(6): p. 349-358. 
545. Pfeiffer E, A short portable mental status questionnaire for the assessment of organic 
brain deﬁcit in elderly patients. Journal of the American Geriatrics Society, 1975. 
23(10): p. 433-41. 
546. Foreman MD, Reliability and Validity Of Mental Status Questionnaires In Elderly 
Hospitalized Patients. Nursing Research, 1987. 36(4): p. 216-220. 
547. Jorm AF and Jacomb PA, The Informant Questionnaire on Cognitive Decline in the 
Elderly (IQCODE): Socio-demographic correlates, reliability, validity and some 
norms. Psychological Medicine, 1989. 19: p. 1015-1022. 
548. Jorm AF, A short form of the Informant Questionnaire on Cognitive Decline in the 
Elderly (IQCODE): development and cross-validation. Psychological Medicine, 1994. 
24: p. 145 - 153. 
549. Jorm AF, The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): 
A review. . International Psychogeriatrics, 2004. 16: p. 1-19. 
550. Jorm AF, et al., Performance of the Informant Questionnaire on Cognitive Decline in 
the Elderly (IQCODE) as a screening test for dementia. Psychological Medicine, 
1991. 21: p. 785-790. 
551. Jorm AF, et al., Informant Ratings of Cognitive Decline of Elderly People: 
Relationship to Longitudinal Change on Cognitive Tests. Age and Ageing, 1996. 25: 
p. 125-129. 
552. Perroco TR, et al., Short IQCODE as a screening tool for MCI and dementia in a 
population with low educational level: preliminary results Dementia and 
Neuropsychologia, 2008. 2(4): p. 300-304. 
553. Tang KW, et al., Can IQCODE detect poststroke dementia? International Journal of 
Geriatric Psychiatry, 2003. 18(8): p. 706-710. 
554. Isella V, et al., Discriminative and predictive power of an informant report in mild 
cognitive impairment. Journal of Neurology, Neurosurgery and Psychiatry, 2006. 
77(2): p. 166-171. 
555. Galvin JE, et al., The AD8 - A brief informant interview to detect dementia. 
Neurology, 2005. 65: p. 559-564. 
556. Galvin JE, et al., Validity and reliability of the AD8 informant interview in dementia. 
Neurology, 2006. 67: p. 1942-1948. 
557. Galvin JE, et al., Patient's Rating of Cognitive Ability: Using the AD8, a Brief 
Informant Interview as a Self-rating Tool to Detect Dementia. Archives of Neurology, 
2007. 64: p. 725 - 730. 
558. Galvin JE, et al., Evaluation of Cognitive Impairment in Older Adults: Combining Brief 
Informant and Performance Measures. Archives of Neurology, 2007. 64: p. 718 - 
724. 
559. Yesavage JA, et al., Development and validation of a geriatric depression screening 
scale: a preliminary report. Journal of Psychiatric Research, 1982-1983. 17(1): p. 37-
49. 
233  
 
560. Agrell B and Dehlin O, Comparison of six depression rating scales in geriatric stroke 
patients. Stroke, 1989. 20: p. 1190-1194. 
561. Nyunt MS, et al., Criterion-based validity and reliability of the Geriatric Depression 
Screening Scale (GDS-15) in a large validation sample of community-living Asian 
older adults. Aging and Mental Health, 2009. 13(3): p. 376-382. 
562. Brown LM and Schinka JA, Development and initial validation of a 15-item informant 
version of the Geriatric Depression Scale. International Journal of Geriatric 
Psychiatry, 2005. 20: p. 911-918. 
563. Bowers D, et al., Understanding Clinical Papers 2002: John Wiley & Sons Ltd. 
564. Van Rompaey B, et al., Risk factors for delirium in intensive care patients: a 
prospective cohort study. Critical Care, 2009. 13(R77). 
565. Moye J, et al., Assessment of capacity in an ageing society American Psychologist, 
2013. 68(3): p. 158-171. 
566. Alonzi A and Pringle M, Mental Capacity Act 2005. British Medical Journal, 
2007(335): p. 898. 
567. Lewis SJ and Heaton KW, Stool Form Scale as a Useful Guide to Intestinal Transit 
Time. Scandinavian Journal of Gastroenterology, 1997. 32(9): p. 920-924. 
568. Elia M, et al., The 'MUST' report. Nutritional screening for adults: a multidisciplinary 
responsibility. Development and use of the 'Malnutrition Universal Screening Tool' 
('MUST') for adults. , Malnutrition Advisory Group of the British Association for 
Paraenteral and Enteral Nutrition, Editor. 2003 
569. Keys A, et al., Indices of relative weight and obesity. Journal of Chronic Diseases, 
1972. 25(6-7): p. 329-343. 
570. Carin-Levy G, et al., Delirium in acute stroke: screening tools, incidence rates and 
predictors: a systematic review. Journal of Neurology, 2012. 259: p. 1590-1599. 
571. Kara H, et al., Acute Confusional State at Early Stage of Stroke. Journal of 
Neurological Sciences (Turkish), 2013. 30(1): p. 1-21. 
572. Kostalova M, et al., Towards a predictive model for post-stroke delirium. Brain, 2012. 
26(7-8): p. 962-971. 
573. Kutlubaev MA, et al., Delirium in the acute phase of stroke: Frequency and 
predisposing factors. Zhurnal Nevrologii i Psihiatrii imeni S.S Korsakova, 2013. 
113(3): p. 37-41. 
574. Melkas S, et al., Post-stroke delirium in relation to dementia and long-term mortality. 
International Journal of Geriatric Psychiatry, 2012. 27(4): p. 401-408. 
575. Mitasova A, et al., Poststroke delirium incidence and outcomes: validation of the 
Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Critical Care 
Medicine, 2012. 40(2): p. 484-490. . 
576. Miu D and Yeung J, Incidence of post-stroke delirium and 1-year outcome. Geriatrics 
and Gerontology International, 2012. 13(1): p. 123-129. 
577. Oldenbeuving A, et al., Delirium in the acute phase after stroke: incidence, risk 
factors, and outcome. Neurology, 2011. 76(11): p. 993-999. 
578. Oldenbeuving AW, et al., An early prediction of delirium in the acute phase after 
stroke. Journal of Neurology, Neurosurgery and Psychiatry, 2014. 85(4): p. 431-4. 
579. Oldenbeuving AW, et al., Delirium in the Acute Phase After Stroke and the Role of 
the Apolipoprotein E Gene. American Journal of Geriatric Psychiatry, 2013. 21(10): p. 
935-937. 
580. Coughlan AK and Storey P, The Wimbledon Self-Report Scale: emotional and mood 
appraisal. Clinical Rehabilitation, 1988. 2(3): p. 207-213. 
581. Bennett HE, et al., Validation of screening measures for assessing mood in stroke 
patients. British Journal of Clinical Psychology, 2006. 45(Pt 3): p. 367-76. 
234  
 
582. Cobley CS, et al., The assessment of low mood in stroke patients with aphasia: 
reliability and validity of the 10-item Hospital version of the Stroke Aphasic 
Depression Questionnaire (SADQH-10). Clinical Rehabilitation, 2011. 0: p. 1-10. 
583. Sheikh J and Yesavage J, Geriatric Depression Scale (GDS) Recent evidence and 
development of a shorter version. . Clinical Gerontology, 1986. 5: p. 165-173. 
584. Astrom M, Generalized Anxiety Disorder in Stroke Patients: A 3-Year Longitudinal 
Study. Stroke, 1996. 27(2): p. 270-275. 
585. Eccles S, et al., Psychological adjustment and self reported coping in stroke 
survivors with and without emotionalism. Journal of Neurology, Neurosurgery and 
Psychiatry, 1999. 67(1): p. 125-126. 
586. Newman JC and Feldman R, Copyright and Open Access at the Bedside. New 
England Journal of Medicine, 2011. 365(26): p. 2447-2449. 
587. Carin-Levy G, et al., Delirium in Acute Stroke: A Survey of Screening and Diagnostic 
Practice in Scotland. ISRN Stroke, 2013. 2013: p. 7. 
588. Lees R, et al., Test accuracy of short screening tests for diagnosis of delirium or 
cognitive impairment in an acute stroke unit setting. Stroke, 2013. 44(11): p. 3078-83. 
589. Bellelli G, et al., Validation of the 4AT, a new instrument for rapid delirium screening: 
a study in 234 hospitalised older people. Age and Ageing, 2014. 0: p. 1-7. 
590. Inouye SK, et al., The CAM-S: Development and Validation of a New Scoring System 
for Delirium Severity in 2 Cohorts. Annals of Internal Medicine, 2014. 160(8): p. 526-
533. 
591. Kostalova M, et al., A predictive statistical model for post-stroke delirium, in 21st 
Meeting of the European Neurological Society 2011, Journal of Neurology: Lisbon 
Portugal. p. S240  
592. Turco R, et al., The effect of poststroke delirium on short-term outcomes of elderly 
patients undergoing rehabilitation. Journal of Geriatric Psychiatry and Neurology, 
2013. 26(2): p. 63-8. 
593. Heaven A, et al., Pilot trial of Stop Delirium! (PiTStop) - a complex intervention to 
prevent delirium in care homes for older people: study protocol for a cluster 
randomised controlled trial. Trials, 2014. 15(1): p. 1-10. 
594. Iranmanesh F, Post-stroke depression and hospital admission. A need for nursing 
care partition according to the clinical condition. Neurosciences, 2010. 15(1): p. 33-6. 
595. Ayerbe L, et al., Natural history, predictors and outcomes of depression after stroke: 
systematic review and meta-analysis. British Journal of Psychiatry, 2013. 202(1): p. 
14-21. 
596. Sloss EM, et al., Selecting target conditions for quality of care improvement in 
vulnerable older adults. Journal of the American Geriatrics Society, 2000. 48(4): p. 
363-369. 
597. O’Keeffe ST and Lavan JN, Subcutaneous Fluids in Elderly Hospital Patients with 
Cognitive Impairment. Gerontology, 1996. 42(1): p. 36-39. 
598. Gustafson YG, Acute confusional state (delirium): Clinical studies in hip fracture and 
stroke patients. 1991, Umea Universitet (Sweden): Sweden. p. 175  
599. MacLullich AMJ and Hall RJ, Who understands delirium? Age and Ageing, 2011. 
40(4): p. 412-414. 
600. Goulia P, et al., Delirium, a ‘confusing’ condition in general hospitals: The experience 
of a Consultation–Liaison Psychiatry Unit in Greece. International Journal of General 
Medicine, 2009. 2: p. 201-207. 
601. Morandi A, et al., Understanding international differences in terminology for delirium 
and other types of acute brain dysfunction in critically ill patients. Intensive Care 
Medicine, 2008. 34(10): p. 1907-1915. 
235  
 
602. Maclullich AMJ, et al., New horizons in the pathogenesis, assessment and 
management of delirium. Age and Ageing, 2013. 42(6): p. 667-674. 
603. Kim KI, et al., Comprehensive geriatric assessment can predict postoperative 
morbidity and mortality in elderly patients undergoing elective surgery. Archives of 
Gerontology and Geriatrics, 2013. 56(3): p. 507-512. 
604. Gordon AL, et al., UK medical teaching about ageing is improving but there is still 
work to be done: The second national survey of undergraduate teaching in ageing 
and geriatric medicine. Age and Ageing, 2014. 43(2): p. 293-297. 
605. Jenkin RPL, et al., Specialty experience in geriatric medicine is associated with a 
small increase in knowledge of delirium. Age and Ageing, 2014. 43(1): p. 141-144. 
606. Leentjens AFG and Diefenbacher A, A survey of delirium guidelines in Europe. 
Journal of Psychosomatic Research, 2006. 61(1): p. 123-128. 
607. Young L and George J, Do guidelines improve the process and outcomes of care in 
delirium? Age and Ageing, 2003. 32(5): p. 525-528. 
 
 
 
 
 
 
 
 
236  
 
Appendices  
Appendix 1: Sample literature search strategy for systematic review 
A list of the databases and search criteria used for the systematic review. 
 
Databases searched include; AMED, BIOSIS, Biological Sciences, CINAHL, 
Cochrane, CSA neurosciences, EMBASE, Global Health, MEDLINE, PsychINFO, TRIP, 
Web of Science/ Knowledge.  
 
1. exp Delirium/ 
2. deliri*.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word, unique identifier] 
3. confus*.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word, unique identifier] 
4. hallucinat*.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word, unique identifier] 
5. disorient*.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word, unique identifier] 
6. hysteri*.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word, unique identifier] 
7. "acute confusional state".mp. [mp=title, original title, abstract, name of substance 
word, subject heading word, unique identifier] 
8. 1 or 2 or 3 or 4 or 5 or 6 or 7 
9. exp Stroke/ 
10. (acute adj2 stroke).mp. [mp=title, original title, abstract, name of substance word, 
subject heading word, unique identifier] 
11. "cerebral infarction".mp. [mp=title, original title, abstract, name of substance word, 
subject heading word, unique identifier] 
12. "cerebrovascular event".mp. [mp=title, original title, abstract, name of substance 
word, subject heading word, unique identifier] 
13. "cerebrovascular accident".mp. [mp=title, original title, abstract, name of substance 
word, subject heading word, unique identifier] 
14. "cerebrovascular incident".mp. [mp=title, original title, abstract, name of substance 
word, subject heading word, unique identifier] 
15. "ischaemic stroke".mp. [mp=title, original title, abstract, name of substance word, 
subject heading word, unique identifier] 
16. "cerebral haemorrhage".mp. [mp=title, original title, abstract, name of substance 
word, subject heading word, unique identifier] 
17. "cerebral hemorrhage".mp. [mp=title, original title, abstract, name of substance 
word, subject heading word, unique identifier] 
18. "haemorrhagic stroke".mp. [mp=title, original title, abstract, name of substance word, 
subject heading word, unique identifier] 
19. "hemorrhagic stroke".mp. [mp=title, original title, abstract, name of substance word, 
subject heading word, unique identifier] 
20. 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 
21. 8 and 20 
22. limit 21 to english language 
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Appendix 2: Data extraction form/ quality scoring sheet  
Study Title: 
 
Author:  
Quality 
score 
Location    
Study design    
Number of participants    
Mean age   
Inclusion/exclusion criteria   
Incidence   
Delirium tool    
Assessment periods   
Outcome measures    
Assessment tools used   
Duration of follow up   
Confounding variables    
Risk factors identified    
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Appendix 3: Patient information sheet 
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Appendix 4: Carer information sheet 
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Appendix 5: Consultee information sheet 
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Appendix 6: General practitioner information sheet 
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Appendix 7: Patient consent forms 
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Appendix 8: Carer consent form 
 
252  
 
Appendix 9: Consultee declaration form 
 
253  
 
Appendix 10: Exclusion case report form 
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Appendix 11a: Clinical assessment: Bamford stroke classification  
 
255  
 
Appendix 11b: Clinical assessment: MEWS and GCS scores 
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Appendix 12: Confusion Assessment Method for Intensive Care 
Unit (CAM-ICU) 
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Appendix 13: Delirium Rating Scale - Revised 98 (DRS-R98) 
 
 
258  
 
Appendix 14: Nottingham Extended Activities of Daily Living 
(NEADL) 
 
 
259  
 
Appendix 15: Geriatric Depression Scale (GDS) 
 
260  
 
Appendix 16: Addenbrooke’s Cognitive Exam - Revised (ACE-R) 
 
 
 
261  
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Appendix 17: Ascertain Dementia (AD-8) 
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Appendix 18: Informant Questionnaire on Cognitive Decline in the 
Elderly (IQCODE) 
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Appendix 19: The Standardised Mini Mental State Exam (SMMSE) 
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Appendix 20: The Telephone Interview for Cognitive Status (TICS) 
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Appendix 21: Scale used to classify levels of education 
The following scales were used to classify the participant’s level of education. 
 
Classifying levels of education  
 
1   No education 
2   Primary school 
3   College/ further training/ apprenticeship  
4   University 
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Appendix 22: Scale used to classify levels of employment 
The following scale was used to classify the participant’s main occupation prior to retirement.  
 
Classifying types of profession  
 
1   Unskilled manual i.e. labourer, cleaner 
2   Semi-skilled manual i.e. farm work, postman 
3   Skilled manual i.e. electrician, bus driver 
4   Skilled non-manual i.e. policeman, salesman 
5   Intermediate i.e. teacher, farmer 
6   Professional/managerial i.e. accountant, doctor 
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Appendix 23: Analysis of the published literature in April 2014  
Forest plots of the April 2014 meta-analysis.  
 
Inpatient mortality 
 
 
6 month mortality 
 
 
12 month mortality 
 
 
Institutionalisation  
 
 
Length of stay  
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Funnel plots of the April 2014 meta-analysis.  
 
 
 
 
 
 
 
 
 
 
 
